cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
STAD	cis	1	rs1000113	chr5:150240076	LOC134466	chr5:150310000-150326146:-	0.35	5.59	4.31E-8	Crohn's disease	
STAD	cis	1	rs10002332	chr4:129875301	C4orf33	chr4:130014829-130033842:+	0.44	6.95	1.52E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs10007789	chr4:165890377	C4orf39	chr4:165878100-165880273:+	0.2	4.59	5.92E-6	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs10008757	chr4:76903036	NAAA	chr4:76831809-76862166:-	-0.41	-5.94	6.4E-9	Longevity	
STAD	cis	1	rs10009541	chr4:17682218	LAP3	chr4:17578927-17609590:+	0.19	3.93	9.95E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs10011259	chr4:54285952	SCFD2	chr4:53739152-54232242:-	0.29	4.3	2.17E-5	DNA methylation (variation)	
STAD	cis	1	rs10012335	chr4:17628630	LAP3	chr4:17578927-17609590:+	-0.19	-3.94	9.48E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs1001373	chr1:171684506	VAMP4	chr1:171669298-171711214:-	0.34	6.29	8.76E-10	Hippocampal atrophy	
STAD	cis	1	rs10017903	chr4:54267009	SCFD2	chr4:53739152-54232242:-	0.29	4.3	2.17E-5	DNA methylation (variation)	
STAD	cis	1	rs10019856	chr4:17615742	LAP3	chr4:17578927-17609590:+	-0.21	-4.38	1.53E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs10023335	chr4:77358987	STBD1	chr4:77172853-77232282:+	-0.29	-4.31	2.06E-5	Creatinine levels	
STAD	cis	1	rs1002675	chr3:38445226	XYLB	chr3:38388251-38456467:+	0.21	4.27	2.49E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs1002676	chr3:38444932	XYLB	chr3:38388251-38456467:+	-0.22	-4.47	1.04E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs10032326	chr4:17630717	LAP3	chr4:17578927-17609590:+	-0.19	-3.96	8.75E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs1003719	chr21:38491095	PIGP	chr21:38437664-38445458:-	-0.25	-5.17	3.72E-7	Eye color traits	
STAD	cis	1	rs1003719	chr21:38491095	TTC3	chr21:38445571-38575406:+	0.24	4.77	2.67E-6	Eye color traits	
STAD	cis	1	rs10041072	chr5:150259642	LOC134466	chr5:150310000-150326146:-	0.29	4.8	2.31E-6	Crohn's disease	
STAD	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.87	17.13	1.97E-49	Type 2 diabetes	
STAD	cis	1	rs10051804	chr5:150226424	LOC134466	chr5:150310000-150326146:-	0.3	4.89	1.45E-6	Crohn's disease	
STAD	cis	1	rs10051924	chr5:150226639	LOC134466	chr5:150310000-150326146:-	0.31	4.91	1.31E-6	Crohn's disease	
STAD	cis	1	rs1005224	chr14:76173860	TTLL5	chr14:76127621-76421421:+	0.22	3.91	0.00011	Large artery stroke	
STAD	cis	1	rs10052606	chr5:150272217	LOC134466	chr5:150310000-150326146:-	0.32	5.06	6.35E-7	Crohn's disease	
STAD	cis	1	rs10053750	chr5:150270051	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs10057988	chr5:150272062	LOC134466	chr5:150310000-150326146:-	0.32	5.06	6.35E-7	Crohn's disease	
STAD	cis	1	rs10058821	chr5:150226385	LOC134466	chr5:150310000-150326146:-	0.3	4.89	1.45E-6	Crohn's disease	
STAD	cis	1	rs10058943	chr5:150226586	LOC134466	chr5:150310000-150326146:-	0.3	4.85	1.76E-6	Crohn's disease	
STAD	cis	1	rs10061105	chr5:150255185	LOC134466	chr5:150310000-150326146:-	0.32	5.05	6.68E-7	Crohn's disease	
STAD	cis	1	rs10065172	chr5:150227998	LOC134466	chr5:150310000-150326146:-	0.28	4.54	7.53E-6	Crohn's disease	
STAD	cis	1	rs1007133	chr10:38225293	HSD17B7P2	chr10:38645308-38667432:+	-0.32	-3.84	0.000145	Obesity (extreme)	
STAD	cis	1	rs1007401	chr5:148382965	ARHGEF37	chr5:148961135-149014527:+	0.25	3.91	0.000109	Diastolic blood pressure	
STAD	cis	1	rs10076701	chr5:131596419	PDLIM4	chr5:131593351-131609145:+	-0.15	-3.83	0.000148	Blood metabolite levels	
STAD	cis	1	rs10078963	chr5:148400424	ARHGEF37	chr5:148961135-149014527:+	0.24	3.87	0.000129	Diastolic blood pressure	
STAD	cis	1	rs10078968	chr5:150244273	LOC134466	chr5:150310000-150326146:-	0.32	5.05	6.68E-7	Crohn's disease	
STAD	cis	1	rs10080429	chr6:109738106	SMPD2	chr6:109761931-109765121:+	0.25	4.92	1.3E-6	Height	
STAD	cis	1	rs1008374	chr4:17683219	LAP3	chr4:17578927-17609590:+	-0.18	-3.89	0.000117	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs1008375	chr4:17682834	LAP3	chr4:17578927-17609590:+	-0.19	-4.08	5.39E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs10092003	chr8:96036422	C8orf38	chr8:95908040-96088396:+	-0.34	-4.13	4.47E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs1009242	chr9:131916832	CRAT	chr9:131857075-131873070:-	0.28	4.97	9.82E-7	Blood metabolite ratios	
STAD	cis	1	rs1009242	chr9:131916832	PPP2R4	chr9:131873244-131911223:+	0.22	4.58	6.32E-6	Blood metabolite ratios	
STAD	cis	1	rs10093594	chr8:96033236	C8orf38	chr8:95908040-96088396:+	0.33	3.99	7.84E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs10096455	chr8:96041250	C8orf38	chr8:95908040-96088396:+	-0.34	-4.13	4.4E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs10098197	chr8:96042890	C8orf38	chr8:95908040-96088396:+	-0.34	-4.13	4.4E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs10100089	chr8:96025093	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs10100842	chr8:96025903	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs10103841	chr8:96025904	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs10106491	chr8:96038959	C8orf38	chr8:95908040-96088396:+	-0.34	-4.13	4.4E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs10110267	chr8:92073814	LRRC69	chr8:92114847-92231464:+	-0.25	-4.5	9.18E-6	Migraine - clinic-based	
STAD	cis	1	rs10111300	chr8:96025631	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs10112230	chr8:96038072	C8orf38	chr8:95908040-96088396:+	-0.34	-4.13	4.4E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs10113545	chr8:96029707	C8orf38	chr8:95908040-96088396:+	-0.33	-3.92	0.000105	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.36	-6.36	5.78E-10	Rheumatoid arthritis	
STAD	cis	1	rs10127539	chr1:110620117	ALX3	chr1:110602998-110613322:-	-0.22	-4.08	5.36E-5	Blood metabolite levels	
STAD	cis	1	rs1013338	chr22:38974154	LOC646851	chr22:38974125-39052634:-	0.24	5.28	2.18E-7	Resting heart rate	
STAD	cis	1	rs10135	chr22:39082174	LOC646851	chr22:38974125-39052634:-	-0.24	-5.19	3.38E-7	Resting heart rate	
STAD	cis	1	rs10144220	chr14:74647904	LIN52	chr14:74551656-74667117:+	-0.37	-6.89	2.2E-11	Common traits (Other)	
STAD	cis	1	rs10150201	chr14:74649157	LIN52	chr14:74551656-74667117:+	-0.37	-6.98	1.31E-11	Common traits (Other)	
STAD	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.49	-7.96	1.86E-14	Homocysteine levels	
STAD	cis	1	rs10164319	chr19:18569833	ISYNA1	chr19:18545625-18548943:-	0.24	4.16	4.0E-5	Breast cancer	
STAD	cis	1	rs10164323	chr19:18569492	ISYNA1	chr19:18545625-18548943:-	0.23	3.95	9.28E-5	Breast cancer	
STAD	cis	1	rs1016669	chr3:41894440	ULK4	chr3:41288091-42003660:-	0.78	12.43	4.11E-30	Diastolic blood pressure	
STAD	cis	1	rs10169714	chr2:73808773	ALMS1P	chr2:73872046-73912692:+	0.49	7.73	9.19E-14	Metabolite levels	
STAD	cis	1	rs10169714	chr2:73808773	TPRKB	chr2:73956957-73964517:-	-0.21	-4.47	1.03E-5	Metabolite levels	
STAD	cis	1	rs10170846	chr2:223517705	FARSB	chr2:223436162-223520827:-	-0.25	-4.87	1.65E-6	Schizophrenia (inflammation and infection response interaction)	
STAD	cis	1	rs10172118	chr2:219913512	SLC23A3	chr2:220026183-220034817:-	0.38	4.38	1.52E-5	Height	
STAD	cis	1	rs10173081	chr2:102957348	IL1RL1	chr2:102927962-102968497:+	0.3	4.58	6.39E-6	Asthma	
STAD	cis	1	rs10177466	chr2:219910988	SLC23A3	chr2:220026183-220034817:-	0.36	4.15	4.02E-5	Height	
STAD	cis	1	rs10178409	chr2:73855507	ALMS1P	chr2:73872046-73912692:+	0.52	8.08	8.48E-15	Urinary metabolites	
STAD	cis	1	rs10178409	chr2:73855507	STAMBP	chr2:74056086-74100759:+	-0.27	-3.99	8.01E-5	Urinary metabolites	
STAD	cis	1	rs10178409	chr2:73855507	TPRKB	chr2:73956957-73964517:-	-0.21	-4.3	2.19E-5	Urinary metabolites	
STAD	cis	1	rs10179134	chr2:73637519	ALMS1P	chr2:73872046-73912692:+	0.47	7.57	2.68E-13	Metabolite levels	
STAD	cis	1	rs10179134	chr2:73637519	TPRKB	chr2:73956957-73964517:-	-0.22	-4.7	3.58E-6	Metabolite levels	
STAD	cis	1	rs10179458	chr2:102934974	IL1RL1	chr2:102927962-102968497:+	0.3	4.37	1.57E-5	Asthma	
STAD	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.66	13.1	9.53E-33	Response to antipsychotic treatment	
STAD	cis	1	rs10187192	chr2:73713500	ALMS1P	chr2:73872046-73912692:+	0.49	7.69	1.25E-13	Metabolite levels	
STAD	cis	1	rs10187192	chr2:73713500	TPRKB	chr2:73956957-73964517:-	-0.23	-4.88	1.52E-6	Metabolite levels	
STAD	cis	1	rs10189154	chr2:102937544	IL1RL1	chr2:102927962-102968497:+	0.31	4.65	4.64E-6	Asthma	
STAD	cis	1	rs10189526	chr2:102937883	IL1RL1	chr2:102927962-102968497:+	0.31	4.65	4.64E-6	Asthma	
STAD	cis	1	rs10190219	chr2:73658331	ALMS1P	chr2:73872046-73912692:+	0.51	7.95	1.99E-14	Metabolite levels	
STAD	cis	1	rs10190219	chr2:73658331	TPRKB	chr2:73956957-73964517:-	-0.21	-4.39	1.49E-5	Metabolite levels	
STAD	cis	1	rs10193373	chr2:281886	SH3YL1	chr2:218138-264810:-	-0.6	-12.63	6.86E-31	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs10197172	chr2:219955936	SLC23A3	chr2:220026183-220034817:-	0.39	4.67	4.23E-6	Height	
STAD	cis	1	rs10201445	chr2:219914717	SLC23A3	chr2:220026183-220034817:-	0.38	4.38	1.52E-5	Height	
STAD	cis	1	rs10207220	chr2:73785046	ALMS1P	chr2:73872046-73912692:+	0.51	8.05	1.01E-14	Metabolite levels	
STAD	cis	1	rs10207220	chr2:73785046	TPRKB	chr2:73956957-73964517:-	-0.2	-4.28	2.38E-5	Metabolite levels	
STAD	cis	1	rs10208728	chr2:219917303	SLC23A3	chr2:220026183-220034817:-	0.38	4.45	1.13E-5	Height	
STAD	cis	1	rs10209928	chr2:108863898	SULT1C2	chr2:108905095-108926370:+	0.27	4.22	2.99E-5	Blood pressure	
STAD	cis	1	rs10209928	chr2:108863898	SULT1C3	chr2:108863651-108881806:+	0.38	7.17	3.83E-12	Blood pressure	
STAD	cis	1	rs1021464	chr1:76375415	ACADM	chr1:76190043-76229353:+	-0.31	-4.48	9.92E-6	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs10216533	chr8:143763690	PSCA	chr8:143761875-143764142:+	0.34	6.96	1.42E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs10218795	chr1:145416056	NOTCH2NL	chr1:145209111-145295525:+	0.55	5.45	9.05E-8	Coronary heart disease	
STAD	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.46	7.3	1.68E-12	Paget's disease	
STAD	cis	1	rs10234309	chr7:135311167	SLC13A4	chr7:135365993-135412933:-	-0.65	-10.22	7.01E-22	Paget's disease	
STAD	cis	1	rs10256972	chr7:1039003	ZFAND2A	chr7:1192544-1199855:-	0.38	6.28	9.23E-10	Longevity;Endometriosis	
STAD	cis	1	rs1028449	chr14:35512995	PPP2R3C	chr14:35554679-35591679:-	0.28	3.98	8.1E-5	Atopic dermatitis	
STAD	cis	1	rs1030831	chr4:130025037	C4orf33	chr4:130014829-130033842:+	-0.42	-6.82	3.39E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs1037147	chr4:130025873	C4orf33	chr4:130014829-130033842:+	-0.42	-6.82	3.41E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs10401507	chr19:52156867	SIGLEC14	chr19:52145808-52150132:-	-0.27	-3.86	0.000132	Plasma plasminogen levels	
STAD	cis	1	rs10402468	chr19:17384003	OCEL1	chr19:17337055-17340027:+	0.36	5.12	4.77E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
STAD	cis	1	rs10403249	chr19:18604942	ISYNA1	chr19:18545625-18548943:-	0.23	4.02	6.98E-5	Breast cancer	
STAD	cis	1	rs10405636	chr19:18538742	ISYNA1	chr19:18545625-18548943:-	0.22	3.92	0.000105	Breast cancer	
STAD	cis	1	rs10406920	chr19:17389648	OCEL1	chr19:17337055-17340027:+	0.33	4.69	3.72E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
STAD	cis	1	rs10409483	chr19:18590223	ISYNA1	chr19:18545625-18548943:-	0.22	3.89	0.000117	Breast cancer	
STAD	cis	1	rs10409505	chr19:18590251	ISYNA1	chr19:18545625-18548943:-	0.22	3.89	0.000117	Breast cancer	
STAD	cis	1	rs10411009	chr19:18606266	ISYNA1	chr19:18545625-18548943:-	0.25	4.4	1.41E-5	Breast cancer	
STAD	cis	1	rs10412972	chr19:52154905	SIGLEC14	chr19:52145808-52150132:-	-0.26	-3.85	0.000138	Plasma plasminogen levels	
STAD	cis	1	rs10416654	chr19:17385176	OCEL1	chr19:17337055-17340027:+	0.34	4.82	2.06E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
STAD	cis	1	rs1041748	chr22:24700854	POM121L9P	chr22:24647589-24661490:+	-0.25	-5.98	5.06E-9	Gut microbiome composition (summer)	
STAD	cis	1	rs10418154	chr19:17386006	OCEL1	chr19:17337055-17340027:+	0.34	4.82	2.06E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
STAD	cis	1	rs10418362	chr19:17386107	OCEL1	chr19:17337055-17340027:+	0.33	4.77	2.58E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
STAD	cis	1	rs10425939	chr19:17397244	OCEL1	chr19:17337055-17340027:+	0.33	4.57	6.55E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
STAD	cis	1	rs10425982	chr19:18586519	ISYNA1	chr19:18545625-18548943:-	0.23	3.93	9.87E-5	Breast cancer	
STAD	cis	1	rs1042658	chr17:38173902	GSDMA	chr17:38119226-38134019:+	-0.31	-5.49	7.23E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs10427083	chr19:18550276	ISYNA1	chr19:18545625-18548943:-	0.22	3.84	0.000146	Breast cancer	
STAD	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.43	7.27	2.0E-12	Multiple sclerosis	
STAD	cis	1	rs10431505	chr12:58178589	TSFM	chr12:58176536-58191367:+	-0.33	-6.93	1.78E-11	Multiple sclerosis	
STAD	cis	1	rs1043441	chr22:39130964	LOC646851	chr22:38974125-39052634:-	0.27	5.61	3.9E-8	Resting heart rate	
STAD	cis	1	rs10440301	chr4:17663199	LAP3	chr4:17578927-17609590:+	-0.22	-4.45	1.14E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs10442	chr19:18545341	ISYNA1	chr19:18545625-18548943:-	0.22	3.84	0.000146	Breast cancer	
STAD	cis	1	rs10445300	chr17:2114587	SRR	chr17:2207248-2228553:+	-0.4	-7.7	1.12E-13	Esophageal cancer (squamous cell)	
STAD	cis	1	rs10445821	chr2:219909780	SLC23A3	chr2:220026183-220034817:-	0.33	3.92	0.000103	Height	
STAD	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.51	-8.4	8.48E-16	Homocysteine levels	
STAD	cis	1	rs10454142	chr2:48646399	GTF2A1L	chr2:48844948-48960284:+	-0.28	-4.81	2.17E-6	Sex hormone-binding globulin levels	
STAD	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs1045531	chr8:143763547	PSCA	chr8:143761875-143764142:+	0.34	6.96	1.42E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.65	-12.66	5.21E-31	Response to antipsychotic treatment	
STAD	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.66	-13.03	1.79E-32	Response to antipsychotic treatment	
STAD	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs1045547	chr8:143763757	PSCA	chr8:143761875-143764142:+	0.34	6.96	1.42E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs1045574	chr8:143763958	LY6K	chr8:143781529-143785582:+	0.25	3.82	0.000153	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs1045574	chr8:143763958	PSCA	chr8:143761875-143764142:+	0.33	6.74	5.64E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs1045605	chr8:143764101	LY6K	chr8:143781529-143785582:+	0.25	3.87	0.000129	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs1045605	chr8:143764101	PSCA	chr8:143761875-143764142:+	0.34	6.94	1.62E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs10456362	chr6:28221816	ZNF323	chr6:28292517-28324048:-	-0.3	-4.08	5.53E-5	Depression	
STAD	cis	1	rs10456622	chr6:49396453	MUT	chr6:49398994-49431031:-	0.39	7.49	4.55E-13	Folate pathway vitamin levels	
STAD	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.87	17.03	4.94E-49	Type 2 diabetes	
STAD	cis	1	rs10463240	chr5:150256853	LOC134466	chr5:150310000-150326146:-	0.31	4.98	9.4E-7	Crohn's disease	
STAD	cis	1	rs10463307	chr5:150254620	LOC134466	chr5:150310000-150326146:-	0.33	5.12	4.79E-7	Crohn's disease	
STAD	cis	1	rs10463310	chr5:150260905	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs1046701	chr14:59939804	C14orf149	chr14:59939406-59951126:-	0.51	4.98	9.52E-7	Schizophrenia	
STAD	cis	1	rs1046875	chr17:80685426	FN3KRP	chr17:80674582-80685889:+	0.31	4.82	2.1E-6	Glycated hemoglobin levels	
STAD	cis	1	rs1046896	chr17:80685533	FN3KRP	chr17:80674582-80685889:+	0.32	5.01	8.28E-7	Glycated hemoglobin levels	
STAD	cis	1	rs1046917	chr17:80685655	FN3KRP	chr17:80674582-80685889:+	0.31	4.85	1.79E-6	Glycated hemoglobin levels	
STAD	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.26	-5.86	9.62E-9	Longevity	
STAD	cis	1	rs10485508	chr20:33605098	PROCR	chr20:33758727-33765164:+	-0.48	-5.12	4.86E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs10487505	chr7:127860163	PAX4	chr7:127250346-127255982:-	-0.19	-4.05	6.21E-5	circulating leptin levels;circulating leptin levels adjusted for BMI	
STAD	cis	1	rs10489249	chr1:171714521	VAMP4	chr1:171669298-171711214:-	0.34	6.35	6.17E-10	Hippocampal atrophy	
STAD	cis	1	rs10489251	chr1:171717534	VAMP4	chr1:171669298-171711214:-	0.33	5.98	5.1E-9	Hippocampal atrophy	
STAD	cis	1	rs1049564	chr14:20940606	PNP	chr14:20937542-20945246:+	-0.24	-4.05	6.09E-5	Interferon alpha levels in systemic lupus erythematosus	
STAD	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.67	13.25	2.38E-33	Response to antipsychotic treatment	
STAD	cis	1	rs10500303	chr19:50512033	SIGLEC16	chr19:50472912-50479075:+	0.69	5.36	1.44E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
STAD	cis	1	rs10509744	chr10:102271579	SEC31B	chr10:102246403-102289636:-	-0.24	-5.72	2.17E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10510761	chr3:52965255	TMEM110	chr3:52867139-52931547:-	-0.4	-4.27	2.42E-5	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs10517825	chr4:165893486	C4orf39	chr4:165878100-165880273:+	-0.21	-4.61	5.42E-6	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs1052483	chr2:219934348	SLC23A3	chr2:220026183-220034817:-	-0.36	-4.2	3.33E-5	Height	
STAD	cis	1	rs1052501	chr3:41925398	ULK4	chr3:41288091-42003660:-	-0.77	-12.12	6.42E-29	Diastolic blood pressure	
STAD	cis	1	rs1052676	chr1:171673054	VAMP4	chr1:171669298-171711214:-	0.34	6.36	5.64E-10	Hippocampal atrophy	
STAD	cis	1	rs10540	chr11:494662	RNH1	chr11:494512-507273:-	-0.43	-5.75	1.83E-8	Body mass index	
STAD	cis	1	rs1054399	chr10:102312565	SEC31B	chr10:102246403-102289636:-	-0.21	-5	8.75E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs1056610	chr22:39080078	LOC646851	chr22:38974125-39052634:-	-0.26	-5.55	5.15E-8	Resting heart rate	
STAD	cis	1	rs1056964	chr22:51017476	CPT1B	chr22:51007291-51017096:-	-0.38	-5.2	3.26E-7	Narcolepsy	
STAD	cis	1	rs1059312	chr12:129278864	MGC16384	chr12:129297749-129299295:-	0.19	3.94	9.49E-5	Systemic lupus erythematosus	
STAD	cis	1	rs1062687	chr22:39134715	LOC646851	chr22:38974125-39052634:-	0.25	5.31	1.85E-7	Resting heart rate	
STAD	cis	1	rs1065201	chr22:39069510	CBY1	chr22:39052658-39069853:+	0.21	4.17	3.83E-5	Resting heart rate	
STAD	cis	1	rs1065201	chr22:39069510	LOC646851	chr22:38974125-39052634:-	0.26	5.51	6.7E-8	Resting heart rate	
STAD	cis	1	rs10734259	chr11:18314865	GTF2H1	chr11:18343816-18388590:+	0.35	5.59	4.26E-8	Pancreatic cancer	
STAD	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.46	7.41	7.98E-13	Homocysteine levels	
STAD	cis	1	rs10739388	chr9:115977175	CDC26	chr9:116029290-116037869:-	-0.38	-6.99	1.18E-11	Hematology traits	
STAD	cis	1	rs10741741	chr11:18342081	GTF2H1	chr11:18343816-18388590:+	-0.36	-6.15	1.97E-9	Pancreatic cancer	
STAD	cis	1	rs10741742	chr11:18342160	GTF2H1	chr11:18343816-18388590:+	0.38	6.45	3.35E-10	Pancreatic cancer	
STAD	cis	1	rs1074407	chr22:38156183	GALR3	chr22:38219389-38221502:+	-0.28	-5.06	6.51E-7	Optic cup area;Vertical cup-disc ratio	
STAD	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.42	7.1	5.83E-12	Multiple sclerosis	
STAD	cis	1	rs10747783	chr12:58176614	TSFM	chr12:58176536-58191367:+	-0.33	-6.93	1.7E-11	Multiple sclerosis	
STAD	cis	1	rs10754323	chr1:89119492	CCBL2	chr1:89401456-89458643:-	0.29	6.43	3.67E-10	Height	
STAD	cis	1	rs10759636	chr9:116018777	CDC26	chr9:116029290-116037869:-	-0.35	-6.33	6.85E-10	Hematology traits	
STAD	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.36	-6.3	7.97E-10	Rheumatoid arthritis	
STAD	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.35	-6.16	1.86E-9	Rheumatoid arthritis	
STAD	cis	1	rs10760589	chr9:131906293	CRAT	chr9:131857075-131873070:-	0.27	4.89	1.47E-6	Blood metabolite ratios	
STAD	cis	1	rs10760589	chr9:131906293	PPP2R4	chr9:131873244-131911223:+	0.22	4.61	5.48E-6	Blood metabolite ratios	
STAD	cis	1	rs10771431	chr12:9380859	LOC642846	chr12:9436253-9466684:+	0.19	4.08	5.48E-5	Breast size	
STAD	cis	1	rs1077889	chr20:25267893	NANP	chr20:25593575-25604648:-	-0.2	-3.84	0.000144	Liver enzyme levels (alkaline phosphatase)	
STAD	cis	1	rs10783594	chr12:54067135	ATP5G2	chr12:54058945-54070512:-	0.22	4.55	7.29E-6	Height	
STAD	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.43	7.27	1.93E-12	Multiple sclerosis	
STAD	cis	1	rs10783847	chr12:58196447	TSFM	chr12:58176536-58191367:+	-0.33	-6.99	1.16E-11	Multiple sclerosis	
STAD	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.43	7.27	2.0E-12	Multiple sclerosis	
STAD	cis	1	rs10783848	chr12:58196528	TSFM	chr12:58176536-58191367:+	-0.33	-6.93	1.78E-11	Multiple sclerosis	
STAD	cis	1	rs10786596	chr10:102282126	SEC31B	chr10:102246403-102289636:-	-0.24	-5.74	1.86E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10786597	chr10:102291287	SEC31B	chr10:102246403-102289636:-	-0.24	-5.86	9.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10786598	chr10:102291579	SEC31B	chr10:102246403-102289636:-	-0.24	-5.86	9.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs1078968	chr3:53123486	RFT1	chr3:53122503-53164470:-	-0.24	-3.87	0.000126	Height	
STAD	cis	1	rs10793273	chr11:77742595	ALG8	chr11:77811988-77850699:-	-0.23	-4.4	1.42E-5	Pelvic organ prolapse	
STAD	cis	1	rs10804632	chr3:134294501	ANAPC13	chr3:134196547-134204865:-	0.39	6.82	3.54E-11	Height	
STAD	cis	1	rs10805359	chr4:17684886	LAP3	chr4:17578927-17609590:+	-0.19	-4.04	6.56E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs1080698	chr10:102295114	SEC31B	chr10:102246403-102289636:-	-0.24	-5.93	6.67E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10818480	chr9:123643170	LOC253039	chr9:123605320-123616644:+	-0.36	-6.46	3.2E-10	Rheumatoid arthritis	
STAD	cis	1	rs10819464	chr9:131876277	CRAT	chr9:131857075-131873070:-	0.27	4.87	1.64E-6	Blood metabolite ratios	
STAD	cis	1	rs10819464	chr9:131876277	PPP2R4	chr9:131873244-131911223:+	0.22	4.61	5.35E-6	Blood metabolite ratios	
STAD	cis	1	rs10819466	chr9:131881492	CRAT	chr9:131857075-131873070:-	0.25	4.56	6.97E-6	Blood metabolite ratios	
STAD	cis	1	rs10819466	chr9:131881492	PPP2R4	chr9:131873244-131911223:+	0.22	4.49	9.52E-6	Blood metabolite ratios	
STAD	cis	1	rs10819469	chr9:131882067	CRAT	chr9:131857075-131873070:-	0.28	4.89	1.49E-6	Blood metabolite ratios	
STAD	cis	1	rs10819469	chr9:131882067	PPP2R4	chr9:131873244-131911223:+	0.22	4.57	6.68E-6	Blood metabolite ratios	
STAD	cis	1	rs10819471	chr9:131896325	CRAT	chr9:131857075-131873070:-	0.25	4.55	7.12E-6	Blood metabolite ratios	
STAD	cis	1	rs10819861	chr9:98867813	C9orf130	chr9:98568372-98638259:-	-0.22	-4.26	2.58E-5	Electrocardiographic traits	
STAD	cis	1	rs10827823	chr10:38039381	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.86	0.000132	Obesity (extreme)	
STAD	cis	1	rs10827824	chr10:38047039	HSD17B7P2	chr10:38645308-38667432:+	0.34	4.1	5.11E-5	Obesity (extreme)	
STAD	cis	1	rs10827829	chr10:38104282	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.88	0.000122	Obesity (extreme)	
STAD	cis	1	rs10827831	chr10:38110813	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.82	0.000157	Obesity (extreme)	
STAD	cis	1	rs10827832	chr10:38119941	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.82	0.000157	Obesity (extreme)	
STAD	cis	1	rs10832921	chr11:18380835	GTF2H1	chr11:18343816-18388590:+	0.36	6.09	2.78E-9	Pancreatic cancer	
STAD	cis	1	rs10838738	chr11:47663049	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.64	1.68E-13	Subjective well-being	
STAD	cis	1	rs10838747	chr11:47716324	C1QTNF4	chr11:47611216-47615961:-	-0.31	-7.56	2.92E-13	Subjective well-being	
STAD	cis	1	rs10838748	chr11:47716381	C1QTNF4	chr11:47611216-47615961:-	-0.31	-7.56	2.92E-13	Subjective well-being	
STAD	cis	1	rs10838748	chr11:47716381	FNBP4	chr11:47738070-47788993:-	0.13	3.82	0.000152	Subjective well-being	
STAD	cis	1	rs10838757	chr11:47763016	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.77	7.06E-14	Subjective well-being	
STAD	cis	1	rs10838912	chr11:48496477	C1QTNF4	chr11:47611216-47615961:-	-0.18	-4.22	3.08E-5	HDL cholesterol	
STAD	cis	1	rs10838917	chr11:48503127	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.96	8.78E-5	HDL cholesterol	
STAD	cis	1	rs10838931	chr11:48540973	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.86	0.00013	HDL cholesterol	
STAD	cis	1	rs10838954	chr11:48579323	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.9	0.000115	HDL cholesterol	
STAD	cis	1	rs10838971	chr11:48606624	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.86	0.000131	HDL cholesterol	
STAD	cis	1	rs10840085	chr11:8613949	TRIM66	chr11:8633586-8693413:-	0.19	4.08	5.53E-5	Body mass index	
STAD	cis	1	rs10849605	chr12:1064438	RAD52	chr12:1021255-1099219:-	-0.22	-4.2	3.27E-5	Lung cancer	
STAD	cis	1	rs1085244	chr1:46563680	CCDC163P	chr1:45960581-45965646:-	-0.22	-3.84	0.000146	Body mass index	
STAD	cis	1	rs10853057	chr17:62998023	AMZ2P1	chr17:62962668-62971703:-	0.4	4.86	1.7E-6	White matter microstructure (global fractional anisotropy)	
STAD	cis	1	rs10859106	chr12:91476568	KERA	chr12:91444273-91452131:-	0.28	4.61	5.58E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs10865914	chr3:41919499	ULK4	chr3:41288091-42003660:-	-0.77	-12.08	8.93E-29	Diastolic blood pressure	
STAD	cis	1	rs10872032	chr6:109676776	SMPD2	chr6:109761931-109765121:+	0.24	4.94	1.16E-6	Height	
STAD	cis	1	rs10876480	chr12:54066271	ATP5G2	chr12:54058945-54070512:-	0.22	4.48	9.65E-6	Height	
STAD	cis	1	rs10876481	chr12:54066743	ATP5G2	chr12:54058945-54070512:-	0.22	4.48	9.65E-6	Height	
STAD	cis	1	rs10877012	chr12:58162085	FAM119B	chr12:58166383-58176323:+	0.42	6.91	1.98E-11	Multiple sclerosis	
STAD	cis	1	rs10877012	chr12:58162085	TSFM	chr12:58176536-58191367:+	-0.33	-6.85	2.97E-11	Multiple sclerosis	
STAD	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.41	7.01	1.09E-11	Multiple sclerosis	
STAD	cis	1	rs10877014	chr12:58167661	TSFM	chr12:58176536-58191367:+	-0.32	-6.9	2.15E-11	Multiple sclerosis	
STAD	cis	1	rs10877015	chr12:58167788	FAM119B	chr12:58166383-58176323:+	0.41	6.9	2.13E-11	Multiple sclerosis	
STAD	cis	1	rs10877015	chr12:58167788	TSFM	chr12:58176536-58191367:+	-0.32	-6.85	2.92E-11	Multiple sclerosis	
STAD	cis	1	rs10877019	chr12:58172929	FAM119B	chr12:58166383-58176323:+	-0.44	-7.38	9.7E-13	Multiple sclerosis	
STAD	cis	1	rs10877019	chr12:58172929	TSFM	chr12:58176536-58191367:+	0.32	6.6	1.32E-10	Multiple sclerosis	
STAD	cis	1	rs10883492	chr10:102206089	SEC31B	chr10:102246403-102289636:-	-0.25	-6.03	3.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883493	chr10:102208188	SEC31B	chr10:102246403-102289636:-	-0.25	-6.03	3.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883496	chr10:102221931	SEC31B	chr10:102246403-102289636:-	-0.25	-6.23	1.23E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883497	chr10:102228519	SEC31B	chr10:102246403-102289636:-	-0.24	-5.94	6.38E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883499	chr10:102232188	SEC31B	chr10:102246403-102289636:-	-0.25	-6.15	1.89E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883500	chr10:102238324	SEC31B	chr10:102246403-102289636:-	-0.25	-6.03	3.72E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883501	chr10:102238326	SEC31B	chr10:102246403-102289636:-	-0.25	-6.03	3.72E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883502	chr10:102238343	SEC31B	chr10:102246403-102289636:-	-0.25	-6.03	3.72E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883503	chr10:102275504	SEC31B	chr10:102246403-102289636:-	-0.24	-5.94	6.21E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883504	chr10:102280687	SEC31B	chr10:102246403-102289636:-	-0.24	-5.86	9.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883505	chr10:102280772	SEC31B	chr10:102246403-102289636:-	-0.24	-5.86	9.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883506	chr10:102289743	SEC31B	chr10:102246403-102289636:-	-0.24	-5.86	9.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883507	chr10:102291275	SEC31B	chr10:102246403-102289636:-	-0.24	-5.86	9.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883508	chr10:102294413	SEC31B	chr10:102246403-102289636:-	-0.24	-5.76	1.71E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883509	chr10:102296461	SEC31B	chr10:102246403-102289636:-	-0.24	-5.86	9.67E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883510	chr10:102297018	SEC31B	chr10:102246403-102289636:-	-0.24	-5.58	4.61E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883511	chr10:102299407	SEC31B	chr10:102246403-102289636:-	-0.24	-5.83	1.15E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883512	chr10:102308516	SEC31B	chr10:102246403-102289636:-	-0.22	-5.31	1.86E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10883513	chr10:102316964	SEC31B	chr10:102246403-102289636:-	-0.25	-5.42	1.04E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs10885997	chr10:118397971	PNLIPRP2	chr10:118380465-118404654:+	0.33	6.51	2.3E-10	Phospholipid levels (plasma)	
STAD	cis	1	rs10888815	chr1:54357645	YIPF1	chr1:54317407-54355453:-	0.54	4.26	2.51E-5	Nonalcoholic fatty liver disease	
STAD	cis	1	rs10890352	chr1:46283628	IPP	chr1:46160000-46216485:-	0.2	3.93	0.000101	Body mass index	
STAD	cis	1	rs10890354	chr1:46305347	IPP	chr1:46160000-46216485:-	0.2	3.84	0.000146	Body mass index	
STAD	cis	1	rs10890361	chr1:46346234	CCDC163P	chr1:45960581-45965646:-	-0.24	-4.14	4.22E-5	Body mass index	
STAD	cis	1	rs10890363	chr1:46356148	IPP	chr1:46160000-46216485:-	-0.2	-3.8	0.000167	Body mass index	
STAD	cis	1	rs10890383	chr1:46588503	CCDC163P	chr1:45960581-45965646:-	-0.23	-4	7.68E-5	Body mass index	
STAD	cis	1	rs10896043	chr11:65543827	CTSW	chr11:65647284-65651212:+	0.35	6.29	8.51E-10	Systemic lupus erythematosus	
STAD	cis	1	rs10896043	chr11:65543827	SNX32	chr11:65601410-65621170:+	-0.3	-4.12	4.58E-5	Systemic lupus erythematosus	
STAD	cis	1	rs10899452	chr11:77995143	GAB2	chr11:77926343-78128766:-	-0.28	-4.07	5.61E-5	Testicular germ cell tumor	
STAD	cis	1	rs10901513	chr10:127699936	UROS	chr10:127477148-127511837:-	-0.24	-4.35	1.78E-5	Visceral fat	
STAD	cis	1	rs10901514	chr10:127700066	UROS	chr10:127477148-127511837:-	-0.24	-4.35	1.78E-5	Visceral fat	
STAD	cis	1	rs10901520	chr10:127718837	UROS	chr10:127477148-127511837:-	-0.23	-4.19	3.44E-5	Visceral fat	
STAD	cis	1	rs10903	chr1:171673236	VAMP4	chr1:171669298-171711214:-	0.34	6.37	5.45E-10	Hippocampal atrophy	
STAD	cis	1	rs10910845	chr1:145723120	PDZK1	chr1:145727726-145764073:+	0.21	4.36	1.65E-5	Urate levels;Urate levels in overweight individuals	
STAD	cis	1	rs10913475	chr1:171650139	VAMP4	chr1:171669298-171711214:-	0.34	6.31	7.77E-10	Hippocampal atrophy	
STAD	cis	1	rs10913489	chr1:171653384	VAMP4	chr1:171669298-171711214:-	0.34	6.11	2.35E-9	Hippocampal atrophy	
STAD	cis	1	rs10913490	chr1:171653401	VAMP4	chr1:171669298-171711214:-	0.34	6.11	2.35E-9	Hippocampal atrophy	
STAD	cis	1	rs10913511	chr1:171668951	VAMP4	chr1:171669298-171711214:-	0.34	6.27	9.66E-10	Hippocampal atrophy	
STAD	cis	1	rs10913514	chr1:171670823	VAMP4	chr1:171669298-171711214:-	0.34	6.36	5.82E-10	Hippocampal atrophy	
STAD	cis	1	rs10913529	chr1:171679465	VAMP4	chr1:171669298-171711214:-	0.34	6.27	9.65E-10	Hippocampal atrophy	
STAD	cis	1	rs10913565	chr1:171706706	VAMP4	chr1:171669298-171711214:-	0.33	6.16	1.85E-9	Hippocampal atrophy	
STAD	cis	1	rs10913582	chr1:171715585	VAMP4	chr1:171669298-171711214:-	0.35	6.44	3.45E-10	Hippocampal atrophy	
STAD	cis	1	rs10916814	chr1:20892931	FAM43B	chr1:20878932-20881512:+	-0.16	-3.84	0.000142	Age-related hearing impairment (interaction)	
STAD	cis	1	rs10916820	chr1:20903792	FAM43B	chr1:20878932-20881512:+	0.17	3.85	0.000139	Age-related hearing impairment (interaction)	
STAD	cis	1	rs10917151	chr1:22422721	HSPC157	chr1:22351707-22357713:+	-0.32	-4.59	5.93E-6	Endometriosis	
STAD	cis	1	rs10930973	chr2:182470425	CERKL	chr2:182401402-182545381:-	-0.29	-5.02	7.7E-7	Response to iloperidone treatment (QT prolongation)	
STAD	cis	1	rs10933518	chr2:241838091	C2orf54	chr2:241825466-241835573:-	0.31	4.94	1.19E-6	Urinary metabolites	
STAD	cis	1	rs10935120	chr3:134233092	ANAPC13	chr3:134196547-134204865:-	-0.4	-7.37	1.01E-12	Height	
STAD	cis	1	rs10935186	chr3:136346206	PCCB	chr3:135969167-136056737:+	0.26	4.4	1.43E-5	Schizophrenia	
STAD	cis	1	rs10939738	chr4:17604295	LAP3	chr4:17578927-17609590:+	-0.19	-3.99	7.93E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs10939742	chr4:17659936	LAP3	chr4:17578927-17609590:+	-0.18	-3.8	0.000165	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs10939743	chr4:17662731	LAP3	chr4:17578927-17609590:+	-0.19	-4.06	6.05E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs10939744	chr4:17664473	LAP3	chr4:17578927-17609590:+	-0.19	-4.07	5.71E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.66	-13.02	1.96E-32	Response to antipsychotic treatment	
STAD	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.47E-32	Response to antipsychotic treatment	
STAD	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs1094677	chr3:195129744	C3orf21	chr3:194789015-194991895:-	-0.26	-4.49	9.31E-6	Body mass index	
STAD	cis	1	rs10988125	chr9:131572903	CCBL1	chr9:131595393-131644354:-	-0.23	-4.01	7.36E-5	Blood metabolite levels	
STAD	cis	1	rs10988214	chr9:131883752	CRAT	chr9:131857075-131873070:-	0.25	4.6	5.62E-6	Blood metabolite ratios	
STAD	cis	1	rs10988214	chr9:131883752	PPP2R4	chr9:131873244-131911223:+	0.22	4.49	9.53E-6	Blood metabolite ratios	
STAD	cis	1	rs10988223	chr9:131903021	CRAT	chr9:131857075-131873070:-	0.29	5.25	2.49E-7	Blood metabolite ratios	
STAD	cis	1	rs10988223	chr9:131903021	PPP2R4	chr9:131873244-131911223:+	0.25	5.05	6.83E-7	Blood metabolite ratios	
STAD	cis	1	rs10988224	chr9:131903334	CRAT	chr9:131857075-131873070:-	0.28	5.07	6.29E-7	Blood metabolite ratios	
STAD	cis	1	rs10988224	chr9:131903334	PPP2R4	chr9:131873244-131911223:+	0.23	4.8	2.22E-6	Blood metabolite ratios	
STAD	cis	1	rs10988232	chr9:131915348	CRAT	chr9:131857075-131873070:-	0.28	4.95	1.09E-6	Blood metabolite ratios	
STAD	cis	1	rs10988232	chr9:131915348	PPP2R4	chr9:131873244-131911223:+	0.22	4.6	5.66E-6	Blood metabolite ratios	
STAD	cis	1	rs11000019	chr10:73591530	ANAPC16	chr10:73975806-73995616:+	0.43	4.9	1.38E-6	Asthma (childhood onset)	
STAD	cis	1	rs11000019	chr10:73591530	DNAJB12	chr10:74092588-74114907:-	0.59	5.44	9.24E-8	Asthma (childhood onset)	
STAD	cis	1	rs11011339	chr10:37996346	HSD17B7P2	chr10:38645308-38667432:+	0.29	3.85	0.000138	Obesity (extreme)	
STAD	cis	1	rs11011344	chr10:38004846	HSD17B7P2	chr10:38645308-38667432:+	0.3	3.98	8.38E-5	Obesity (extreme)	
STAD	cis	1	rs11011366	chr10:38074158	HSD17B7P2	chr10:38645308-38667432:+	0.34	4.07	5.65E-5	Obesity (extreme)	
STAD	cis	1	rs11011370	chr10:38083018	HSD17B7P2	chr10:38645308-38667432:+	0.34	4.07	5.65E-5	Obesity (extreme)	
STAD	cis	1	rs11011372	chr10:38087283	HSD17B7P2	chr10:38645308-38667432:+	0.34	4.07	5.65E-5	Obesity (extreme)	
STAD	cis	1	rs11039255	chr11:47495746	C1QTNF4	chr11:47611216-47615961:-	-0.33	-7.89	2.99E-14	Subjective well-being	
STAD	cis	1	rs11039390	chr11:47796295	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.71	1.09E-13	Subjective well-being	
STAD	cis	1	rs11039412	chr11:47841581	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.64	1.73E-13	Subjective well-being	
STAD	cis	1	rs11039426	chr11:47863119	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.7	1.15E-13	Subjective well-being	
STAD	cis	1	rs11039745	chr11:48463811	C1QTNF4	chr11:47611216-47615961:-	-0.18	-4.14	4.28E-5	HDL cholesterol	
STAD	cis	1	rs11039777	chr11:48517049	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.82	0.000153	HDL cholesterol	
STAD	cis	1	rs11039779	chr11:48517895	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.83	0.000152	HDL cholesterol	
STAD	cis	1	rs11039819	chr11:48562181	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.98	8.13E-5	HDL cholesterol	
STAD	cis	1	rs11039857	chr11:48610853	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.86	0.000131	HDL cholesterol	
STAD	cis	1	rs11039859	chr11:48611988	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.86	0.000131	HDL cholesterol	
STAD	cis	1	rs11043133	chr11:2232665	CD81	chr11:2398547-2418649:+	-0.28	-4.66	4.28E-6	Prostate cancer (early onset);Prostate cancer (gene x gene interaction);Prostate cancer	
STAD	cis	1	rs11043134	chr11:2232682	CD81	chr11:2398547-2418649:+	-0.28	-4.66	4.28E-6	Prostate cancer (early onset);Prostate cancer (gene x gene interaction);Prostate cancer	
STAD	cis	1	rs11043143	chr11:2234093	CD81	chr11:2398547-2418649:+	-0.29	-4.91	1.37E-6	Prostate cancer (early onset);Prostate cancer (gene x gene interaction);Prostate cancer	
STAD	cis	1	rs11059919	chr12:129289190	MGC16384	chr12:129297749-129299295:-	-0.22	-4.53	7.97E-6	Systemic lupus erythematosus	
STAD	cis	1	rs1106287	chr1:113242122	ST7L	chr1:113066142-113162405:-	0.4	7.2	3.02E-12	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs11064881	chr12:120146925	PRKAB1	chr12:120105757-120119428:+	-0.7	-6.48	2.69E-10	Ulcerative colitis;Inflammatory bowel disease	
STAD	cis	1	rs11065611	chr12:110704487	TRPV4	chr12:110220894-110271212:-	-0.51	-4.9	1.38E-6	Protein quantitative trait loci	
STAD	cis	1	rs1106565	chr10:102211613	SEC31B	chr10:102246403-102289636:-	-0.25	-6.01	4.38E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11067231	chr12:109993603	MYO1H	chr12:109826524-109886176:+	0.2	3.91	0.00011	HDL cholesterol	
STAD	cis	1	rs11072603	chr15:76881138	SCAPER	chr15:76640529-77197744:-	-0.25	-5.17	3.7E-7	Blood metabolite levels	
STAD	cis	1	rs1107328	chr9:131917534	CRAT	chr9:131857075-131873070:-	-0.31	-5.22	2.87E-7	Blood metabolite ratios	
STAD	cis	1	rs1107328	chr9:131917534	PPP2R4	chr9:131873244-131911223:+	-0.24	-4.6	5.62E-6	Blood metabolite ratios	
STAD	cis	1	rs11079034	chr17:40288890	DHX58	chr17:40253422-40264751:-	-0.35	-6.39	4.62E-10	Fibrinogen levels	
STAD	cis	1	rs1109227	chr3:48479207	TREX1	chr3:48501186-48509043:+	-0.26	-5.9	7.96E-9	Longevity	
STAD	cis	1	rs1110042	chr1:113236534	ST7L	chr1:113066142-113162405:-	0.4	7.2	3.02E-12	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs11105972	chr12:91471955	KERA	chr12:91444273-91452131:-	0.28	4.65	4.65E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs11105973	chr12:91472347	KERA	chr12:91444273-91452131:-	0.28	4.65	4.65E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs11105974	chr12:91476481	KERA	chr12:91444273-91452131:-	0.28	4.61	5.58E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs11105983	chr12:91480976	KERA	chr12:91444273-91452131:-	0.28	4.76	2.7E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs11105988	chr12:91498299	KERA	chr12:91444273-91452131:-	0.29	4.9	1.38E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs11119429	chr1:210345078	SYT14	chr1:210111538-210337631:+	0.22	3.86	0.000131	Manic episodes in bipolar disorder	
STAD	cis	1	rs1112137	chr1:247215375	ZNF670	chr1:247200087-247242069:-	-0.27	-4.05	6.27E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs11121533	chr1:10292888	PGD	chr1:10459085-10480200:+	0.23	3.9	0.000112	Hepatocellular carcinoma	
STAD	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.48	-7.83	4.61E-14	Renal function-related traits (BUN)	
STAD	cis	1	rs11123170	chr2:113978940	PAX8	chr2:113973575-114036498:-	-0.51	-8.85	3.11E-17	Renal function-related traits (BUN)	
STAD	cis	1	rs111237243	chr14:59991030	C14orf149	chr14:59939406-59951126:-	-0.51	-4.81	2.14E-6	Schizophrenia	
STAD	cis	1	rs11127188	chr2:28972852	TRMT61B	chr2:29072690-29093175:-	-0.32	-5.44	9.41E-8	Body mass index	
STAD	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.25	-5.77	1.58E-8	Longevity	
STAD	cis	1	rs11130171	chr3:48462461	TREX1	chr3:48501186-48509043:+	-0.25	-5.69	2.44E-8	Longevity	
STAD	cis	1	rs11130338	chr3:53120924	RFT1	chr3:53122503-53164470:-	-0.25	-4.19	3.49E-5	Height	
STAD	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-0.78	-10.52	5.83E-23	Triptolide cytotoxicity	
STAD	cis	1	rs111355947	chr14:59911985	C14orf149	chr14:59939406-59951126:-	-0.58	-5.43	9.92E-8	Schizophrenia	
STAD	cis	1	rs1114380	chr2:73804708	ALMS1P	chr2:73872046-73912692:+	0.49	7.73	9.19E-14	Metabolite levels	
STAD	cis	1	rs1114380	chr2:73804708	TPRKB	chr2:73956957-73964517:-	-0.21	-4.47	1.03E-5	Metabolite levels	
STAD	cis	1	rs111476301	chr14:59920191	C14orf149	chr14:59939406-59951126:-	-0.58	-5.43	9.92E-8	Schizophrenia	
STAD	cis	1	rs111489600	chr14:59993021	C14orf149	chr14:59939406-59951126:-	-0.51	-4.81	2.14E-6	Schizophrenia	
STAD	cis	1	rs11159067	chr14:74637444	LIN52	chr14:74551656-74667117:+	0.34	6.3	7.98E-10	Common traits (Other)	
STAD	cis	1	rs111596617	chr6:26191678	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.67E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs111641740	chr20:33707177	PROCR	chr20:33758727-33765164:+	-0.45	-4.87	1.62E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11167254	chr20:33654584	PROCR	chr20:33758727-33765164:+	-0.49	-5.32	1.78E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11167260	chr20:33775200	PROCR	chr20:33758727-33765164:+	-0.5	-5.36	1.39E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11167515	chr5:150239471	LOC134466	chr5:150310000-150326146:-	0.41	6.32	6.98E-10	Crohn's disease	
STAD	cis	1	rs11167518	chr5:150258920	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs11167519	chr5:150265407	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs11167520	chr5:150265639	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs11167521	chr5:150271785	LOC134466	chr5:150310000-150326146:-	0.29	4.59	6.01E-6	Crohn's disease	
STAD	cis	1	rs11168078	chr5:148377582	ARHGEF37	chr5:148961135-149014527:+	0.26	3.96	8.95E-5	Diastolic blood pressure	
STAD	cis	1	rs11168079	chr5:148377838	ARHGEF37	chr5:148961135-149014527:+	0.25	3.86	0.000133	Diastolic blood pressure	
STAD	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.41	6.81	3.61E-11	Multiple sclerosis	
STAD	cis	1	rs11172333	chr12:58170335	TSFM	chr12:58176536-58191367:+	-0.34	-7.14	4.63E-12	Multiple sclerosis	
STAD	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.43	7.18	3.6E-12	Multiple sclerosis	
STAD	cis	1	rs11172335	chr12:58175201	TSFM	chr12:58176536-58191367:+	-0.33	-6.91	2.04E-11	Multiple sclerosis	
STAD	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.43	7.18	3.6E-12	Multiple sclerosis	
STAD	cis	1	rs11172342	chr12:58187758	TSFM	chr12:58176536-58191367:+	-0.33	-6.91	2.04E-11	Multiple sclerosis	
STAD	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.43	7.18	3.6E-12	Multiple sclerosis	
STAD	cis	1	rs11172343	chr12:58188157	TSFM	chr12:58176536-58191367:+	-0.33	-6.91	2.04E-11	Multiple sclerosis	
STAD	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.43	7.27	2.0E-12	Multiple sclerosis	
STAD	cis	1	rs11172344	chr12:58193448	TSFM	chr12:58176536-58191367:+	-0.33	-6.93	1.78E-11	Multiple sclerosis	
STAD	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.42	7	1.13E-11	Multiple sclerosis	
STAD	cis	1	rs11172349	chr12:58212528	TSFM	chr12:58176536-58191367:+	-0.32	-6.68	8.12E-11	Multiple sclerosis	
STAD	cis	1	rs11172351	chr12:58213485	FAM119B	chr12:58166383-58176323:+	0.42	7.03	9.02E-12	Multiple sclerosis	
STAD	cis	1	rs11172351	chr12:58213485	TSFM	chr12:58176536-58191367:+	-0.32	-6.59	1.4E-10	Multiple sclerosis	
STAD	cis	1	rs1117367	chr15:76872330	SCAPER	chr15:76640529-77197744:-	-0.23	-4.75	2.8E-6	Blood metabolite levels	
STAD	cis	1	rs111745772	chr14:60011260	C14orf149	chr14:59939406-59951126:-	-0.59	-5.7	2.33E-8	Schizophrenia	
STAD	cis	1	rs111803315	chr14:59965293	C14orf149	chr14:59939406-59951126:-	-0.46	-4.1	5.0E-5	Schizophrenia	
STAD	cis	1	rs111882043	chr14:59899356	C14orf149	chr14:59939406-59951126:-	-0.55	-5.25	2.49E-7	Schizophrenia	
STAD	cis	1	rs11188396	chr10:97367510	ENTPD1	chr10:97471536-97637022:+	0.14	3.83	0.000149	Blood metabolite levels	
STAD	cis	1	rs11188398	chr10:97369093	ENTPD1	chr10:97471536-97637022:+	0.14	3.83	0.000151	Blood metabolite levels	
STAD	cis	1	rs11188400	chr10:97371327	ENTPD1	chr10:97471536-97637022:+	0.14	3.83	0.000151	Blood metabolite levels	
STAD	cis	1	rs111902838	chr19:50496614	SIGLEC16	chr19:50472912-50479075:+	0.68	5.31	1.81E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
STAD	cis	1	rs11190540	chr10:102202629	SEC31B	chr10:102246403-102289636:-	-0.24	-5.98	4.98E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190541	chr10:102203071	SEC31B	chr10:102246403-102289636:-	-0.24	-5.93	6.83E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190551	chr10:102204734	SEC31B	chr10:102246403-102289636:-	-0.25	-6.03	3.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190552	chr10:102206607	SEC31B	chr10:102246403-102289636:-	-0.25	-5.98	5.08E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190555	chr10:102209160	SEC31B	chr10:102246403-102289636:-	-0.25	-6.05	3.32E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190556	chr10:102209223	SEC31B	chr10:102246403-102289636:-	-0.25	-6.05	3.32E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190557	chr10:102209369	SEC31B	chr10:102246403-102289636:-	-0.25	-6.05	3.32E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190558	chr10:102209397	SEC31B	chr10:102246403-102289636:-	-0.25	-6.05	3.32E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190569	chr10:102227409	SEC31B	chr10:102246403-102289636:-	-0.27	-6.62	1.16E-10	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190570	chr10:102227702	SEC31B	chr10:102246403-102289636:-	-0.26	-6.36	5.79E-10	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190572	chr10:102232879	SEC31B	chr10:102246403-102289636:-	-0.25	-6.13	2.11E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190578	chr10:102238953	SEC31B	chr10:102246403-102289636:-	-0.25	-6.03	3.72E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190587	chr10:102266638	SEC31B	chr10:102246403-102289636:-	-0.25	-6.05	3.33E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190589	chr10:102275471	SEC31B	chr10:102246403-102289636:-	-0.24	-5.85	1.06E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190592	chr10:102291059	SEC31B	chr10:102246403-102289636:-	-0.24	-5.86	9.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190595	chr10:102291761	SEC31B	chr10:102246403-102289636:-	-0.24	-5.86	9.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190596	chr10:102293238	SEC31B	chr10:102246403-102289636:-	-0.24	-5.65	3.06E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190597	chr10:102293676	SEC31B	chr10:102246403-102289636:-	-0.24	-5.78	1.55E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190599	chr10:102295420	SEC31B	chr10:102246403-102289636:-	-0.24	-5.79	1.48E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190601	chr10:102296730	SEC31B	chr10:102246403-102289636:-	-0.23	-5.67	2.83E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190602	chr10:102297256	SEC31B	chr10:102246403-102289636:-	-0.24	-5.83	1.18E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190604	chr10:102302457	SEC31B	chr10:102246403-102289636:-	-0.23	-5.53	5.75E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190607	chr10:102303614	SEC31B	chr10:102246403-102289636:-	-0.22	-5.31	1.86E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11190613	chr10:102313997	SEC31B	chr10:102246403-102289636:-	0.2	5.06	6.59E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11191419	chr10:104612335	C10orf32	chr10:104613967-104624718:+	-0.38	-6.93	1.72E-11	Schizophrenia	
STAD	cis	1	rs1121089	chr4:17676476	LAP3	chr4:17578927-17609590:+	-0.2	-4.35	1.72E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs1121090	chr4:17676437	LAP3	chr4:17578927-17609590:+	-0.2	-4.35	1.72E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs1121091	chr4:17676386	LAP3	chr4:17578927-17609590:+	-0.2	-4.35	1.72E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.49	-8.01	1.37E-14	Homocysteine levels	
STAD	cis	1	rs11211199	chr1:46287869	IPP	chr1:46160000-46216485:-	0.2	3.84	0.000146	Body mass index	
STAD	cis	1	rs11211234	chr1:46438787	IPP	chr1:46160000-46216485:-	0.2	3.97	8.5E-5	Body mass index	
STAD	cis	1	rs11211234	chr1:46438787	TMEM69	chr1:46153847-46160108:+	0.18	3.92	0.000104	Body mass index	
STAD	cis	1	rs11211241	chr1:46452683	IPP	chr1:46160000-46216485:-	0.2	3.97	8.5E-5	Body mass index	
STAD	cis	1	rs11211241	chr1:46452683	TMEM69	chr1:46153847-46160108:+	0.18	3.92	0.000104	Body mass index	
STAD	cis	1	rs11216831	chr11:118117018	DSCAML1	chr11:117298489-117688240:-	0.48	4.38	1.56E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
STAD	cis	1	rs1122326	chr17:40274873	DHX58	chr17:40253422-40264751:-	-0.32	-5.64	3.26E-8	Fibrinogen levels	
STAD	cis	1	rs112261101	chr14:59917544	C14orf149	chr14:59939406-59951126:-	-0.58	-5.43	9.92E-8	Schizophrenia	
STAD	cis	1	rs11227284	chr11:65503224	CTSW	chr11:65647284-65651212:+	-0.36	-6.4	4.56E-10	Systemic lupus erythematosus	
STAD	cis	1	rs11227284	chr11:65503224	SNX32	chr11:65601410-65621170:+	0.3	4.02	7.02E-5	Systemic lupus erythematosus	
STAD	cis	1	rs11227288	chr11:65516588	CTSW	chr11:65647284-65651212:+	-0.35	-6.26	1.02E-9	Systemic lupus erythematosus	
STAD	cis	1	rs11228580	chr11:69002342	MYEOV	chr11:69061622-69156449:+	0.37	4.25	2.64E-5	Prostate cancer	
STAD	cis	1	rs112293138	chr1:171714002	VAMP4	chr1:171669298-171711214:-	0.34	6.41	4.11E-10	Hippocampal atrophy	
STAD	cis	1	rs11237469	chr11:78072875	GAB2	chr11:77926343-78128766:-	-0.26	-3.82	0.000155	Testicular germ cell tumor	
STAD	cis	1	rs112401426	chr1:76466103	ACADM	chr1:76190043-76229353:+	-0.31	-4.32	1.94E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs112476368	chr14:59991452	C14orf149	chr14:59939406-59951126:-	-0.51	-4.81	2.14E-6	Schizophrenia	
STAD	cis	1	rs112529587	chr8:96060035	C8orf38	chr8:95908040-96088396:+	-0.34	-4.01	7.2E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs112555934	chr14:59977232	C14orf149	chr14:59939406-59951126:-	-0.51	-4.81	2.14E-6	Schizophrenia	
STAD	cis	1	rs11264422	chr1:155907823	RAB25	chr1:156030966-156040293:+	-0.18	-4.13	4.43E-5	Crohn's disease;Inflammatory bowel disease	
STAD	cis	1	rs112661971	chr14:59901054	C14orf149	chr14:59939406-59951126:-	-0.55	-5.25	2.49E-7	Schizophrenia	
STAD	cis	1	rs112751982	chr6:26191958	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.67E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs112777695	chr20:33693177	PROCR	chr20:33758727-33765164:+	-0.5	-5.43	9.72E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs112819780	chr14:60001564	C14orf149	chr14:59939406-59951126:-	-0.58	-5.63	3.49E-8	Schizophrenia	
STAD	cis	1	rs112879614	chr14:60001681	C14orf149	chr14:59939406-59951126:-	-0.58	-5.63	3.49E-8	Schizophrenia	
STAD	cis	1	rs11292	chr10:102313607	SEC31B	chr10:102246403-102289636:-	-0.22	-5.31	1.87E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs1129448	chr22:38170026	GALR3	chr22:38219389-38221502:+	-0.3	-5.32	1.73E-7	Optic cup area;Vertical cup-disc ratio	
STAD	cis	1	rs112952088	chr14:60027907	C14orf149	chr14:59939406-59951126:-	-0.59	-5.74	1.88E-8	Schizophrenia	
STAD	cis	1	rs1130650	chr14:20940626	PNP	chr14:20937542-20945246:+	-0.25	-4.16	3.84E-5	Interferon alpha levels in systemic lupus erythematosus	
STAD	cis	1	rs113097743	chr14:60018216	C14orf149	chr14:59939406-59951126:-	-0.58	-5.32	1.79E-7	Schizophrenia	
STAD	cis	1	rs113112586	chr14:59969142	C14orf149	chr14:59939406-59951126:-	-0.49	-4.48	9.99E-6	Schizophrenia	
STAD	cis	1	rs113143821	chr5:127893353	FBN2	chr5:127593602-127873916:-	0.55	4.92	1.29E-6	Multiple system atrophy	
STAD	cis	1	rs113172694	chr14:59998219	C14orf149	chr14:59939406-59951126:-	-0.54	-4.97	1.01E-6	Schizophrenia	
STAD	cis	1	rs113284747	chr14:59955937	C14orf149	chr14:59939406-59951126:-	-0.46	-4	7.6E-5	Schizophrenia	
STAD	cis	1	rs113337957	chr14:59967329	C14orf149	chr14:59939406-59951126:-	-0.49	-4.48	9.99E-6	Schizophrenia	
STAD	cis	1	rs1133483	chr4:100023923	ADH4	chr4:100044835-100065449:-	-0.23	-3.98	8.25E-5	HDL cholesterol	
STAD	cis	1	rs11344	chr16:29910518	LOC440356	chr16:29875004-29879374:+	-0.21	-3.86	0.000134	Response to taxane treatment (placlitaxel)	
STAD	cis	1	rs113482756	chr14:59948622	C14orf149	chr14:59939406-59951126:-	-0.51	-4.67	4.09E-6	Schizophrenia	
STAD	cis	1	rs113558975	chr14:59998385	C14orf149	chr14:59939406-59951126:-	-0.54	-4.97	1.01E-6	Schizophrenia	
STAD	cis	1	rs113613442	chr14:59972563	C14orf149	chr14:59939406-59951126:-	-0.49	-4.48	9.99E-6	Schizophrenia	
STAD	cis	1	rs1138273	chr3:134261437	ANAPC13	chr3:134196547-134204865:-	0.38	6.86	2.7E-11	Height	
STAD	cis	1	rs113869004	chr14:59918731	C14orf149	chr14:59939406-59951126:-	-0.54	-4.74	2.99E-6	Schizophrenia	
STAD	cis	1	rs113878281	chr14:59917494	C14orf149	chr14:59939406-59951126:-	-0.58	-5.43	9.92E-8	Schizophrenia	
STAD	cis	1	rs1140047	chr11:18327684	GTF2H1	chr11:18343816-18388590:+	0.38	6.18	1.64E-9	Pancreatic cancer	
STAD	cis	1	rs114007205	chr20:33647503	PROCR	chr20:33758727-33765164:+	-0.49	-5.22	2.9E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs1141313	chr2:27460968	C2orf28	chr2:27434899-27440044:+	0.24	4.23	2.91E-5	Blood metabolite levels	
STAD	cis	1	rs1141321	chr6:49412433	MUT	chr6:49398994-49431031:-	0.37	6.85	2.88E-11	Folate pathway vitamin levels	
STAD	cis	1	rs114200987	chr14:35586916	PPP2R3C	chr14:35554679-35591679:-	0.3	4.36	1.7E-5	Atopic dermatitis	
STAD	cis	1	rs114244137	chr5:150264753	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs1144333	chr1:76275100	ACADM	chr1:76190043-76229353:+	0.3	4.42	1.29E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs114490726	chr4:17680898	LAP3	chr4:17578927-17609590:+	-0.19	-4.03	6.79E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs114562844	chr3:52991584	TMEM110	chr3:52867139-52931547:-	0.49	4.96	1.03E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs114827034	chr12:91480042	KERA	chr12:91444273-91452131:-	0.28	4.76	2.7E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs11492508	chr10:38098136	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.88	0.000122	Obesity (extreme)	
STAD	cis	1	rs114948279	chr20:33733641	PROCR	chr20:33758727-33765164:+	-0.52	-5.77	1.65E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs114960066	chr3:41882323	ULK4	chr3:41288091-42003660:-	0.78	12.44	3.76E-30	Diastolic blood pressure	
STAD	cis	1	rs114976176	chr2:264621	SH3YL1	chr2:218138-264810:-	-0.61	-12.82	1.18E-31	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs11513751	chr12:91482180	KERA	chr12:91444273-91452131:-	0.28	4.76	2.7E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs11513752	chr12:91482198	KERA	chr12:91444273-91452131:-	0.28	4.76	2.7E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs11513822	chr12:91482005	KERA	chr12:91444273-91452131:-	0.28	4.76	2.7E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs11513823	chr12:91482359	KERA	chr12:91444273-91452131:-	0.28	4.76	2.7E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs11519665	chr12:91482036	KERA	chr12:91444273-91452131:-	0.28	4.76	2.7E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs11532322	chr12:123731423	CDK2AP1	chr12:123745542-123756687:-	0.29	5.24	2.64E-7	Schizophrenia	
STAD	cis	1	rs11538349	chr7:65421871	CCT6P1	chr7:65216092-65228661:+	0.27	4.13	4.46E-5	Diabetic kidney disease	
STAD	cis	1	rs11553746	chr2:272203	SH3YL1	chr2:218138-264810:-	-0.6	-12.75	2.28E-31	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs1156199	chr4:109963955	CASP6	chr4:110609785-110624629:-	0.18	3.88	0.000123	Body mass index	
STAD	cis	1	rs11576221	chr1:171653696	VAMP4	chr1:171669298-171711214:-	0.34	6.11	2.35E-9	Hippocampal atrophy	
STAD	cis	1	rs11577073	chr1:171716724	VAMP4	chr1:171669298-171711214:-	-0.35	-6.25	1.09E-9	Hippocampal atrophy	
STAD	cis	1	rs11577745	chr1:171720909	VAMP4	chr1:171669298-171711214:-	0.33	6.09	2.77E-9	Hippocampal atrophy	
STAD	cis	1	rs11578699	chr1:171719769	VAMP4	chr1:171669298-171711214:-	0.33	5.96	5.68E-9	Hippocampal atrophy	
STAD	cis	1	rs11579634	chr1:46466391	IPP	chr1:46160000-46216485:-	-0.21	-4.05	6.26E-5	Body mass index	
STAD	cis	1	rs11579698	chr1:171666922	VAMP4	chr1:171669298-171711214:-	0.32	5.93	6.62E-9	Hippocampal atrophy	
STAD	cis	1	rs11580415	chr1:171666832	VAMP4	chr1:171669298-171711214:-	0.32	5.89	8.53E-9	Hippocampal atrophy	
STAD	cis	1	rs11580522	chr1:171720978	VAMP4	chr1:171669298-171711214:-	-0.34	-6.45	3.34E-10	Hippocampal atrophy	
STAD	cis	1	rs1158282	chr14:76172916	TTLL5	chr14:76127621-76421421:+	0.26	4.46	1.07E-5	Large artery stroke	
STAD	cis	1	rs11583920	chr1:171683611	VAMP4	chr1:171669298-171711214:-	0.34	6.29	8.76E-10	Hippocampal atrophy	
STAD	cis	1	rs11588062	chr1:46779764	NSUN4	chr1:46806390-46830690:+	0.23	4.34	1.8E-5	Age-related hearing impairment (interaction)	
STAD	cis	1	rs11589562	chr1:46466721	IPP	chr1:46160000-46216485:-	-0.22	-4.03	6.62E-5	Body mass index	
STAD	cis	1	rs11589562	chr1:46466721	TMEM69	chr1:46153847-46160108:+	-0.2	-4.22	3.02E-5	Body mass index	
STAD	cis	1	rs11590680	chr1:171716574	VAMP4	chr1:171669298-171711214:-	0.34	6.35	5.95E-10	Hippocampal atrophy	
STAD	cis	1	rs11590714	chr1:171716779	VAMP4	chr1:171669298-171711214:-	0.32	5.9	8.02E-9	Hippocampal atrophy	
STAD	cis	1	rs11595684	chr10:38083804	HSD17B7P2	chr10:38645308-38667432:+	0.34	4.07	5.65E-5	Obesity (extreme)	
STAD	cis	1	rs115965884	chr22:24594662	SUSD2	chr22:24577444-24585074:+	0.89	8.59	2.11E-16	Amyotrophic lateral sclerosis	
STAD	cis	1	rs11597286	chr10:38106455	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.88	0.000122	Obesity (extreme)	
STAD	cis	1	rs11601161	chr11:78073280	GAB2	chr11:77926343-78128766:-	-0.26	-3.82	0.000155	Testicular germ cell tumor	
STAD	cis	1	rs11605774	chr11:47832793	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.66	1.44E-13	Subjective well-being	
STAD	cis	1	rs116101630	chr11:506826	RNH1	chr11:494512-507273:-	-0.43	-5.47	8.08E-8	Body mass index	
STAD	cis	1	rs11620543	chr13:44798371	SERP2	chr13:44947978-44971849:+	0.22	3.85	0.000139	Amyotrophic lateral sclerosis	
STAD	cis	1	rs11622475	chr14:104509076	TDRD9	chr14:104394817-104519002:+	0.24	4	7.73E-5	Bipolar disorder	
STAD	cis	1	rs11625697	chr14:104464800	TDRD9	chr14:104394817-104519002:+	0.22	3.84	0.000141	Bipolar disorder	
STAD	cis	1	rs11628710	chr14:74649280	LIN52	chr14:74551656-74667117:+	0.38	7.19	3.32E-12	Common traits (Other)	
STAD	cis	1	rs11632465	chr15:85282045	LOC388152	chr15:84867600-84898920:-	-0.28	-4.25	2.71E-5	Schizophrenia	
STAD	cis	1	rs11637142	chr15:85295927	LOC388152	chr15:84867600-84898920:-	-0.28	-4.23	2.94E-5	Schizophrenia	
STAD	cis	1	rs11638290	chr15:85227636	LOC388152	chr15:84867600-84898920:-	-0.29	-4.34	1.85E-5	Schizophrenia	
STAD	cis	1	rs11638297	chr15:84782417	LOC388152	chr15:84867600-84898920:-	-0.27	-4.01	7.26E-5	Schizophrenia	
STAD	cis	1	rs11638394	chr15:84778928	LOC388152	chr15:84867600-84898920:-	-0.28	-4.09	5.19E-5	Schizophrenia	
STAD	cis	1	rs11638815	chr15:83352282	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.21	4.66	4.27E-6	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	
STAD	cis	1	rs11645002	chr16:20617841	ACSM1	chr16:20634559-20709066:-	0.45	5.55	5.19E-8	Urinary metabolites	
STAD	cis	1	rs11650372	chr17:45721795	C17orf57	chr17:45401142-45518675:+	0.31	6.51	2.31E-10	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
STAD	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.48	-9.17	2.86E-18	Eye color traits	
STAD	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.47	9.02	8.68E-18	Eye color traits	
STAD	cis	1	rs11674602	chr2:73723185	ALMS1P	chr2:73872046-73912692:+	0.47	7.48	4.93E-13	Metabolite levels	
STAD	cis	1	rs11674602	chr2:73723185	TPRKB	chr2:73956957-73964517:-	-0.23	-4.89	1.45E-6	Metabolite levels	
STAD	cis	1	rs1167827	chr7:75163169	NCF1C	chr7:74572446-74587759:-	0.13	3.8	0.000167	Body mass index	
STAD	cis	1	rs1167827	chr7:75163169	STAG3L1	chr7:74988447-75026250:+	-0.31	-5.47	7.99E-8	Body mass index	
STAD	cis	1	rs116876680	chr11:517473	RNH1	chr11:494512-507273:-	-0.42	-5.2	3.15E-7	Body mass index	
STAD	cis	1	rs11688129	chr2:28952581	TRMT61B	chr2:29072690-29093175:-	0.31	5.28	2.12E-7	Body mass index	
STAD	cis	1	rs11690423	chr2:28951537	TRMT61B	chr2:29072690-29093175:-	0.31	5.23	2.76E-7	Body mass index	
STAD	cis	1	rs11698834	chr20:23832595	CST2	chr20:23804404-23807312:-	0.25	4.08	5.45E-5	Response to TNF antagonist treatment	
STAD	cis	1	rs116988415	chr14:65292145	CHURC1	chr14:65381140-65411309:+	0.4	4.2	3.26E-5	Daytime sleep phenotypes	
STAD	cis	1	rs11699452	chr20:23837189	CST2	chr20:23804404-23807312:-	-0.27	-4.3	2.15E-5	Response to TNF antagonist treatment	
STAD	cis	1	rs11699520	chr20:23837634	CST2	chr20:23804404-23807312:-	-0.27	-4.3	2.15E-5	Response to TNF antagonist treatment	
STAD	cis	1	rs11699607	chr20:23830834	CST2	chr20:23804404-23807312:-	-0.28	-4.52	8.29E-6	Response to TNF antagonist treatment	
STAD	cis	1	rs11703914	chr22:24767602	POM121L9P	chr22:24647589-24661490:+	-0.27	-6.09	2.67E-9	Gut microbiome composition (summer)	
STAD	cis	1	rs11704021	chr22:39074716	CBY1	chr22:39052658-39069853:+	0.21	4.01	7.34E-5	Resting heart rate	
STAD	cis	1	rs11704021	chr22:39074716	LOC646851	chr22:38974125-39052634:-	0.25	5.41	1.08E-7	Resting heart rate	
STAD	cis	1	rs11705483	chr22:46630544	PKDREJ	chr22:46651561-46659219:-	-0.5	-4.54	7.4E-6	Cholesterol, total;LDL cholesterol	
STAD	cis	1	rs11706035	chr3:53011868	TMEM110	chr3:52867139-52931547:-	0.49	4.95	1.13E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs11706117	chr3:134212526	ANAPC13	chr3:134196547-134204865:-	0.38	6.8	3.83E-11	Height	
STAD	cis	1	rs11707780	chr3:53084326	TMEM110	chr3:52867139-52931547:-	-0.33	-3.91	0.00011	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.4	7.3	1.68E-12	Height	
STAD	cis	1	rs11710292	chr3:53117798	TMEM110	chr3:52867139-52931547:-	0.41	4.51	8.6E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs11710434	chr3:49346130	CCDC36	chr3:49235861-49295537:+	0.21	3.86	0.000133	Menarche (age at onset)	
STAD	cis	1	rs11710707	chr3:52975916	TMEM110	chr3:52867139-52931547:-	0.49	4.91	1.35E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.27	-6.09	2.64E-9	Longevity	
STAD	cis	1	rs11713206	chr3:52999243	TMEM110	chr3:52867139-52931547:-	0.54	5.33	1.7E-7	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs11713290	chr3:52971579	TMEM110	chr3:52867139-52931547:-	0.46	4.64	4.75E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs11713859	chr3:53042080	TMEM110	chr3:52867139-52931547:-	0.48	4.83	1.94E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs11714406	chr3:121372513	IQCB1	chr3:121488610-121553926:-	0.29	4.98	9.78E-7	Cognitive performance	
STAD	cis	1	rs11714876	chr3:53101640	TMEM110	chr3:52867139-52931547:-	-0.41	-4.61	5.56E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs11717619	chr3:53003179	TMEM110	chr3:52867139-52931547:-	0.42	4.38	1.54E-5	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs11718538	chr3:52975987	TMEM110	chr3:52867139-52931547:-	0.46	4.64	4.75E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs11718834	chr3:52963668	TMEM110	chr3:52867139-52931547:-	0.42	4.3	2.13E-5	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs11719458	chr3:121382005	IQCB1	chr3:121488610-121553926:-	0.27	4.65	4.47E-6	Cognitive performance	
STAD	cis	1	rs11720191	chr3:53013839	TMEM110	chr3:52867139-52931547:-	0.49	4.95	1.13E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs11720542	chr3:49357427	CCDC36	chr3:49235861-49295537:+	0.2	3.84	0.000141	Menarche (age at onset)	
STAD	cis	1	rs11721318	chr3:121429485	IQCB1	chr3:121488610-121553926:-	0.27	4.55	7.19E-6	Cognitive performance	
STAD	cis	1	rs11722037	chr4:17683811	LAP3	chr4:17578927-17609590:+	-0.2	-4.19	3.43E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs11723615	chr4:276983	ZNF718	chr4:53272-156488:+	0.33	3.97	8.45E-5	Immune response to smallpox vaccine (IL-6)	
STAD	cis	1	rs117236853	chr20:33667783	PROCR	chr20:33758727-33765164:+	-0.51	-5.38	1.27E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs117249133	chr20:33773630	PROCR	chr20:33758727-33765164:+	-0.5	-5.47	7.96E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11726829	chr4:224948	ZNF876P	chr4:206389-249771:+	-0.28	-3.91	0.00011	Immune response to smallpox vaccine (IL-6)	
STAD	cis	1	rs11727312	chr4:17669185	LAP3	chr4:17578927-17609590:+	-0.19	-4.13	4.39E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs11729657	chr4:1737585	FAM53A	chr4:1641609-1685854:-	-0.43	-6.56	1.74E-10	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs117316403	chr20:33693175	PROCR	chr20:33758727-33765164:+	-0.51	-5.54	5.71E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11732213	chr4:1704244	FAM53A	chr4:1641609-1685854:-	0.47	6.71	7.05E-11	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs11733284	chr4:48028097	CNGA1	chr4:47937996-48018610:-	0.22	4.41	1.35E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs117339389	chr11:505025	RNH1	chr11:494512-507273:-	-0.43	-5.65	3.15E-8	Body mass index	
STAD	cis	1	rs11737268	chr4:224452	ZNF876P	chr4:206389-249771:+	-0.28	-3.91	0.00011	Immune response to smallpox vaccine (IL-6)	
STAD	cis	1	rs1173736	chr5:32771938	GOLPH3	chr5:32124824-32174425:-	-0.27	-3.99	7.75E-5	Height	
STAD	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.88	16.99	7.25E-49	Type 2 diabetes	
STAD	cis	1	rs11739619	chr5:150264662	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs11741861	chr5:150277909	LOC134466	chr5:150310000-150326146:-	-0.39	-6.01	4.15E-9	Crohn's disease	
STAD	cis	1	rs11743488	chr5:150279218	LOC134466	chr5:150310000-150326146:-	0.41	6.13	2.14E-9	Crohn's disease	
STAD	cis	1	rs11746108	chr5:150264622	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs11747270	chr5:150258867	LOC134466	chr5:150310000-150326146:-	-0.3	-4.77	2.67E-6	Crohn's disease	
STAD	cis	1	rs11748151	chr5:150226292	LOC134466	chr5:150310000-150326146:-	0.3	4.89	1.45E-6	Crohn's disease	
STAD	cis	1	rs11748158	chr5:150226345	LOC134466	chr5:150310000-150326146:-	0.3	4.89	1.45E-6	Crohn's disease	
STAD	cis	1	rs11749391	chr5:150229066	LOC134466	chr5:150310000-150326146:-	0.28	4.61	5.54E-6	Crohn's disease	
STAD	cis	1	rs11754744	chr6:26202605	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.7E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs11755210	chr6:26202768	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.7E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs117573845	chr20:33651621	PROCR	chr20:33758727-33765164:+	-0.52	-5.56	4.96E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11758351	chr6:26203910	HIST1H2AE	chr6:26217148-26217711:+	-0.33	-4.5	8.8E-6	Renal underexcretion gout;Gout	
STAD	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.67	-12.95	3.66E-32	Response to antipsychotic treatment	
STAD	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.67	-13.24	2.6E-33	Response to antipsychotic treatment	
STAD	cis	1	rs117616040	chr20:33565528	PROCR	chr20:33758727-33765164:+	-0.47	-4.98	9.39E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11776189	chr8:96036741	C8orf38	chr8:95908040-96088396:+	-0.34	-4.13	4.47E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs117802529	chr20:33786677	PROCR	chr20:33758727-33765164:+	-0.51	-5.73	2.0E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11780931	chr8:96043829	C8orf38	chr8:95908040-96088396:+	-0.35	-4.34	1.84E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs11781040	chr8:96041746	C8orf38	chr8:95908040-96088396:+	-0.34	-4.13	4.4E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs11782652	chr8:82653644	CHMP4C	chr8:82644688-82671746:+	-0.84	-9.39	5.07E-19	Epithelial ovarian cancer;Ovarian cancer	
STAD	cis	1	rs11786380	chr8:96028136	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs11786878	chr8:96033292	C8orf38	chr8:95908040-96088396:+	-0.33	-3.95	9.3E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.71	-14.71	2.94E-39	Response to antipsychotic treatment	
STAD	cis	1	rs11792861	chr9:111809295	C9orf5	chr9:111777416-111882225:-	0.21	4.18	3.54E-5	Menarche (age at onset)	
STAD	cis	1	rs11799420	chr1:171652978	VAMP4	chr1:171669298-171711214:-	-0.35	-6.44	3.54E-10	Hippocampal atrophy	
STAD	cis	1	rs11801846	chr1:171674241	VAMP4	chr1:171669298-171711214:-	0.34	6.33	6.69E-10	Hippocampal atrophy	
STAD	cis	1	rs11802265	chr1:171649936	VAMP4	chr1:171669298-171711214:-	0.34	6.35	5.91E-10	Hippocampal atrophy	
STAD	cis	1	rs11803174	chr1:171674338	VAMP4	chr1:171669298-171711214:-	0.34	6.33	6.69E-10	Hippocampal atrophy	
STAD	cis	1	rs11807862	chr1:3279268	ARHGEF16	chr1:3371147-3397675:+	-0.3	-3.88	0.000123	Response to statin therapy	
STAD	cis	1	rs11810993	chr1:46478793	TMEM69	chr1:46153847-46160108:+	0.18	3.81	0.000163	Body mass index	
STAD	cis	1	rs118110670	chr10:81792242	LOC219347	chr10:81805991-81838949:-	0.57	7.4	8.58E-13	Chronic obstructive pulmonary disease-related biomarkers	
STAD	cis	1	rs11811780	chr1:171652759	VAMP4	chr1:171669298-171711214:-	0.34	6.3	8.11E-10	Hippocampal atrophy	
STAD	cis	1	rs11816840	chr10:102309220	SEC31B	chr10:102246403-102289636:-	-0.22	-5.31	1.86E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs11844747	chr14:65870128	LOC645431	chr14:65877313-65879335:-	0.37	4.4	1.39E-5	Ischemic stroke	
STAD	cis	1	rs11850847	chr14:65933798	LOC645431	chr14:65877313-65879335:-	-0.37	-4.09	5.19E-5	Ischemic stroke	
STAD	cis	1	rs11851772	chr14:66022047	LOC645431	chr14:65877313-65879335:-	-0.34	-3.92	0.000103	Ischemic stroke	
STAD	cis	1	rs11856184	chr15:43919162	ADAL	chr15:43622872-43646094:+	-0.47	-5.71	2.25E-8	Tumor biomarkers	
STAD	cis	1	rs11856184	chr15:43919162	CATSPER2	chr15:43922774-43959900:-	-0.41	-7.12	5.27E-12	Tumor biomarkers	
STAD	cis	1	rs11862744	chr16:31057800	MYST1	chr16:31128985-31142713:+	0.24	4.19	3.51E-5	Response to metformin (IC50)	
STAD	cis	1	rs11869069	chr17:40287101	DHX58	chr17:40253422-40264751:-	-0.34	-6.31	7.75E-10	Fibrinogen levels	
STAD	cis	1	rs11870935	chr17:45732605	C17orf57	chr17:45401142-45518675:+	-0.29	-6.22	1.29E-9	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
STAD	cis	1	rs11893118	chr2:241828308	C2orf54	chr2:241825466-241835573:-	0.34	5.28	2.18E-7	Urinary metabolites	
STAD	cis	1	rs11893832	chr2:88507537	THNSL2	chr2:88469835-88486145:+	-0.58	-6.16	1.84E-9	Plasma clusterin levels	
STAD	cis	1	rs11898716	chr2:241828311	C2orf54	chr2:241825466-241835573:-	0.26	3.91	0.00011	Urinary metabolites	
STAD	cis	1	rs11899740	chr2:73631212	ALMS1P	chr2:73872046-73912692:+	0.47	7.4	8.28E-13	Metabolite levels	
STAD	cis	1	rs11899740	chr2:73631212	TPRKB	chr2:73956957-73964517:-	-0.23	-5	8.87E-7	Metabolite levels	
STAD	cis	1	rs11905354	chr20:33677164	PROCR	chr20:33758727-33765164:+	-0.49	-5.39	1.22E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11906148	chr20:33784021	PROCR	chr20:33758727-33765164:+	-0.51	-5.73	2.0E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11906318	chr20:33729442	PROCR	chr20:33758727-33765164:+	-0.5	-5.58	4.51E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11907010	chr20:33737661	PROCR	chr20:33758727-33765164:+	-0.53	-5.73	1.98E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11907011	chr20:33767770	PROCR	chr20:33758727-33765164:+	-0.52	-5.91	7.57E-9	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11907438	chr20:33641220	PROCR	chr20:33758727-33765164:+	-0.49	-5.31	1.82E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11907594	chr20:33673843	PROCR	chr20:33758727-33765164:+	-0.49	-5.32	1.78E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11908100	chr20:33729479	PROCR	chr20:33758727-33765164:+	-0.5	-5.58	4.51E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11908232	chr20:33729477	PROCR	chr20:33758727-33765164:+	-0.5	-5.58	4.51E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11908683	chr20:33720920	PROCR	chr20:33758727-33765164:+	-0.5	-5.47	8.05E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs11919350	chr3:134235970	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.86	2.66E-11	Height	
STAD	cis	1	rs11920570	chr3:122090102	WDR5B	chr3:122130700-122134882:-	0.22	4.08	5.44E-5	Resting heart rate	
STAD	cis	1	rs11927068	chr3:134266321	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.75	5.47E-11	Height	
STAD	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.39	-7.03	9.3E-12	Height	
STAD	cis	1	rs11928580	chr3:41885722	ULK4	chr3:41288091-42003660:-	0.78	12.2	3.33E-29	Diastolic blood pressure	
STAD	cis	1	rs11947857	chr4:17691047	LAP3	chr4:17578927-17609590:+	0.2	3.92	0.000106	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs11950957	chr5:150253914	LOC134466	chr5:150310000-150326146:-	0.32	5.05	6.68E-7	Crohn's disease	
STAD	cis	1	rs11951694	chr5:150254338	LOC134466	chr5:150310000-150326146:-	0.32	5.05	6.68E-7	Crohn's disease	
STAD	cis	1	rs11955172	chr5:150254378	LOC134466	chr5:150310000-150326146:-	0.32	5.05	6.68E-7	Crohn's disease	
STAD	cis	1	rs11957134	chr5:150230950	LOC134466	chr5:150310000-150326146:-	-0.38	-5.97	5.45E-9	Crohn's disease	
STAD	cis	1	rs11975942	chr7:143740580	ARHGEF35	chr7:143883677-143892736:-	-0.38	-5.93	6.73E-9	Obesity-related traits	
STAD	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	0.92	15.94	2.15E-44	Educational attainment (years of education)	
STAD	cis	1	rs11976037	chr7:143741024	ARHGEF35	chr7:143883677-143892736:-	-0.38	-6.03	3.8E-9	Obesity-related traits	
STAD	cis	1	rs11976180	chr7:143741580	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.85	1.04E-8	Obesity-related traits	
STAD	cis	1	rs12021587	chr1:46472759	TMEM69	chr1:46153847-46160108:+	0.18	3.88	0.000123	Body mass index	
STAD	cis	1	rs12024880	chr1:155908910	RAB25	chr1:156030966-156040293:+	-0.18	-4.13	4.48E-5	Crohn's disease;Inflammatory bowel disease	
STAD	cis	1	rs12028193	chr1:54353785	YIPF1	chr1:54317407-54355453:-	0.51	3.95	9.2E-5	Nonalcoholic fatty liver disease	
STAD	cis	1	rs12030612	chr1:113215637	ST7L	chr1:113066142-113162405:-	0.37	6.79	4.29E-11	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs12030641	chr1:113215717	ST7L	chr1:113066142-113162405:-	0.37	6.79	4.29E-11	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs12033668	chr1:210341410	SYT14	chr1:210111538-210337631:+	0.23	3.98	8.27E-5	Manic episodes in bipolar disorder	
STAD	cis	1	rs12037222	chr1:40064961	PPIEL	chr1:39987953-40025370:-	0.25	4.16	3.92E-5	C-reactive protein levels or triglyceride levels (pleiotropy)	
STAD	cis	1	rs12040988	chr1:113173804	ST7L	chr1:113066142-113162405:-	0.37	6.68	8.08E-11	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs12049588	chr1:46472422	TMEM69	chr1:46153847-46160108:+	0.18	3.88	0.000123	Body mass index	
STAD	cis	1	rs12054923	chr5:150249059	LOC134466	chr5:150310000-150326146:-	0.33	5.25	2.53E-7	Crohn's disease	
STAD	cis	1	rs12078893	chr1:76370862	ACADM	chr1:76190043-76229353:+	-0.31	-4.48	9.92E-6	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs12082448	chr1:76353225	ACADM	chr1:76190043-76229353:+	-0.3	-4.32	1.99E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs12091564	chr1:145395604	NOTCH2NL	chr1:145209111-145295525:+	-0.53	-5.45	9.06E-8	Coronary heart disease	
STAD	cis	1	rs12095069	chr1:76463072	ACADM	chr1:76190043-76229353:+	-0.31	-4.31	2.04E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs12105996	chr20:33731010	PROCR	chr20:33758727-33765164:+	-0.49	-5.48	7.47E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs12117765	chr1:10268170	PGD	chr1:10459085-10480200:+	0.23	3.93	0.000101	Hepatocellular carcinoma	
STAD	cis	1	rs12120182	chr1:227814332	SNAP47	chr1:227916240-227968932:+	-0.23	-3.86	0.00013	Height	
STAD	cis	1	rs12120956	chr1:113202571	ST7L	chr1:113066142-113162405:-	0.38	6.81	3.77E-11	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs12122290	chr1:247215810	ZNF670	chr1:247200087-247242069:-	-0.27	-4.07	5.7E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs12125429	chr1:171651153	VAMP4	chr1:171669298-171711214:-	0.34	6.34	6.29E-10	Hippocampal atrophy	
STAD	cis	1	rs12126971	chr1:113231286	ST7L	chr1:113066142-113162405:-	0.37	6.69	7.54E-11	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs12128536	chr1:171674607	VAMP4	chr1:171669298-171711214:-	0.34	6.3	7.88E-10	Hippocampal atrophy	
STAD	cis	1	rs12129035	chr1:10291166	PGD	chr1:10459085-10480200:+	0.23	3.9	0.000112	Hepatocellular carcinoma	
STAD	cis	1	rs12130075	chr1:247218491	ZNF670	chr1:247200087-247242069:-	-0.28	-4.3	2.2E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs12130219	chr1:152162106	FLG2	chr1:152321214-152332482:-	0.26	4.29	2.25E-5	Inflammatory skin disease	
STAD	cis	1	rs12130219	chr1:152162106	FLG	chr1:152274651-152297679:-	0.48	7.96	1.93E-14	Inflammatory skin disease	
STAD	cis	1	rs12130243	chr1:113169667	ST7L	chr1:113066142-113162405:-	0.37	6.68	8.08E-11	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs12132221	chr1:171685694	VAMP4	chr1:171669298-171711214:-	0.34	6.29	8.76E-10	Hippocampal atrophy	
STAD	cis	1	rs12133583	chr1:113240790	ST7L	chr1:113066142-113162405:-	0.4	7.2	3.02E-12	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs12136376	chr1:10296452	PGD	chr1:10459085-10480200:+	0.23	3.86	0.000131	Hepatocellular carcinoma	
STAD	cis	1	rs12141416	chr1:10327867	PGD	chr1:10459085-10480200:+	0.23	4.01	7.18E-5	Hepatocellular carcinoma	
STAD	cis	1	rs12145310	chr1:20901064	FAM43B	chr1:20878932-20881512:+	0.18	4.19	3.44E-5	Age-related hearing impairment (interaction)	
STAD	cis	1	rs12145351	chr1:20901181	FAM43B	chr1:20878932-20881512:+	0.18	4.17	3.79E-5	Age-related hearing impairment (interaction)	
STAD	cis	1	rs12148786	chr15:76800362	SCAPER	chr15:76640529-77197744:-	-0.2	-4.15	4.06E-5	Blood metabolite levels	
STAD	cis	1	rs12153124	chr5:148389198	ARHGEF37	chr5:148961135-149014527:+	0.25	3.91	0.000109	Diastolic blood pressure	
STAD	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12171333	chr4:129879711	C4orf33	chr4:130014829-130033842:+	0.44	6.83	3.29E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs12172	chr2:97500852	CNNM3	chr2:97481991-97501120:+	-0.34	-4.05	6.26E-5	Erectile dysfunction and prostate cancer treatment	
STAD	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.66	-12.84	1.04E-31	Response to antipsychotic treatment	
STAD	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.66	-13.14	6.87E-33	Response to antipsychotic treatment	
STAD	cis	1	rs12192208	chr6:124693764	HDDC2	chr6:125596496-125623282:-	0.22	3.88	0.000123	Neuroticism	
STAD	cis	1	rs12192208	chr6:124693764	NKAIN2	chr6:124125069-125146784:+	0.36	6.23	1.2E-9	Neuroticism	
STAD	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.67	-13.24	2.6E-33	Response to antipsychotic treatment	
STAD	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.66	-13.02	1.96E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.65	-12.65	5.84E-31	Response to antipsychotic treatment	
STAD	cis	1	rs12196937	chr6:49382808	MUT	chr6:49398994-49431031:-	0.39	7.34	1.25E-12	Folate pathway vitamin levels	
STAD	cis	1	rs12197114	chr6:109735498	SMPD2	chr6:109761931-109765121:+	0.24	4.58	6.38E-6	Height	
STAD	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.65	-12.78	1.79E-31	Response to antipsychotic treatment	
STAD	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.66	-13.08	1.1E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.67	-13.3	1.5E-33	Response to antipsychotic treatment	
STAD	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.67	-13.24	2.6E-33	Response to antipsychotic treatment	
STAD	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.66	-12.97	2.99E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.65	-12.77	1.93E-31	Response to antipsychotic treatment	
STAD	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12202075	chr6:49427655	MUT	chr6:49398994-49431031:-	0.38	7.06	7.88E-12	Folate pathway vitamin levels	
STAD	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.29E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.29E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.71	-15.18	3.09E-41	Response to antipsychotic treatment	
STAD	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.66	-12.98	2.97E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.66	-13.07	1.28E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.65	-12.66	5.1E-31	Response to antipsychotic treatment	
STAD	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.66	-13.11	9.01E-33	Response to antipsychotic treatment	
STAD	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.67	-13.24	2.6E-33	Response to antipsychotic treatment	
STAD	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.66	-13.02	2.02E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.66	-13.05	1.56E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.67	-13.24	2.6E-33	Response to antipsychotic treatment	
STAD	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.66	-13.06	1.43E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.65	-12.83	1.08E-31	Response to antipsychotic treatment	
STAD	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.65	-12.87	7.83E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.67	-13.24	2.6E-33	Response to antipsychotic treatment	
STAD	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.67	-13.22	3.26E-33	Response to antipsychotic treatment	
STAD	cis	1	rs12219158	chr10:102302923	SEC31B	chr10:102246403-102289636:-	-0.22	-5.31	1.86E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs12219789	chr10:102213778	SEC31B	chr10:102246403-102289636:-	-0.25	-6.01	4.38E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs12220311	chr10:79681507	DLG5	chr10:79550551-79686348:-	0.29	4.9	1.41E-6	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs12220311	chr10:79681507	POLR3A	chr10:79735906-79789259:-	0.22	4.2	3.25E-5	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs12220328	chr10:79681482	DLG5	chr10:79550551-79686348:-	0.29	4.99	9.0E-7	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs12220328	chr10:79681482	POLR3A	chr10:79735906-79789259:-	0.2	3.83	0.000151	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs12220777	chr10:81788104	LOC219347	chr10:81805991-81838949:-	-0.62	-8.14	5.52E-15	Chronic obstructive pulmonary disease-related biomarkers	
STAD	cis	1	rs12220902	chr10:79682918	DLG5	chr10:79550551-79686348:-	0.28	4.93	1.2E-6	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs12220902	chr10:79682918	POLR3A	chr10:79735906-79789259:-	0.2	3.94	9.5E-5	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs12286683	chr11:18348662	GTF2H1	chr11:18343816-18388590:+	0.4	6.44	3.48E-10	Pancreatic cancer	
STAD	cis	1	rs12287832	chr11:65553492	CTSW	chr11:65647284-65651212:+	-0.34	-6.04	3.55E-9	Systemic lupus erythematosus	
STAD	cis	1	rs12287832	chr11:65553492	SNX32	chr11:65601410-65621170:+	0.29	3.88	0.000125	Systemic lupus erythematosus	
STAD	cis	1	rs12299125	chr12:123862447	CDK2AP1	chr12:123745542-123756687:-	-0.37	-5.86	1.01E-8	Educational attainment;Height;Head circumference (infant)	
STAD	cis	1	rs12324805	chr15:82352200	LOC80154	chr15:82944795-82975797:+;chr15	0.22	3.83	0.000151	Body mass index	
STAD	cis	1	rs12354411	chr10:102294537	SEC31B	chr10:102246403-102289636:-	-0.24	-5.79	1.48E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs12355721	chr10:102244911	SEC31B	chr10:102246403-102289636:-	-0.24	-5.88	8.79E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs12357418	chr10:37993860	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.91	0.000109	Obesity (extreme)	
STAD	cis	1	rs12358094	chr10:38015506	HSD17B7P2	chr10:38645308-38667432:+	0.35	4.1	4.97E-5	Obesity (extreme)	
STAD	cis	1	rs12358108	chr10:38015607	HSD17B7P2	chr10:38645308-38667432:+	0.35	4.1	4.97E-5	Obesity (extreme)	
STAD	cis	1	rs12358187	chr10:102284449	SEC31B	chr10:102246403-102289636:-	-0.24	-5.86	9.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs12359272	chr10:97365163	ENTPD1	chr10:97471536-97637022:+	0.15	4	7.54E-5	Blood metabolite levels	
STAD	cis	1	rs12360411	chr10:38046634	HSD17B7P2	chr10:38645308-38667432:+	0.34	4.1	5.11E-5	Obesity (extreme)	
STAD	cis	1	rs12361031	chr11:47783076	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.71	1.09E-13	Subjective well-being	
STAD	cis	1	rs12363232	chr11:47623890	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.7	1.15E-13	Subjective well-being	
STAD	cis	1	rs12366208	chr11:48563128	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.91	0.000108	HDL cholesterol	
STAD	cis	1	rs12372754	chr12:91481578	KERA	chr12:91444273-91452131:-	0.28	4.76	2.7E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs12410724	chr1:76459134	ACADM	chr1:76190043-76229353:+	-0.3	-4.24	2.74E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs12411269	chr1:46271052	IPP	chr1:46160000-46216485:-	0.2	3.93	0.000101	Body mass index	
STAD	cis	1	rs12414891	chr10:81690385	PLAC9	chr10:81892258-81904784:+	-0.38	-5.99	4.79E-9	Chronic obstructive pulmonary disease-related biomarkers	
STAD	cis	1	rs12416687	chr10:104629011	AS3MT	chr10:104613967-104661653:+	-0.22	-4.14	4.33E-5	Arsenic metabolism	
STAD	cis	1	rs12416687	chr10:104629011	C10orf32	chr10:104613967-104624718:+	-0.61	-10.15	1.26E-21	Arsenic metabolism	
STAD	cis	1	rs12417087	chr11:69003979	MYEOV	chr11:69061622-69156449:+	0.37	4.23	2.87E-5	Prostate cancer	
STAD	cis	1	rs12418639	chr11:473300	RNH1	chr11:494512-507273:-	0.43	5.65	3.05E-8	Body mass index	
STAD	cis	1	rs12418852	chr11:47868853	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.7	1.15E-13	Subjective well-being	
STAD	cis	1	rs12419692	chr11:47624714	C1QTNF4	chr11:47611216-47615961:-	0.31	7.55	3.05E-13	Subjective well-being	
STAD	cis	1	rs12419716	chr11:503385	RNH1	chr11:494512-507273:-	-0.43	-5.65	3.15E-8	Body mass index	
STAD	cis	1	rs12419766	chr11:503710	RNH1	chr11:494512-507273:-	-0.43	-5.65	3.15E-8	Body mass index	
STAD	cis	1	rs12420372	chr11:48497603	C1QTNF4	chr11:47611216-47615961:-	0.17	3.88	0.000123	HDL cholesterol	
STAD	cis	1	rs12421210	chr11:47779586	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.71	1.09E-13	Subjective well-being	
STAD	cis	1	rs12421457	chr11:505780	RNH1	chr11:494512-507273:-	-0.43	-5.65	3.15E-8	Body mass index	
STAD	cis	1	rs12422267	chr12:132601596	DDX51	chr12:132621142-132628880:-	0.43	4.31	2.06E-5	Plasma amyloid beta peptide concentrations (ABx-40)	
STAD	cis	1	rs12422267	chr12:132601596	EP400NL	chr12:132568828-132600084:+;chr12	-0.67	-6.32	7.23E-10	Plasma amyloid beta peptide concentrations (ABx-40)	
STAD	cis	1	rs12441433	chr15:76816015	SCAPER	chr15:76640529-77197744:-	-0.24	-5.01	8.39E-7	Blood metabolite levels	
STAD	cis	1	rs12443102	chr15:43932103	ADAL	chr15:43622872-43646094:+	-0.49	-5.82	1.21E-8	Tumor biomarkers	
STAD	cis	1	rs12443102	chr15:43932103	CATSPER2	chr15:43922774-43959900:-	-0.36	-5.91	7.35E-9	Tumor biomarkers	
STAD	cis	1	rs12443137	chr15:76840832	SCAPER	chr15:76640529-77197744:-	-0.23	-4.81	2.15E-6	Blood metabolite levels	
STAD	cis	1	rs12445650	chr16:31044897	MYST1	chr16:31128985-31142713:+	0.24	4.2	3.37E-5	Response to metformin (IC50)	
STAD	cis	1	rs12455557	chr18:46317088	DYM	chr18:46570172-46987079:-	-0.3	-3.85	0.000136	Lung function (FVC)	
STAD	cis	1	rs12470450	chr2:232113888	ARMC9	chr2:232063342-232238606:+	0.2	4.41	1.35E-5	Food antigen IgG levels	
STAD	cis	1	rs12470505	chr2:219908369	SLC23A3	chr2:220026183-220034817:-	-0.37	-4.37	1.63E-5	Height	
STAD	cis	1	rs12472278	chr2:108873433	SULT1C2	chr2:108905095-108926370:+	-0.28	-4.5	8.84E-6	Blood pressure	
STAD	cis	1	rs12472278	chr2:108873433	SULT1C3	chr2:108863651-108881806:+	-0.37	-6.87	2.63E-11	Blood pressure	
STAD	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.65	-7.04	8.61E-12	Plasma clusterin levels	
STAD	cis	1	rs12477202	chr2:108867112	SULT1C2	chr2:108905095-108926370:+	0.24	3.82	0.000154	Blood pressure	
STAD	cis	1	rs12477202	chr2:108867112	SULT1C3	chr2:108863651-108881806:+	0.37	6.85	2.96E-11	Blood pressure	
STAD	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.27	-6.19	1.57E-9	Longevity	
STAD	cis	1	rs12490835	chr3:134223730	ANAPC13	chr3:134196547-134204865:-	0.38	6.81	3.73E-11	Height	
STAD	cis	1	rs12498808	chr4:165906905	C4orf39	chr4:165878100-165880273:+	0.2	4.46	1.07E-5	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs12507142	chr4:17656103	LAP3	chr4:17578927-17609590:+	-0.2	-4.24	2.85E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs12509366	chr4:107003343	TBCK	chr4:106967233-107237861:-	0.26	3.98	8.31E-5	Airflow obstruction	
STAD	cis	1	rs12512283	chr4:165908927	C4orf39	chr4:165878100-165880273:+	0.19	4.19	3.5E-5	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs12512683	chr4:106999471	TBCK	chr4:106967233-107237861:-	0.24	3.81	0.000162	Airflow obstruction	
STAD	cis	1	rs1253099	chr14:59946830	C14orf149	chr14:59939406-59951126:-	-0.51	-4.66	4.37E-6	Schizophrenia	
STAD	cis	1	rs1253102	chr14:59947861	C14orf149	chr14:59939406-59951126:-	-0.51	-4.66	4.37E-6	Schizophrenia	
STAD	cis	1	rs1253107	chr14:59952947	C14orf149	chr14:59939406-59951126:-	-0.49	-4.63	4.88E-6	Schizophrenia	
STAD	cis	1	rs12545109	chr8:57313906	PENK	chr8:57353513-57359282:-	-0.25	-4.87	1.59E-6	Obesity-related traits	
STAD	cis	1	rs12564445	chr1:201345487	TNNI1	chr1:201372895-201398994:-	-0.29	-4.34	1.81E-5	Cardiac Troponin-T levels	
STAD	cis	1	rs12571820	chr10:38009354	HSD17B7P2	chr10:38645308-38667432:+	0.35	4.17	3.75E-5	Obesity (extreme)	
STAD	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.38	-6.76	5.01E-11	Forced vital capacity	
STAD	cis	1	rs12590407	chr14:24835115	LTB4R2	chr14:24778161-24781259:+	-0.21	-3.8	0.000166	Height	
STAD	cis	1	rs12591296	chr15:59486640	CCNB2	chr15:59397320-59417243:+	-0.23	-3.81	0.000163	Metabolite levels	
STAD	cis	1	rs12594212	chr15:76802014	SCAPER	chr15:76640529-77197744:-	-0.21	-4.48	1.0E-5	Blood metabolite levels	
STAD	cis	1	rs12594541	chr15:76834368	SCAPER	chr15:76640529-77197744:-	-0.23	-4.81	2.2E-6	Blood metabolite levels	
STAD	cis	1	rs12603327	chr17:40290552	DHX58	chr17:40253422-40264751:-	-0.34	-6.21	1.36E-9	Fibrinogen levels	
STAD	cis	1	rs12603330	chr17:40290589	DHX58	chr17:40253422-40264751:-	-0.34	-6.18	1.6E-9	Fibrinogen levels	
STAD	cis	1	rs12612513	chr2:86301225	GNLY	chr2:85921414-85925874:+	0.34	3.81	0.000164	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
STAD	cis	1	rs12614260	chr2:86303079	GNLY	chr2:85921414-85925874:+	0.34	3.81	0.000164	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
STAD	cis	1	rs12616140	chr2:108867728	SULT1C2	chr2:108905095-108926370:+	0.25	3.88	0.000124	Blood pressure	
STAD	cis	1	rs12616140	chr2:108867728	SULT1C3	chr2:108863651-108881806:+	0.37	6.94	1.62E-11	Blood pressure	
STAD	cis	1	rs12621280	chr2:232132984	ARMC9	chr2:232063342-232238606:+	0.24	4.57	6.47E-6	Food antigen IgG levels	
STAD	cis	1	rs12621567	chr2:232118813	ARMC9	chr2:232063342-232238606:+	0.19	4.12	4.59E-5	Food antigen IgG levels	
STAD	cis	1	rs12637751	chr3:134266124	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.75	5.47E-11	Height	
STAD	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	0.74	12	1.93E-28	Diastolic blood pressure	
STAD	cis	1	rs12642900	chr4:107010329	TBCK	chr4:106967233-107237861:-	0.24	3.82	0.000157	Airflow obstruction	
STAD	cis	1	rs12648232	chr4:17612537	LAP3	chr4:17578927-17609590:+	0.18	3.93	0.000101	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs12652003	chr5:150231945	LOC134466	chr5:150310000-150326146:-	0.38	5.97	5.28E-9	Crohn's disease	
STAD	cis	1	rs12656538	chr5:150251380	LOC134466	chr5:150310000-150326146:-	0.42	6.29	8.39E-10	Crohn's disease	
STAD	cis	1	rs12656600	chr5:150311872	LOC134466	chr5:150310000-150326146:-	0.34	5.55	5.27E-8	Crohn's disease	
STAD	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.66	-13.02	1.96E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.66	-12.98	2.97E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.65	12.78	1.7E-31	Response to antipsychotic treatment	
STAD	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.65	12.89	6.2E-32	Response to antipsychotic treatment	
STAD	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.65	-12.69	4.12E-31	Response to antipsychotic treatment	
STAD	cis	1	rs12698509	chr7:65418876	CCT6P1	chr7:65216092-65228661:+	0.27	4.06	5.93E-5	Diabetic kidney disease	
STAD	cis	1	rs12704290	chr7:86427626	ABCB4	chr7:87031361-87105019:-	-0.33	-4.4	1.41E-5	Schizophrenia	
STAD	cis	1	rs1273153	chr14:59946459	C14orf149	chr14:59939406-59951126:-	0.52	4.89	1.5E-6	Schizophrenia	
STAD	cis	1	rs12733173	chr1:152173972	FLG2	chr1:152321214-152332482:-	0.26	4.2	3.25E-5	Inflammatory skin disease	
STAD	cis	1	rs12733173	chr1:152173972	FLG	chr1:152274651-152297679:-	0.47	7.79	6.17E-14	Inflammatory skin disease	
STAD	cis	1	rs12740374	chr1:109817590	PSRC1	chr1:109822179-109825808:-	0.23	4.15	4.01E-5	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
STAD	cis	1	rs1275501	chr2:27419282	C2orf28	chr2:27434899-27440044:+	-0.25	-4.38	1.51E-5	Blood metabolite levels	
STAD	cis	1	rs12755094	chr1:10305711	PGD	chr1:10459085-10480200:+	0.23	3.86	0.000134	Hepatocellular carcinoma	
STAD	cis	1	rs1275522	chr2:27426878	C2orf28	chr2:27434899-27440044:+	-0.25	-4.42	1.29E-5	Blood metabolite levels	
STAD	cis	1	rs1275528	chr2:27430781	C2orf28	chr2:27434899-27440044:+	-0.26	-4.48	9.87E-6	Blood metabolite levels	
STAD	cis	1	rs1275530	chr2:27432547	C2orf28	chr2:27434899-27440044:+	-0.22	-3.94	9.63E-5	Blood metabolite levels	
STAD	cis	1	rs1275537	chr2:27441302	C2orf28	chr2:27434899-27440044:+	0.22	3.83	0.000149	Blood metabolite levels	
STAD	cis	1	rs1275538	chr2:27441397	C2orf28	chr2:27434899-27440044:+	0.23	3.97	8.72E-5	Blood metabolite levels	
STAD	cis	1	rs12757820	chr1:10266671	PGD	chr1:10459085-10480200:+	0.23	3.96	8.77E-5	Hepatocellular carcinoma	
STAD	cis	1	rs12763390	chr10:38084432	HSD17B7P2	chr10:38645308-38667432:+	0.34	4.07	5.65E-5	Obesity (extreme)	
STAD	cis	1	rs12763409	chr10:38092690	HSD17B7P2	chr10:38645308-38667432:+	0.33	3.95	9.2E-5	Obesity (extreme)	
STAD	cis	1	rs12766567	chr10:38035222	HSD17B7P2	chr10:38645308-38667432:+	0.34	3.99	7.99E-5	Obesity (extreme)	
STAD	cis	1	rs12772239	chr10:37988944	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.91	0.000109	Obesity (extreme)	
STAD	cis	1	rs12781703	chr10:38044627	HSD17B7P2	chr10:38645308-38667432:+	0.34	4.1	5.11E-5	Obesity (extreme)	
STAD	cis	1	rs12782327	chr10:38092443	HSD17B7P2	chr10:38645308-38667432:+	0.33	3.91	0.000108	Obesity (extreme)	
STAD	cis	1	rs12786555	chr11:506229	RNH1	chr11:494512-507273:-	-0.43	-5.65	3.15E-8	Body mass index	
STAD	cis	1	rs12787330	chr11:47812311	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.64	1.73E-13	Subjective well-being	
STAD	cis	1	rs12788729	chr11:502371	RNH1	chr11:494512-507273:-	-0.43	-5.67	2.74E-8	Body mass index	
STAD	cis	1	rs12794284	chr11:477623	RNH1	chr11:494512-507273:-	-0.43	-5.77	1.6E-8	Body mass index	
STAD	cis	1	rs12795301	chr11:68992285	MYEOV	chr11:69061622-69156449:+	0.39	4.5	8.96E-6	Prostate cancer	
STAD	cis	1	rs12800378	chr11:87865942	RAB38	chr11:87846431-87908599:-	0.22	3.81	0.000161	Frontotemporal dementia	
STAD	cis	1	rs12801148	chr11:511707	RNH1	chr11:494512-507273:-	-0.43	-5.36	1.45E-7	Body mass index	
STAD	cis	1	rs12801271	chr11:508720	RNH1	chr11:494512-507273:-	-0.43	-5.36	1.45E-7	Body mass index	
STAD	cis	1	rs12814773	chr12:129280786	MGC16384	chr12:129297749-129299295:-	-0.2	-4.2	3.32E-5	Systemic lupus erythematosus	
STAD	cis	1	rs12889168	chr14:104481957	TDRD9	chr14:104394817-104519002:+	0.22	3.8	0.000166	Bipolar disorder	
STAD	cis	1	rs12898430	chr15:76874923	SCAPER	chr15:76640529-77197744:-	-0.25	-5.17	3.73E-7	Blood metabolite levels	
STAD	cis	1	rs12899592	chr15:89233041	RLBP1	chr15:89753099-89764922:-	0.24	4.06	6.02E-5	Obesity-related traits	
STAD	cis	1	rs12899981	chr15:85302373	LOC388152	chr15:84867600-84898920:-	-0.28	-4.23	2.94E-5	Schizophrenia	
STAD	cis	1	rs12902672	chr15:84716986	LOC388152	chr15:84867600-84898920:-	-0.3	-4.39	1.49E-5	Schizophrenia	
STAD	cis	1	rs12903134	chr15:85337699	LOC388152	chr15:84867600-84898920:-	-0.28	-4.31	2.11E-5	Schizophrenia	
STAD	cis	1	rs12903820	chr15:84723820	LOC388152	chr15:84867600-84898920:-	-0.29	-4.25	2.63E-5	Schizophrenia	
STAD	cis	1	rs12905057	chr15:85210765	LOC388152	chr15:84867600-84898920:-	-0.29	-4.31	2.07E-5	Schizophrenia	
STAD	cis	1	rs12908161	chr15:85207825	LOC388152	chr15:84867600-84898920:-	-0.29	-4.4	1.42E-5	Schizophrenia	
STAD	cis	1	rs12908549	chr15:85322351	LOC388152	chr15:84867600-84898920:-	-0.28	-4.24	2.78E-5	Schizophrenia	
STAD	cis	1	rs12910012	chr15:85298662	LOC388152	chr15:84867600-84898920:-	-0.28	-4.23	2.94E-5	Schizophrenia	
STAD	cis	1	rs12910992	chr15:90372465	AP3S2	chr15:90373832-90456222:-	-0.64	-9.27	1.25E-18	Type 2 diabetes	
STAD	cis	1	rs12911736	chr15:85240008	LOC388152	chr15:84867600-84898920:-	-0.28	-4.28	2.4E-5	Schizophrenia	
STAD	cis	1	rs12912388	chr15:85344550	LOC388152	chr15:84867600-84898920:-	-0.27	-4.11	4.88E-5	Schizophrenia	
STAD	cis	1	rs12915234	chr15:84758301	LOC388152	chr15:84867600-84898920:-	-0.29	-4.15	4.06E-5	Schizophrenia	
STAD	cis	1	rs12916348	chr15:84765527	LOC388152	chr15:84867600-84898920:-	-0.28	-4.06	5.97E-5	Schizophrenia	
STAD	cis	1	rs12917429	chr15:85425097	LOC388152	chr15:84867600-84898920:-	0.28	3.98	8.06E-5	Alzheimer's disease (age of onset)	
STAD	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.48	9.11	4.44E-18	Eye color traits	
STAD	cis	1	rs12983728	chr19:58671267	ZNF329	chr19:58637619-58666477:-	-0.45	-5	8.85E-7	Cholesterol, total	
STAD	cis	1	rs13006833	chr2:191205499	HIBCH	chr2:191069361-191184559:-	0.4	6.59	1.43E-10	Urinary metabolites	
STAD	cis	1	rs13020137	chr2:130757304	LOC440905	chr2:130783572-130808704:-	-0.2	-3.9	0.000115	Schizophrenia	
STAD	cis	1	rs13053389	chr22:30337445	DUSP18	chr22:31048039-31063872:-	-0.5	-4.04	6.45E-5	LDL cholesterol	
STAD	cis	1	rs13056719	chr22:24724099	POM121L9P	chr22:24647589-24661490:+	-0.25	-5.93	6.85E-9	Gut microbiome composition (summer)	
STAD	cis	1	rs13058817	chr3:53024139	TMEM110	chr3:52867139-52931547:-	0.53	5.28	2.12E-7	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs13058903	chr3:38513365	XYLB	chr3:38388251-38456467:+	-0.22	-4.34	1.86E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs13059720	chr3:134242021	ANAPC13	chr3:134196547-134204865:-	-0.37	-6.66	9.53E-11	Height	
STAD	cis	1	rs13059906	chr3:46208858	CCR2	chr3:46395235-46402412:+	0.19	3.86	0.000132	Celiac disease	
STAD	cis	1	rs13069006	chr3:52973305	TMEM110	chr3:52867139-52931547:-	0.49	4.91	1.35E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs13069467	chr3:46201875	CCR2	chr3:46395235-46402412:+	0.22	3.94	9.68E-5	Celiac disease	
STAD	cis	1	rs13069724	chr3:48478039	TREX1	chr3:48501186-48509043:+	-0.24	-5.28	2.16E-7	Longevity	
STAD	cis	1	rs13069750	chr3:46224850	CCR2	chr3:46395235-46402412:+	0.22	3.9	0.000113	Celiac disease	
STAD	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.27	-6.11	2.46E-9	Longevity	
STAD	cis	1	rs13071551	chr3:134310867	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.84	3.06E-11	Height	
STAD	cis	1	rs13072395	chr3:52980573	TMEM110	chr3:52867139-52931547:-	0.5	4.95	1.12E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs13072457	chr3:53102389	TMEM110	chr3:52867139-52931547:-	0.45	4.78	2.45E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs13072809	chr3:38468171	XYLB	chr3:38388251-38456467:+	0.22	4.37	1.6E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs13072818	chr3:53074263	TMEM110	chr3:52867139-52931547:-	0.4	4.42	1.3E-5	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs13074025	chr3:38455704	XYLB	chr3:38388251-38456467:+	0.21	4.21	3.16E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs13074160	chr3:38455650	XYLB	chr3:38388251-38456467:+	0.21	4.21	3.16E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs13074524	chr3:52974184	TMEM110	chr3:52867139-52931547:-	0.46	4.64	4.75E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs13075836	chr3:46186638	CCR2	chr3:46395235-46402412:+	0.22	3.93	0.000101	Celiac disease	
STAD	cis	1	rs13076033	chr3:52898427	TMEM110	chr3:52867139-52931547:-	0.49	5.03	7.51E-7	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs13076076	chr3:48479039	TREX1	chr3:48501186-48509043:+	-0.25	-5.78	1.57E-8	Longevity	
STAD	cis	1	rs13078971	chr3:53103645	TMEM110	chr3:52867139-52931547:-	0.42	4.55	7.29E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs13079757	chr3:38491444	XYLB	chr3:38388251-38456467:+	0.21	4.32	1.97E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs13080979	chr3:46233690	CCR2	chr3:46395235-46402412:+	0.23	3.86	0.000132	Celiac disease	
STAD	cis	1	rs13081177	chr3:134289860	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.67	8.7E-11	Height	
STAD	cis	1	rs13081688	chr3:134259954	ANAPC13	chr3:134196547-134204865:-	-0.37	-6.66	9.53E-11	Height	
STAD	cis	1	rs13083794	chr3:121464928	IQCB1	chr3:121488610-121553926:-	0.27	4.55	7.19E-6	Cognitive performance	
STAD	cis	1	rs13083881	chr3:46184620	CCR2	chr3:46395235-46402412:+	0.22	3.93	9.93E-5	Celiac disease	
STAD	cis	1	rs13087578	chr3:121369207	IQCB1	chr3:121488610-121553926:-	0.3	4.96	1.07E-6	Cognitive performance	
STAD	cis	1	rs13087719	chr3:41951576	ULK4	chr3:41288091-42003660:-	-0.78	-12.23	2.51E-29	Diastolic blood pressure	
STAD	cis	1	rs13087875	chr3:134261123	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.75	5.47E-11	Height	
STAD	cis	1	rs13088281	chr3:53147576	TMEM110	chr3:52867139-52931547:-	-0.37	-4.04	6.41E-5	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs13088309	chr3:49368317	CCDC36	chr3:49235861-49295537:+	0.21	3.87	0.000125	Menarche (age at onset)	
STAD	cis	1	rs13089394	chr3:38446309	XYLB	chr3:38388251-38456467:+	0.22	4.47	1.02E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs13089966	chr3:134279197	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.75	5.47E-11	Height	
STAD	cis	1	rs13090969	chr3:134307257	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.84	3.06E-11	Height	
STAD	cis	1	rs13091785	chr3:48494098	TREX1	chr3:48501186-48509043:+	-0.25	-5.66	2.95E-8	Longevity	
STAD	cis	1	rs13091844	chr3:53010271	TMEM110	chr3:52867139-52931547:-	0.49	4.97	1.03E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs13092160	chr3:46254791	CCR2	chr3:46395235-46402412:+	0.2	3.99	7.95E-5	Celiac disease	
STAD	cis	1	rs13092352	chr3:52969697	TMEM110	chr3:52867139-52931547:-	0.46	4.64	4.75E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs13095940	chr3:46246816	CCR2	chr3:46395235-46402412:+	0.23	3.89	0.000118	Celiac disease	
STAD	cis	1	rs13095946	chr3:46253812	CCR2	chr3:46395235-46402412:+	0.23	3.88	0.00012	Celiac disease	
STAD	cis	1	rs13096307	chr3:46246953	CCR2	chr3:46395235-46402412:+	0.23	3.89	0.000118	Celiac disease	
STAD	cis	1	rs13096325	chr3:46186838	CCR2	chr3:46395235-46402412:+	0.22	3.92	0.000104	Celiac disease	
STAD	cis	1	rs13096474	chr3:49443081	CCDC36	chr3:49235861-49295537:+	-0.2	-3.81	0.000158	Menarche (age at onset)	
STAD	cis	1	rs13096604	chr3:134250099	ANAPC13	chr3:134196547-134204865:-	-0.37	-6.66	9.53E-11	Height	
STAD	cis	1	rs13096657	chr3:121300728	FAM162A	chr3:122103023-122128960:+	-0.3	-3.83	0.00015	Postprandial triglyceride response to high fat diet meal	
STAD	cis	1	rs13097340	chr3:46187118	CCR2	chr3:46395235-46402412:+	0.22	3.93	0.000101	Celiac disease	
STAD	cis	1	rs13097666	chr3:46234467	CCR2	chr3:46395235-46402412:+	0.23	3.87	0.000125	Celiac disease	
STAD	cis	1	rs13098911	chr3:46235201	CCR2	chr3:46395235-46402412:+	0.23	3.86	0.000132	Celiac disease	
STAD	cis	1	rs13106338	chr4:17676871	LAP3	chr4:17578927-17609590:+	0.19	3.81	0.000159	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs13109003	chr4:129975969	C4orf33	chr4:130014829-130033842:+	-0.43	-6.8	3.85E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs13120847	chr4:48030036	CNGA1	chr4:47937996-48018610:-	0.23	4.44	1.19E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs13122400	chr4:39713743	RPL9	chr4:39455747-39460568:-	-0.32	-5.25	2.55E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
STAD	cis	1	rs13125949	chr4:48026560	CNGA1	chr4:47937996-48018610:-	0.22	4.41	1.32E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs13130762	chr4:130022875	C4orf33	chr4:130014829-130033842:+	-0.42	-6.82	3.41E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs13134489	chr4:165889437	C4orf39	chr4:165878100-165880273:+	0.2	4.53	7.97E-6	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs13140968	chr4:48025095	CNGA1	chr4:47937996-48018610:-	0.24	4.6	5.65E-6	Renal underexcretion gout;Gout	
STAD	cis	1	rs13142905	chr4:48025298	CNGA1	chr4:47937996-48018610:-	0.23	4.43	1.24E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs13168670	chr5:140146899	WDR55	chr5:140044384-140050551:+	-0.21	-3.9	0.000112	Schizophrenia	
STAD	cis	1	rs1317149	chr11:47486885	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.66	1.51E-13	Subjective well-being	
STAD	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.67	-13.3	1.5E-33	Response to antipsychotic treatment	
STAD	cis	1	rs1319540	chr4:109964237	CASP6	chr4:110609785-110624629:-	0.18	3.88	0.000123	Body mass index	
STAD	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.67	-13.18	4.68E-33	Response to antipsychotic treatment	
STAD	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.72	-15.26	1.41E-41	Response to antipsychotic treatment	
STAD	cis	1	rs13200462	chr6:28218199	ZNF323	chr6:28292517-28324048:-	0.29	3.9	0.000115	Depression	
STAD	cis	1	rs13200462	chr6:28218199	ZSCAN23	chr6:28393287-28411279:-	0.24	3.85	0.000135	Depression	
STAD	cis	1	rs1320146	chr2:97507727	CNNM3	chr2:97481991-97501120:+	-0.35	-4.23	2.85E-5	Erectile dysfunction and prostate cancer treatment	
STAD	cis	1	rs1320893	chr7:143752112	ARHGEF35	chr7:143883677-143892736:-	-0.36	-5.64	3.28E-8	Obesity-related traits	
STAD	cis	1	rs1320894	chr7:143751802	ARHGEF35	chr7:143883677-143892736:-	-0.36	-5.59	4.29E-8	Obesity-related traits	
STAD	cis	1	rs1320996	chr6:56100431	COL21A1	chr6:55921389-56258892:-	0.28	6.03	3.84E-9	Pulse pressure	
STAD	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.67	-13.15	6.03E-33	Response to antipsychotic treatment	
STAD	cis	1	rs13220510	chr6:56779141	BEND6	chr6:56819773-56892138:+	-0.24	-5.06	6.56E-7	Menarche (age at onset)	
STAD	cis	1	rs13220979	chr7:65363204	CCT6P1	chr7:65216092-65228661:+	0.26	3.99	7.81E-5	Diabetic kidney disease	
STAD	cis	1	rs13226728	chr7:143746578	ARHGEF35	chr7:143883677-143892736:-	-0.4	-6.26	9.94E-10	Obesity-related traits	
STAD	cis	1	rs13239254	chr7:110917686	IMMP2L	chr7:110303110-111202538:-	0.24	4.14	4.24E-5	Schizophrenia	
STAD	cis	1	rs13240464	chr7:110898915	IMMP2L	chr7:110303110-111202538:-	0.23	3.98	8.22E-5	Schizophrenia	
STAD	cis	1	rs13243677	chr7:143746572	ARHGEF35	chr7:143883677-143892736:-	-0.4	-6.26	9.94E-10	Obesity-related traits	
STAD	cis	1	rs13247184	chr7:65358928	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.24E-5	Diabetic kidney disease	
STAD	cis	1	rs13250359	chr8:29359440	RBPMS	chr8:30241944-30429734:+	-0.15	-3.83	0.000148	Response to statin therapy	
STAD	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	0.6	11.96	2.63E-28	Bone mineral density	
STAD	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	0.58	11.55	9.7E-27	Bone mineral density	
STAD	cis	1	rs13255935	chr8:95965685	TP53INP1	chr8:95938201-95961615:-	-0.17	-3.84	0.000141	Type 2 diabetes	
STAD	cis	1	rs13274558	chr8:29357789	RBPMS	chr8:30241944-30429734:+	-0.16	-3.9	0.000113	Response to statin therapy	
STAD	cis	1	rs13276082	chr8:21823184	NPM2	chr8:21881636-21894407:+	-0.23	-3.99	7.94E-5	Mean corpuscular volume	
STAD	cis	1	rs13310597	chr7:65598540	CCT6P1	chr7:65216092-65228661:+	0.29	4.34	1.85E-5	Diabetic kidney disease	
STAD	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.25	5.86	9.86E-9	Longevity	
STAD	cis	1	rs13322305	chr3:134310791	ANAPC13	chr3:134196547-134204865:-	0.39	6.78	4.41E-11	Height	
STAD	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.74	11.1	4.45E-25	Diastolic blood pressure	
STAD	cis	1	rs13361189	chr5:150223387	LOC134466	chr5:150310000-150326146:-	0.28	4.67	4.16E-6	Crohn's disease	
STAD	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.44E-32	Response to antipsychotic treatment	
STAD	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.66	-13.05	1.56E-32	Response to antipsychotic treatment	
STAD	cis	1	rs13384952	chr2:73723959	ALMS1P	chr2:73872046-73912692:+	-0.43	-5.2	3.28E-7	Metabolite levels	
STAD	cis	1	rs13385191	chr2:20888265	C2orf43	chr2:20883803-21022827:-	-0.56	-8.84	3.42E-17	Prostate cancer	
STAD	cis	1	rs13386793	chr2:219972574	SLC23A3	chr2:220026183-220034817:-	0.36	4.19	3.4E-5	Height	
STAD	cis	1	rs13393738	chr2:219914144	SLC23A3	chr2:220026183-220034817:-	0.36	4.09	5.31E-5	Height	
STAD	cis	1	rs13394499	chr2:219969085	SLC23A3	chr2:220026183-220034817:-	0.4	4.59	5.88E-6	Height	
STAD	cis	1	rs13396442	chr2:219971530	SLC23A3	chr2:220026183-220034817:-	0.4	4.67	4.07E-6	Height	
STAD	cis	1	rs13398075	chr2:202376269	PPIL3	chr2:201735680-201753999:-	0.49	5.38	1.28E-7	Rheumatoid arthritis	
STAD	cis	1	rs13398898	chr2:219927747	SLC23A3	chr2:220026183-220034817:-	0.39	4.62	5.33E-6	Height	
STAD	cis	1	rs13398956	chr2:73720258	ALMS1P	chr2:73872046-73912692:+	0.49	7.76	7.41E-14	Metabolite levels	
STAD	cis	1	rs13398956	chr2:73720258	TPRKB	chr2:73956957-73964517:-	-0.23	-4.8	2.31E-6	Metabolite levels	
STAD	cis	1	rs13404123	chr2:219916797	SLC23A3	chr2:220026183-220034817:-	-0.35	-4.08	5.43E-5	Height	
STAD	cis	1	rs13404123	chr2:219916797	VIL1	chr2:219283838-219314246:+	-0.24	-3.83	0.000148	Height	
STAD	cis	1	rs1340684	chr1:76471146	ACADM	chr1:76190043-76229353:+	-0.32	-4.5	8.92E-6	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs13408294	chr2:202171573	PPIL3	chr2:201735680-201753999:-	-0.53	-7.1	5.83E-12	Rheumatoid arthritis	
STAD	cis	1	rs13408337	chr2:219971526	SLC23A3	chr2:220026183-220034817:-	0.4	4.67	4.07E-6	Height	
STAD	cis	1	rs13408569	chr2:102955056	IL1RL1	chr2:102927962-102968497:+	0.3	4.58	6.39E-6	Asthma	
STAD	cis	1	rs13408661	chr2:102955082	IL1RL1	chr2:102927962-102968497:+	0.3	4.58	6.35E-6	Asthma	
STAD	cis	1	rs13415839	chr2:232126534	ARMC9	chr2:232063342-232238606:+	0.2	4.54	7.37E-6	Food antigen IgG levels	
STAD	cis	1	rs1341759	chr6:26195502	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.67E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs13419073	chr2:97507554	CNNM3	chr2:97481991-97501120:+	-0.34	-4.1	5.0E-5	Erectile dysfunction and prostate cancer treatment	
STAD	cis	1	rs13419740	chr2:219969097	SLC23A3	chr2:220026183-220034817:-	0.38	4.47	1.03E-5	Height	
STAD	cis	1	rs13421462	chr2:73719875	ALMS1P	chr2:73872046-73912692:+	0.49	7.78	6.44E-14	Metabolite levels	
STAD	cis	1	rs13421462	chr2:73719875	TPRKB	chr2:73956957-73964517:-	-0.23	-4.79	2.38E-6	Metabolite levels	
STAD	cis	1	rs13431267	chr2:73782200	ALMS1P	chr2:73872046-73912692:+	0.51	8.05	1.01E-14	Metabolite levels	
STAD	cis	1	rs13431267	chr2:73782200	TPRKB	chr2:73956957-73964517:-	-0.2	-4.28	2.38E-5	Metabolite levels	
STAD	cis	1	rs13431828	chr2:102954653	IL1RL1	chr2:102927962-102968497:+	0.3	4.58	6.39E-6	Asthma	
STAD	cis	1	rs13432605	chr2:73810981	ALMS1P	chr2:73872046-73912692:+	0.49	7.68	1.32E-13	Metabolite levels	
STAD	cis	1	rs13432605	chr2:73810981	TPRKB	chr2:73956957-73964517:-	-0.21	-4.43	1.25E-5	Metabolite levels	
STAD	cis	1	rs134869	chr22:42652074	C22orf32	chr22:42475699-42480287:+	0.22	4.43	1.21E-5	Cognitive function	
STAD	cis	1	rs134869	chr22:42652074	CYP2D6	chr22:42522502-42526883:-	-0.35	-6.32	7.15E-10	Cognitive function	
STAD	cis	1	rs134869	chr22:42652074	NAGA	chr22:42454339-42466846:-	0.21	3.96	8.98E-5	Cognitive function	
STAD	cis	1	rs134869	chr22:42652074	PHF5A	chr22:41855722-41864708:-	0.19	3.91	0.000109	Cognitive function	
STAD	cis	1	rs134873	chr22:42657566	C22orf32	chr22:42475699-42480287:+	0.21	4.31	2.06E-5	Cognitive function	
STAD	cis	1	rs134873	chr22:42657566	CYP2D6	chr22:42522502-42526883:-	-0.33	-5.8	1.35E-8	Cognitive function	
STAD	cis	1	rs134873	chr22:42657566	NAGA	chr22:42454339-42466846:-	0.21	3.86	0.000133	Cognitive function	
STAD	cis	1	rs134882	chr22:42670965	C22orf32	chr22:42475699-42480287:+	0.19	3.88	0.000121	Cognitive function	
STAD	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.34	-6.03	3.81E-9	Cognitive function	
STAD	cis	1	rs134900	chr22:42683343	C22orf32	chr22:42475699-42480287:+	0.21	4.05	6.23E-5	Cognitive function	
STAD	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.34	-5.84	1.08E-8	Cognitive function	
STAD	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.34	-6.13	2.17E-9	Cognitive function	
STAD	cis	1	rs1357762	chr3:134264859	ANAPC13	chr3:134196547-134204865:-	0.39	6.93	1.77E-11	Height	
STAD	cis	1	rs1360172	chr9:131907980	CRAT	chr9:131857075-131873070:-	0.28	5.12	4.83E-7	Blood metabolite ratios	
STAD	cis	1	rs1360172	chr9:131907980	PPP2R4	chr9:131873244-131911223:+	0.23	4.79	2.39E-6	Blood metabolite ratios	
STAD	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.61	-9.06	6.46E-18	Type 2 diabetes	
STAD	cis	1	rs1374469	chr4:1724799	FAM53A	chr4:1641609-1685854:-	-0.46	-6.93	1.78E-11	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs138209	chr22:50539413	MLC1	chr22:50497820-50524358:-	-0.31	-5.24	2.65E-7	Gestational age at birth in labor-initiated deliveries (child effect)	
STAD	cis	1	rs138244	chr22:50565367	MLC1	chr22:50497820-50524358:-	-0.34	-5.66	2.88E-8	Gestational age at birth in labor-initiated deliveries (child effect)	
STAD	cis	1	rs138249	chr22:50569790	MLC1	chr22:50497820-50524358:-	-0.35	-5.76	1.68E-8	Gestational age at birth in labor-initiated deliveries (child effect)	
STAD	cis	1	rs138250	chr22:50570361	MLC1	chr22:50497820-50524358:-	-0.34	-5.72	2.17E-8	Gestational age at birth in labor-initiated deliveries (child effect)	
STAD	cis	1	rs138252	chr22:50570873	MLC1	chr22:50497820-50524358:-	-0.35	-5.8	1.36E-8	Gestational age at birth in labor-initiated deliveries (child effect)	
STAD	cis	1	rs138702	chr22:39132601	LOC646851	chr22:38974125-39052634:-	-0.24	-5.29	2.06E-7	Resting heart rate	
STAD	cis	1	rs138704	chr22:39133410	LOC646851	chr22:38974125-39052634:-	0.24	5.12	4.71E-7	Resting heart rate	
STAD	cis	1	rs138705	chr22:39133803	LOC646851	chr22:38974125-39052634:-	0.26	5.53	6.0E-8	Resting heart rate	
STAD	cis	1	rs138706	chr22:39137834	LOC646851	chr22:38974125-39052634:-	0.26	5.52	6.26E-8	Resting heart rate	
STAD	cis	1	rs138709	chr22:39139216	LOC646851	chr22:38974125-39052634:-	0.26	5.53	5.99E-8	Resting heart rate	
STAD	cis	1	rs138712	chr22:39141600	CBY1	chr22:39052658-39069853:+	0.22	4.14	4.29E-5	Resting heart rate	
STAD	cis	1	rs138712	chr22:39141600	LOC646851	chr22:38974125-39052634:-	0.26	5.46	8.57E-8	Resting heart rate	
STAD	cis	1	rs138713	chr22:39142615	LOC646851	chr22:38974125-39052634:-	0.23	4.91	1.34E-6	Resting heart rate	
STAD	cis	1	rs138716	chr22:39146527	LOC646851	chr22:38974125-39052634:-	0.25	5.25	2.54E-7	Resting heart rate	
STAD	cis	1	rs1388527	chr11:6948441	ZNF215	chr11:6947654-7005861:+	-0.45	-5.24	2.67E-7	Response to cytadine analogues (cytosine arabinoside)	
STAD	cis	1	rs1390006	chr17:56890663	RAD51C	chr17:56769963-56811690:+	-0.22	-4.13	4.43E-5	Cognitive test performance	
STAD	cis	1	rs1391708	chr12:57305580	ARHGAP9	chr12:57866039-57882597:-	-0.15	-4.64	4.66E-6	Airway wall thickness	
STAD	cis	1	rs13943	chr22:22116202	THAP7	chr22:21354061-21356404:-	0.19	4.41	1.33E-5	Multiple sclerosis	
STAD	cis	1	rs1395	chr2:27424636	C2orf28	chr2:27434899-27440044:+	-0.25	-4.36	1.63E-5	Blood metabolite levels	
STAD	cis	1	rs1403284	chr2:73726662	ALMS1P	chr2:73872046-73912692:+	-0.48	-7.56	2.99E-13	Metabolite levels	
STAD	cis	1	rs1403284	chr2:73726662	STAMBP	chr2:74056086-74100759:+	0.27	3.94	9.73E-5	Metabolite levels	
STAD	cis	1	rs1403284	chr2:73726662	TPRKB	chr2:73956957-73964517:-	0.23	4.73	3.19E-6	Metabolite levels	
STAD	cis	1	rs1404147	chr7:65264524	CCT6P1	chr7:65216092-65228661:+	0.28	4.37	1.57E-5	Diabetic kidney disease	
STAD	cis	1	rs1406947	chr20:33969530	GDF5	chr20:33897002-34042568:-	-0.18	-3.98	8.25E-5	Height	
STAD	cis	1	rs1406947	chr20:33969530	UQCC	chr20:33890383-33999833:-	0.23	4.18	3.59E-5	Height	
STAD	cis	1	rs1412444	chr10:91002927	LIPA	chr10:90973328-91174382:-	0.17	3.84	0.000146	Fibrinogen levels	
STAD	cis	1	rs1413695	chr1:210326476	SYT14	chr1:210111538-210337631:+	0.24	4.12	4.66E-5	Manic episodes in bipolar disorder	
STAD	cis	1	rs1414852	chr9:73065164	APBA1	chr9:72042449-72287275:-	-0.18	-3.9	0.000112	Migraine with aura	
STAD	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.29E-32	Response to antipsychotic treatment	
STAD	cis	1	rs1417823	chr10:102227886	SEC31B	chr10:102246403-102289636:-	0.25	6.27	9.6E-10	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs1418788	chr1:90947832	HFM1	chr1:91726324-91870426:-	0.24	4.01	7.27E-5	Coronary artery calcification	
STAD	cis	1	rs1419183	chr6:28242794	ZSCAN23	chr6:28393287-28411279:-	0.24	3.89	0.000118	Depression	
STAD	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.85	16.3	6.23E-46	Type 2 diabetes	
STAD	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.83	16.26	9.36E-46	Type 2 diabetes	
STAD	cis	1	rs1425350	chr4:109976046	CASP6	chr4:110609785-110624629:-	0.19	4.09	5.14E-5	Body mass index	
STAD	cis	1	rs1428551	chr5:150259832	LOC134466	chr5:150310000-150326146:-	0.31	4.87	1.62E-6	Crohn's disease	
STAD	cis	1	rs1428552	chr5:150259831	LOC134466	chr5:150310000-150326146:-	0.3	4.75	2.92E-6	Crohn's disease	
STAD	cis	1	rs1428554	chr5:150257616	LOC134466	chr5:150310000-150326146:-	0.31	4.94	1.19E-6	Crohn's disease	
STAD	cis	1	rs1428555	chr5:150257391	LOC134466	chr5:150310000-150326146:-	-0.27	-4.61	5.36E-6	Crohn's disease	
STAD	cis	1	rs144098432	chr18:51816394	POLI	chr18:51795849-51824602:+	0.24	4.16	3.86E-5	Inflammatory skin disease	
STAD	cis	1	rs144250387	chr10:16966414	VIM	chr10:17270258-17279592:+	0.15	3.87	0.000129	Urinary albumin-to-creatinine ratio	
STAD	cis	1	rs1451707	chr6:56801877	BEND6	chr6:56819773-56892138:+	-0.25	-5.21	3.09E-7	Menarche (age at onset)	
STAD	cis	1	rs1451708	chr6:56802201	BEND6	chr6:56819773-56892138:+	-0.25	-5.21	3.09E-7	Menarche (age at onset)	
STAD	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.27	6.04	3.52E-9	Longevity	
STAD	cis	1	rs1460561	chr6:56797574	BEND6	chr6:56819773-56892138:+	-0.22	-4.45	1.14E-5	Menarche (age at onset)	
STAD	cis	1	rs1466211	chr2:108856412	SULT1C2	chr2:108905095-108926370:+	0.26	4.08	5.52E-5	Blood pressure	
STAD	cis	1	rs1466211	chr2:108856412	SULT1C3	chr2:108863651-108881806:+	0.38	7.06	7.59E-12	Blood pressure	
STAD	cis	1	rs1466212	chr2:108856532	SULT1C2	chr2:108905095-108926370:+	0.26	4.03	6.82E-5	Blood pressure	
STAD	cis	1	rs1466212	chr2:108856532	SULT1C3	chr2:108863651-108881806:+	0.38	7.02	9.71E-12	Blood pressure	
STAD	cis	1	rs1466213	chr2:108856607	SULT1C2	chr2:108905095-108926370:+	0.29	4.48	9.95E-6	Blood pressure	
STAD	cis	1	rs1466213	chr2:108856607	SULT1C3	chr2:108863651-108881806:+	0.39	7.34	1.22E-12	Blood pressure	
STAD	cis	1	rs1471633	chr1:145723739	PDZK1	chr1:145727726-145764073:+	-0.21	-4.28	2.36E-5	Urate levels;Urate levels in overweight individuals	
STAD	cis	1	rs1474698	chr6:56064197	COL21A1	chr6:55921389-56258892:-	-0.28	-6.12	2.22E-9	Pulse pressure	
STAD	cis	1	rs1481824	chr4:54241402	SCFD2	chr4:53739152-54232242:-	0.27	4.11	4.88E-5	DNA methylation (variation)	
STAD	cis	1	rs1485483	chr11:77930138	GAB2	chr11:77926343-78128766:-	-0.27	-3.95	9.09E-5	Testicular germ cell tumor	
STAD	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.38	6.87	2.55E-11	Height	
STAD	cis	1	rs151222	chr16:20674492	ACSM1	chr16:20634559-20709066:-	-0.42	-5.15	4.19E-7	Schizophrenia	
STAD	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.56	-12.31	1.25E-29	Ankylosing spondylitis	
STAD	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.49	8.36	1.13E-15	Ankylosing spondylitis	
STAD	cis	1	rs1520884	chr11:18309700	GTF2H1	chr11:18343816-18388590:+	-0.37	-5.87	9.14E-9	Pancreatic cancer	
STAD	cis	1	rs1533266	chr7:143766714	ARHGEF35	chr7:143883677-143892736:-	-0.36	-5.71	2.27E-8	Obesity-related traits	
STAD	cis	1	rs1533267	chr7:143766440	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.82	1.22E-8	Obesity-related traits	
STAD	cis	1	rs1533268	chr7:143766358	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.85	1.07E-8	Obesity-related traits	
STAD	cis	1	rs1534025	chr3:134313304	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.84	3.06E-11	Height	
STAD	cis	1	rs1534026	chr3:134284767	ANAPC13	chr3:134196547-134204865:-	0.39	6.89	2.32E-11	Height	
STAD	cis	1	rs1540894	chr7:143767676	ARHGEF35	chr7:143883677-143892736:-	-0.36	-5.59	4.25E-8	Obesity-related traits	
STAD	cis	1	rs1540927	chr20:33931344	GDF5	chr20:33897002-34042568:-	-0.18	-3.97	8.49E-5	Height	
STAD	cis	1	rs1540927	chr20:33931344	UQCC	chr20:33890383-33999833:-	0.24	4.23	2.97E-5	Height	
STAD	cis	1	rs1548226	chr20:43983777	SYS1-DBNDD2	chr20:43991701-44039245:+	0.29	4.3	2.12E-5	Psoriasis	
STAD	cis	1	rs1549907	chr5:148392565	ARHGEF37	chr5:148961135-149014527:+	0.25	3.98	8.37E-5	Diastolic blood pressure	
STAD	cis	1	rs1552994	chr1:152171461	FLG2	chr1:152321214-152332482:-	0.26	4.2	3.25E-5	Inflammatory skin disease	
STAD	cis	1	rs1552994	chr1:152171461	FLG	chr1:152274651-152297679:-	0.47	7.79	6.17E-14	Inflammatory skin disease	
STAD	cis	1	rs1554120	chr3:150935371	P2RY12	chr3:151055238-151102544:-	0.24	3.84	0.000146	Heschl's gyrus morphology	
STAD	cis	1	rs1555569	chr17:2149425	SRR	chr17:2207248-2228553:+	-0.4	-7.8	5.71E-14	Esophageal cancer (squamous cell)	
STAD	cis	1	rs1558377	chr4:17650758	LAP3	chr4:17578927-17609590:+	-0.18	-3.8	0.000165	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs1558378	chr4:17650351	LAP3	chr4:17578927-17609590:+	-0.18	-3.8	0.000165	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.84	16.01	1.09E-44	Type 2 diabetes	
STAD	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.27	-6.19	1.53E-9	Longevity	
STAD	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	0.74	12	1.93E-28	Diastolic blood pressure	
STAD	cis	1	rs15655	chr1:171673272	VAMP4	chr1:171669298-171711214:-	0.34	6.36	5.82E-10	Hippocampal atrophy	
STAD	cis	1	rs1569716	chr22:38998519	LOC646851	chr22:38974125-39052634:-	0.24	5.29	2.09E-7	Resting heart rate	
STAD	cis	1	rs1570004	chr20:33958253	GDF5	chr20:33897002-34042568:-	-0.17	-3.85	0.00014	Height	
STAD	cis	1	rs1570004	chr20:33958253	UQCC	chr20:33890383-33999833:-	0.26	4.66	4.38E-6	Height	
STAD	cis	1	rs1571229	chr9:131913711	CRAT	chr9:131857075-131873070:-	0.27	4.89	1.47E-6	Blood metabolite ratios	
STAD	cis	1	rs1571229	chr9:131913711	PPP2R4	chr9:131873244-131911223:+	0.22	4.61	5.48E-6	Blood metabolite ratios	
STAD	cis	1	rs1573897	chr1:247215054	ZNF670	chr1:247200087-247242069:-	-0.25	-4	7.58E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.66	-12.9	5.93E-32	Response to antipsychotic treatment	
STAD	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.29E-32	Response to antipsychotic treatment	
STAD	cis	1	rs1586936	chr1:76366877	ACADM	chr1:76190043-76229353:+	-0.31	-4.4	1.42E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs1599280	chr6:56792576	BEND6	chr6:56819773-56892138:+	-0.24	-5.11	5.06E-7	Menarche (age at onset)	
STAD	cis	1	rs1599281	chr6:56789311	BEND6	chr6:56819773-56892138:+	0.2	4.22	3.03E-5	Menarche (age at onset)	
STAD	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.43	7.18	3.6E-12	Multiple sclerosis	
STAD	cis	1	rs1599932	chr12:58177943	TSFM	chr12:58176536-58191367:+	-0.33	-6.91	2.04E-11	Multiple sclerosis	
STAD	cis	1	rs160637	chr7:65584318	CCT6P1	chr7:65216092-65228661:+	0.29	4.28	2.36E-5	Diabetic kidney disease	
STAD	cis	1	rs160639	chr7:65579987	CCT6P1	chr7:65216092-65228661:+	0.28	4.15	4.08E-5	Diabetic kidney disease	
STAD	cis	1	rs160642	chr7:65558373	CCT6P1	chr7:65216092-65228661:+	0.29	4.35	1.75E-5	Diabetic kidney disease	
STAD	cis	1	rs160643	chr7:65558222	CCT6P1	chr7:65216092-65228661:+	0.23	3.8	0.000167	Diabetic kidney disease	
STAD	cis	1	rs160643	chr7:65558222	INTS4L1	chr7:64601603-64694599:+	0.36	4.21	3.12E-5	Diabetic kidney disease	
STAD	cis	1	rs160644	chr7:65558186	CCT6P1	chr7:65216092-65228661:+	0.29	4.35	1.75E-5	Diabetic kidney disease	
STAD	cis	1	rs160646	chr7:65556280	CCT6P1	chr7:65216092-65228661:+	0.29	4.34	1.84E-5	Diabetic kidney disease	
STAD	cis	1	rs160648	chr7:65543384	CCT6P1	chr7:65216092-65228661:+	0.28	4.02	6.85E-5	Diabetic kidney disease	
STAD	cis	1	rs160652	chr7:65538431	CCT6P1	chr7:65216092-65228661:+	0.28	4.02	7.0E-5	Diabetic kidney disease	
STAD	cis	1	rs1607908	chr3:41905196	ULK4	chr3:41288091-42003660:-	0.77	12.3	1.33E-29	Diastolic blood pressure	
STAD	cis	1	rs1609810	chr9:123642351	LOC253039	chr9:123605320-123616644:+	-0.36	-6.42	3.94E-10	Rheumatoid arthritis	
STAD	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-0.77	-12.13	6.07E-29	Diastolic blood pressure	
STAD	cis	1	rs1613759	chr3:41906183	ULK4	chr3:41288091-42003660:-	0.77	12.13	5.72E-29	Diastolic blood pressure	
STAD	cis	1	rs1615243	chr3:41965234	ULK4	chr3:41288091-42003660:-	-0.78	-12.31	1.15E-29	Diastolic blood pressure	
STAD	cis	1	rs1615543	chr3:41906404	ULK4	chr3:41288091-42003660:-	0.77	12.13	5.72E-29	Diastolic blood pressure	
STAD	cis	1	rs1628874	chr3:41955714	ULK4	chr3:41288091-42003660:-	-0.78	-12.31	1.16E-29	Diastolic blood pressure	
STAD	cis	1	rs1629460	chr3:41927449	ULK4	chr3:41288091-42003660:-	-0.77	-12.1	7.8E-29	Diastolic blood pressure	
STAD	cis	1	rs1633360	chr12:58108052	FAM119B	chr12:58166383-58176323:+	-0.29	-4.77	2.61E-6	Rheumatoid arthritis	
STAD	cis	1	rs1633360	chr12:58108052	TSFM	chr12:58176536-58191367:+	0.21	4.29	2.23E-5	Rheumatoid arthritis	
STAD	cis	1	rs1659685	chr2:27420690	C2orf28	chr2:27434899-27440044:+	-0.25	-4.33	1.88E-5	Blood metabolite levels	
STAD	cis	1	rs1659695	chr2:27406944	C2orf28	chr2:27434899-27440044:+	-0.26	-4.5	9.15E-6	Blood metabolite levels	
STAD	cis	1	rs1665362	chr4:1726367	FAM53A	chr4:1641609-1685854:-	-0.43	-6.63	1.1E-10	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs1665364	chr4:1727206	FAM53A	chr4:1641609-1685854:-	0.45	6.82	3.53E-11	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs1665366	chr4:1728381	FAM53A	chr4:1641609-1685854:-	0.44	6.55	1.79E-10	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs1679709	chr6:28228342	ZSCAN23	chr6:28393287-28411279:-	-0.23	-3.83	0.000146	Depression	
STAD	cis	1	rs1679732	chr6:28221264	ZNF323	chr6:28292517-28324048:-	-0.29	-3.86	0.000131	Depression	
STAD	cis	1	rs16826864	chr3:156580033	LEKR1	chr3:156544076-156763918:+	-0.37	-3.96	8.92E-5	Bone mineral density	
STAD	cis	1	rs16837131	chr2:202173812	BZW1	chr2:201676612-201688559:+	0.35	4.15	4.09E-5	Rheumatoid arthritis	
STAD	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.58	7.59	2.31E-13	Rheumatoid arthritis	
STAD	cis	1	rs16867454	chr2:182462485	CERKL	chr2:182401402-182545381:-	-0.29	-4.99	9.15E-7	Response to iloperidone treatment (QT prolongation)	
STAD	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.71	-14.96	2.51E-40	Response to antipsychotic treatment	
STAD	cis	1	rs16891378	chr6:26188864	HIST1H2AE	chr6:26217148-26217711:+	-0.31	-4.29	2.26E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs16891397	chr6:26200256	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.44	1.18E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs16891401	chr6:26202337	HIST1H2AE	chr6:26217148-26217711:+	-0.33	-4.44	1.16E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs16891405	chr6:26204506	HIST1H2AE	chr6:26217148-26217711:+	-0.33	-4.44	1.2E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs16916041	chr10:63146547	C10orf107	chr10:63422719-63526089:+	-0.36	-4.76	2.7E-6	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	
STAD	cis	1	rs16917224	chr8:96030110	C8orf38	chr8:95908040-96088396:+	-0.33	-3.92	0.000105	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs16917233	chr8:96044967	C8orf38	chr8:95908040-96088396:+	0.34	4.06	5.91E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs16952009	chr17:2102437	SRR	chr17:2207248-2228553:+	-0.38	-7.45	6.22E-13	Esophageal cancer (squamous cell)	
STAD	cis	1	rs16958432	chr18:44631773	HDHD2	chr18:44633782-44676871:-	0.55	5.36	1.43E-7	Sitting height ratio	
STAD	cis	1	rs16958440	chr18:44632884	HDHD2	chr18:44633782-44676871:-	0.56	5.41	1.09E-7	Sitting height ratio	
STAD	cis	1	rs16958701	chr18:44655241	HDHD2	chr18:44633782-44676871:-	0.51	4.96	1.07E-6	Sitting height ratio	
STAD	cis	1	rs1699379	chr4:129992337	C4orf33	chr4:130014829-130033842:+	-0.39	-6.35	5.99E-10	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs1699389	chr4:130004079	C4orf33	chr4:130014829-130033842:+	-0.39	-6.25	1.06E-9	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs1699391	chr4:130005096	C4orf33	chr4:130014829-130033842:+	-0.39	-6.25	1.06E-9	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs1699392	chr4:130022347	C4orf33	chr4:130014829-130033842:+	-0.41	-6.73	6.14E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs1699393	chr4:130019352	C4orf33	chr4:130014829-130033842:+	-0.43	-6.82	3.38E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs1699394	chr4:130019312	C4orf33	chr4:130014829-130033842:+	-0.41	-6.68	8.22E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs17018691	chr12:91473900	KERA	chr12:91444273-91452131:-	0.28	4.65	4.65E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs17018694	chr12:91474052	KERA	chr12:91444273-91452131:-	0.28	4.65	4.65E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs17018731	chr12:91499367	KERA	chr12:91444273-91452131:-	0.31	5.37	1.36E-7	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs17025455	chr1:110651022	AMPD2	chr1:110162126-110174677:+	0.46	4.13	4.53E-5	Visceral adipose tissue/subcutaneous adipose tissue ratio	
STAD	cis	1	rs17030613	chr1:113190807	ST7L	chr1:113066142-113162405:-	0.38	6.8	3.86E-11	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs17030651	chr1:113239382	ST7L	chr1:113066142-113162405:-	0.38	6.82	3.4E-11	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs17036821	chr3:12533148	TSEN2	chr3:12525931-12581122:+	-0.37	-4.24	2.84E-5	Prostate cancer (gene x gene interaction)	
STAD	cis	1	rs17037427	chr1:11873416	CLCN6	chr1:11866207-11907674:+	0.27	4.06	5.9E-5	QRS complex (12-leadsum)	
STAD	cis	1	rs17037429	chr1:11873787	CLCN6	chr1:11866207-11907674:+	-0.27	-4.17	3.73E-5	QRS complex (12-leadsum)	
STAD	cis	1	rs17037452	chr1:11895675	CLCN6	chr1:11866207-11907674:+	0.29	4.28	2.35E-5	QRS complex (12-leadsum)	
STAD	cis	1	rs17052727	chr3:53070914	TMEM110	chr3:52867139-52931547:-	0.39	4.44	1.18E-5	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs17061431	chr3:41792655	ULK4	chr3:41288091-42003660:-	0.75	11.69	2.86E-27	Diastolic blood pressure	
STAD	cis	1	rs17062109	chr3:41810364	ULK4	chr3:41288091-42003660:-	0.74	11.99	2.01E-28	Diastolic blood pressure	
STAD	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	0.74	12	1.93E-28	Diastolic blood pressure	
STAD	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	0.74	12	1.93E-28	Diastolic blood pressure	
STAD	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	0.76	12.24	2.24E-29	Diastolic blood pressure	
STAD	cis	1	rs17064124	chr3:41890803	ULK4	chr3:41288091-42003660:-	0.78	12.43	4.11E-30	Diastolic blood pressure	
STAD	cis	1	rs17070580	chr6:109738714	SMPD2	chr6:109761931-109765121:+	-0.24	-4.85	1.81E-6	Height	
STAD	cis	1	rs1707321	chr1:46505309	CCDC163P	chr1:45960581-45965646:-	-0.23	-3.96	8.8E-5	Body mass index	
STAD	cis	1	rs1707335	chr1:46571921	CCDC163P	chr1:45960581-45965646:-	-0.22	-3.84	0.000146	Body mass index	
STAD	cis	1	rs1707336	chr1:46493460	TMEM69	chr1:46153847-46160108:+	0.18	3.92	0.000106	Body mass index	
STAD	cis	1	rs17082782	chr4:54306440	SCFD2	chr4:53739152-54232242:-	0.29	4.23	2.98E-5	DNA methylation (variation)	
STAD	cis	1	rs17092215	chr20:33595913	PROCR	chr20:33758727-33765164:+	-0.48	-5.21	3.09E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs17092297	chr20:33703134	PROCR	chr20:33758727-33765164:+	0.41	4.76	2.71E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs17093141	chr14:74326903	PTGR2	chr14:74318534-74352166:+	0.51	6.17	1.75E-9	Morning vs. evening chronotype	
STAD	cis	1	rs17093474	chr14:74342413	PTGR2	chr14:74318534-74352166:+	0.51	6.18	1.59E-9	Morning vs. evening chronotype	
STAD	cis	1	rs17094021	chr14:74394295	PTGR2	chr14:74318534-74352166:+	0.47	5.51	6.44E-8	Morning vs. evening chronotype	
STAD	cis	1	rs17096228	chr14:74558669	LIN52	chr14:74551656-74667117:+	0.37	6.83	3.37E-11	Common traits (Other)	
STAD	cis	1	rs17097836	chr1:76462006	ACADM	chr1:76190043-76229353:+	-0.31	-4.31	2.04E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs17097841	chr1:76462641	ACADM	chr1:76190043-76229353:+	-0.31	-4.31	2.04E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs17097863	chr1:76468787	ACADM	chr1:76190043-76229353:+	-0.31	-4.32	1.99E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs17111376	chr5:150226899	LOC134466	chr5:150310000-150326146:-	0.3	4.89	1.45E-6	Crohn's disease	
STAD	cis	1	rs17113137	chr10:102241998	SEC31B	chr10:102246403-102289636:-	-0.24	-5.94	6.48E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs17164851	chr7:130003487	CPA5	chr7:129984630-130008571:+	0.6	8.93	1.68E-17	Age-related hearing impairment (interaction)	
STAD	cis	1	rs1716642	chr3:41965865	ULK4	chr3:41288091-42003660:-	-0.78	-12.31	1.15E-29	Diastolic blood pressure	
STAD	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-0.77	-12.09	8.77E-29	Diastolic blood pressure	
STAD	cis	1	rs1716651	chr3:41975099	ULK4	chr3:41288091-42003660:-	-0.78	-12.31	1.15E-29	Diastolic blood pressure	
STAD	cis	1	rs1716657	chr3:41918456	ULK4	chr3:41288091-42003660:-	-0.77	-12.08	8.93E-29	Diastolic blood pressure	
STAD	cis	1	rs1716660	chr3:41929960	ULK4	chr3:41288091-42003660:-	-0.77	-12.26	1.84E-29	Diastolic blood pressure	
STAD	cis	1	rs1716661	chr3:41962818	ULK4	chr3:41288091-42003660:-	-0.77	-12.19	3.54E-29	Diastolic blood pressure	
STAD	cis	1	rs1716664	chr3:41948378	ULK4	chr3:41288091-42003660:-	-0.76	-11.94	3.32E-28	Diastolic blood pressure	
STAD	cis	1	rs1716668	chr3:41907850	ULK4	chr3:41288091-42003660:-	0.77	12.13	5.72E-29	Diastolic blood pressure	
STAD	cis	1	rs1716669	chr3:41908681	ULK4	chr3:41288091-42003660:-	0.77	12.17	4.09E-29	Diastolic blood pressure	
STAD	cis	1	rs1716676	chr3:41903208	ULK4	chr3:41288091-42003660:-	0.77	12.19	3.64E-29	Diastolic blood pressure	
STAD	cis	1	rs1716683	chr3:41923074	ULK4	chr3:41288091-42003660:-	-0.75	-11.85	7.31E-28	Diastolic blood pressure	
STAD	cis	1	rs1716685	chr3:41925301	ULK4	chr3:41288091-42003660:-	0.77	12.34	9.47E-30	Diastolic blood pressure	
STAD	cis	1	rs1716688	chr3:41926546	ULK4	chr3:41288091-42003660:-	-0.77	-12.1	7.8E-29	Diastolic blood pressure	
STAD	cis	1	rs1716690	chr3:41922102	ULK4	chr3:41288091-42003660:-	-0.75	-11.85	7.31E-28	Diastolic blood pressure	
STAD	cis	1	rs1716692	chr3:41983786	ULK4	chr3:41288091-42003660:-	-0.77	-12.11	7.06E-29	Diastolic blood pressure	
STAD	cis	1	rs1716693	chr3:41985600	ULK4	chr3:41288091-42003660:-	-0.75	-12.14	5.3E-29	Diastolic blood pressure	
STAD	cis	1	rs1716696	chr3:41935811	ULK4	chr3:41288091-42003660:-	-0.77	-12.26	1.84E-29	Diastolic blood pressure	
STAD	cis	1	rs1716984	chr3:41965532	ULK4	chr3:41288091-42003660:-	-0.77	-12.31	1.19E-29	Diastolic blood pressure	
STAD	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-0.76	-11.99	2.08E-28	Diastolic blood pressure	
STAD	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-0.77	-12.09	8.77E-29	Diastolic blood pressure	
STAD	cis	1	rs1716997	chr3:41924333	ULK4	chr3:41288091-42003660:-	-0.75	-11.85	7.31E-28	Diastolic blood pressure	
STAD	cis	1	rs1716999	chr3:41930041	ULK4	chr3:41288091-42003660:-	-0.77	-12.26	1.84E-29	Diastolic blood pressure	
STAD	cis	1	rs1717000	chr3:41930219	ULK4	chr3:41288091-42003660:-	-0.77	-12.24	2.15E-29	Diastolic blood pressure	
STAD	cis	1	rs1717001	chr3:41934949	ULK4	chr3:41288091-42003660:-	-0.77	-12.1	7.8E-29	Diastolic blood pressure	
STAD	cis	1	rs1717006	chr3:41940448	ULK4	chr3:41288091-42003660:-	0.77	12.31	1.16E-29	Diastolic blood pressure	
STAD	cis	1	rs1717009	chr3:41946308	ULK4	chr3:41288091-42003660:-	-0.77	-12.1	7.97E-29	Diastolic blood pressure	
STAD	cis	1	rs1717011	chr3:41980199	ULK4	chr3:41288091-42003660:-	-0.78	-12.31	1.15E-29	Diastolic blood pressure	
STAD	cis	1	rs1717014	chr3:41917395	ULK4	chr3:41288091-42003660:-	0.77	12.08	8.93E-29	Diastolic blood pressure	
STAD	cis	1	rs1717017	chr3:41915616	ULK4	chr3:41288091-42003660:-	0.77	12.08	8.93E-29	Diastolic blood pressure	
STAD	cis	1	rs1717020	chr3:41981490	ULK4	chr3:41288091-42003660:-	0.76	12.11	7.18E-29	Diastolic blood pressure	
STAD	cis	1	rs1717021	chr3:41983860	ULK4	chr3:41288091-42003660:-	-0.77	-12.11	7.06E-29	Diastolic blood pressure	
STAD	cis	1	rs1717024	chr3:41984888	ULK4	chr3:41288091-42003660:-	-0.69	-11.25	1.26E-25	Diastolic blood pressure	
STAD	cis	1	rs1717027	chr3:41987920	ULK4	chr3:41288091-42003660:-	-0.75	-12.14	5.3E-29	Diastolic blood pressure	
STAD	cis	1	rs1717031	chr3:41905791	ULK4	chr3:41288091-42003660:-	0.77	12.13	5.72E-29	Diastolic blood pressure	
STAD	cis	1	rs1717033	chr3:41910216	ULK4	chr3:41288091-42003660:-	0.77	12.17	4.09E-29	Diastolic blood pressure	
STAD	cis	1	rs17246007	chr14:65865671	LOC645431	chr14:65877313-65879335:-	0.41	4.86	1.72E-6	Ischemic stroke	
STAD	cis	1	rs17246042	chr14:65874330	LOC645431	chr14:65877313-65879335:-	-0.37	-4.4	1.41E-5	Ischemic stroke	
STAD	cis	1	rs17282391	chr3:46179481	CCR2	chr3:46395235-46402412:+	-0.22	-3.88	0.000122	Celiac disease	
STAD	cis	1	rs17282797	chr3:46232765	CCR2	chr3:46395235-46402412:+	0.23	3.86	0.000132	Celiac disease	
STAD	cis	1	rs17310467	chr20:33545616	PROCR	chr20:33758727-33765164:+	-0.49	-5.22	2.92E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs17311679	chr19:50521331	SIGLEC16	chr19:50472912-50479075:+	-0.68	-5.3	1.98E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
STAD	cis	1	rs17317888	chr20:33594959	PROCR	chr20:33758727-33765164:+	-0.46	-4.89	1.47E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs17319967	chr20:33693650	PROCR	chr20:33758727-33765164:+	-0.48	-5.3	1.92E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs17401737	chr20:33552642	PROCR	chr20:33758727-33765164:+	-0.49	-5.21	3.0E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs17422573	chr12:22548865	KIAA0528	chr12:22601526-22697452:-	-0.39	-3.93	9.85E-5	Coronary artery calcification	
STAD	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.84	20.99	5.14E-66	Carotid intima media thickness	
STAD	cis	1	rs17433780	chr1:89474818	GBP7	chr1:89597434-89641723:-	0.27	4.54	7.66E-6	Carotid intima media thickness	
STAD	cis	1	rs17450853	chr6:56788004	BEND6	chr6:56819773-56892138:+	-0.23	-5.23	2.77E-7	Menarche (age at onset)	
STAD	cis	1	rs174551	chr11:61573684	FADS2	chr11:61583728-61634825:+	0.23	4.14	4.32E-5	LDL cholesterol	
STAD	cis	1	rs17459044	chr9:131853624	CRAT	chr9:131857075-131873070:-	0.27	4.68	3.91E-6	Pelvic organ prolapse (moderate/severe)	
STAD	cis	1	rs17459044	chr9:131853624	PPP2R4	chr9:131873244-131911223:+	0.23	4.62	5.17E-6	Pelvic organ prolapse (moderate/severe)	
STAD	cis	1	rs17496332	chr1:107546375	PRMT6	chr1:107599267-107601907:+	0.53	9.22	1.87E-18	Sex hormone-binding globulin levels	
STAD	cis	1	rs17507481	chr4:17620066	LAP3	chr4:17578927-17609590:+	-0.18	-3.88	0.000121	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs1752435	chr14:59946094	C14orf149	chr14:59939406-59951126:-	-0.51	-4.66	4.38E-6	Schizophrenia	
STAD	cis	1	rs17540777	chr11:118150259	DSCAML1	chr11:117298489-117688240:-	0.5	4.42	1.26E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
STAD	cis	1	rs17551370	chr5:110404185	WDR36	chr5:110427870-110466201:+	0.28	4.22	3.05E-5	Eosinophil counts	
STAD	cis	1	rs1757924	chr4:130019599	C4orf33	chr4:130014829-130033842:+	-0.4	-6.55	1.8E-10	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs1757925	chr4:130020791	C4orf33	chr4:130014829-130033842:+	0.4	6.59	1.39E-10	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs1757927	chr4:130022069	C4orf33	chr4:130014829-130033842:+	-0.42	-6.82	3.41E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs1757928	chr4:130022161	C4orf33	chr4:130014829-130033842:+	-0.42	-6.82	3.41E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs1757930	chr4:130022356	C4orf33	chr4:130014829-130033842:+	-0.41	-6.61	1.26E-10	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs1757935	chr4:130023759	C4orf33	chr4:130014829-130033842:+	-0.42	-6.82	3.41E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.4	-7.69	1.22E-13	Forced vital capacity	
STAD	cis	1	rs17598927	chr6:26184640	HIST1H2AE	chr6:26217148-26217711:+	0.38	4.97	1.02E-6	Renal underexcretion gout;Gout	
STAD	cis	1	rs17600551	chr15:85319258	LOC388152	chr15:84867600-84898920:-	-0.28	-4.22	3.07E-5	Schizophrenia	
STAD	cis	1	rs17601029	chr15:85347709	LOC388152	chr15:84867600-84898920:-	-0.27	-4.05	6.11E-5	Schizophrenia	
STAD	cis	1	rs17605685	chr19:50486741	SIGLEC16	chr19:50472912-50479075:+	0.69	5.5	6.87E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
STAD	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.41	-7.78	6.39E-14	Temperament	
STAD	cis	1	rs17608677	chr2:219936871	SLC23A3	chr2:220026183-220034817:-	-0.32	-4.18	3.54E-5	Height	
STAD	cis	1	rs17649068	chr1:171713893	VAMP4	chr1:171669298-171711214:-	0.34	6.35	6.17E-10	Hippocampal atrophy	
STAD	cis	1	rs17649250	chr1:171720586	VAMP4	chr1:171669298-171711214:-	0.33	5.82	1.26E-8	Hippocampal atrophy	
STAD	cis	1	rs17655003	chr2:219930481	SLC23A3	chr2:220026183-220034817:-	0.37	4.32	1.95E-5	Height	
STAD	cis	1	rs17661933	chr19:50534520	SIGLEC16	chr19:50472912-50479075:+	-0.58	-4.7	3.69E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
STAD	cis	1	rs1766347	chr13:78387963	FBXL3	chr13:77579390-77601331:-	0.23	4.34	1.84E-5	Hair color	
STAD	cis	1	rs17685143	chr6:56774788	BEND6	chr6:56819773-56892138:+	-0.24	-5.03	7.66E-7	Menarche (age at onset)	
STAD	cis	1	rs17691170	chr3:121357626	IQCB1	chr3:121488610-121553926:-	0.28	4.69	3.73E-6	Cognitive performance	
STAD	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.38	7.02	9.99E-12	Height	
STAD	cis	1	rs17713396	chr2:227201	SH3YL1	chr2:218138-264810:-	-0.59	-12.46	3.19E-30	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs17713729	chr2:249092	SH3YL1	chr2:218138-264810:-	-0.61	-12.8	1.48E-31	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs17714252	chr2:285471	SH3YL1	chr2:218138-264810:-	-0.58	-12.18	3.74E-29	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs17722209	chr5:148406386	ARHGEF37	chr5:148961135-149014527:+	0.26	4.03	6.65E-5	Diastolic blood pressure	
STAD	cis	1	rs17727568	chr5:150244688	LOC134466	chr5:150310000-150326146:-	0.43	6.42	4.04E-10	Crohn's disease	
STAD	cis	1	rs17733640	chr3:38446742	XYLB	chr3:38388251-38456467:+	0.23	4.55	7.28E-6	Electrocardiographic conduction measures	
STAD	cis	1	rs17746014	chr10:102315354	SEC31B	chr10:102246403-102289636:-	-0.21	-5	8.75E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs1775148	chr1:205757824	RAB7L1	chr1:205737115-205744610:-	0.27	4.93	1.2E-6	Prostate cancer	
STAD	cis	1	rs1775151	chr1:205745684	RAB7L1	chr1:205737115-205744610:-	0.28	4.66	4.39E-6	Parkinson's disease	
STAD	cis	1	rs17752459	chr6:56798755	BEND6	chr6:56819773-56892138:+	-0.24	-5.13	4.6E-7	Menarche (age at onset)	
STAD	cis	1	rs17753121	chr13:28052613	GTF3A	chr13:27998681-28009846:+	-0.38	-4.08	5.55E-5	Weight	
STAD	cis	1	rs17753763	chr13:28077734	GTF3A	chr13:27998681-28009846:+	-0.35	-3.83	0.00015	Weight	
STAD	cis	1	rs1778508	chr6:28229881	ZNF323	chr6:28292517-28324048:-	-0.31	-4.15	4.16E-5	Depression	
STAD	cis	1	rs1778511	chr6:28229411	ZSCAN23	chr6:28393287-28411279:-	-0.24	-3.88	0.000122	Depression	
STAD	cis	1	rs1779410	chr1:205248759	DSTYK	chr1:205111632-205180727:-	0.21	3.89	0.000119	Mean platelet volume	
STAD	cis	1	rs17795097	chr5:148369653	ARHGEF37	chr5:148961135-149014527:+	-0.25	-3.99	7.9E-5	Diastolic blood pressure	
STAD	cis	1	rs17800886	chr5:150309539	LOC134466	chr5:150310000-150326146:-	0.34	5.58	4.43E-8	Crohn's disease	
STAD	cis	1	rs17826790	chr14:66103427	LOC645431	chr14:65877313-65879335:-	-0.37	-4.28	2.35E-5	Ischemic stroke	
STAD	cis	1	rs17826820	chr14:66113837	LOC645431	chr14:65877313-65879335:-	-0.36	-4.14	4.24E-5	Ischemic stroke	
STAD	cis	1	rs17839567	chr16:31057945	MYST1	chr16:31128985-31142713:+	0.24	4.19	3.45E-5	Response to metformin (IC50)	
STAD	cis	1	rs1800662	chr10:102289078	SEC31B	chr10:102246403-102289636:-	-0.24	-5.86	9.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.37	6.58	1.55E-10	Height	
STAD	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.36	6.55	1.87E-10	Height	
STAD	cis	1	rs1816256	chr5:150272853	LOC134466	chr5:150310000-150326146:-	0.31	4.86	1.71E-6	Crohn's disease	
STAD	cis	1	rs1818950	chr15:84722521	LOC388152	chr15:84867600-84898920:-	-0.3	-4.32	2.0E-5	Schizophrenia	
STAD	cis	1	rs1820682	chr5:150262142	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs1823874	chr15:100357435	C15orf51	chr15:100330361-100347132:-	-0.24	-5.04	7.03E-7	IgG glycosylation	
STAD	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.84	16.2	1.61E-45	Type 2 diabetes	
STAD	cis	1	rs1841777	chr3:38484819	XYLB	chr3:38388251-38456467:+	0.21	4.32	1.97E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs1848093	chr15:84755527	LOC388152	chr15:84867600-84898920:-	-0.29	-4.15	4.06E-5	Schizophrenia	
STAD	cis	1	rs1854774	chr4:129988405	C4orf33	chr4:130014829-130033842:+	-0.44	-6.93	1.74E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.67	-13.24	2.6E-33	Response to antipsychotic treatment	
STAD	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs1860596	chr4:17660082	LAP3	chr4:17578927-17609590:+	-0.21	-4.47	1.02E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs1861444	chr2:37464511	CEBPZ	chr2:37428778-37458740:-	0.2	3.81	0.000159	Chronic lymphocytic leukemia	
STAD	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.84	16.09	4.76E-45	Type 2 diabetes	
STAD	cis	1	rs186378	chr7:65582058	CCT6P1	chr7:65216092-65228661:+	0.29	4.28	2.36E-5	Diabetic kidney disease	
STAD	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.37	6.72	6.34E-11	Height	
STAD	cis	1	rs1863998	chr5:150271753	LOC134466	chr5:150310000-150326146:-	0.29	4.59	6.01E-6	Crohn's disease	
STAD	cis	1	rs1869365	chr17:40293865	DHX58	chr17:40253422-40264751:-	-0.36	-6.79	4.09E-11	Fibrinogen levels	
STAD	cis	1	rs1873872	chr11:129473993	NFRKB	chr11:129733671-129765490:-	0.21	4.04	6.38E-5	Type 2 diabetes;Breast cancer	
STAD	cis	1	rs1874883	chr3:134205071	ANAPC13	chr3:134196547-134204865:-	0.36	6.56	1.7E-10	Height	
STAD	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.43	7.18	3.6E-12	Multiple sclerosis	
STAD	cis	1	rs1875124	chr12:58196802	TSFM	chr12:58176536-58191367:+	-0.33	-6.91	2.04E-11	Multiple sclerosis	
STAD	cis	1	rs1880376	chr3:134270347	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.75	5.47E-11	Height	
STAD	cis	1	rs1880377	chr3:134270468	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.75	5.47E-11	Height	
STAD	cis	1	rs1882140	chr12:91479826	KERA	chr12:91444273-91452131:-	0.28	4.76	2.7E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs1888999	chr20:25291848	ZNF337	chr20:25654852-25677469:-	-0.18	-3.93	0.000101	Liver enzyme levels (alkaline phosphatase)	
STAD	cis	1	rs1890967	chr1:76459544	ACADM	chr1:76190043-76229353:+	-0.3	-4.25	2.63E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs1892846	chr22:22186479	THAP7	chr22:21354061-21356404:-	0.18	4.28	2.4E-5	Multiple sclerosis	
STAD	cis	1	rs1892848	chr22:22186562	THAP7	chr22:21354061-21356404:-	0.18	4.28	2.4E-5	Multiple sclerosis	
STAD	cis	1	rs1896707	chr5:150245129	LOC134466	chr5:150310000-150326146:-	0.32	5.05	6.68E-7	Crohn's disease	
STAD	cis	1	rs1896708	chr5:150245076	LOC134466	chr5:150310000-150326146:-	0.33	5.2	3.16E-7	Crohn's disease	
STAD	cis	1	rs1896709	chr5:150245032	LOC134466	chr5:150310000-150326146:-	0.32	5.05	6.68E-7	Crohn's disease	
STAD	cis	1	rs1903330	chr6:56776985	BEND6	chr6:56819773-56892138:+	0.24	5.01	8.09E-7	Menarche (age at onset)	
STAD	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.88	17.68	8.3E-52	Type 2 diabetes	
STAD	cis	1	rs1911155	chr15:84787635	LOC388152	chr15:84867600-84898920:-	-0.27	-3.9	0.000111	Schizophrenia	
STAD	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.72	-15.26	1.41E-41	Response to antipsychotic treatment	
STAD	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs1914859	chr4:165906141	C4orf39	chr4:165878100-165880273:+	0.19	4.23	2.97E-5	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs1917130	chr3:134313773	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.85	2.8E-11	Height	
STAD	cis	1	rs1919948	chr7:143762843	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.76	1.71E-8	Obesity-related traits	
STAD	cis	1	rs1919949	chr7:143767723	ARHGEF35	chr7:143883677-143892736:-	-0.36	-5.54	5.64E-8	Obesity-related traits	
STAD	cis	1	rs1919950	chr7:143767898	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.69	2.44E-8	Obesity-related traits	
STAD	cis	1	rs1919951	chr7:143768891	ARHGEF35	chr7:143883677-143892736:-	-0.38	-5.76	1.74E-8	Obesity-related traits	
STAD	cis	1	rs1920790	chr12:91492788	KERA	chr12:91444273-91452131:-	0.28	4.72	3.22E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs1925148	chr6:56095672	COL21A1	chr6:55921389-56258892:-	0.27	5.86	9.68E-9	Pulse pressure	
STAD	cis	1	rs1925152	chr6:56102709	COL21A1	chr6:55921389-56258892:-	0.27	5.88	8.78E-9	Pulse pressure	
STAD	cis	1	rs1936365	chr6:28268452	ZNF323	chr6:28292517-28324048:-	-0.33	-4.58	6.15E-6	Depression	
STAD	cis	1	rs1953126	chr9:123640500	LOC253039	chr9:123605320-123616644:+	-0.38	-6.76	5.21E-11	Rheumatoid arthritis	
STAD	cis	1	rs1961779	chr12:91483139	KERA	chr12:91444273-91452131:-	0.28	4.76	2.7E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.66	-13.29	1.6E-33	Response to antipsychotic treatment	
STAD	cis	1	rs1967017	chr1:145723645	PDZK1	chr1:145727726-145764073:+	-0.21	-4.28	2.36E-5	Urate levels;Urate levels in overweight individuals	
STAD	cis	1	rs1971762	chr12:54058238	ATP5G2	chr12:54058945-54070512:-	0.22	4.46	1.07E-5	Height	
STAD	cis	1	rs1974624	chr4:17650281	LAP3	chr4:17578927-17609590:+	-0.19	-4.07	5.8E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs1975284	chr8:57314663	PENK	chr8:57353513-57359282:-	-0.28	-5.2	3.16E-7	Obesity-related traits	
STAD	cis	1	rs1977447	chr9:131868196	CRAT	chr9:131857075-131873070:-	-0.28	-4.76	2.74E-6	Blood metabolite ratios	
STAD	cis	1	rs1977447	chr9:131868196	PPP2R4	chr9:131873244-131911223:+	-0.23	-4.34	1.79E-5	Blood metabolite ratios	
STAD	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.86	-10.19	8.98E-22	Schizophrenia	
STAD	cis	1	rs1982861	chr3:49577665	CCDC36	chr3:49235861-49295537:+	0.2	3.81	0.000159	Menarche (age at onset)	
STAD	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.77	11.86	6.42E-28	Diastolic blood pressure	
STAD	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.66	-13.17	4.87E-33	Response to antipsychotic treatment	
STAD	cis	1	rs2003284	chr10:102202338	SEC31B	chr10:102246403-102289636:-	-0.25	-5.99	4.78E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2004711	chr5:150225068	LOC134466	chr5:150310000-150326146:-	0.3	4.84	1.9E-6	Crohn's disease	
STAD	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.38	-6.86	2.73E-11	Forced vital capacity	
STAD	cis	1	rs2006893	chr22:22128678	THAP7	chr22:21354061-21356404:-	0.16	3.83	0.00015	Multiple sclerosis	
STAD	cis	1	rs2007981	chr19:18567555	ISYNA1	chr19:18545625-18548943:-	0.24	4.17	3.69E-5	Breast cancer	
STAD	cis	1	rs2008905	chr11:17184623	NUCB2	chr11:17281887-17371521:+	0.25	3.85	0.000141	Schizophrenia	
STAD	cis	1	rs2014252	chr2:27462405	C2orf28	chr2:27434899-27440044:+	0.24	4.22	3.06E-5	Blood metabolite levels	
STAD	cis	1	rs2014521	chr17:40283413	DHX58	chr17:40253422-40264751:-	-0.34	-6.2	1.48E-9	Fibrinogen levels	
STAD	cis	1	rs201466262	chr8:52407936	PXDNL	chr8:52232144-52722005:-	-0.34	-4.8	2.24E-6	Mild influenza (H1N1) infection	
STAD	cis	1	rs2019097	chr2:202193463	PPIL3	chr2:201735680-201753999:-	-0.49	-6.43	3.8E-10	Rheumatoid arthritis	
STAD	cis	1	rs2028299	chr15:90374257	AP3S2	chr15:90373832-90456222:-	-0.64	-9.36	6.36E-19	Type 2 diabetes	
STAD	cis	1	rs2038227	chr16:539140	DECR2	chr16:451858-462486:+	-0.27	-5.19	3.36E-7	Venous thromboembolism (SNP x SNP interaction)	
STAD	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.25	5.56	5.01E-8	Longevity	
STAD	cis	1	rs2050265	chr1:11879699	CLCN6	chr1:11866207-11907674:+	0.26	3.98	8.3E-5	QRS complex (12-leadsum)	
STAD	cis	1	rs2056544	chr15:76826003	SCAPER	chr15:76640529-77197744:-	-0.23	-4.8	2.26E-6	Blood metabolite levels	
STAD	cis	1	rs2056603	chr3:134312749	ANAPC13	chr3:134196547-134204865:-	0.39	6.84	3.17E-11	Height	
STAD	cis	1	rs2056604	chr3:134312648	ANAPC13	chr3:134196547-134204865:-	0.38	6.72	6.3E-11	Height	
STAD	cis	1	rs2056938	chr20:44022672	SYS1-DBNDD2	chr20:43991701-44039245:+	0.27	3.93	0.000101	Psoriasis	
STAD	cis	1	rs2058059	chr7:72311817	TYW1B	chr7:72023729-72298813:-	-0.45	-5.87	9.24E-9	Subcutaneous adipose tissue	
STAD	cis	1	rs2058338	chr4:17678600	LAP3	chr4:17578927-17609590:+	0.18	3.92	0.000105	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs2058339	chr4:17678456	LAP3	chr4:17578927-17609590:+	-0.18	-4.02	6.98E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs2058805	chr12:109998591	MYO1H	chr12:109826524-109886176:+	0.2	3.8	0.000167	HDL cholesterol	
STAD	cis	1	rs2061164	chr11:18329006	GTF2H1	chr11:18343816-18388590:+	0.38	6.21	1.39E-9	Pancreatic cancer	
STAD	cis	1	rs2064088	chr22:39053382	LOC646851	chr22:38974125-39052634:-	0.23	4.86	1.73E-6	Resting heart rate	
STAD	cis	1	rs2069502	chr12:58144665	FAM119B	chr12:58166383-58176323:+	-0.41	-6.78	4.53E-11	Multiple sclerosis	
STAD	cis	1	rs2069502	chr12:58144665	TSFM	chr12:58176536-58191367:+	0.32	6.54	1.88E-10	Multiple sclerosis	
STAD	cis	1	rs2069940	chr20:33759272	PROCR	chr20:33758727-33765164:+	-0.5	-5.75	1.77E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs2070180	chr3:121351338	IQCB1	chr3:121488610-121553926:-	-0.27	-4.55	7.29E-6	Cognitive performance	
STAD	cis	1	rs2070488	chr3:38442490	XYLB	chr3:38388251-38456467:+	-0.21	-4.31	2.11E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs2072052	chr12:58146719	FAM119B	chr12:58166383-58176323:+	0.4	6.61	1.28E-10	Multiple sclerosis	
STAD	cis	1	rs2072052	chr12:58146719	TSFM	chr12:58176536-58191367:+	-0.34	-6.99	1.22E-11	Multiple sclerosis	
STAD	cis	1	rs2072209	chr7:107592198	PRKAR2B	chr7:106685178-106802255:+	0.29	3.82	0.000155	IgG glycosylation	
STAD	cis	1	rs2072293	chr14:74537885	LIN52	chr14:74551656-74667117:+	0.35	6.36	5.66E-10	Common traits (Other)	
STAD	cis	1	rs2072794	chr22:39150543	LOC646851	chr22:38974125-39052634:-	0.26	5.34	1.61E-7	Resting heart rate	
STAD	cis	1	rs2072795	chr22:39064209	CBY1	chr22:39052658-39069853:+	-0.21	-4.09	5.24E-5	Resting heart rate	
STAD	cis	1	rs2072795	chr22:39064209	LOC646851	chr22:38974125-39052634:-	-0.26	-5.49	7.12E-8	Resting heart rate	
STAD	cis	1	rs2072796	chr22:39064230	LOC646851	chr22:38974125-39052634:-	0.24	5.07	6.11E-7	Resting heart rate	
STAD	cis	1	rs2072798	chr22:39148483	LOC646851	chr22:38974125-39052634:-	0.24	5.04	7.26E-7	Resting heart rate	
STAD	cis	1	rs2074038	chr11:44087989	ACCS	chr11:44087475-44105569:+	0.94	14.56	1.22E-38	IgA nephropathy	
STAD	cis	1	rs2076028	chr22:39150450	LOC646851	chr22:38974125-39052634:-	0.25	5.34	1.61E-7	Resting heart rate	
STAD	cis	1	rs2077659	chr4:109951796	CASP6	chr4:110609785-110624629:-	0.18	3.9	0.000112	Body mass index	
STAD	cis	1	rs2077660	chr4:109951797	CASP6	chr4:110609785-110624629:-	0.18	3.9	0.000112	Body mass index	
STAD	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.5	-8.05	9.96E-15	Homocysteine levels	
STAD	cis	1	rs2083634	chr4:129976478	C4orf33	chr4:130014829-130033842:+	-0.43	-6.81	3.62E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs2090117	chr4:54300591	SCFD2	chr4:53739152-54232242:-	-0.26	-3.86	0.000131	DNA methylation (variation)	
STAD	cis	1	rs2093395	chr6:41155026	UNC5CL	chr6:40994772-41039015:-	0.18	4.02	6.91E-5	Alzheimer's disease (late onset)	
STAD	cis	1	rs2093396	chr6:41155000	UNC5CL	chr6:40994772-41039015:-	-0.17	-3.89	0.000116	Alzheimer's disease (late onset)	
STAD	cis	1	rs2101966	chr1:31029307	ZCCHC17	chr1:31769842-31837780:+	-0.26	-3.88	0.000122	Low high density lipoprotein cholesterol levels	
STAD	cis	1	rs2103936	chr10:38253333	HSD17B7P2	chr10:38645308-38667432:+	-0.33	-3.89	0.000119	Obesity (extreme)	
STAD	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.86	15.91	2.91E-44	Type 2 diabetes	
STAD	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	0.87	17.79	2.89E-52	Type 2 diabetes	
STAD	cis	1	rs2115069	chr5:150252365	LOC134466	chr5:150310000-150326146:-	0.32	5.13	4.63E-7	Crohn's disease	
STAD	cis	1	rs2123694	chr2:108857505	SULT1C3	chr2:108863651-108881806:+	0.38	7.02	1.02E-11	Blood pressure	
STAD	cis	1	rs2126129	chr2:212548	SH3YL1	chr2:218138-264810:-	-0.58	-12.05	1.16E-28	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	0.75	12.09	8.22E-29	Diastolic blood pressure	
STAD	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	0.74	12	1.93E-28	Diastolic blood pressure	
STAD	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.4	-7.43	6.95E-13	Kawasaki disease	
STAD	cis	1	rs2143062	chr6:27353852	ZNF391	chr6:27356524-27369227:+	0.33	4.95	1.1E-6	Glomerular filtration rate (creatinine)	
STAD	cis	1	rs2143346	chr6:26198449	HIST1H2AE	chr6:26217148-26217711:+	0.3	4.02	6.91E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs2143347	chr6:26198494	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.37	1.6E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs2143950	chr14:35572357	PPP2R3C	chr14:35554679-35591679:-	0.3	4.33	1.88E-5	Atopic dermatitis	
STAD	cis	1	rs2144845	chr10:38221519	HSD17B7P2	chr10:38645308-38667432:+	-0.35	-4.04	6.45E-5	Obesity (extreme)	
STAD	cis	1	rs2154536	chr21:38492147	PIGP	chr21:38437664-38445458:-	-0.25	-5.09	5.54E-7	Eye color traits	
STAD	cis	1	rs2154536	chr21:38492147	TTC3	chr21:38445571-38575406:+	0.24	4.79	2.35E-6	Eye color traits	
STAD	cis	1	rs2159583	chr4:17658838	LAP3	chr4:17578927-17609590:+	-0.18	-3.8	0.000165	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs2159584	chr4:17620568	LAP3	chr4:17578927-17609590:+	-0.19	-4.04	6.55E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs2163167	chr3:53131772	RFT1	chr3:53122503-53164470:-	-0.24	-3.95	9.16E-5	Height	
STAD	cis	1	rs216345	chr9:33799370	NUDT2	chr9:34329504-34343695:+	-0.23	-4.54	7.53E-6	Bipolar disorder	
STAD	cis	1	rs2166580	chr4:1743169	FAM53A	chr4:1641609-1685854:-	-0.48	-7.19	3.31E-12	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.7	-14.71	2.83E-39	Response to antipsychotic treatment	
STAD	cis	1	rs2169748	chr2:28957753	TRMT61B	chr2:29072690-29093175:-	0.33	5.67	2.83E-8	Body mass index	
STAD	cis	1	rs2169751	chr2:28966758	TRMT61B	chr2:29072690-29093175:-	-0.31	-5.28	2.12E-7	Body mass index	
STAD	cis	1	rs2177601	chr3:134245434	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.75	5.47E-11	Height	
STAD	cis	1	rs2177703	chr7:65391717	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs2179142	chr22:39037954	LOC646851	chr22:38974125-39052634:-	0.23	4.76	2.75E-6	Resting heart rate	
STAD	cis	1	rs2198042	chr4:129885499	C4orf33	chr4:130014829-130033842:+	0.41	6.48	2.78E-10	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs2198463	chr2:108875093	SULT1C2	chr2:108905095-108926370:+	0.26	4.12	4.58E-5	Blood pressure	
STAD	cis	1	rs2198463	chr2:108875093	SULT1C3	chr2:108863651-108881806:+	0.37	6.89	2.22E-11	Blood pressure	
STAD	cis	1	rs2202019	chr1:76299181	ACADM	chr1:76190043-76229353:+	-0.33	-4.75	2.9E-6	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs2205802	chr22:39046327	LOC646851	chr22:38974125-39052634:-	0.23	4.86	1.73E-6	Resting heart rate	
STAD	cis	1	rs2210913	chr1:157668993	FCRL3	chr1:157646278-157670775:-	0.25	7.29	1.71E-12	Type 1 diabetes autoantibodies	
STAD	cis	1	rs2215450	chr4:17675394	LAP3	chr4:17578927-17609590:+	-0.2	-4.25	2.72E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs2217266	chr5:150272621	LOC134466	chr5:150310000-150326146:-	0.32	5.06	6.35E-7	Crohn's disease	
STAD	cis	1	rs2217957	chr8:57313360	PENK	chr8:57353513-57359282:-	-0.25	-4.84	1.85E-6	Obesity-related traits	
STAD	cis	1	rs2219078	chr2:108875198	SULT1C2	chr2:108905095-108926370:+	0.26	4.03	6.7E-5	Blood pressure	
STAD	cis	1	rs2219078	chr2:108875198	SULT1C3	chr2:108863651-108881806:+	0.37	6.85	2.95E-11	Blood pressure	
STAD	cis	1	rs2227336	chr17:38174855	GSDMA	chr17:38119226-38134019:+	-0.31	-5.47	8.01E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.31	6.02	4.1E-9	Homocysteine levels	
STAD	cis	1	rs2231626	chr20:44002665	SYS1-DBNDD2	chr20:43991701-44039245:+	0.29	4.35	1.7E-5	Psoriasis	
STAD	cis	1	rs2235230	chr22:39124467	LOC646851	chr22:38974125-39052634:-	-0.24	-4.91	1.37E-6	Resting heart rate	
STAD	cis	1	rs2236786	chr4:1719294	FAM53A	chr4:1641609-1685854:-	0.49	6.98	1.3E-11	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs2239557	chr14:74551970	LIN52	chr14:74551656-74667117:+	0.37	6.7	7.22E-11	Common traits (Other)	
STAD	cis	1	rs2240009	chr17:40283142	DHX58	chr17:40253422-40264751:-	-0.34	-6.2	1.48E-9	Fibrinogen levels	
STAD	cis	1	rs2240010	chr17:40278081	DHX58	chr17:40253422-40264751:-	-0.34	-6.2	1.48E-9	Fibrinogen levels	
STAD	cis	1	rs2242150	chr3:48505964	TREX1	chr3:48501186-48509043:+	0.24	5.53	5.88E-8	Longevity	
STAD	cis	1	rs2242471	chr4:76878716	NAAA	chr4:76831809-76862166:-	0.4	5.86	9.7E-9	Longevity	
STAD	cis	1	rs2242473	chr4:76878956	NAAA	chr4:76831809-76862166:-	0.41	5.87	9.44E-9	Longevity	
STAD	cis	1	rs2242474	chr4:76878982	NAAA	chr4:76831809-76862166:-	0.4	5.86	9.7E-9	Longevity	
STAD	cis	1	rs224329	chr20:34019579	GDF5	chr20:33897002-34042568:-	0.2	4.57	6.65E-6	Height	
STAD	cis	1	rs224329	chr20:34019579	UQCC	chr20:33890383-33999833:-	-0.22	-3.93	9.96E-5	Height	
STAD	cis	1	rs224333	chr20:34023962	GDF5	chr20:33897002-34042568:-	0.2	4.33	1.91E-5	Height	
STAD	cis	1	rs224333	chr20:34023962	UQCC	chr20:33890383-33999833:-	-0.23	-3.98	8.06E-5	Height	
STAD	cis	1	rs2245717	chr20:43995880	SYS1-DBNDD2	chr20:43991701-44039245:+	0.33	4.93	1.22E-6	Psoriasis	
STAD	cis	1	rs2248393	chr20:33926103	GDF5	chr20:33897002-34042568:-	0.18	4.11	4.81E-5	Height	
STAD	cis	1	rs2248407	chr11:77937800	GAB2	chr11:77926343-78128766:-	-0.26	-3.8	0.000166	Testicular germ cell tumor	
STAD	cis	1	rs2248637	chr20:43997240	SYS1-DBNDD2	chr20:43991701-44039245:+	-0.32	-4.74	2.96E-6	Psoriasis	
STAD	cis	1	rs2251115	chr6:49446509	CENPQ	chr6:49431096-49460820:+	-0.23	-4.79	2.32E-6	Homocysteine levels	
STAD	cis	1	rs2251115	chr6:49446509	MUT	chr6:49398994-49431031:-	0.26	4.82	2.02E-6	Homocysteine levels	
STAD	cis	1	rs2253105	chr20:44011301	SYS1-DBNDD2	chr20:43991701-44039245:+	0.27	4.03	6.61E-5	Psoriasis	
STAD	cis	1	rs2253685	chr3:53119703	RFT1	chr3:53122503-53164470:-	-0.24	-4.03	6.72E-5	Height	
STAD	cis	1	rs2253796	chr3:53120098	RFT1	chr3:53122503-53164470:-	-0.25	-4.19	3.49E-5	Height	
STAD	cis	1	rs2254230	chr9:131905177	CRAT	chr9:131857075-131873070:-	-0.3	-5.2	3.15E-7	Blood metabolite ratios	
STAD	cis	1	rs2254230	chr9:131905177	PPP2R4	chr9:131873244-131911223:+	-0.24	-4.82	2.05E-6	Blood metabolite ratios	
STAD	cis	1	rs2256187	chr11:77919768	GAB2	chr11:77926343-78128766:-	-0.29	-4.19	3.47E-5	Testicular germ cell tumor	
STAD	cis	1	rs2256686	chr20:44017331	SYS1-DBNDD2	chr20:43991701-44039245:+	0.27	3.99	7.91E-5	Psoriasis	
STAD	cis	1	rs2257790	chr7:65600450	CCT6P1	chr7:65216092-65228661:+	0.28	4.21	3.23E-5	Diabetic kidney disease	
STAD	cis	1	rs2257991	chr20:25270339	NANP	chr20:25593575-25604648:-	0.21	4.15	4.05E-5	Liver enzyme levels (alkaline phosphatase)	
STAD	cis	1	rs2257991	chr20:25270339	ZNF337	chr20:25654852-25677469:-	0.19	4.16	3.92E-5	Liver enzyme levels (alkaline phosphatase)	
STAD	cis	1	rs2260160	chr15:43895643	ADAL	chr15:43622872-43646094:+	-0.46	-5.87	9.25E-9	Tumor biomarkers	
STAD	cis	1	rs2260160	chr15:43895643	CATSPER2	chr15:43922774-43959900:-	-0.37	-6.63	1.15E-10	Tumor biomarkers	
STAD	cis	1	rs2263764	chr20:44025815	SYS1-DBNDD2	chr20:43991701-44039245:+	0.26	3.91	0.000111	Psoriasis	
STAD	cis	1	rs2266967	chr22:22156789	THAP7	chr22:21354061-21356404:-	0.18	4.09	5.3E-5	Multiple sclerosis	
STAD	cis	1	rs2267393	chr22:39101619	LOC646851	chr22:38974125-39052634:-	0.26	5.57	4.64E-8	Resting heart rate	
STAD	cis	1	rs2267394	chr22:39101633	LOC646851	chr22:38974125-39052634:-	0.26	5.57	4.64E-8	Resting heart rate	
STAD	cis	1	rs2267395	chr22:39113903	LOC646851	chr22:38974125-39052634:-	0.26	5.38	1.27E-7	Resting heart rate	
STAD	cis	1	rs2268185	chr1:54362193	YIPF1	chr1:54317407-54355453:-	0.52	3.94	9.65E-5	Nonalcoholic fatty liver disease	
STAD	cis	1	rs2268753	chr3:38500189	XYLB	chr3:38388251-38456467:+	0.21	4.22	3.0E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs2268757	chr3:38505853	XYLB	chr3:38388251-38456467:+	0.2	4.11	4.84E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs2268758	chr3:38514049	XYLB	chr3:38388251-38456467:+	0.21	4.29	2.3E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs2268957	chr14:66113233	LOC645431	chr14:65877313-65879335:-	0.37	4.32	1.98E-5	Ischemic stroke	
STAD	cis	1	rs2269381	chr22:51020069	CPT1B	chr22:51007291-51017096:-	-0.39	-4.39	1.46E-5	Narcolepsy	
STAD	cis	1	rs2269382	chr22:51018911	CPT1B	chr22:51007291-51017096:-	-0.4	-4.66	4.34E-6	Narcolepsy	
STAD	cis	1	rs2269558	chr16:682250	WFIKKN1	chr16:679239-684116:+	0.47	8.29	1.92E-15	Height	
STAD	cis	1	rs2271554	chr4:54252222	SCFD2	chr4:53739152-54232242:-	0.29	4.4	1.41E-5	DNA methylation (variation)	
STAD	cis	1	rs2272006	chr3:41997059	ULK4	chr3:41288091-42003660:-	-0.75	-12.05	1.22E-28	Diastolic blood pressure	
STAD	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-0.77	-12.38	6.3E-30	Diastolic blood pressure	
STAD	cis	1	rs2272390	chr2:202195311	PPIL3	chr2:201735680-201753999:-	-0.54	-5.72	2.11E-8	Rheumatoid arthritis	
STAD	cis	1	rs2273694	chr10:102256496	SEC31B	chr10:102246403-102289636:-	-0.24	-6.01	4.35E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2273695	chr10:102259568	SEC31B	chr10:102246403-102289636:-	-0.22	-5.61	3.76E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2273	chr4:76889388	NAAA	chr4:76831809-76862166:-	0.39	5.82	1.23E-8	Longevity	
STAD	cis	1	rs2275426	chr1:46487552	TMEM69	chr1:46153847-46160108:+	0.18	3.81	0.000163	Body mass index	
STAD	cis	1	rs2276540	chr3:38512507	XYLB	chr3:38388251-38456467:+	0.21	4.21	3.12E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs2276547	chr2:28975107	TRMT61B	chr2:29072690-29093175:-	-0.32	-5.45	8.83E-8	Body mass index	
STAD	cis	1	rs2276654	chr2:97492479	CNNM3	chr2:97481991-97501120:+	-0.34	-4.03	6.61E-5	Erectile dysfunction and prostate cancer treatment	
STAD	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.45	-6.28	9.24E-10	Cholesterol, total	
STAD	cis	1	rs2277862	chr20:34152782	ERGIC3	chr20:34129778-34145404:+	-0.3	-4.75	2.87E-6	Cholesterol, total	
STAD	cis	1	rs2278218	chr10:79680399	DLG5	chr10:79550551-79686348:-	0.28	4.85	1.81E-6	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs2278218	chr10:79680399	POLR3A	chr10:79735906-79789259:-	0.23	4.33	1.88E-5	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs2278238	chr19:18576484	ISYNA1	chr19:18545625-18548943:-	0.23	3.96	8.95E-5	Breast cancer	
STAD	cis	1	rs2279077	chr3:48474249	TREX1	chr3:48501186-48509043:+	-0.25	-5.83	1.17E-8	Longevity	
STAD	cis	1	rs2281019	chr22:39064378	LOC646851	chr22:38974125-39052634:-	0.24	5.07	6.11E-7	Resting heart rate	
STAD	cis	1	rs2281020	chr22:39064406	LOC646851	chr22:38974125-39052634:-	0.24	5.07	6.11E-7	Resting heart rate	
STAD	cis	1	rs2281021	chr22:39064667	LOC646851	chr22:38974125-39052634:-	0.24	5.07	6.11E-7	Resting heart rate	
STAD	cis	1	rs2282064	chr13:44805870	SERP2	chr13:44947978-44971849:+	0.22	3.82	0.000158	Amyotrophic lateral sclerosis	
STAD	cis	1	rs2283792	chr22:22131125	THAP7	chr22:21354061-21356404:-	0.2	4.66	4.35E-6	Multiple sclerosis	
STAD	cis	1	rs2284073	chr22:39105948	LOC646851	chr22:38974125-39052634:-	0.26	5.67	2.8E-8	Resting heart rate	
STAD	cis	1	rs2285087	chr4:3088211	GRK4	chr4:2965343-3042474:+	-0.22	-3.98	8.2E-5	Parental longevity (mother's age at death)	
STAD	cis	1	rs2285657	chr17:40272594	DHX58	chr17:40253422-40264751:-	-0.33	-5.94	6.31E-9	Fibrinogen levels	
STAD	cis	1	rs2288073	chr2:24413298	C2orf84	chr2:24397531-24414566:+	-0.36	-5.91	7.65E-9	Venous thromboembolism (SNP x SNP interaction)	
STAD	cis	1	rs2289130	chr18:44626630	HDHD2	chr18:44633782-44676871:-	0.56	5.41	1.09E-7	Sitting height ratio	
STAD	cis	1	rs2289131	chr18:44602864	HDHD2	chr18:44633782-44676871:-	0.52	5	8.57E-7	Sitting height ratio	
STAD	cis	1	rs2289132	chr18:44602292	HDHD2	chr18:44633782-44676871:-	0.52	5	8.57E-7	Sitting height ratio	
STAD	cis	1	rs2289681	chr17:42989088	CCDC103	chr17:42977154-42982758:+	0.47	5.06	6.42E-7	Cognitive function	
STAD	cis	1	rs2290822	chr3:48473204	TREX1	chr3:48501186-48509043:+	-0.25	-5.78	1.57E-8	Longevity	
STAD	cis	1	rs2290850	chr11:47807774	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.72	1.02E-13	Subjective well-being	
STAD	cis	1	rs2290911	chr2:224919	SH3YL1	chr2:218138-264810:-	-0.6	-12.83	1.14E-31	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs2291350	chr12:129283711	MGC16384	chr12:129297749-129299295:-	-0.2	-4.27	2.41E-5	Systemic lupus erythematosus	
STAD	cis	1	rs2292239	chr12:56482180	MYO1A	chr12:57422302-57443901:-	0.18	4.13	4.42E-5	Cognitive function	
STAD	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.48	9.54	1.59E-19	Cognitive function	
STAD	cis	1	rs2294008	chr8:143761931	PSCA	chr8:143761875-143764142:+	0.34	6.97	1.38E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2294010	chr8:143762430	PSCA	chr8:143761875-143764142:+	0.34	6.96	1.42E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2294296	chr22:39053049	LOC646851	chr22:38974125-39052634:-	0.23	4.86	1.73E-6	Resting heart rate	
STAD	cis	1	rs2294510	chr1:54359922	YIPF1	chr1:54317407-54355453:-	0.48	3.8	0.000165	Nonalcoholic fatty liver disease	
STAD	cis	1	rs229528	chr22:37581677	C1QTNF6	chr22:37576206-37594341:-	-0.16	-3.88	0.000124	Type 1 diabetes	
STAD	cis	1	rs229531	chr22:37585736	C1QTNF6	chr22:37576206-37594341:-	-0.16	-4.01	7.19E-5	Type 1 diabetes	
STAD	cis	1	rs229533	chr22:37587111	C1QTNF6	chr22:37576206-37594341:-	-0.17	-4.01	7.14E-5	Type 1 diabetes	
STAD	cis	1	rs229536	chr22:37589869	C1QTNF6	chr22:37576206-37594341:-	-0.17	-4.02	6.92E-5	Type 1 diabetes	
STAD	cis	1	rs229540	chr22:37591290	C1QTNF6	chr22:37576206-37594341:-	-0.18	-4.43	1.25E-5	Type 1 diabetes	
STAD	cis	1	rs229541	chr22:37591318	C1QTNF6	chr22:37576206-37594341:-	0.19	4.31	2.03E-5	Type 1 diabetes	
STAD	cis	1	rs229542	chr22:37592106	C1QTNF6	chr22:37576206-37594341:-	-0.17	-4.14	4.22E-5	Type 1 diabetes	
STAD	cis	1	rs2295700	chr20:33591627	PROCR	chr20:33758727-33765164:+	-0.46	-4.89	1.47E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs2295770	chr10:102239829	SEC31B	chr10:102246403-102289636:-	-0.25	-6.08	2.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2295772	chr10:102265183	SEC31B	chr10:102246403-102289636:-	-0.24	-5.89	8.51E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2295773	chr10:102265815	SEC31B	chr10:102246403-102289636:-	-0.24	-5.89	8.51E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2295774	chr10:102265847	SEC31B	chr10:102246403-102289636:-	-0.25	-5.99	4.77E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2295776	chr10:102295629	SEC31B	chr10:102246403-102289636:-	-0.24	-5.85	1.03E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2295779	chr10:102296061	SEC31B	chr10:102246403-102289636:-	-0.23	-5.76	1.69E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2295780	chr10:102305965	SEC31B	chr10:102246403-102289636:-	-0.23	-5.4	1.17E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2295888	chr20:33722863	PROCR	chr20:33758727-33765164:+	-0.44	-4.94	1.18E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs2296691	chr10:97370989	ENTPD1	chr10:97471536-97637022:+	0.14	3.83	0.000151	Blood metabolite levels	
STAD	cis	1	rs2297112	chr9:131900180	CRAT	chr9:131857075-131873070:-	0.26	4.77	2.64E-6	Blood metabolite ratios	
STAD	cis	1	rs2297112	chr9:131900180	PPP2R4	chr9:131873244-131911223:+	0.22	4.63	5.04E-6	Blood metabolite ratios	
STAD	cis	1	rs2298074	chr10:102247526	SEC31B	chr10:102246403-102289636:-	-0.26	-6.22	1.25E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2298075	chr10:102247408	SEC31B	chr10:102246403-102289636:-	-0.24	-5.88	8.79E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2298914	chr1:171710405	VAMP4	chr1:171669298-171711214:-	0.33	6.02	4.04E-9	Hippocampal atrophy	
STAD	cis	1	rs2300871	chr14:66147694	LOC645431	chr14:65877313-65879335:-	0.34	4.02	6.96E-5	Ischemic stroke	
STAD	cis	1	rs2302138	chr14:74363305	PTGR2	chr14:74318534-74352166:+	0.52	6.23	1.23E-9	Morning vs. evening chronotype	
STAD	cis	1	rs2302139	chr14:74362935	PTGR2	chr14:74318534-74352166:+	0.5	6.13	2.17E-9	Morning vs. evening chronotype	
STAD	cis	1	rs2303695	chr19:18562624	ISYNA1	chr19:18545625-18548943:-	0.24	4.2	3.34E-5	Breast cancer	
STAD	cis	1	rs2304641	chr1:85513398	MCOLN2	chr1:85391267-85462796:-	-0.3	-4.18	3.63E-5	Serum sulfate level	
STAD	cis	1	rs2305188	chr4:1739592	FAM53A	chr4:1641609-1685854:-	-0.43	-6.56	1.67E-10	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs2306937	chr1:113246506	ST7L	chr1:113066142-113162405:-	0.37	6.61	1.24E-10	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs2306940	chr1:113241052	ST7L	chr1:113066142-113162405:-	0.41	7.27	1.97E-12	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs2310173	chr2:102663628	IL1R2	chr2:102608306-102644880:+	-0.24	-4.71	3.51E-6	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);Ankylosing spondylitis;Ulcerative colitis	
STAD	cis	1	rs2310997	chr3:48678011	WDR6	chr3:49044637-49053386:+	0.39	4.63	5.0E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
STAD	cis	1	rs2312462	chr3:49601255	CCDC36	chr3:49235861-49295537:+	0.21	4.06	5.87E-5	Menarche (age at onset)	
STAD	cis	1	rs2315556	chr4:17670861	LAP3	chr4:17578927-17609590:+	-0.18	-3.92	0.000104	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs2315560	chr4:17677305	LAP3	chr4:17578927-17609590:+	-0.2	-4.35	1.72E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs2315561	chr4:17679695	LAP3	chr4:17578927-17609590:+	-0.18	-3.98	8.34E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.66	-13.03	1.79E-32	Response to antipsychotic treatment	
STAD	cis	1	rs2326680	chr20:5942955	MCM8	chr20:5931298-5975829:+	-0.21	-4.18	3.66E-5	HIV-1 viral setpoint	
STAD	cis	1	rs2336540	chr3:52974589	TMEM110	chr3:52867139-52931547:-	0.46	4.64	4.75E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs2336541	chr3:52974630	TMEM110	chr3:52867139-52931547:-	0.46	4.64	4.75E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs2344180	chr5:150267357	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs2344181	chr5:150262574	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs2344869	chr4:109964397	CASP6	chr4:110609785-110624629:-	0.18	3.88	0.000123	Body mass index	
STAD	cis	1	rs2345001	chr5:150266518	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.62	-9.19	2.36E-18	Type 2 diabetes	
STAD	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.62	-9.19	2.36E-18	Type 2 diabetes	
STAD	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.5	-8.07	8.68E-15	Homocysteine levels	
STAD	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.46	-7.43	7.01E-13	Homocysteine levels	
STAD	cis	1	rs2358628	chr14:74631757	LIN52	chr14:74551656-74667117:+	-0.35	-6.28	8.85E-10	Common traits (Other)	
STAD	cis	1	rs2358633	chr14:74647418	LIN52	chr14:74551656-74667117:+	-0.35	-6.44	3.42E-10	Common traits (Other)	
STAD	cis	1	rs236104	chr20:5958960	MCM8	chr20:5931298-5975829:+	-0.19	-3.87	0.000127	HIV-1 viral setpoint	
STAD	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.26	-5.93	6.78E-9	Longevity	
STAD	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.26	5.83	1.16E-8	Longevity	
STAD	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.65	-7.01	1.07E-11	Plasma clusterin levels	
STAD	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.37	6.69	7.72E-11	Height	
STAD	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.38	6.98	1.29E-11	Height	
STAD	cis	1	rs2370642	chr3:134222136	ANAPC13	chr3:134196547-134204865:-	0.37	6.78	4.51E-11	Height	
STAD	cis	1	rs2371244	chr7:143757611	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.75	1.81E-8	Obesity-related traits	
STAD	cis	1	rs2371247	chr7:143764179	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.83	1.19E-8	Obesity-related traits	
STAD	cis	1	rs2371248	chr7:143764189	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.83	1.19E-8	Obesity-related traits	
STAD	cis	1	rs2371627	chr3:41839219	ULK4	chr3:41288091-42003660:-	0.78	12.25	2.11E-29	Diastolic blood pressure	
STAD	cis	1	rs2373865	chr3:134291556	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.76	5.0E-11	Height	
STAD	cis	1	rs2384207	chr12:113607502	C12orf52	chr12:113623555-113630119:+	-0.27	-4.17	3.74E-5	Response to fenofibrate (adiponectin levels)	
STAD	cis	1	rs2404602	chr15:77030792	SCAPER	chr15:76640529-77197744:-	-0.23	-4.95	1.12E-6	Blood metabolite levels	
STAD	cis	1	rs2404740	chr15:76852143	SCAPER	chr15:76640529-77197744:-	-0.22	-4.64	4.86E-6	Blood metabolite levels	
STAD	cis	1	rs2404741	chr15:76851735	SCAPER	chr15:76640529-77197744:-	-0.22	-4.64	4.86E-6	Blood metabolite levels	
STAD	cis	1	rs2412488	chr4:54330867	SCFD2	chr4:53739152-54232242:-	0.29	4.23	2.97E-5	DNA methylation (variation)	
STAD	cis	1	rs2412979	chr22:30580161	ASCC2	chr22:30184603-30234254:-	-0.37	-3.93	0.000101	LDL cholesterol	
STAD	cis	1	rs2413544	chr22:39059404	LOC646851	chr22:38974125-39052634:-	0.24	5.05	6.87E-7	Resting heart rate	
STAD	cis	1	rs2413545	chr22:39092524	CBY1	chr22:39052658-39069853:+	0.21	3.96	8.87E-5	Resting heart rate	
STAD	cis	1	rs2413545	chr22:39092524	LOC646851	chr22:38974125-39052634:-	0.27	5.69	2.54E-8	Resting heart rate	
STAD	cis	1	rs2413546	chr22:39107001	CBY1	chr22:39052658-39069853:+	0.22	4.19	3.45E-5	Resting heart rate	
STAD	cis	1	rs2413546	chr22:39107001	LOC646851	chr22:38974125-39052634:-	0.27	5.75	1.83E-8	Resting heart rate	
STAD	cis	1	rs2413547	chr22:39107338	CBY1	chr22:39052658-39069853:+	0.22	4.19	3.45E-5	Resting heart rate	
STAD	cis	1	rs2413547	chr22:39107338	LOC646851	chr22:38974125-39052634:-	0.27	5.75	1.83E-8	Resting heart rate	
STAD	cis	1	rs2421647	chr3:169113110	LOC100128164	chr3:169661774-169684522:-	0.18	4.11	4.82E-5	Systolic blood pressure;Magnesium levels	
STAD	cis	1	rs2425065	chr20:33926268	GDF5	chr20:33897002-34042568:-	0.18	4.04	6.39E-5	Height	
STAD	cis	1	rs2425065	chr20:33926268	UQCC	chr20:33890383-33999833:-	-0.23	-4.18	3.61E-5	Height	
STAD	cis	1	rs2425066	chr20:33927006	GDF5	chr20:33897002-34042568:-	0.18	3.98	8.2E-5	Height	
STAD	cis	1	rs2425066	chr20:33927006	UQCC	chr20:33890383-33999833:-	-0.23	-4.21	3.23E-5	Height	
STAD	cis	1	rs2425697	chr20:44025175	SYS1-DBNDD2	chr20:43991701-44039245:+	0.26	3.88	0.000124	Psoriasis	
STAD	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.88	17.65	1.11E-51	Type 2 diabetes	
STAD	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.46	5.97	5.4E-9	Tumor biomarkers	
STAD	cis	1	rs2447196	chr15:43893818	CATSPER2	chr15:43922774-43959900:-	0.4	7.42	7.61E-13	Tumor biomarkers	
STAD	cis	1	rs2447208	chr15:43933895	ADAL	chr15:43622872-43646094:+	-0.45	-5.73	2.0E-8	Tumor biomarkers	
STAD	cis	1	rs2447208	chr15:43933895	CATSPER2	chr15:43922774-43959900:-	-0.41	-7.56	2.84E-13	Tumor biomarkers	
STAD	cis	1	rs2447211	chr15:43936351	ADAL	chr15:43622872-43646094:+	-0.47	-5.71	2.25E-8	Tumor biomarkers	
STAD	cis	1	rs2447211	chr15:43936351	CATSPER2	chr15:43922774-43959900:-	-0.41	-7.12	5.27E-12	Tumor biomarkers	
STAD	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.25	5.32	1.72E-7	Homocysteine levels	
STAD	cis	1	rs2448704	chr6:49453672	MUT	chr6:49398994-49431031:-	-0.23	-4.15	4.09E-5	Homocysteine levels	
STAD	cis	1	rs2448707	chr6:49446951	MUT	chr6:49398994-49431031:-	-0.38	-7.04	8.89E-12	Folate pathway vitamin levels	
STAD	cis	1	rs244899	chr5:167911040	FBLL1	chr5:167956582-167957638:+	0.4	6.44	3.48E-10	Response to platinum-based chemotherapy (carboplatin)	
STAD	cis	1	rs2458413	chr8:105359432	TM7SF4	chr8:105352054-105368916:+	0.23	4.12	4.54E-5	Paget's disease	
STAD	cis	1	rs2458414	chr8:105355840	TM7SF4	chr8:105352054-105368916:+	0.23	4.18	3.64E-5	Paget's disease	
STAD	cis	1	rs2460422	chr7:65601505	CCT6P1	chr7:65216092-65228661:+	0.29	4.34	1.85E-5	Diabetic kidney disease	
STAD	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.56	-12.31	1.25E-29	Ankylosing spondylitis	
STAD	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.49	8.36	1.13E-15	Ankylosing spondylitis	
STAD	cis	1	rs2470134	chr15:43849886	ADAL	chr15:43622872-43646094:+	0.47	5.81	1.26E-8	Tumor biomarkers	
STAD	cis	1	rs2470134	chr15:43849886	CATSPER2	chr15:43922774-43959900:-	0.33	5.69	2.54E-8	Tumor biomarkers	
STAD	cis	1	rs2479411	chr1:55509900	ACOT11	chr1:55007930-55100417:+	-0.37	-3.92	0.000105	Wilms tumor	
STAD	cis	1	rs2489034	chr10:102319192	SEC31B	chr10:102246403-102289636:-	-0.23	-5.36	1.4E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489035	chr10:102319395	SEC31B	chr10:102246403-102289636:-	-0.24	-5.57	4.86E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489036	chr10:102319581	SEC31B	chr10:102246403-102289636:-	-0.23	-5.36	1.4E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489037	chr10:102319918	SEC31B	chr10:102246403-102289636:-	0.24	5.81	1.27E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489039	chr10:102328036	SEC31B	chr10:102246403-102289636:-	-0.23	-5.4	1.16E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489040	chr10:102331298	SEC31B	chr10:102246403-102289636:-	-0.22	-5.21	3.06E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489043	chr10:102334327	SEC31B	chr10:102246403-102289636:-	-0.22	-5.14	4.37E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489045	chr10:102344754	SEC31B	chr10:102246403-102289636:-	-0.23	-5.23	2.73E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489046	chr10:102346282	SEC31B	chr10:102246403-102289636:-	-0.23	-5.36	1.44E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489047	chr10:102347028	SEC31B	chr10:102246403-102289636:-	-0.23	-5.37	1.36E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489048	chr10:102348497	SEC31B	chr10:102246403-102289636:-	-0.23	-5.39	1.23E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489049	chr10:102350732	SEC31B	chr10:102246403-102289636:-	-0.23	-5.41	1.08E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489050	chr10:102350898	SEC31B	chr10:102246403-102289636:-	-0.24	-5.43	9.76E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489051	chr10:102351785	SEC31B	chr10:102246403-102289636:-	0.22	5.45	9.13E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2489053	chr10:102353341	SEC31B	chr10:102246403-102289636:-	-0.22	-5.22	2.87E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495479	chr1:55511068	ACOT11	chr1:55007930-55100417:+	-0.37	-3.89	0.000117	Wilms tumor	
STAD	cis	1	rs2495480	chr1:55509355	ACOT11	chr1:55007930-55100417:+	-0.36	-3.82	0.000156	Wilms tumor	
STAD	cis	1	rs2495732	chr10:102357780	SEC31B	chr10:102246403-102289636:-	-0.23	-5.14	4.34E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495734	chr10:102338686	SEC31B	chr10:102246403-102289636:-	-0.24	-5.45	8.88E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495736	chr10:102338410	SEC31B	chr10:102246403-102289636:-	-0.24	-5.45	8.88E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495737	chr10:102338344	SEC31B	chr10:102246403-102289636:-	-0.23	-5.44	9.22E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495739	chr10:102335507	SEC31B	chr10:102246403-102289636:-	-0.23	-5.33	1.62E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495741	chr10:102331795	SEC31B	chr10:102246403-102289636:-	-0.24	-5.57	4.86E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495742	chr10:102331364	SEC31B	chr10:102246403-102289636:-	-0.24	-5.58	4.51E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495743	chr10:102329739	SEC31B	chr10:102246403-102289636:-	-0.25	-5.73	1.98E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495745	chr10:102329075	SEC31B	chr10:102246403-102289636:-	-0.23	-5.53	6.03E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495747	chr10:102328247	SEC31B	chr10:102246403-102289636:-	-0.22	-5.24	2.69E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495750	chr10:102327708	SEC31B	chr10:102246403-102289636:-	-0.23	-5.32	1.77E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495751	chr10:102327260	SEC31B	chr10:102246403-102289636:-	-0.23	-5.44	9.25E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495752	chr10:102326115	SEC31B	chr10:102246403-102289636:-	-0.23	-5.41	1.12E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495753	chr10:102325640	SEC31B	chr10:102246403-102289636:-	-0.24	-5.49	7.22E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495754	chr10:102324812	SEC31B	chr10:102246403-102289636:-	-0.23	-5.41	1.12E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495755	chr10:102324649	SEC31B	chr10:102246403-102289636:-	-0.24	-5.43	1.02E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495758	chr10:102321900	SEC31B	chr10:102246403-102289636:-	-0.24	-5.43	1.02E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495759	chr10:102320363	SEC31B	chr10:102246403-102289636:-	-0.24	-5.34	1.62E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2495760	chr10:102318771	SEC31B	chr10:102246403-102289636:-	-0.23	-5.28	2.21E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2501962	chr6:49453636	MUT	chr6:49398994-49431031:-	-0.38	-7.02	9.85E-12	Folate pathway vitamin levels	
STAD	cis	1	rs2501963	chr6:49454281	MUT	chr6:49398994-49431031:-	-0.38	-7	1.15E-11	Folate pathway vitamin levels	
STAD	cis	1	rs2510045	chr11:77920563	GAB2	chr11:77926343-78128766:-	-0.27	-3.9	0.000111	Testicular germ cell tumor	
STAD	cis	1	rs2511180	chr11:77937255	GAB2	chr11:77926343-78128766:-	-0.27	-3.94	9.54E-5	Testicular germ cell tumor	
STAD	cis	1	rs2524005	chr6:29899677	HCG2P7	chr6:29866808-29870429:+	-0.29	-4.42	1.29E-5	Bipolar disorder and schizophrenia	
STAD	cis	1	rs2524005	chr6:29899677	HCG4	chr6:29758809-29760850:-	-0.31	-4.58	6.31E-6	Bipolar disorder and schizophrenia	
STAD	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.39	5.13	4.65E-7	Bipolar disorder and schizophrenia	
STAD	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	0.88	17.74	4.9E-52	Type 2 diabetes	
STAD	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	0.9	18.16	7.57E-54	Type 2 diabetes	
STAD	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.87	17.78	3.25E-52	Type 2 diabetes	
STAD	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.88	18.35	1.21E-54	Type 2 diabetes	
STAD	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.88	17.6	1.82E-51	Type 2 diabetes	
STAD	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	0.9	17.99	4.21E-53	Type 2 diabetes	
STAD	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.89	-17.56	2.84E-51	Type 2 diabetes	
STAD	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.88	17.95	6.16E-53	Type 2 diabetes	
STAD	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.88	17.92	8.24E-53	Type 2 diabetes	
STAD	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.88	18.39	8.17E-55	Type 2 diabetes	
STAD	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.88	18.39	8.17E-55	Type 2 diabetes	
STAD	cis	1	rs2541161	chr9:131884802	CRAT	chr9:131857075-131873070:-	-0.29	-5.09	5.62E-7	Blood metabolite ratios	
STAD	cis	1	rs2541161	chr9:131884802	PPP2R4	chr9:131873244-131911223:+	-0.23	-4.61	5.46E-6	Blood metabolite ratios	
STAD	cis	1	rs2541164	chr9:131876908	CRAT	chr9:131857075-131873070:-	0.28	4.76	2.77E-6	Blood metabolite ratios	
STAD	cis	1	rs2541164	chr9:131876908	PPP2R4	chr9:131873244-131911223:+	0.22	4.32	1.95E-5	Blood metabolite ratios	
STAD	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.88	18.3	1.99E-54	Type 2 diabetes	
STAD	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.88	18.32	1.5E-54	Type 2 diabetes	
STAD	cis	1	rs256572	chr2:190717867	ORMDL1	chr2:190634994-190649097:-	0.26	4.29	2.25E-5	Subcutaneous adipose tissue	
STAD	cis	1	rs2567954	chr4:171891614	MFAP3L	chr4:170907750-170947429:-	0.28	3.92	0.000105	Lupus nephritis in systemic lupus erythematosus	
STAD	cis	1	rs2572910	chr8:143770135	LY6K	chr8:143781529-143785582:+	0.27	4.12	4.58E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2572910	chr8:143770135	PSCA	chr8:143761875-143764142:+	0.35	7.01	1.06E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2581782	chr3:53122257	RFT1	chr3:53122503-53164470:-	-0.26	-4.19	3.38E-5	Height	
STAD	cis	1	rs2581783	chr3:53122258	RFT1	chr3:53122503-53164470:-	-0.26	-4.19	3.38E-5	Height	
STAD	cis	1	rs2581786	chr3:53126143	RFT1	chr3:53122503-53164470:-	-0.24	-3.92	0.000105	Height	
STAD	cis	1	rs2581787	chr3:53127677	RFT1	chr3:53122503-53164470:-	-0.23	-3.83	0.000147	Height	
STAD	cis	1	rs2581800	chr3:53109352	RFT1	chr3:53122503-53164470:-	-0.25	-3.98	8.06E-5	Height	
STAD	cis	1	rs2585179	chr8:143774193	LY6K	chr8:143781529-143785582:+	0.27	4.12	4.54E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2585179	chr8:143774193	PSCA	chr8:143761875-143764142:+	0.35	7.01	1.05E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2595500	chr11:6963165	ZNF215	chr11:6947654-7005861:+	0.44	5.28	2.13E-7	Response to cytadine analogues (cytosine arabinoside)	
STAD	cis	1	rs2595501	chr11:6955340	ZNF215	chr11:6947654-7005861:+	-0.45	-5.21	2.99E-7	Response to cytadine analogues (cytosine arabinoside)	
STAD	cis	1	rs2602836	chr4:100014805	ADH4	chr4:100044835-100065449:-	0.26	4.25	2.64E-5	HDL cholesterol	
STAD	cis	1	rs261360	chr20:5037774	C20orf30	chr20:5049130-5093733:-	-0.19	-3.91	0.000107	Hair morphology	
STAD	cis	1	rs2614811	chr15:43913487	ADAL	chr15:43622872-43646094:+	-0.47	-5.6	3.98E-8	Tumor biomarkers	
STAD	cis	1	rs2614811	chr15:43913487	CATSPER2	chr15:43922774-43959900:-	-0.44	-7.47	5.22E-13	Tumor biomarkers	
STAD	cis	1	rs2617170	chr12:10560957	KLRC2	chr12:10579193-10588592:-	-0.29	-5.48	7.58E-8	Behcet's disease	
STAD	cis	1	rs2617170	chr12:10560957	KLRC4	chr12:10559985-10562356:-	-0.19	-4.29	2.22E-5	Behcet's disease	
STAD	cis	1	rs2625667	chr3:41900951	ULK4	chr3:41288091-42003660:-	0.78	12.43	4.11E-30	Diastolic blood pressure	
STAD	cis	1	rs2625668	chr3:41905930	ULK4	chr3:41288091-42003660:-	0.77	12.13	5.72E-29	Diastolic blood pressure	
STAD	cis	1	rs262641	chr1:2104981	LOC148413	chr1:1334910-1338075:+	-0.23	-3.87	0.000126	Height	
STAD	cis	1	rs2629540	chr10:126426148	METTL10	chr10:126447406-126480439:-	0.28	4.07	5.67E-5	Cocaine dependence	
STAD	cis	1	rs2638090	chr11:6955142	ZNF215	chr11:6947654-7005861:+	-0.45	-5.21	2.99E-7	Response to cytadine analogues (cytosine arabinoside)	
STAD	cis	1	rs2638092	chr11:6961746	ZNF215	chr11:6947654-7005861:+	-0.44	-5.2	3.15E-7	Response to cytadine analogues (cytosine arabinoside)	
STAD	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.55	-12.09	8.14E-29	Ankylosing spondylitis	
STAD	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.49	8.29	1.79E-15	Ankylosing spondylitis	
STAD	cis	1	rs2655310	chr4:130017919	C4orf33	chr4:130014829-130033842:+	-0.41	-6.6	1.33E-10	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs2683695	chr3:41914928	ULK4	chr3:41288091-42003660:-	0.77	12.17	4.09E-29	Diastolic blood pressure	
STAD	cis	1	rs2683696	chr3:41914898	ULK4	chr3:41288091-42003660:-	0.76	12.15	5.21E-29	Diastolic blood pressure	
STAD	cis	1	rs26965	chr5:112739017	YTHDC2	chr5:112849410-112930979:+	0.24	3.88	0.000123	F-cell distribution	
STAD	cis	1	rs271623	chr19:18628947	ISYNA1	chr19:18545625-18548943:-	0.23	3.97	8.6E-5	Breast cancer	
STAD	cis	1	rs2717562	chr8:143776668	LY6K	chr8:143781529-143785582:+	0.27	4.12	4.54E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2717562	chr8:143776668	PSCA	chr8:143761875-143764142:+	0.35	7.01	1.03E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2730260	chr7:158846929	WDR60	chr7:158649269-158738882:+	0.23	3.93	0.000102	Myopia (pathological)	
STAD	cis	1	rs2734839	chr11:113286490	TTC12	chr11:113185251-113244016:+	-0.38	-6.58	1.5E-10	Information processing speed	
STAD	cis	1	rs2738186	chr10:38255989	HSD17B7P2	chr10:38645308-38667432:+	-0.33	-3.89	0.000119	Obesity (extreme)	
STAD	cis	1	rs2738187	chr10:38260305	HSD17B7P2	chr10:38645308-38667432:+	-0.33	-3.89	0.000119	Obesity (extreme)	
STAD	cis	1	rs2738191	chr10:38265786	HSD17B7P2	chr10:38645308-38667432:+	0.32	4	7.72E-5	Obesity (extreme)	
STAD	cis	1	rs2738222	chr10:38183674	HSD17B7P2	chr10:38645308-38667432:+	-0.32	-3.85	0.000139	Obesity (extreme)	
STAD	cis	1	rs2738223	chr10:38185898	HSD17B7P2	chr10:38645308-38667432:+	-0.32	-3.86	0.000134	Obesity (extreme)	
STAD	cis	1	rs2741432	chr20:43989514	SYS1-DBNDD2	chr20:43991701-44039245:+	0.32	4.77	2.66E-6	Psoriasis	
STAD	cis	1	rs2741435	chr20:43988198	SYS1-DBNDD2	chr20:43991701-44039245:+	0.3	4.51	8.71E-6	Psoriasis	
STAD	cis	1	rs2741611	chr20:44020809	SYS1-DBNDD2	chr20:43991701-44039245:+	0.27	4	7.69E-5	Psoriasis	
STAD	cis	1	rs2741612	chr20:44019972	SYS1-DBNDD2	chr20:43991701-44039245:+	0.27	4	7.69E-5	Psoriasis	
STAD	cis	1	rs2741639	chr20:44008432	SYS1-DBNDD2	chr20:43991701-44039245:+	0.27	4.03	6.63E-5	Psoriasis	
STAD	cis	1	rs2741640	chr20:44008408	SYS1-DBNDD2	chr20:43991701-44039245:+	0.29	4.34	1.83E-5	Psoriasis	
STAD	cis	1	rs2743402	chr20:43985204	SYS1-DBNDD2	chr20:43991701-44039245:+	0.32	4.81	2.21E-6	Psoriasis	
STAD	cis	1	rs2743414	chr20:43991566	SYS1-DBNDD2	chr20:43991701-44039245:+	0.32	4.79	2.34E-6	Psoriasis	
STAD	cis	1	rs2743419	chr20:43992645	SYS1-DBNDD2	chr20:43991701-44039245:+	0.32	4.79	2.34E-6	Psoriasis	
STAD	cis	1	rs2743423	chr20:43993539	SYS1-DBNDD2	chr20:43991701-44039245:+	0.32	4.79	2.34E-6	Psoriasis	
STAD	cis	1	rs2743424	chr20:43993934	SYS1-DBNDD2	chr20:43991701-44039245:+	0.32	4.79	2.34E-6	Psoriasis	
STAD	cis	1	rs2743439	chr20:43999636	SYS1-DBNDD2	chr20:43991701-44039245:+	0.29	4.41	1.32E-5	Psoriasis	
STAD	cis	1	rs2749564	chr10:38178815	HSD17B7P2	chr10:38645308-38667432:+	-0.32	-3.85	0.000139	Obesity (extreme)	
STAD	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.54	-11.9	4.7E-28	Ankylosing spondylitis	
STAD	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.47	8.13	5.58E-15	Ankylosing spondylitis	
STAD	cis	1	rs2753878	chr10:38171504	HSD17B7P2	chr10:38645308-38667432:+	-0.32	-3.86	0.000134	Obesity (extreme)	
STAD	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.53	11.71	2.47E-27	Ankylosing spondylitis	
STAD	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.47	-8.22	2.99E-15	Ankylosing spondylitis	
STAD	cis	1	rs2799077	chr6:28234597	ZSCAN23	chr6:28393287-28411279:-	0.25	4	7.65E-5	Depression	
STAD	cis	1	rs2799495	chr10:38237984	HSD17B7P2	chr10:38645308-38667432:+	-0.33	-3.92	0.000103	Obesity (extreme)	
STAD	cis	1	rs2799505	chr10:38223014	HSD17B7P2	chr10:38645308-38667432:+	-0.32	-3.84	0.000145	Obesity (extreme)	
STAD	cis	1	rs2799507	chr10:38227064	HSD17B7P2	chr10:38645308-38667432:+	-0.32	-3.84	0.000145	Obesity (extreme)	
STAD	cis	1	rs280603	chr4:129915063	C4orf33	chr4:130014829-130033842:+	-0.41	-6.57	1.57E-10	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs280604	chr4:129921170	C4orf33	chr4:130014829-130033842:+	-0.43	-6.76	4.97E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.72	-15.26	1.41E-41	Response to antipsychotic treatment	
STAD	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.71	-15.37	5.16E-42	Response to antipsychotic treatment	
STAD	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.72	-15.31	9.16E-42	Response to antipsychotic treatment	
STAD	cis	1	rs2835607	chr21:38491973	PIGP	chr21:38437664-38445458:-	-0.25	-5.12	4.71E-7	Eye color traits	
STAD	cis	1	rs2835607	chr21:38491973	TTC3	chr21:38445571-38575406:+	0.24	4.83	2.0E-6	Eye color traits	
STAD	cis	1	rs2835608	chr21:38493455	PIGP	chr21:38437664-38445458:-	-0.25	-5.09	5.54E-7	Eye color traits	
STAD	cis	1	rs2835608	chr21:38493455	TTC3	chr21:38445571-38575406:+	0.24	4.79	2.35E-6	Eye color traits	
STAD	cis	1	rs28363725	chr8:96027108	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs28365850	chr14:35591316	PPP2R3C	chr14:35554679-35591679:-	0.3	4.36	1.7E-5	Atopic dermatitis	
STAD	cis	1	rs28374715	chr15:41563950	NDUFAF1	chr15:41679553-41694642:-	0.31	4.1	5.13E-5	Ulcerative colitis	
STAD	cis	1	rs28378156	chr8:96027127	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs28391259	chr4:107014012	TBCK	chr4:106967233-107237861:-	0.25	3.84	0.000141	Airflow obstruction	
STAD	cis	1	rs2839181	chr21:47685939	C21orf56	chr21:47581063-47604373:-	-0.3	-5.25	2.52E-7	Testicular germ cell tumor	
STAD	cis	1	rs2839181	chr21:47685939	C21orf57	chr21:47706267-47717664:+	-0.4	-7.12	5.17E-12	Testicular germ cell tumor	
STAD	cis	1	rs2839186	chr21:47690068	C21orf56	chr21:47581063-47604373:-	-0.23	-4.03	6.72E-5	Testicular germ cell tumor	
STAD	cis	1	rs2839186	chr21:47690068	C21orf57	chr21:47706267-47717664:+	-0.42	-7.66	1.47E-13	Testicular germ cell tumor	
STAD	cis	1	rs2839337	chr21:47987167	C21orf56	chr21:47581063-47604373:-	0.24	4.02	6.89E-5	Lymphocyte counts	
STAD	cis	1	rs2839337	chr21:47987167	C21orf57	chr21:47706267-47717664:+	0.26	4.24	2.8E-5	Lymphocyte counts	
STAD	cis	1	rs28406132	chr8:96030377	C8orf38	chr8:95908040-96088396:+	-0.34	-4.06	5.92E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs28409322	chr3:134252385	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.75	5.47E-11	Height	
STAD	cis	1	rs28440026	chr8:96026744	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs28453840	chr2:136522941	LCT	chr2:136545415-136594750:-	0.27	5.4	1.15E-7	Cholesterol, total	
STAD	cis	1	rs28469723	chr20:33700717	PROCR	chr20:33758727-33765164:+	-0.48	-5.27	2.31E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs28477467	chr8:96032905	C8orf38	chr8:95908040-96088396:+	-0.34	-4.06	5.92E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs28480159	chr4:17685707	LAP3	chr4:17578927-17609590:+	-0.18	-3.91	0.000107	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs28485881	chr17:80690014	FN3KRP	chr17:80674582-80685889:+	-0.31	-4.9	1.38E-6	Glycated hemoglobin levels	
STAD	cis	1	rs28496357	chr8:96030511	C8orf38	chr8:95908040-96088396:+	-0.33	-3.99	7.75E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs28497813	chr4:17685503	LAP3	chr4:17578927-17609590:+	-0.18	-3.91	0.000107	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs285098	chr13:98827035	FARP1	chr13:98794816-99102016:+	-0.21	-4.21	3.21E-5	Migraine	
STAD	cis	1	rs285102	chr13:98815212	FARP1	chr13:98794816-99102016:+	-0.21	-4.24	2.82E-5	Migraine	
STAD	cis	1	rs28522614	chr10:102323141	SEC31B	chr10:102246403-102289636:-	-0.23	-5.46	8.66E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs2854218	chr17:61942940	DDX42	chr17:61851567-61896676:+	-0.24	-3.84	0.000141	Body mass index	
STAD	cis	1	rs28572537	chr19:18552208	ISYNA1	chr19:18545625-18548943:-	0.23	4.05	6.24E-5	Breast cancer	
STAD	cis	1	rs2857891	chr11:6962957	ZNF215	chr11:6947654-7005861:+	-0.45	-5.28	2.11E-7	Response to cytadine analogues (cytosine arabinoside)	
STAD	cis	1	rs28616734	chr8:96021443	C8orf38	chr8:95908040-96088396:+	-0.34	-4.12	4.64E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.38	6.75	5.31E-11	Forced vital capacity	
STAD	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.37	6.69	7.96E-11	Forced vital capacity	
STAD	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.37	-6.66	9.6E-11	Forced vital capacity	
STAD	cis	1	rs28651964	chr8:96026781	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs28661978	chr3:156579739	LEKR1	chr3:156544076-156763918:+	-0.36	-3.96	8.97E-5	Bone mineral density	
STAD	cis	1	rs28683528	chr12:123845351	CDK2AP1	chr12:123745542-123756687:-	-0.38	-6.01	4.17E-9	Educational attainment;Height;Head circumference (infant)	
STAD	cis	1	rs28697089	chr12:56938703	SPRYD4	chr12:56862301-56864765:+	-0.23	-4.22	3.0E-5	Adiponectin levels	
STAD	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.77	11.86	6.42E-28	Diastolic blood pressure	
STAD	cis	1	rs28712702	chr8:96026980	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs2872958	chr4:17665032	LAP3	chr4:17578927-17609590:+	-0.19	-4.06	5.82E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs2872959	chr4:17677163	LAP3	chr4:17578927-17609590:+	0.19	3.87	0.000129	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	0.76	12.24	2.24E-29	Diastolic blood pressure	
STAD	cis	1	rs2874490	chr3:156635513	LEKR1	chr3:156544076-156763918:+	-0.42	-4.84	1.88E-6	Bone mineral density	
STAD	cis	1	rs2874491	chr3:156649111	LEKR1	chr3:156544076-156763918:+	-0.4	-4.58	6.18E-6	Bone mineral density	
STAD	cis	1	rs2880791	chr5:150267376	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.27	-6.19	1.57E-9	Longevity	
STAD	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.26	5.84	1.11E-8	Longevity	
STAD	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.37	6.61	1.28E-10	Height	
STAD	cis	1	rs2889873	chr20:33646841	PROCR	chr20:33758727-33765164:+	-0.49	-5.32	1.74E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs2891586	chr10:38101643	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.88	0.000122	Obesity (extreme)	
STAD	cis	1	rs2896954	chr15:76851692	SCAPER	chr15:76640529-77197744:-	-0.23	-4.84	1.91E-6	Blood metabolite levels	
STAD	cis	1	rs2901354	chr10:124733038	PSTK	chr10:124739556-124749906:+	0.24	3.84	0.000144	Migraine without aura	
STAD	cis	1	rs2911131	chr5:96185949	ERAP1	chr5:96096515-96149837:-	0.23	3.85	0.000136	Urate levels (BMI interaction)	
STAD	cis	1	rs2920292	chr8:143765699	LY6K	chr8:143781529-143785582:+	0.25	3.88	0.000125	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2920292	chr8:143765699	PSCA	chr8:143761875-143764142:+	0.34	7	1.12E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2920293	chr8:143765414	LY6K	chr8:143781529-143785582:+	0.25	3.88	0.000125	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2920293	chr8:143765414	PSCA	chr8:143761875-143764142:+	0.34	7	1.12E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2920294	chr8:143765326	LY6K	chr8:143781529-143785582:+	0.25	3.88	0.000125	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2920294	chr8:143765326	PSCA	chr8:143761875-143764142:+	0.34	7	1.12E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2920295	chr8:143764937	LY6K	chr8:143781529-143785582:+	0.25	3.96	8.98E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2920295	chr8:143764937	PSCA	chr8:143761875-143764142:+	0.34	6.88	2.4E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2920296	chr8:143763109	PSCA	chr8:143761875-143764142:+	0.34	6.96	1.42E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2920297	chr8:143763083	PSCA	chr8:143761875-143764142:+	0.34	6.96	1.42E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2920298	chr8:143763043	PSCA	chr8:143761875-143764142:+	0.34	6.96	1.42E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2920781	chr15:43924682	ADAL	chr15:43622872-43646094:+	-0.47	-5.71	2.25E-8	Tumor biomarkers	
STAD	cis	1	rs2920781	chr15:43924682	CATSPER2	chr15:43922774-43959900:-	-0.41	-7.12	5.27E-12	Tumor biomarkers	
STAD	cis	1	rs2924584	chr4:99988208	ADH4	chr4:100044835-100065449:-	-0.24	-3.96	9.0E-5	HDL cholesterol	
STAD	cis	1	rs2927072	chr15:43922398	ADAL	chr15:43622872-43646094:+	-0.47	-5.71	2.25E-8	Tumor biomarkers	
STAD	cis	1	rs2927072	chr15:43922398	CATSPER2	chr15:43922774-43959900:-	-0.41	-7.12	5.27E-12	Tumor biomarkers	
STAD	cis	1	rs2935183	chr17:45607572	C17orf57	chr17:45401142-45518675:+	-0.27	-5.73	1.99E-8	Multiple sclerosis or amyotrophic lateral sclerosis	
STAD	cis	1	rs2945232	chr8:8098038	DEFB4A	chr8:7752199-7754236:+	0.18	3.96	8.8E-5	Schizophrenia	
STAD	cis	1	rs2945232	chr8:8098038	FLJ10661	chr8:8086092-8102386:+	0.45	7.73	9.22E-14	Schizophrenia	
STAD	cis	1	rs2951308	chr7:143767149	ARHGEF35	chr7:143883677-143892736:-	0.35	5.48	7.61E-8	Obesity-related traits	
STAD	cis	1	rs2951353	chr7:143761116	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.76	1.71E-8	Obesity-related traits	
STAD	cis	1	rs2951354	chr7:143761001	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.75	1.81E-8	Obesity-related traits	
STAD	cis	1	rs2951360	chr7:143757349	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.73	1.99E-8	Obesity-related traits	
STAD	cis	1	rs2951363	chr7:143754724	ARHGEF35	chr7:143883677-143892736:-	-0.36	-5.59	4.29E-8	Obesity-related traits	
STAD	cis	1	rs2951364	chr7:143754483	ARHGEF35	chr7:143883677-143892736:-	-0.36	-5.59	4.29E-8	Obesity-related traits	
STAD	cis	1	rs2951368	chr7:143752821	ARHGEF35	chr7:143883677-143892736:-	-0.36	-5.59	4.29E-8	Obesity-related traits	
STAD	cis	1	rs2951369	chr7:143752638	ARHGEF35	chr7:143883677-143892736:-	-0.36	-5.59	4.29E-8	Obesity-related traits	
STAD	cis	1	rs2951371	chr7:143750328	ARHGEF35	chr7:143883677-143892736:-	-0.3	-4.48	9.89E-6	Obesity-related traits	
STAD	cis	1	rs2951372	chr7:143749503	ARHGEF35	chr7:143883677-143892736:-	-0.36	-5.63	3.39E-8	Obesity-related traits	
STAD	cis	1	rs2961102	chr7:65424658	CCT6P1	chr7:65216092-65228661:+	0.29	4.36	1.63E-5	Diabetic kidney disease	
STAD	cis	1	rs2961115	chr7:143753371	ARHGEF35	chr7:143883677-143892736:-	-0.36	-5.6	4.05E-8	Obesity-related traits	
STAD	cis	1	rs2961117	chr7:143755253	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.62	5.3E-6	Obesity-related traits	
STAD	cis	1	rs2961118	chr7:143755443	ARHGEF35	chr7:143883677-143892736:-	-0.35	-5.52	6.1E-8	Obesity-related traits	
STAD	cis	1	rs2961119	chr7:143755852	ARHGEF35	chr7:143883677-143892736:-	-0.35	-5.52	6.1E-8	Obesity-related traits	
STAD	cis	1	rs2961120	chr7:143756585	ARHGEF35	chr7:143883677-143892736:-	-0.36	-5.53	5.91E-8	Obesity-related traits	
STAD	cis	1	rs2961125	chr7:143761770	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.76	1.71E-8	Obesity-related traits	
STAD	cis	1	rs2961126	chr7:143762736	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.76	1.71E-8	Obesity-related traits	
STAD	cis	1	rs2961128	chr7:143763483	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.83	1.19E-8	Obesity-related traits	
STAD	cis	1	rs2961132	chr7:143768128	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.73	2.02E-8	Obesity-related traits	
STAD	cis	1	rs2961134	chr7:143771062	ARHGEF35	chr7:143883677-143892736:-	-0.35	-5.35	1.47E-7	Obesity-related traits	
STAD	cis	1	rs2961144	chr7:143747870	ARHGEF35	chr7:143883677-143892736:-	0.38	5.98	5.08E-9	Obesity-related traits	
STAD	cis	1	rs2976392	chr8:143762932	PSCA	chr8:143761875-143764142:+	0.34	6.94	1.66E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2976394	chr8:143763622	PSCA	chr8:143761875-143764142:+	0.34	6.96	1.42E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2976396	chr8:143764001	PSCA	chr8:143761875-143764142:+	-0.32	-6.62	1.21E-10	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2976398	chr8:143764879	LY6K	chr8:143781529-143785582:+	0.25	3.85	0.000139	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2976398	chr8:143764879	PSCA	chr8:143761875-143764142:+	0.34	6.94	1.61E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2978982	chr8:143763490	PSCA	chr8:143761875-143764142:+	0.34	6.96	1.42E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
STAD	cis	1	rs2993207	chr1:155873314	RAB25	chr1:156030966-156040293:+	-0.17	-3.88	0.000123	Crohn's disease;Inflammatory bowel disease	
STAD	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.48	-7.66	1.47E-13	Homocysteine levels	
STAD	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.56	-12.21	3.05E-29	Ankylosing spondylitis	
STAD	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.49	8.22	2.95E-15	Ankylosing spondylitis	
STAD	cis	1	rs3020556	chr1:201343115	TNNI1	chr1:201372895-201398994:-	-0.29	-4.28	2.37E-5	Cardiac Troponin-T levels	
STAD	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.56	-12.34	8.87E-30	Ankylosing spondylitis	
STAD	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.49	8.2	3.42E-15	Ankylosing spondylitis	
STAD	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.56	-12.34	8.87E-30	Ankylosing spondylitis	
STAD	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.49	8.2	3.42E-15	Ankylosing spondylitis	
STAD	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.56	-12.34	8.87E-30	Ankylosing spondylitis	
STAD	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.49	8.2	3.42E-15	Ankylosing spondylitis	
STAD	cis	1	rs3096474	chr4:109965679	CASP6	chr4:110609785-110624629:-	0.18	3.81	0.000161	Body mass index	
STAD	cis	1	rs3096484	chr4:109972083	CASP6	chr4:110609785-110624629:-	0.18	3.88	0.000125	Body mass index	
STAD	cis	1	rs3097417	chr3:53088601	TMEM110	chr3:52867139-52931547:-	-0.33	-3.86	0.000132	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	0.88	18.33	1.41E-54	Type 2 diabetes	
STAD	cis	1	rs3099555	chr4:1725651	FAM53A	chr4:1641609-1685854:-	-0.42	-6.36	5.74E-10	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs3099899	chr4:129917368	C4orf33	chr4:130014829-130033842:+	-0.43	-6.76	4.97E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.48	-5.82	1.24E-8	Tumor biomarkers	
STAD	cis	1	rs3101443	chr15:43912372	CATSPER2	chr15:43922774-43959900:-	-0.42	-7.36	1.12E-12	Tumor biomarkers	
STAD	cis	1	rs3104435	chr1:31045509	ZCCHC17	chr1:31769842-31837780:+	-0.26	-3.91	0.000108	Low high density lipoprotein cholesterol levels	
STAD	cis	1	rs3105369	chr4:130022448	C4orf33	chr4:130014829-130033842:+	-0.42	-6.82	3.41E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs3108925	chr4:109973620	CASP6	chr4:110609785-110624629:-	0.18	3.98	8.24E-5	Body mass index	
STAD	cis	1	rs3108941	chr4:109965338	CASP6	chr4:110609785-110624629:-	0.18	3.89	0.000118	Body mass index	
STAD	cis	1	rs3108942	chr4:109964703	CASP6	chr4:110609785-110624629:-	0.18	3.88	0.000123	Body mass index	
STAD	cis	1	rs3110496	chr17:27917771	TP53I13	chr17:27895739-27900174:+	0.16	3.83	0.000147	Height	
STAD	cis	1	rs3113489	chr4:129961179	C4orf33	chr4:130014829-130033842:+	-0.44	-6.93	1.71E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs311729	chr5:109771127	TMEM232	chr5:109624934-110062381:-	0.37	4.42	1.26E-5	Cardiac structure and function	
STAD	cis	1	rs3118625	chr9:131873256	CRAT	chr9:131857075-131873070:-	-0.28	-4.74	2.98E-6	Blood metabolite ratios	
STAD	cis	1	rs3118625	chr9:131873256	PPP2R4	chr9:131873244-131911223:+	-0.22	-4.32	1.96E-5	Blood metabolite ratios	
STAD	cis	1	rs3118632	chr9:131901284	CRAT	chr9:131857075-131873070:-	-0.29	-5.12	4.82E-7	Blood metabolite ratios	
STAD	cis	1	rs3118632	chr9:131901284	PPP2R4	chr9:131873244-131911223:+	-0.24	-4.96	1.06E-6	Blood metabolite ratios	
STAD	cis	1	rs3124322	chr1:31033238	ZCCHC17	chr1:31769842-31837780:+	-0.26	-3.86	0.000134	Low high density lipoprotein cholesterol levels	
STAD	cis	1	rs3124323	chr1:31034859	ZCCHC17	chr1:31769842-31837780:+	-0.26	-3.84	0.000145	Low high density lipoprotein cholesterol levels	
STAD	cis	1	rs3124324	chr1:31037257	ZCCHC17	chr1:31769842-31837780:+	-0.27	-3.98	8.37E-5	Low high density lipoprotein cholesterol levels	
STAD	cis	1	rs3124325	chr1:31042578	ZCCHC17	chr1:31769842-31837780:+	-0.27	-4.09	5.28E-5	Low high density lipoprotein cholesterol levels	
STAD	cis	1	rs3124510	chr9:131899690	CRAT	chr9:131857075-131873070:-	-0.28	-5.06	6.62E-7	Blood metabolite ratios	
STAD	cis	1	rs3124510	chr9:131899690	PPP2R4	chr9:131873244-131911223:+	-0.26	-5.32	1.79E-7	Blood metabolite ratios	
STAD	cis	1	rs3124511	chr9:131901458	CRAT	chr9:131857075-131873070:-	-0.29	-5.08	5.85E-7	Blood metabolite ratios	
STAD	cis	1	rs3124511	chr9:131901458	PPP2R4	chr9:131873244-131911223:+	-0.24	-4.7	3.7E-6	Blood metabolite ratios	
STAD	cis	1	rs3124512	chr9:131903881	CRAT	chr9:131857075-131873070:-	-0.31	-5.29	2.08E-7	Blood metabolite ratios	
STAD	cis	1	rs3124512	chr9:131903881	PPP2R4	chr9:131873244-131911223:+	-0.26	-5.17	3.75E-7	Blood metabolite ratios	
STAD	cis	1	rs3124513	chr9:131904593	CRAT	chr9:131857075-131873070:-	-0.3	-5.24	2.65E-7	Blood metabolite ratios	
STAD	cis	1	rs3124513	chr9:131904593	PPP2R4	chr9:131873244-131911223:+	-0.25	-5.08	5.77E-7	Blood metabolite ratios	
STAD	cis	1	rs3124514	chr9:131904608	CRAT	chr9:131857075-131873070:-	-0.3	-5.24	2.65E-7	Blood metabolite ratios	
STAD	cis	1	rs3124514	chr9:131904608	PPP2R4	chr9:131873244-131911223:+	-0.25	-5.08	5.77E-7	Blood metabolite ratios	
STAD	cis	1	rs313820	chr7:65574466	CCT6P1	chr7:65216092-65228661:+	0.28	4.24	2.76E-5	Diabetic kidney disease	
STAD	cis	1	rs313824	chr7:65581207	CCT6P1	chr7:65216092-65228661:+	0.29	4.28	2.36E-5	Diabetic kidney disease	
STAD	cis	1	rs313831	chr7:65551226	CCT6P1	chr7:65216092-65228661:+	0.28	4.06	5.89E-5	Diabetic kidney disease	
STAD	cis	1	rs313832	chr7:65550891	CCT6P1	chr7:65216092-65228661:+	0.28	4.06	5.89E-5	Diabetic kidney disease	
STAD	cis	1	rs316307	chr7:65570171	CCT6P1	chr7:65216092-65228661:+	0.27	4.06	6.0E-5	Diabetic kidney disease	
STAD	cis	1	rs316312	chr7:65596491	CCT6P1	chr7:65216092-65228661:+	0.29	4.32	1.99E-5	Diabetic kidney disease	
STAD	cis	1	rs316313	chr7:65593548	CCT6P1	chr7:65216092-65228661:+	0.29	4.35	1.75E-5	Diabetic kidney disease	
STAD	cis	1	rs316330	chr7:65605372	CCT6P1	chr7:65216092-65228661:+	0.27	4.03	6.7E-5	Diabetic kidney disease	
STAD	cis	1	rs316331	chr7:65604622	CCT6P1	chr7:65216092-65228661:+	-0.27	-4	7.54E-5	Diabetic kidney disease	
STAD	cis	1	rs316332	chr7:65604299	CCT6P1	chr7:65216092-65228661:+	0.26	3.9	0.000112	Diabetic kidney disease	
STAD	cis	1	rs316334	chr7:65602126	CCT6P1	chr7:65216092-65228661:+	0.29	4.34	1.85E-5	Diabetic kidney disease	
STAD	cis	1	rs3176824	chr3:46248385	CCR2	chr3:46395235-46402412:+	0.23	4.02	7.02E-5	Celiac disease	
STAD	cis	1	rs3176825	chr3:46248224	CCR2	chr3:46395235-46402412:+	0.23	4.02	7.02E-5	Celiac disease	
STAD	cis	1	rs3180872	chr22:51017394	CPT1B	chr22:51007291-51017096:-	-0.39	-5.25	2.46E-7	Narcolepsy	
STAD	cis	1	rs3181076	chr3:46250733	CCR2	chr3:46395235-46402412:+	0.23	4.02	7.02E-5	Celiac disease	
STAD	cis	1	rs3181078	chr3:46250584	CCR2	chr3:46395235-46402412:+	0.23	4.02	7.02E-5	Celiac disease	
STAD	cis	1	rs3181080	chr3:46249929	CCR2	chr3:46395235-46402412:+	0.23	4.02	7.02E-5	Celiac disease	
STAD	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.75	-7.83	4.62E-14	Dental caries	
STAD	cis	1	rs3213446	chr22:51015674	CPT1B	chr22:51007291-51017096:-	-0.4	-5.48	7.78E-8	Narcolepsy	
STAD	cis	1	rs3213762	chr17:38178627	GSDMA	chr17:38119226-38134019:+	-0.29	-5.18	3.53E-7	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.26	-5.86	9.62E-9	Longevity	
STAD	cis	1	rs321622	chr4:48024380	CNGA1	chr4:47937996-48018610:-	0.24	4.61	5.42E-6	Renal underexcretion gout;Gout	
STAD	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	0.88	17.52	3.98E-51	Type 2 diabetes	
STAD	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.88	18.4	6.93E-55	Type 2 diabetes	
STAD	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	0.88	18.35	1.2E-54	Type 2 diabetes	
STAD	cis	1	rs33955793	chr3:12544829	TSEN2	chr3:12525931-12581122:+	0.42	4.55	7.26E-6	Prostate cancer (gene x gene interaction)	
STAD	cis	1	rs33988592	chr3:121415610	IQCB1	chr3:121488610-121553926:-	0.27	4.55	7.19E-6	Cognitive performance	
STAD	cis	1	rs33999310	chr3:52883332	TMEM110	chr3:52867139-52931547:-	0.48	4.97	1.01E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs34010330	chr19:18559657	ISYNA1	chr19:18545625-18548943:-	0.23	4.01	7.24E-5	Breast cancer	
STAD	cis	1	rs34047458	chr3:46253599	CCR2	chr3:46395235-46402412:+	0.23	3.88	0.00012	Celiac disease	
STAD	cis	1	rs34055941	chr9:131895076	CRAT	chr9:131857075-131873070:-	0.27	4.8	2.26E-6	Blood metabolite ratios	
STAD	cis	1	rs34055941	chr9:131895076	PPP2R4	chr9:131873244-131911223:+	0.22	4.5	8.99E-6	Blood metabolite ratios	
STAD	cis	1	rs340630	chr4:87958395	SPARCL1	chr4:88394490-88450655:-	0.11	4.21	3.21E-5	Systemic lupus erythematosus	
STAD	cis	1	rs34084277	chr19:17387176	OCEL1	chr19:17337055-17340027:+	0.29	4.32	1.95E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
STAD	cis	1	rs34086988	chr3:121352745	IQCB1	chr3:121488610-121553926:-	0.29	4.94	1.16E-6	Cognitive performance	
STAD	cis	1	rs34101673	chr3:46197286	CCR2	chr3:46395235-46402412:+	0.23	4.11	4.86E-5	Celiac disease	
STAD	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs34121720	chr3:53072167	TMEM110	chr3:52867139-52931547:-	0.4	4.37	1.59E-5	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs34128973	chr11:47851376	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.7	1.15E-13	Subjective well-being	
STAD	cis	1	rs34134191	chr3:46221531	CCR2	chr3:46395235-46402412:+	0.22	3.9	0.000113	Celiac disease	
STAD	cis	1	rs34136756	chr7:65381256	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs34156253	chr5:150226230	LOC134466	chr5:150310000-150326146:-	0.29	4.57	6.66E-6	Crohn's disease	
STAD	cis	1	rs34171762	chr19:18559410	ISYNA1	chr19:18545625-18548943:-	0.23	3.99	7.85E-5	Breast cancer	
STAD	cis	1	rs34174778	chr20:33544277	PROCR	chr20:33758727-33765164:+	-0.49	-5.22	2.92E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs34193460	chr7:65393110	CCT6P1	chr7:65216092-65228661:+	0.29	4.37	1.57E-5	Diabetic kidney disease	
STAD	cis	1	rs34198655	chr3:46215107	CCR2	chr3:46395235-46402412:+	0.19	3.86	0.000132	Celiac disease	
STAD	cis	1	rs34244302	chr3:53102236	TMEM110	chr3:52867139-52931547:-	0.45	4.78	2.45E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs34256197	chr19:18606472	ISYNA1	chr19:18545625-18548943:-	0.24	4.09	5.33E-5	Breast cancer	
STAD	cis	1	rs34258593	chr3:38464565	XYLB	chr3:38388251-38456467:+	0.22	4.43	1.2E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs34280313	chr3:46252505	CCR2	chr3:46395235-46402412:+	0.23	4	7.56E-5	Celiac disease	
STAD	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.67	-13.22	3.26E-33	Response to antipsychotic treatment	
STAD	cis	1	rs34285886	chr12:57302520	ARHGAP9	chr12:57866039-57882597:-	-0.14	-4.47	1.02E-5	Airway wall thickness	
STAD	cis	1	rs34313969	chr3:52995166	TMEM110	chr3:52867139-52931547:-	0.49	4.97	9.81E-7	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs34333482	chr6:116855952	FAM162B	chr6:117073360-117086886:-	0.2	4.07	5.65E-5	Pelvic organ prolapse (moderate/severe)	
STAD	cis	1	rs34333482	chr6:116855952	FAM26E	chr6:116832808-116839708:+	0.16	4.18	3.6E-5	Pelvic organ prolapse (moderate/severe)	
STAD	cis	1	rs34340501	chr3:46225216	CCR2	chr3:46395235-46402412:+	0.22	3.82	0.000158	Celiac disease	
STAD	cis	1	rs34340609	chr3:53077276	TMEM110	chr3:52867139-52931547:-	0.34	4.03	6.84E-5	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs34378541	chr3:46239649	CCR2	chr3:46395235-46402412:+	0.23	3.86	0.000132	Celiac disease	
STAD	cis	1	rs344081	chr3:156555984	LEKR1	chr3:156544076-156763918:+	-0.4	-4.66	4.26E-6	Bone mineral density	
STAD	cis	1	rs344088	chr3:156561361	LEKR1	chr3:156544076-156763918:+	-0.38	-4.35	1.77E-5	Bone mineral density	
STAD	cis	1	rs344090	chr3:156563140	LEKR1	chr3:156544076-156763918:+	-0.38	-4.35	1.77E-5	Bone mineral density	
STAD	cis	1	rs34409160	chr2:28943865	TRMT61B	chr2:29072690-29093175:-	0.31	5.19	3.37E-7	Body mass index	
STAD	cis	1	rs34409248	chr3:46198071	CCR2	chr3:46395235-46402412:+	0.23	4.11	4.86E-5	Celiac disease	
STAD	cis	1	rs34423195	chr3:46249722	CCR2	chr3:46395235-46402412:+	0.23	4.02	7.02E-5	Celiac disease	
STAD	cis	1	rs34428306	chr1:152184316	FLG2	chr1:152321214-152332482:-	0.25	4.07	5.81E-5	Inflammatory skin disease	
STAD	cis	1	rs34428306	chr1:152184316	FLG	chr1:152274651-152297679:-	0.47	7.72	9.55E-14	Inflammatory skin disease	
STAD	cis	1	rs34496143	chr10:37992658	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.91	0.000109	Obesity (extreme)	
STAD	cis	1	rs34523728	chr3:46219833	CCR2	chr3:46395235-46402412:+	0.22	3.9	0.000113	Celiac disease	
STAD	cis	1	rs34524359	chr8:92420276	RUNX1T1	chr8:92971152-93107706:-	0.22	3.81	0.000164	Fat distribution (HIV)	
STAD	cis	1	rs34529418	chr7:65403209	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs34560516	chr7:65404092	CCT6P1	chr7:65216092-65228661:+	0.29	4.29	2.28E-5	Diabetic kidney disease	
STAD	cis	1	rs34567015	chr3:46202212	CCR2	chr3:46395235-46402412:+	0.22	3.94	9.68E-5	Celiac disease	
STAD	cis	1	rs34570071	chr15:85280212	LOC388152	chr15:84867600-84898920:-	-0.28	-4.31	2.04E-5	Schizophrenia	
STAD	cis	1	rs34570200	chr3:46220500	CCR2	chr3:46395235-46402412:+	0.22	3.9	0.000113	Celiac disease	
STAD	cis	1	rs34577383	chr7:65385726	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.66	-13.14	6.87E-33	Response to antipsychotic treatment	
STAD	cis	1	rs34589111	chr1:54353126	YIPF1	chr1:54317407-54355453:-	0.51	3.92	0.000103	Nonalcoholic fatty liver disease	
STAD	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs34637256	chr7:65360131	CCT6P1	chr7:65216092-65228661:+	0.26	3.99	7.81E-5	Diabetic kidney disease	
STAD	cis	1	rs34638686	chr3:48682658	WDR6	chr3:49044637-49053386:+	0.38	4.43	1.2E-5	Educational attainment (years of education)	
STAD	cis	1	rs34693386	chr3:46195402	CCR2	chr3:46395235-46402412:+	0.23	4.11	4.86E-5	Celiac disease	
STAD	cis	1	rs34700722	chr8:96021876	C8orf38	chr8:95908040-96088396:+	-0.33	-3.99	8.04E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs34702770	chr7:65344823	CCT6P1	chr7:65216092-65228661:+	0.26	3.99	7.81E-5	Diabetic kidney disease	
STAD	cis	1	rs34703416	chr7:65300642	CCT6P1	chr7:65216092-65228661:+	0.27	4	7.66E-5	Diabetic kidney disease	
STAD	cis	1	rs34746918	chr19:18539744	ISYNA1	chr19:18545625-18548943:-	0.24	4.12	4.61E-5	Breast cancer	
STAD	cis	1	rs34751999	chr15:84758419	LOC388152	chr15:84867600-84898920:-	-0.29	-4.15	4.06E-5	Schizophrenia	
STAD	cis	1	rs34812189	chr6:56806727	BEND6	chr6:56819773-56892138:+	-0.24	-4.98	9.46E-7	Menarche (age at onset)	
STAD	cis	1	rs34815098	chr7:65292254	CCT6P1	chr7:65216092-65228661:+	0.26	3.99	7.81E-5	Diabetic kidney disease	
STAD	cis	1	rs34844680	chr15:89232751	RLBP1	chr15:89753099-89764922:-	0.24	4.06	6.02E-5	Obesity-related traits	
STAD	cis	1	rs34848593	chr1:113240106	ST7L	chr1:113066142-113162405:-	0.4	7.2	3.02E-12	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.66	-12.98	2.97E-32	Response to antipsychotic treatment	
STAD	cis	1	rs34897745	chr3:46198376	CCR2	chr3:46395235-46402412:+	0.23	4.11	4.86E-5	Celiac disease	
STAD	cis	1	rs34900908	chr15:85257599	LOC388152	chr15:84867600-84898920:-	-0.28	-4.22	3.03E-5	Schizophrenia	
STAD	cis	1	rs34910028	chr11:47758449	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.77	7.08E-14	Subjective well-being	
STAD	cis	1	rs34919616	chr3:46250008	CCR2	chr3:46395235-46402412:+	0.23	4.02	7.02E-5	Celiac disease	
STAD	cis	1	rs34933390	chr3:53006265	TMEM110	chr3:52867139-52931547:-	0.47	4.82	2.05E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs34933526	chr7:65383199	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs34943350	chr3:53012888	TMEM110	chr3:52867139-52931547:-	0.51	5.11	5.06E-7	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs34949904	chr22:24695298	POM121L9P	chr22:24647589-24661490:+	-0.25	-5.98	5.12E-9	Gut microbiome composition (summer)	
STAD	cis	1	rs34964872	chr14:104448435	TDRD9	chr14:104394817-104519002:+	0.24	4.03	6.66E-5	Bipolar disorder	
STAD	cis	1	rs34970380	chr7:65431493	CCT6P1	chr7:65216092-65228661:+	0.27	3.94	9.82E-5	Diabetic kidney disease	
STAD	cis	1	rs34974928	chr7:65364006	CCT6P1	chr7:65216092-65228661:+	0.26	3.99	7.81E-5	Diabetic kidney disease	
STAD	cis	1	rs34981496	chr3:121302182	FAM162A	chr3:122103023-122128960:+	-0.3	-3.89	0.000117	Postprandial triglyceride response to high fat diet meal	
STAD	cis	1	rs34996127	chr3:46198173	CCR2	chr3:46395235-46402412:+	0.23	4.11	4.86E-5	Celiac disease	
STAD	cis	1	rs35006492	chr4:129878342	C4orf33	chr4:130014829-130033842:+	0.44	6.98	1.28E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs35046236	chr7:65408613	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs35056702	chr6:109736326	SMPD2	chr6:109761931-109765121:+	0.24	4.8	2.3E-6	Height	
STAD	cis	1	rs35058610	chr7:65390925	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.41	-7.77	6.94E-14	Forced vital capacity	
STAD	cis	1	rs35068485	chr11:466032	RNH1	chr11:494512-507273:-	-0.43	-5.77	1.6E-8	Body mass index	
STAD	cis	1	rs35106985	chr10:102307542	SEC31B	chr10:102246403-102289636:-	-0.21	-5.03	7.35E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs35162796	chr3:46204379	CCR2	chr3:46395235-46402412:+	0.23	4.11	4.86E-5	Celiac disease	
STAD	cis	1	rs35163227	chr3:53127876	TMEM110	chr3:52867139-52931547:-	0.48	5.01	8.12E-7	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs35174175	chr3:53041509	TMEM110	chr3:52867139-52931547:-	0.48	4.83	1.94E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs35178150	chr3:46194769	CCR2	chr3:46395235-46402412:+	0.23	4.03	6.66E-5	Celiac disease	
STAD	cis	1	rs35184688	chr17:40272406	DHX58	chr17:40253422-40264751:-	-0.33	-6	4.52E-9	Fibrinogen levels	
STAD	cis	1	rs35202312	chr6:56788937	BEND6	chr6:56819773-56892138:+	-0.25	-5.4	1.17E-7	Menarche (age at onset)	
STAD	cis	1	rs35231079	chr11:515224	RNH1	chr11:494512-507273:-	-0.42	-5.2	3.15E-7	Body mass index	
STAD	cis	1	rs35255804	chr11:492617	RNH1	chr11:494512-507273:-	-0.43	-5.73	2.03E-8	Body mass index	
STAD	cis	1	rs35258216	chr10:38018220	HSD17B7P2	chr10:38645308-38667432:+	0.29	3.8	0.000168	Obesity (extreme)	
STAD	cis	1	rs35283677	chr7:65359233	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.24E-5	Diabetic kidney disease	
STAD	cis	1	rs35288652	chr3:46209427	CCR2	chr3:46395235-46402412:+	0.23	4.11	4.86E-5	Celiac disease	
STAD	cis	1	rs35297609	chr15:84772896	LOC388152	chr15:84867600-84898920:-	-0.28	-4.06	5.97E-5	Schizophrenia	
STAD	cis	1	rs35303215	chr22:24801535	POM121L9P	chr22:24647589-24661490:+	-0.26	-5.96	5.61E-9	Gut microbiome composition (summer)	
STAD	cis	1	rs35316992	chr15:85248133	LOC388152	chr15:84867600-84898920:-	-0.28	-4.27	2.42E-5	Schizophrenia	
STAD	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.72	-15.31	9.16E-42	Response to antipsychotic treatment	
STAD	cis	1	rs35391607	chr7:65360829	CCT6P1	chr7:65216092-65228661:+	0.26	3.99	7.81E-5	Diabetic kidney disease	
STAD	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.67	-13.22	3.26E-33	Response to antipsychotic treatment	
STAD	cis	1	rs35421653	chr7:65363429	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.24E-5	Diabetic kidney disease	
STAD	cis	1	rs35429781	chr3:46253607	CCR2	chr3:46395235-46402412:+	0.23	3.88	0.00012	Celiac disease	
STAD	cis	1	rs35432774	chr7:65393019	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.48	9.17	2.86E-18	Eye color traits	
STAD	cis	1	rs35454259	chr6:27254475	LOC100270746	chr6:26987146-26988085:-	0.36	4.9	1.43E-6	Schizophrenia	
STAD	cis	1	rs35463759	chr1:54356721	YIPF1	chr1:54317407-54355453:-	0.53	4.24	2.85E-5	Nonalcoholic fatty liver disease	
STAD	cis	1	rs35468353	chr16:31056433	MYST1	chr16:31128985-31142713:+	0.24	4.19	3.51E-5	Response to metformin (IC50)	
STAD	cis	1	rs35507120	chr3:53053924	TMEM110	chr3:52867139-52931547:-	0.48	4.83	1.94E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs35522482	chr22:39063015	LOC646851	chr22:38974125-39052634:-	0.24	5.07	6.11E-7	Resting heart rate	
STAD	cis	1	rs35524990	chr15:85258203	LOC388152	chr15:84867600-84898920:-	-0.28	-4.22	3.03E-5	Schizophrenia	
STAD	cis	1	rs35527216	chr6:56791278	BEND6	chr6:56819773-56892138:+	-0.25	-5.42	1.02E-7	Menarche (age at onset)	
STAD	cis	1	rs35552264	chr20:33544973	PROCR	chr20:33758727-33765164:+	-0.49	-5.22	2.92E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs35565791	chr22:39063011	LOC646851	chr22:38974125-39052634:-	0.24	5.07	6.11E-7	Resting heart rate	
STAD	cis	1	rs35566550	chr3:46210512	CCR2	chr3:46395235-46402412:+	0.23	4.11	4.86E-5	Celiac disease	
STAD	cis	1	rs35571434	chr1:90948313	HFM1	chr1:91726324-91870426:-	0.24	4.01	7.27E-5	Coronary artery calcification	
STAD	cis	1	rs35576914	chr3:53092270	TMEM110	chr3:52867139-52931547:-	0.4	4.38	1.54E-5	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs35608327	chr15:90369204	AP3S2	chr15:90373832-90456222:-	-0.64	-9.33	8.4E-19	Type 2 diabetes	
STAD	cis	1	rs35624992	chr11:47615798	C1QTNF4	chr11:47611216-47615961:-	-0.31	-7.65	1.54E-13	Subjective well-being	
STAD	cis	1	rs35630683	chr15:85349231	LOC388152	chr15:84867600-84898920:-	-0.28	-4.26	2.55E-5	Schizophrenia	
STAD	cis	1	rs35648189	chr15:84740748	LOC388152	chr15:84867600-84898920:-	-0.29	-4.15	4.06E-5	Schizophrenia	
STAD	cis	1	rs35658069	chr15:84780146	LOC388152	chr15:84867600-84898920:-	-0.28	-4.09	5.19E-5	Schizophrenia	
STAD	cis	1	rs35685805	chr3:46202778	CCR2	chr3:46395235-46402412:+	0.22	3.94	9.68E-5	Celiac disease	
STAD	cis	1	rs35718987	chr3:134272783	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.75	5.47E-11	Height	
STAD	cis	1	rs35720014	chr3:52982110	TMEM110	chr3:52867139-52931547:-	0.49	4.91	1.35E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs35726233	chr15:85337800	LOC388152	chr15:84867600-84898920:-	-0.28	-4.22	3.02E-5	Schizophrenia	
STAD	cis	1	rs35735127	chr7:65300423	CCT6P1	chr7:65216092-65228661:+	0.26	3.99	7.81E-5	Diabetic kidney disease	
STAD	cis	1	rs35737577	chr3:53002557	TMEM110	chr3:52867139-52931547:-	0.47	4.78	2.52E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.72	-15.31	9.16E-42	Response to antipsychotic treatment	
STAD	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.66	-12.97	3.09E-32	Response to antipsychotic treatment	
STAD	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.66	-13.17	4.87E-33	Response to antipsychotic treatment	
STAD	cis	1	rs35808647	chr15:85377441	LOC388152	chr15:84867600-84898920:-	-0.26	-3.85	0.000137	Schizophrenia	
STAD	cis	1	rs35811812	chr11:498442	RNH1	chr11:494512-507273:-	-0.42	-5.63	3.53E-8	Body mass index	
STAD	cis	1	rs35820085	chr7:65442758	CCT6P1	chr7:65216092-65228661:+	0.28	4.04	6.45E-5	Diabetic kidney disease	
STAD	cis	1	rs35825738	chr7:65318027	CCT6P1	chr7:65216092-65228661:+	0.26	3.98	8.09E-5	Diabetic kidney disease	
STAD	cis	1	rs35835884	chr10:127708468	UROS	chr10:127477148-127511837:-	-0.23	-4.28	2.32E-5	Visceral fat	
STAD	cis	1	rs35849389	chr3:53005235	TMEM110	chr3:52867139-52931547:-	0.47	4.82	2.05E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs35853141	chr3:46198388	CCR2	chr3:46395235-46402412:+	0.23	4.11	4.86E-5	Celiac disease	
STAD	cis	1	rs35869328	chr1:54356647	YIPF1	chr1:54317407-54355453:-	0.51	3.92	0.000103	Nonalcoholic fatty liver disease	
STAD	cis	1	rs35874808	chr11:506442	RNH1	chr11:494512-507273:-	-0.43	-5.65	3.15E-8	Body mass index	
STAD	cis	1	rs35898083	chr11:484469	RNH1	chr11:494512-507273:-	-0.43	-5.8	1.41E-8	Body mass index	
STAD	cis	1	rs35902101	chr11:47795169	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.71	1.09E-13	Subjective well-being	
STAD	cis	1	rs35919278	chr3:46213594	CCR2	chr3:46395235-46402412:+	0.23	4.11	4.86E-5	Celiac disease	
STAD	cis	1	rs35951606	chr10:38088347	HSD17B7P2	chr10:38645308-38667432:+	0.34	4.07	5.65E-5	Obesity (extreme)	
STAD	cis	1	rs35960805	chr15:85343980	LOC388152	chr15:84867600-84898920:-	-0.27	-4.11	4.88E-5	Schizophrenia	
STAD	cis	1	rs35962538	chr12:22560743	KIAA0528	chr12:22601526-22697452:-	0.45	4.38	1.55E-5	Coronary artery calcification	
STAD	cis	1	rs35988617	chr3:121432902	IQCB1	chr3:121488610-121553926:-	0.27	4.55	7.33E-6	Cognitive performance	
STAD	cis	1	rs36006749	chr3:38443312	XYLB	chr3:38388251-38456467:+	0.22	4.47	1.01E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs36033484	chr7:65390558	CCT6P1	chr7:65216092-65228661:+	0.29	4.29	2.28E-5	Diabetic kidney disease	
STAD	cis	1	rs36033486	chr15:85319692	LOC388152	chr15:84867600-84898920:-	-0.28	-4.24	2.78E-5	Schizophrenia	
STAD	cis	1	rs36035949	chr6:109736614	SMPD2	chr6:109761931-109765121:+	0.25	5	8.72E-7	Height	
STAD	cis	1	rs36068983	chr7:65408991	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs36090694	chr3:53010742	TMEM110	chr3:52867139-52931547:-	0.5	5.09	5.66E-7	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs36123022	chr3:12552980	TSEN2	chr3:12525931-12581122:+	0.44	4.6	5.81E-6	Prostate cancer (gene x gene interaction)	
STAD	cis	1	rs36216559	chr2:262335	SH3YL1	chr2:218138-264810:-	-0.6	-12.85	9.1E-32	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs3731878	chr2:219920565	SLC23A3	chr2:220026183-220034817:-	0.38	4.36	1.67E-5	Height	
STAD	cis	1	rs3732408	chr3:121421179	IQCB1	chr3:121488610-121553926:-	0.27	4.55	7.19E-6	Cognitive performance	
STAD	cis	1	rs3733418	chr4:165878335	C4orf39	chr4:165878100-165880273:+	0.22	4.08	5.39E-5	Obesity-related traits	
STAD	cis	1	rs3733419	chr4:165878170	C4orf39	chr4:165878100-165880273:+	0.22	4.06	5.85E-5	Obesity-related traits	
STAD	cis	1	rs3734530	chr6:26195408	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.67E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs3739843	chr9:131882961	CRAT	chr9:131857075-131873070:-	0.25	4.57	6.64E-6	Blood metabolite ratios	
STAD	cis	1	rs3739843	chr9:131882961	PPP2R4	chr9:131873244-131911223:+	0.22	4.48	9.74E-6	Blood metabolite ratios	
STAD	cis	1	rs3739847	chr9:131911574	CRAT	chr9:131857075-131873070:-	-0.29	-5.16	3.93E-7	Blood metabolite ratios	
STAD	cis	1	rs3739847	chr9:131911574	PPP2R4	chr9:131873244-131911223:+	-0.24	-4.96	1.04E-6	Blood metabolite ratios	
STAD	cis	1	rs3740711	chr11:18379839	GTF2H1	chr11:18343816-18388590:+	0.36	6.09	2.78E-9	Pancreatic cancer	
STAD	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.44	-9.07	5.93E-18	IgG glycosylation	
STAD	cis	1	rs3747113	chr22:24717518	POM121L9P	chr22:24647589-24661490:+	0.26	6.1	2.58E-9	Gut microbiome composition (summer)	
STAD	cis	1	rs3747170	chr22:39067331	LOC646851	chr22:38974125-39052634:-	0.24	5.07	6.11E-7	Resting heart rate	
STAD	cis	1	rs3747172	chr22:39067524	CBY1	chr22:39052658-39069853:+	0.21	4.17	3.83E-5	Resting heart rate	
STAD	cis	1	rs3747172	chr22:39067524	LOC646851	chr22:38974125-39052634:-	0.26	5.51	6.7E-8	Resting heart rate	
STAD	cis	1	rs3747174	chr22:39069181	CBY1	chr22:39052658-39069853:+	0.21	4.17	3.83E-5	Resting heart rate	
STAD	cis	1	rs3747174	chr22:39069181	LOC646851	chr22:38974125-39052634:-	0.26	5.51	6.7E-8	Resting heart rate	
STAD	cis	1	rs3748578	chr1:10420918	PGD	chr1:10459085-10480200:+	-0.25	-4.35	1.73E-5	Hepatocellular carcinoma	
STAD	cis	1	rs3748656	chr1:113236681	ST7L	chr1:113066142-113162405:-	0.4	7.2	3.02E-12	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs3750626	chr10:102266316	SEC31B	chr10:102246403-102289636:-	-0.24	-5.89	8.51E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs3750627	chr10:102275642	SEC31B	chr10:102246403-102289636:-	-0.25	-6.12	2.26E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs3750629	chr10:102275727	SEC31B	chr10:102246403-102289636:-	-0.24	-6	4.56E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs3750630	chr10:102275780	SEC31B	chr10:102246403-102289636:-	-0.23	-5.72	2.17E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs3750633	chr10:102308214	SEC31B	chr10:102246403-102289636:-	-0.24	-5.69	2.52E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs3750719	chr10:102248950	SEC31B	chr10:102246403-102289636:-	-0.26	-6.22	1.31E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs3750720	chr10:102248884	SEC31B	chr10:102246403-102289636:-	-0.26	-6.18	1.57E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs3751913	chr17:80405552	C17orf62	chr17:80400520-80408694:-	-0.24	-3.82	0.000152	Protein quantitative trait loci	
STAD	cis	1	rs3751972	chr17:26206414	C17orf108	chr17:26205341-26220409:-	0.29	5.31	1.85E-7	Fractional exhaled nitric oxide (childhood)	
STAD	cis	1	rs3752749	chr4:1737262	FAM53A	chr4:1641609-1685854:-	-0.47	-6.9	2.06E-11	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs3753037	chr1:10355834	PGD	chr1:10459085-10480200:+	0.23	3.88	0.000121	Hepatocellular carcinoma	
STAD	cis	1	rs3754439	chr1:110615094	ALX3	chr1:110602998-110613322:-	-0.21	-3.82	0.000157	Blood metabolite levels	
STAD	cis	1	rs3754440	chr1:110613674	ALX3	chr1:110602998-110613322:-	-0.21	-3.87	0.00013	Blood metabolite levels	
STAD	cis	1	rs3757135	chr6:26200707	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.35	1.73E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs3761454	chr22:39066820	LOC646851	chr22:38974125-39052634:-	0.24	5.07	6.11E-7	Resting heart rate	
STAD	cis	1	rs3761959	chr1:157669278	FCRL3	chr1:157646278-157670775:-	0.25	7.34	1.25E-12	Type 1 diabetes autoantibodies	
STAD	cis	1	rs3762318	chr1:67597119	SLC35D1	chr1:67465015-67520080:-	0.27	3.83	0.000147	Leprosy	
STAD	cis	1	rs3763695	chr10:102269206	SEC31B	chr10:102246403-102289636:-	-0.24	-5.93	6.63E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs3765158	chr4:54327584	SCFD2	chr4:53739152-54232242:-	0.29	4.23	2.97E-5	DNA methylation (variation)	
STAD	cis	1	rs3769143	chr2:27450724	C2orf28	chr2:27434899-27440044:+	-0.25	-4.36	1.68E-5	Blood metabolite levels	
STAD	cis	1	rs3771175	chr2:102960210	IL1RL1	chr2:102927962-102968497:+	-0.31	-4.73	3.12E-6	Asthma	
STAD	cis	1	rs3771180	chr2:102953617	IL1RL1	chr2:102927962-102968497:+	0.3	4.58	6.39E-6	Asthma	
STAD	cis	1	rs3772128	chr3:121345094	IQCB1	chr3:121488610-121553926:-	0.29	4.89	1.49E-6	Cognitive performance	
STAD	cis	1	rs3772130	chr3:121344140	IQCB1	chr3:121488610-121553926:-	0.29	4.96	1.04E-6	Cognitive performance	
STAD	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.78	12.21	2.89E-29	Diastolic blood pressure	
STAD	cis	1	rs3774808	chr3:48481647	TREX1	chr3:48501186-48509043:+	-0.25	-5.83	1.17E-8	Longevity	
STAD	cis	1	rs3778483	chr6:46627100	TDRD6	chr6:46655866-46670149:+	0.19	4.02	6.87E-5	QRS complex (Sokolow-Lyon)	
STAD	cis	1	rs3781001	chr10:127706028	UROS	chr10:127477148-127511837:-	-0.23	-4.28	2.32E-5	Visceral fat	
STAD	cis	1	rs3782130	chr12:58161898	FAM119B	chr12:58166383-58176323:+	0.42	7.03	9.01E-12	Multiple sclerosis	
STAD	cis	1	rs3782130	chr12:58161898	TSFM	chr12:58176536-58191367:+	-0.33	-6.98	1.28E-11	Multiple sclerosis	
STAD	cis	1	rs3782894	chr12:110026024	MYO1H	chr12:109826524-109886176:+	0.2	3.94	9.73E-5	HDL cholesterol	
STAD	cis	1	rs3788332	chr22:22171567	THAP7	chr22:21354061-21356404:-	0.18	4.29	2.23E-5	Multiple sclerosis	
STAD	cis	1	rs3788544	chr22:39064966	LOC646851	chr22:38974125-39052634:-	0.24	4.98	9.59E-7	Resting heart rate	
STAD	cis	1	rs3788545	chr22:39065172	LOC646851	chr22:38974125-39052634:-	0.24	5.05	6.87E-7	Resting heart rate	
STAD	cis	1	rs3791220	chr2:227066	SH3YL1	chr2:218138-264810:-	-0.6	-13.03	1.79E-32	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs3791221	chr2:226933	SH3YL1	chr2:218138-264810:-	-0.61	-13.22	3.32E-33	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs3791223	chr2:222336	SH3YL1	chr2:218138-264810:-	-0.59	-12.55	1.37E-30	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs3791224	chr2:221981	SH3YL1	chr2:218138-264810:-	-0.6	-12.75	2.4E-31	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs3792527	chr3:38493212	XYLB	chr3:38388251-38456467:+	0.21	4.32	1.97E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs3793706	chr10:102269085	SEC31B	chr10:102246403-102289636:-	0.24	6.03	3.81E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs3793771	chr10:102222957	SEC31B	chr10:102246403-102289636:-	-0.25	-6.23	1.23E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs3793772	chr10:102222825	SEC31B	chr10:102246403-102289636:-	-0.25	-6.08	2.89E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs3795819	chr1:113234179	ST7L	chr1:113066142-113162405:-	-0.41	-7.23	2.57E-12	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs3796352	chr3:52913279	TMEM110	chr3:52867139-52931547:-	0.51	4.96	1.04E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs3796689	chr4:185649866	MLF1IP	chr4:185615220-185655286:-	-0.47	-8.88	2.47E-17	Kawasaki disease	
STAD	cis	1	rs3800316	chr6:27256102	LOC100270746	chr6:26987146-26988085:-	0.29	4.4	1.42E-5	Schizophrenia	
STAD	cis	1	rs3806692	chr3:53080987	TMEM110	chr3:52867139-52931547:-	0.4	4.62	5.29E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs3806988	chr6:49431569	MUT	chr6:49398994-49431031:-	0.4	7.48	4.94E-13	Folate pathway vitamin levels	
STAD	cis	1	rs3809868	chr17:45750596	C17orf57	chr17:45401142-45518675:+	-0.28	-5.95	5.87E-9	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
STAD	cis	1	rs3810429	chr19:18543270	ISYNA1	chr19:18545625-18548943:-	0.22	3.84	0.000146	Breast cancer	
STAD	cis	1	rs3810610	chr22:22115498	THAP7	chr22:21354061-21356404:-	0.19	4.37	1.6E-5	Multiple sclerosis	
STAD	cis	1	rs3811782	chr4:54243905	SCFD2	chr4:53739152-54232242:-	0.29	4.4	1.41E-5	DNA methylation (variation)	
STAD	cis	1	rs3814184	chr10:69966251	ATOH7	chr10:69990386-69991855:-	-0.32	-3.81	0.000162	Optic nerve measurement (disc area)	
STAD	cis	1	rs3814492	chr9:131873222	CRAT	chr9:131857075-131873070:-	0.25	4.46	1.1E-5	Blood metabolite ratios	
STAD	cis	1	rs3814492	chr9:131873222	PPP2R4	chr9:131873244-131911223:+	0.22	4.45	1.11E-5	Blood metabolite ratios	
STAD	cis	1	rs3815413	chr4:17654648	LAP3	chr4:17578927-17609590:+	-0.19	-4.08	5.45E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs3821815	chr3:186434262	KNG1	chr3:186435120-186461741:+	-0.2	-3.99	7.89E-5	Adiponectin levels	
STAD	cis	1	rs3823114	chr6:49431720	MUT	chr6:49398994-49431031:-	0.38	7.01	1.04E-11	Folate pathway vitamin levels	
STAD	cis	1	rs3824584	chr10:38091309	HSD17B7P2	chr10:38645308-38667432:+	0.34	4.07	5.65E-5	Obesity (extreme)	
STAD	cis	1	rs3824585	chr10:38109421	HSD17B7P2	chr10:38645308-38667432:+	0.31	3.8	0.000169	Obesity (extreme)	
STAD	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.41	6.89	2.18E-11	Multiple sclerosis	
STAD	cis	1	rs3825079	chr12:58203354	TSFM	chr12:58176536-58191367:+	-0.33	-6.86	2.71E-11	Multiple sclerosis	
STAD	cis	1	rs3825180	chr12:129279242	MGC16384	chr12:129297749-129299295:-	0.19	3.98	8.29E-5	Systemic lupus erythematosus	
STAD	cis	1	rs3826061	chr16:88927221	TRAPPC2L	chr16:88922628-88927591:+	-0.19	-4.09	5.34E-5	Parkinson disease and lewy body pathology	
STAD	cis	1	rs3826331	chr17:38150492	GSDMA	chr17:38119226-38134019:+	0.31	5.45	9.17E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs3827357	chr22:39079413	CBY1	chr22:39052658-39069853:+	0.21	4.17	3.83E-5	Resting heart rate	
STAD	cis	1	rs3827357	chr22:39079413	LOC646851	chr22:38974125-39052634:-	0.26	5.51	6.7E-8	Resting heart rate	
STAD	cis	1	rs3828165	chr2:220889	SH3YL1	chr2:218138-264810:-	-0.59	-12.46	3.1E-30	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs383402	chr7:65586653	CCT6P1	chr7:65216092-65228661:+	-0.26	-4.04	6.5E-5	Diabetic kidney disease	
STAD	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.38	6.8	3.94E-11	Height	
STAD	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.4	7.39	8.98E-13	Height	
STAD	cis	1	rs3846926	chr6:56092186	COL21A1	chr6:55921389-56258892:-	0.27	5.88	8.67E-9	Pulse pressure	
STAD	cis	1	rs3850304	chr14:59895019	C14orf149	chr14:59939406-59951126:-	-0.5	-5.05	6.76E-7	Schizophrenia	
STAD	cis	1	rs385039	chr1:2077409	LOC148413	chr1:1334910-1338075:+	-0.25	-4.3	2.14E-5	Height	
STAD	cis	1	rs3856807	chr3:12527600	TSEN2	chr3:12525931-12581122:+	0.42	4.48	9.61E-6	Prostate cancer (gene x gene interaction)	
STAD	cis	1	rs3857422	chr5:150268609	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs387676	chr7:65598220	CCT6P1	chr7:65216092-65228661:+	0.29	4.32	1.99E-5	Diabetic kidney disease	
STAD	cis	1	rs3885839	chr7:65290403	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.24E-5	Diabetic kidney disease	
STAD	cis	1	rs3892761	chr12:54070445	ATP5G2	chr12:54058945-54070512:-	0.22	4.49	9.37E-6	Height	
STAD	cis	1	rs3900064	chr5:150264414	LOC134466	chr5:150310000-150326146:-	-0.29	-4.49	9.55E-6	Crohn's disease	
STAD	cis	1	rs3905330	chr3:49550774	CCDC36	chr3:49235861-49295537:+	0.2	3.83	0.00015	Menarche (age at onset)	
STAD	cis	1	rs3906527	chr5:150266392	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs3906528	chr5:150266718	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs391396	chr4:130037653	C4orf33	chr4:130014829-130033842:+	-0.42	-6.85	2.82E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.38	6.87	2.55E-11	Height	
STAD	cis	1	rs3933453	chr4:17636319	LAP3	chr4:17578927-17609590:+	-0.19	-4.07	5.8E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-0.76	-11.99	2.08E-28	Diastolic blood pressure	
STAD	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.48	9.17	2.86E-18	Eye color traits	
STAD	cis	1	rs3936203	chr2:241834654	C2orf54	chr2:241825466-241835573:-	-0.26	-3.99	7.95E-5	Urinary metabolites	
STAD	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.62	-9.19	2.36E-18	Type 2 diabetes	
STAD	cis	1	rs396508	chr16:20682354	ACSM1	chr16:20634559-20709066:-	-0.33	-5.6	4.0E-8	Schizophrenia	
STAD	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.53	-11.02	9.1E-25	Inflammatory skin disease	
STAD	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.56	9.26	1.39E-18	Inflammatory skin disease	
STAD	cis	1	rs400736	chr1:8078309	UTS2	chr1:7903144-7973294:-	0.21	3.84	0.000143	Response to antidepressants and depression	
STAD	cis	1	rs4073846	chr1:46462881	IPP	chr1:46160000-46216485:-	-0.2	-3.97	8.57E-5	Body mass index	
STAD	cis	1	rs4073846	chr1:46462881	TMEM69	chr1:46153847-46160108:+	-0.18	-3.92	0.000104	Body mass index	
STAD	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.48	-9.17	2.86E-18	Eye color traits	
STAD	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.48	-9.17	2.86E-18	Eye color traits	
STAD	cis	1	rs4076006	chr1:46438076	IPP	chr1:46160000-46216485:-	0.2	3.96	8.92E-5	Body mass index	
STAD	cis	1	rs4076006	chr1:46438076	TMEM69	chr1:46153847-46160108:+	0.18	3.87	0.000126	Body mass index	
STAD	cis	1	rs4076054	chr11:2231341	CD81	chr11:2398547-2418649:+	-0.28	-4.66	4.28E-6	Prostate cancer (early onset);Prostate cancer (gene x gene interaction);Prostate cancer	
STAD	cis	1	rs4078160	chr10:52565940	ASAH2B	chr10:52499696-52514567:+	-0.36	-5.02	7.71E-7	Urate levels in lean individuals	
STAD	cis	1	rs409035	chr20:5943649	MCM8	chr20:5931298-5975829:+	-0.21	-4.18	3.66E-5	HIV-1 viral setpoint	
STAD	cis	1	rs410128	chr7:65603173	CCT6P1	chr7:65216092-65228661:+	0.29	4.23	2.94E-5	Diabetic kidney disease	
STAD	cis	1	rs41266807	chr6:26199822	HIST1H2AE	chr6:26217148-26217711:+	-0.33	-4.46	1.09E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs41275472	chr1:11876300	CLCN6	chr1:11866207-11907674:+	0.26	4.02	7.03E-5	QRS complex (12-leadsum)	
STAD	cis	1	rs4130590	chr9:130107964	SLC2A8	chr9:130159465-130170161:+	0.24	4.55	7.12E-6	Bipolar disorder	
STAD	cis	1	rs4140574	chr6:56099424	COL21A1	chr6:55921389-56258892:-	0.27	5.75	1.76E-8	Pulse pressure	
STAD	cis	1	rs4140575	chr6:56099222	COL21A1	chr6:55921389-56258892:-	0.28	6.04	3.63E-9	Pulse pressure	
STAD	cis	1	rs4144937	chr6:46628516	SLC25A27	chr6:46620679-46645925:+	-0.15	-3.82	0.000154	QRS complex (Sokolow-Lyon)	
STAD	cis	1	rs4144937	chr6:46628516	TDRD6	chr6:46655866-46670149:+	0.18	4	7.59E-5	QRS complex (Sokolow-Lyon)	
STAD	cis	1	rs4147024	chr3:38456664	XYLB	chr3:38388251-38456467:+	0.21	4.25	2.71E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs4147025	chr3:38456531	XYLB	chr3:38388251-38456467:+	0.21	4.22	3.05E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs4150550	chr11:18350898	GTF2H1	chr11:18343816-18388590:+	0.41	6.72	6.52E-11	Pancreatic cancer	
STAD	cis	1	rs4150562	chr11:18354995	GTF2H1	chr11:18343816-18388590:+	0.39	6.39	4.68E-10	Pancreatic cancer	
STAD	cis	1	rs4150564	chr11:18355308	GTF2H1	chr11:18343816-18388590:+	0.4	6.39	4.63E-10	Pancreatic cancer	
STAD	cis	1	rs4150566	chr11:18355599	GTF2H1	chr11:18343816-18388590:+	0.39	6.29	8.71E-10	Pancreatic cancer	
STAD	cis	1	rs4150575	chr11:18356466	GTF2H1	chr11:18343816-18388590:+	0.38	6.08	2.87E-9	Pancreatic cancer	
STAD	cis	1	rs4150579	chr11:18357180	GTF2H1	chr11:18343816-18388590:+	-0.35	-5.75	1.78E-8	Pancreatic cancer	
STAD	cis	1	rs4150610	chr11:18364140	GTF2H1	chr11:18343816-18388590:+	0.38	6.16	1.8E-9	Pancreatic cancer	
STAD	cis	1	rs4150612	chr11:18364358	GTF2H1	chr11:18343816-18388590:+	0.37	5.98	5.03E-9	Pancreatic cancer	
STAD	cis	1	rs4150615	chr11:18365028	GTF2H1	chr11:18343816-18388590:+	-0.39	-6.42	3.92E-10	Pancreatic cancer	
STAD	cis	1	rs4150622	chr11:18365710	GTF2H1	chr11:18343816-18388590:+	0.38	6.04	3.52E-9	Pancreatic cancer	
STAD	cis	1	rs4150641	chr11:18370739	GTF2H1	chr11:18343816-18388590:+	0.38	6.09	2.78E-9	Pancreatic cancer	
STAD	cis	1	rs4150650	chr11:18374279	GTF2H1	chr11:18343816-18388590:+	0.38	6.38	5.13E-10	Pancreatic cancer	
STAD	cis	1	rs4150651	chr11:18374425	GTF2H1	chr11:18343816-18388590:+	0.38	6.38	5.13E-10	Pancreatic cancer	
STAD	cis	1	rs4150655	chr11:18375164	GTF2H1	chr11:18343816-18388590:+	-0.36	-5.71	2.25E-8	Pancreatic cancer	
STAD	cis	1	rs4150661	chr11:18379629	GTF2H1	chr11:18343816-18388590:+	0.36	5.9	7.69E-9	Pancreatic cancer	
STAD	cis	1	rs4150673	chr11:18383449	GTF2H1	chr11:18343816-18388590:+	0.36	5.98	4.96E-9	Pancreatic cancer	
STAD	cis	1	rs419603	chr7:65597341	CCT6P1	chr7:65216092-65228661:+	0.29	4.32	1.99E-5	Diabetic kidney disease	
STAD	cis	1	rs420259	chr16:23634026	DCTN5	chr16:23652807-23681182:+	-0.37	-6.2	1.44E-9	Bipolar disorder	
STAD	cis	1	rs422164	chr7:65586605	CCT6P1	chr7:65216092-65228661:+	0.28	4.23	2.91E-5	Diabetic kidney disease	
STAD	cis	1	rs4234797	chr4:7219907	SORCS2	chr4:7194374-7744563:+	-0.17	-4.19	3.53E-5	Insulin-like growth factors	
STAD	cis	1	rs4234798	chr4:7219933	SORCS2	chr4:7194374-7744563:+	0.18	4.65	4.58E-6	Insulin-like growth factors	
STAD	cis	1	rs4235388	chr4:17682030	LAP3	chr4:17578927-17609590:+	-0.19	-4.02	7.1E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.38	6.72	6.29E-11	Forced vital capacity	
STAD	cis	1	rs4241407	chr3:49600319	CCDC36	chr3:49235861-49295537:+	0.22	4.19	3.46E-5	Menarche (age at onset)	
STAD	cis	1	rs4244338	chr10:102272802	SEC31B	chr10:102246403-102289636:-	-0.23	-5.63	3.47E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs4246215	chr11:61564299	FADS2	chr11:61583728-61634825:+	0.23	4.03	6.78E-5	Phospholipid levels (plasma);Platelet count;Red blood cell fatty acid levels;Trans fatty acid levels;Inflammatory bowel disease	
STAD	cis	1	rs4246753	chr5:2014721	IRX2	chr5:2746281-2751769:-	-0.26	-3.83	0.000151	Gut microbiome composition (winter)	
STAD	cis	1	rs4253766	chr22:46623905	PKDREJ	chr22:46651561-46659219:-	-0.49	-4.66	4.34E-6	Cholesterol, total;LDL cholesterol	
STAD	cis	1	rs4253772	chr22:46627603	PKDREJ	chr22:46651561-46659219:-	-0.51	-4.72	3.35E-6	Cholesterol, total;LDL cholesterol	
STAD	cis	1	rs4256922	chr10:52568616	ASAH2B	chr10:52499696-52514567:+	-0.36	-5.01	8.16E-7	Urate levels in lean individuals	
STAD	cis	1	rs4263408	chr4:39785276	RPL9	chr4:39455747-39460568:-	-0.31	-5.11	5.06E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
STAD	cis	1	rs4267943	chr6:49439805	MUT	chr6:49398994-49431031:-	-0.35	-6.17	1.72E-9	Folate pathway vitamin levels	
STAD	cis	1	rs4275490	chr1:55509939	ACOT11	chr1:55007930-55100417:+	-0.37	-3.92	0.000105	Wilms tumor	
STAD	cis	1	rs4282209	chr4:76919536	NAAA	chr4:76831809-76862166:-	-0.37	-5.23	2.73E-7	Longevity	
STAD	cis	1	rs4294134	chr7:135293128	PL-5283	chr7:135347221-135378160:+	0.44	6.91	1.96E-11	Paget's disease	
STAD	cis	1	rs4294134	chr7:135293128	SLC13A4	chr7:135365993-135412933:-	-0.64	-10.05	2.78E-21	Paget's disease	
STAD	cis	1	rs4309773	chr3:134277301	ANAPC13	chr3:134196547-134204865:-	0.38	6.88	2.38E-11	Height	
STAD	cis	1	rs431076	chr7:65600320	CCT6P1	chr7:65216092-65228661:+	0.29	4.34	1.85E-5	Diabetic kidney disease	
STAD	cis	1	rs431328	chr19:22222236	ZNF257	chr19:22235266-22273901:+	0.22	3.94	9.47E-5	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	0.88	18.35	1.2E-54	Type 2 diabetes	
STAD	cis	1	rs4323442	chr8:96022986	C8orf38	chr8:95908040-96088396:+	-0.33	-3.99	8.04E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.36	-6.38	4.88E-10	Rheumatoid arthritis	
STAD	cis	1	rs4332428	chr10:4965434	AKR1C1	chr10:4934796-5020157:+	0.37	3.85	0.000139	Height	
STAD	cis	1	rs4334685	chr3:134304335	ANAPC13	chr3:134196547-134204865:-	0.39	6.78	4.41E-11	Height	
STAD	cis	1	rs433598	chr16:20680206	ACSM1	chr16:20634559-20709066:-	0.33	5.65	3.1E-8	Schizophrenia	
STAD	cis	1	rs4341440	chr10:4965293	AKR1C1	chr10:4934796-5020157:+	0.37	3.85	0.000139	Height	
STAD	cis	1	rs4348727	chr1:10265606	PGD	chr1:10459085-10480200:+	0.25	4.15	4.09E-5	Hepatocellular carcinoma	
STAD	cis	1	rs4353250	chr11:18323517	GTF2H1	chr11:18343816-18388590:+	0.35	5.6	4.04E-8	Pancreatic cancer	
STAD	cis	1	rs4353	chr17:61570422	ACE	chr17:61554434-61599203:+	0.33	5.81	1.28E-8	Blood metabolite levels	
STAD	cis	1	rs4355180	chr20:23831427	CST2	chr20:23804404-23807312:-	-0.28	-4.47	1.01E-5	Response to TNF antagonist treatment	
STAD	cis	1	rs4356841	chr3:87764884	HTR1F	chr3:88031726-88042919:+	-0.24	-3.93	0.000102	Electroencephalographic traits in alcoholism	
STAD	cis	1	rs4367113	chr3:134287975	ANAPC13	chr3:134196547-134204865:-	0.39	6.79	4.25E-11	Height	
STAD	cis	1	rs4368544	chr3:134300014	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.84	3.06E-11	Height	
STAD	cis	1	rs4372836	chr2:28973883	TRMT61B	chr2:29072690-29093175:-	-0.31	-5.26	2.42E-7	Body mass index	
STAD	cis	1	rs4375701	chr17:45712218	C17orf57	chr17:45401142-45518675:+	0.3	6.38	5.03E-10	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
STAD	cis	1	rs4376778	chr1:46288846	IPP	chr1:46160000-46216485:-	0.2	3.84	0.000146	Body mass index	
STAD	cis	1	rs439295	chr3:156572455	LEKR1	chr3:156544076-156763918:+	-0.38	-4.44	1.19E-5	Bone mineral density	
STAD	cis	1	rs4394010	chr4:129894649	C4orf33	chr4:130014829-130033842:+	0.41	6.49	2.67E-10	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs4415360	chr8:29369491	RBPMS	chr8:30241944-30429734:+	0.15	3.93	0.000101	Response to statin therapy	
STAD	cis	1	rs4417907	chr3:134291363	ANAPC13	chr3:134196547-134204865:-	0.39	6.87	2.51E-11	Height	
STAD	cis	1	rs4421592	chr1:210338196	SYT14	chr1:210111538-210337631:+	0.23	4.04	6.41E-5	Manic episodes in bipolar disorder	
STAD	cis	1	rs4423247	chr12:91476875	KERA	chr12:91444273-91452131:-	0.28	4.61	5.58E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs4423809	chr3:134300107	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.89	2.2E-11	Height	
STAD	cis	1	rs4431687	chr9:130111697	SLC2A8	chr9:130159465-130170161:+	-0.27	-4.6	5.78E-6	Metabolite levels (HVA)	
STAD	cis	1	rs4466058	chr4:129923879	C4orf33	chr4:130014829-130033842:+	-0.43	-6.78	4.56E-11	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs4469291	chr6:49440614	MUT	chr6:49398994-49431031:-	0.38	7.06	7.78E-12	Folate pathway vitamin levels	
STAD	cis	1	rs4478072	chr3:53106125	TMEM110	chr3:52867139-52931547:-	0.34	3.87	0.00013	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs4490383	chr3:48484683	TREX1	chr3:48501186-48509043:+	-0.25	-5.69	2.49E-8	Longevity	
STAD	cis	1	rs4490669	chr6:56789465	BEND6	chr6:56819773-56892138:+	-0.23	-5.23	2.77E-7	Menarche (age at onset)	
STAD	cis	1	rs4493873	chr8:92075643	LRRC69	chr8:92114847-92231464:+	-0.24	-4.41	1.32E-5	Migraine - clinic-based	
STAD	cis	1	rs4497901	chr2:239969	SH3YL1	chr2:218138-264810:-	-0.6	-12.93	4.34E-32	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.37	6.69	7.72E-11	Height	
STAD	cis	1	rs4519728	chr3:87779738	HTR1F	chr3:88031726-88042919:+	-0.24	-3.89	0.000118	Electroencephalographic traits in alcoholism	
STAD	cis	1	rs4535272	chr3:134299916	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.68	8.5E-11	Height	
STAD	cis	1	rs454422	chr20:5943693	MCM8	chr20:5931298-5975829:+	-0.21	-4.18	3.66E-5	HIV-1 viral setpoint	
STAD	cis	1	rs4545281	chr1:46360054	CCDC163P	chr1:45960581-45965646:-	-0.23	-4.01	7.23E-5	Body mass index	
STAD	cis	1	rs4545281	chr1:46360054	IPP	chr1:46160000-46216485:-	0.21	4.01	7.38E-5	Body mass index	
STAD	cis	1	rs4548056	chr7:65298873	CCT6P1	chr7:65216092-65228661:+	0.26	3.91	0.000109	Diabetic kidney disease	
STAD	cis	1	rs4549034	chr2:28972579	TRMT61B	chr2:29072690-29093175:-	-0.31	-5.28	2.12E-7	Body mass index	
STAD	cis	1	rs45559033	chr14:74341124	PTGR2	chr14:74318534-74352166:+	0.5	6.13	2.15E-9	Morning vs. evening chronotype	
STAD	cis	1	rs4560537	chr5:150262586	LOC134466	chr5:150310000-150326146:-	0.29	4.63	5.02E-6	Crohn's disease	
STAD	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.36	6.55	1.82E-10	Hematology traits	
STAD	cis	1	rs4568579	chr8:92072144	LRRC69	chr8:92114847-92231464:+	-0.26	-4.75	2.82E-6	Migraine - clinic-based	
STAD	cis	1	rs4572812	chr3:134291177	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.76	5.0E-11	Height	
STAD	cis	1	rs4579248	chr5:150268151	LOC134466	chr5:150310000-150326146:-	0.42	6.18	1.63E-9	Crohn's disease	
STAD	cis	1	rs4594164	chr14:35509571	PPP2R3C	chr14:35554679-35591679:-	0.29	4.09	5.23E-5	Atopic dermatitis	
STAD	cis	1	rs4595905	chr19:18547305	ISYNA1	chr19:18545625-18548943:-	0.22	3.84	0.000146	Breast cancer	
STAD	cis	1	rs4604732	chr1:247623872	LOC148824	chr1:247687982-247694106:-	0.27	4.48	9.82E-6	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
STAD	cis	1	rs4604805	chr10:102261409	SEC31B	chr10:102246403-102289636:-	-0.25	-6.3	7.95E-10	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs4605213	chr17:49244747	NME1-NME2	chr17:49230920-49249104:+	0.25	4.26	2.61E-5	Height	
STAD	cis	1	rs4609941	chr18:44645491	HDHD2	chr18:44633782-44676871:-	0.51	4.94	1.15E-6	Sitting height ratio	
STAD	cis	1	rs462853	chr7:65558167	CCT6P1	chr7:65216092-65228661:+	0.29	4.35	1.75E-5	Diabetic kidney disease	
STAD	cis	1	rs4631830	chr10:51543344	MSMB	chr10:51549553-51562590:+	0.37	7.11	5.42E-12	Prostate-specific antigen levels	
STAD	cis	1	rs4640348	chr2:28965479	TRMT61B	chr2:29072690-29093175:-	-0.31	-5.28	2.12E-7	Body mass index	
STAD	cis	1	rs4643294	chr15:85250253	LOC388152	chr15:84867600-84898920:-	-0.28	-4.27	2.42E-5	Schizophrenia	
STAD	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.42	7.25	2.29E-12	Multiple sclerosis	
STAD	cis	1	rs4646536	chr12:58157988	TSFM	chr12:58176536-58191367:+	-0.31	-6.79	4.21E-11	Multiple sclerosis	
STAD	cis	1	rs4646536	chr12:58157988	XRCC6BP1	chr12:58335445-58351051:+	-0.21	-3.82	0.000156	Multiple sclerosis	
STAD	cis	1	rs465359	chr7:65558164	CCT6P1	chr7:65216092-65228661:+	0.29	4.35	1.75E-5	Diabetic kidney disease	
STAD	cis	1	rs4654863	chr1:20902244	FAM43B	chr1:20878932-20881512:+	0.17	3.84	0.000141	Age-related hearing impairment (interaction)	
STAD	cis	1	rs4660303	chr1:40060473	PPIEL	chr1:39987953-40025370:-	0.24	4.12	4.7E-5	C-reactive protein levels or triglyceride levels (pleiotropy)	
STAD	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.49	8.06	9.74E-15	Homocysteine levels	
STAD	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.47	-7.51	3.97E-13	Homocysteine levels	
STAD	cis	1	rs4660956	chr1:47158486	CYP4A11	chr1:47394848-47407156:-	-0.31	-4.25	2.71E-5	Response to hepatitis C treatment	
STAD	cis	1	rs4665958	chr2:27443196	C2orf28	chr2:27434899-27440044:+	0.24	4.19	3.45E-5	Blood metabolite levels	
STAD	cis	1	rs4666118	chr2:28951698	TRMT61B	chr2:29072690-29093175:-	-0.3	-5.14	4.33E-7	Body mass index	
STAD	cis	1	rs4666119	chr2:28975690	TRMT61B	chr2:29072690-29093175:-	-0.32	-5.43	9.78E-8	Body mass index	
STAD	cis	1	rs4675868	chr2:241828542	C2orf54	chr2:241825466-241835573:-	0.25	3.8	0.000168	Urinary metabolites	
STAD	cis	1	rs4684106	chr3:12550199	TSEN2	chr3:12525931-12581122:+	-0.36	-4.35	1.76E-5	Prostate cancer (gene x gene interaction)	
STAD	cis	1	rs4689088	chr4:7222253	SORCS2	chr4:7194374-7744563:+	-0.19	-4.8	2.24E-6	Insulin-like growth factors	
STAD	cis	1	rs4689653	chr4:7223319	SORCS2	chr4:7194374-7744563:+	-0.2	-5.08	5.85E-7	Insulin-like growth factors	
STAD	cis	1	rs4690071	chr4:3086753	GRK4	chr4:2965343-3042474:+	-0.22	-3.94	9.56E-5	Parental longevity (mother's age at death)	
STAD	cis	1	rs4691139	chr4:165908721	C4orf39	chr4:165878100-165880273:+	0.19	4.18	3.6E-5	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs4692025	chr4:25949759	C4orf52	chr4:25915814-25931500:+	-0.24	-4.21	3.11E-5	Obesity-related traits	
STAD	cis	1	rs4692025	chr4:25949759	STIM2	chr4:26862364-27025808:+	-0.21	-4.09	5.17E-5	Obesity-related traits	
STAD	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.56	-12.34	8.87E-30	Ankylosing spondylitis	
STAD	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.49	8.2	3.42E-15	Ankylosing spondylitis	
STAD	cis	1	rs4698198	chr4:17656536	LAP3	chr4:17578927-17609590:+	-0.18	-3.84	0.000143	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs4698199	chr4:17656738	LAP3	chr4:17578927-17609590:+	-0.18	-3.84	0.000143	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs4698432	chr4:15964763	FGFBP2	chr4:15961864-15964859:-	0.24	3.96	8.83E-5	QT interval	
STAD	cis	1	rs4698433	chr4:15964863	FGFBP2	chr4:15961864-15964859:-	-0.24	-4.01	7.28E-5	QT interval	
STAD	cis	1	rs4698635	chr4:17630242	LAP3	chr4:17578927-17609590:+	-0.19	-3.94	9.48E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs4698641	chr4:17642630	LAP3	chr4:17578927-17609590:+	-0.19	-4.07	5.8E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.71	-14.87	5.97E-40	Response to antipsychotic treatment	
STAD	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.72	-15.26	1.41E-41	Response to antipsychotic treatment	
STAD	cis	1	rs4712120	chr6:56092916	COL21A1	chr6:55921389-56258892:-	0.26	5.69	2.54E-8	Pulse pressure	
STAD	cis	1	rs4713	chr9:131910805	CRAT	chr9:131857075-131873070:-	-0.27	-4.77	2.59E-6	Blood metabolite ratios	
STAD	cis	1	rs4713	chr9:131910805	PPP2R4	chr9:131873244-131911223:+	-0.22	-4.46	1.08E-5	Blood metabolite ratios	
STAD	cis	1	rs4715129	chr6:49415043	MUT	chr6:49398994-49431031:-	0.39	7.31	1.5E-12	Folate pathway vitamin levels	
STAD	cis	1	rs4715130	chr6:49416825	MUT	chr6:49398994-49431031:-	0.39	7.2	3.12E-12	Folate pathway vitamin levels	
STAD	cis	1	rs4715590	chr6:56060017	COL21A1	chr6:55921389-56258892:-	0.28	6.12	2.25E-9	Pulse pressure	
STAD	cis	1	rs4718269	chr7:65200778	CCT6P1	chr7:65216092-65228661:+	-0.27	-4.17	3.7E-5	Diabetic kidney disease	
STAD	cis	1	rs4718270	chr7:65202407	CCT6P1	chr7:65216092-65228661:+	0.27	4.08	5.39E-5	Diabetic kidney disease	
STAD	cis	1	rs4726669	chr7:143758191	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.75	1.81E-8	Obesity-related traits	
STAD	cis	1	rs4727443	chr7:99593346	TRIM4	chr7:99488037-99517154:-	-0.24	-3.87	0.000126	Interstitial lung disease	
STAD	cis	1	rs4728142	chr7:128573967	IRF5	chr7:128577769-128590086:+	0.29	5.38	1.31E-7	Systemic lupus erythematosus;Ulcerative colitis;Inflammatory bowel disease	
STAD	cis	1	rs473073	chr10:131429646	MGMT	chr10:131265454-131565783:+	0.24	4.28	2.32E-5	Response to temozolomide	
STAD	cis	1	rs473651	chr2:239335401	ASB1	chr2:239335626-239360890:+	-0.2	-3.97	8.46E-5	Multiple system atrophy	
STAD	cis	1	rs473771	chr10:131408155	MGMT	chr10:131265454-131565783:+	0.24	4.19	3.45E-5	Response to temozolomide	
STAD	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.24	-4.26	2.57E-5	Response to temozolomide	
STAD	cis	1	rs4752797	chr11:47874364	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.71	1.09E-13	Subjective well-being	
STAD	cis	1	rs4752856	chr11:47648042	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.73	9.25E-14	Subjective well-being	
STAD	cis	1	rs4752857	chr11:47655752	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.69	1.21E-13	Subjective well-being	
STAD	cis	1	rs4752873	chr11:47857520	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.75	8.29E-14	Subjective well-being	
STAD	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.36	-6.29	8.6E-10	Forced vital capacity	
STAD	cis	1	rs4759229	chr12:56474480	MYO1A	chr12:57422302-57443901:-	-0.17	-3.82	0.000154	Cognitive function	
STAD	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.48	-9.47	2.66E-19	Cognitive function	
STAD	cis	1	rs4763879	chr12:9910164	CLECL1	chr12:9868457-9885860:-	-0.18	-5.57	4.68E-8	Type 1 diabetes	
STAD	cis	1	rs477692	chr10:131426022	MGMT	chr10:131265454-131565783:+	0.24	4.11	4.82E-5	Response to temozolomide	
STAD	cis	1	rs4789693	chr17:80421870	HEXDC	chr17:80376252-80400515:+	0.25	4.23	2.89E-5	Glucocorticoid-induced osteonecrosis	
STAD	cis	1	rs4794016	chr17:45725931	C17orf57	chr17:45401142-45518675:+	-0.3	-6.35	6.11E-10	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
STAD	cis	1	rs4794048	chr17:45763073	C17orf57	chr17:45401142-45518675:+	0.28	5.82	1.23E-8	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
STAD	cis	1	rs4794202	chr17:45930539	SCRN2	chr17:45915049-45918699:-	-0.34	-3.93	0.000101	Alzheimer's disease (cognitive decline)	
STAD	cis	1	rs479478	chr10:131428959	MGMT	chr10:131265454-131565783:+	0.24	4.28	2.32E-5	Response to temozolomide	
STAD	cis	1	rs4794823	chr17:38166265	GSDMA	chr17:38119226-38134019:+	-0.33	-5.83	1.19E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs4794824	chr17:38179290	GSDMA	chr17:38119226-38134019:+	-0.31	-5.57	4.65E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs4795412	chr17:38150604	GSDMA	chr17:38119226-38134019:+	-0.32	-5.78	1.54E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs4795415	chr17:38157995	GSDMA	chr17:38119226-38134019:+	-0.32	-5.77	1.6E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs4795416	chr17:38158133	GSDMA	chr17:38119226-38134019:+	-0.32	-5.66	2.89E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs4795418	chr17:38164851	GSDMA	chr17:38119226-38134019:+	-0.33	-5.83	1.19E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.35	6.97	1.4E-11	Schizophrenia	
STAD	cis	1	rs4808133	chr19:18608518	ISYNA1	chr19:18545625-18548943:-	0.24	4.11	4.77E-5	Breast cancer	
STAD	cis	1	rs4808134	chr19:18608579	ISYNA1	chr19:18545625-18548943:-	0.24	4.11	4.77E-5	Breast cancer	
STAD	cis	1	rs4808136	chr19:18618867	ISYNA1	chr19:18545625-18548943:-	-0.28	-4.86	1.69E-6	Breast cancer	
STAD	cis	1	rs4808801	chr19:18571141	ISYNA1	chr19:18545625-18548943:-	0.24	4.25	2.68E-5	Breast cancer	
STAD	cis	1	rs4820345	chr22:39091151	CBY1	chr22:39052658-39069853:+	0.21	4.01	7.27E-5	Resting heart rate	
STAD	cis	1	rs4820345	chr22:39091151	LOC646851	chr22:38974125-39052634:-	0.27	5.71	2.26E-8	Resting heart rate	
STAD	cis	1	rs4821798	chr22:39021165	LOC646851	chr22:38974125-39052634:-	0.24	5.1	5.44E-7	Resting heart rate	
STAD	cis	1	rs4821808	chr22:39065739	LOC646851	chr22:38974125-39052634:-	0.23	4.99	9.27E-7	Resting heart rate	
STAD	cis	1	rs4821809	chr22:39065743	LOC646851	chr22:38974125-39052634:-	0.23	4.99	9.27E-7	Resting heart rate	
STAD	cis	1	rs4821810	chr22:39072098	LOC646851	chr22:38974125-39052634:-	0.25	5.45	8.74E-8	Resting heart rate	
STAD	cis	1	rs4821811	chr22:39075145	CBY1	chr22:39052658-39069853:+	0.22	4.21	3.14E-5	Resting heart rate	
STAD	cis	1	rs4821811	chr22:39075145	LOC646851	chr22:38974125-39052634:-	0.26	5.49	7.13E-8	Resting heart rate	
STAD	cis	1	rs4821812	chr22:39075235	CBY1	chr22:39052658-39069853:+	0.21	4.17	3.83E-5	Resting heart rate	
STAD	cis	1	rs4821812	chr22:39075235	LOC646851	chr22:38974125-39052634:-	0.26	5.51	6.7E-8	Resting heart rate	
STAD	cis	1	rs4821816	chr22:39113134	LOC646851	chr22:38974125-39052634:-	0.26	5.39	1.23E-7	Resting heart rate	
STAD	cis	1	rs485576	chr10:131425496	MGMT	chr10:131265454-131565783:+	0.24	4.11	4.82E-5	Response to temozolomide	
STAD	cis	1	rs4858793	chr3:48415007	TREX1	chr3:48501186-48509043:+	0.26	5.78	1.53E-8	Longevity	
STAD	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.25	5.72	2.12E-8	Longevity	
STAD	cis	1	rs4859097	chr3:87761841	HTR1F	chr3:88031726-88042919:+	0.23	3.86	0.000132	Electroencephalographic traits in alcoholism	
STAD	cis	1	rs4859413	chr4:76898250	NAAA	chr4:76831809-76862166:-	0.4	5.77	1.63E-8	Longevity	
STAD	cis	1	rs4859581	chr4:76906974	NAAA	chr4:76831809-76862166:-	-0.41	-6.09	2.74E-9	Longevity	
STAD	cis	1	rs4859582	chr4:76907213	NAAA	chr4:76831809-76862166:-	-0.42	-6.08	2.79E-9	Longevity	
STAD	cis	1	rs4862406	chr4:185629339	CCDC111	chr4:185570767-185616112:+	-0.25	-3.89	0.000116	Kawasaki disease	
STAD	cis	1	rs4862406	chr4:185629339	MLF1IP	chr4:185615220-185655286:-	0.44	8.32	1.49E-15	Kawasaki disease	
STAD	cis	1	rs4864759	chr4:54259408	SCFD2	chr4:53739152-54232242:-	0.29	4.35	1.77E-5	DNA methylation (variation)	
STAD	cis	1	rs4865463	chr4:1742400	FAM53A	chr4:1641609-1685854:-	-0.43	-6.61	1.26E-10	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs4865467	chr4:1745500	FAM53A	chr4:1641609-1685854:-	0.45	6.73	6.01E-11	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs4869313	chr5:96223880	ERAP1	chr5:96096515-96149837:-	0.29	5.96	5.52E-9	Pediatric autoimmune diseases	
STAD	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-0.99	-28.66	5.33E-98	Pediatric autoimmune diseases	
STAD	cis	1	rs4881994	chr11:48498139	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.97	8.71E-5	HDL cholesterol	
STAD	cis	1	rs4882015	chr11:48565573	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.91	0.000108	HDL cholesterol	
STAD	cis	1	rs4882017	chr11:48570182	C1QTNF4	chr11:47611216-47615961:-	0.17	3.82	0.000153	HDL cholesterol	
STAD	cis	1	rs4882019	chr11:48598748	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.95	9.25E-5	HDL cholesterol	
STAD	cis	1	rs4882021	chr11:48615966	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.86	0.000131	HDL cholesterol	
STAD	cis	1	rs4882117	chr11:48565468	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.91	0.000108	HDL cholesterol	
STAD	cis	1	rs4882134	chr11:48598795	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.95	9.25E-5	HDL cholesterol	
STAD	cis	1	rs4886818	chr15:76880939	SCAPER	chr15:76640529-77197744:-	-0.25	-5.17	3.7E-7	Blood metabolite levels	
STAD	cis	1	rs4887783	chr16:74700743	RFWD3	chr16:74655298-74700779:-	-0.26	-5.88	8.87E-9	Testicular germ cell tumor	
STAD	cis	1	rs4888262	chr16:74670458	RFWD3	chr16:74655298-74700779:-	-0.25	-5.62	3.55E-8	Testicular germ cell tumor	
STAD	cis	1	rs4888264	chr16:74681632	RFWD3	chr16:74655298-74700779:-	-0.22	-5.02	7.95E-7	Testicular germ cell tumor	
STAD	cis	1	rs4888265	chr16:74683737	RFWD3	chr16:74655298-74700779:-	-0.23	-5.08	6.0E-7	Testicular germ cell tumor	
STAD	cis	1	rs4889609	chr16:31026427	MYST1	chr16:31128985-31142713:+	0.24	4.01	7.22E-5	Response to metformin (IC50)	
STAD	cis	1	rs4911178	chr20:33952620	GDF5	chr20:33897002-34042568:-	-0.17	-3.95	9.45E-5	Height	
STAD	cis	1	rs4911178	chr20:33952620	UQCC	chr20:33890383-33999833:-	0.24	4.36	1.68E-5	Height	
STAD	cis	1	rs4911180	chr20:33972948	GDF5	chr20:33897002-34042568:-	-0.18	-4.13	4.45E-5	Height	
STAD	cis	1	rs4911180	chr20:33972948	UQCC	chr20:33890383-33999833:-	0.22	3.93	9.98E-5	Height	
STAD	cis	1	rs4911491	chr20:33947285	GDF5	chr20:33897002-34042568:-	-0.18	-4.03	6.62E-5	Height	
STAD	cis	1	rs4911491	chr20:33947285	UQCC	chr20:33890383-33999833:-	0.23	4.2	3.32E-5	Height	
STAD	cis	1	rs4911492	chr20:33951799	GDF5	chr20:33897002-34042568:-	-0.18	-3.99	7.9E-5	Height	
STAD	cis	1	rs4911492	chr20:33951799	UQCC	chr20:33890383-33999833:-	0.24	4.27	2.43E-5	Height	
STAD	cis	1	rs4911494	chr20:33971914	GDF5	chr20:33897002-34042568:-	-0.18	-4.16	3.93E-5	Height	
STAD	cis	1	rs4911494	chr20:33971914	UQCC	chr20:33890383-33999833:-	0.23	4.22	3.11E-5	Height	
STAD	cis	1	rs4911496	chr20:33972053	UQCC	chr20:33890383-33999833:-	-0.24	-4.36	1.64E-5	Height	
STAD	cis	1	rs4917385	chr10:105003721	C10orf32	chr10:104613967-104624718:+	-0.23	-3.9	0.000112	Systemic lupus erythematosus	
STAD	cis	1	rs4917901	chr10:102201773	SEC31B	chr10:102246403-102289636:-	-0.25	-5.99	4.78E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs4919464	chr10:102221195	SEC31B	chr10:102246403-102289636:-	-0.25	-6.14	2.09E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs4919465	chr10:102221703	SEC31B	chr10:102246403-102289636:-	-0.25	-6.23	1.23E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs4919466	chr10:102241213	SEC31B	chr10:102246403-102289636:-	-0.24	-5.92	7.03E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs4919468	chr10:102288343	SEC31B	chr10:102246403-102289636:-	-0.24	-5.83	1.14E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs4919469	chr10:102298855	SEC31B	chr10:102246403-102289636:-	-0.24	-5.83	1.18E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs4919470	chr10:102298920	SEC31B	chr10:102246403-102289636:-	-0.24	-5.57	4.71E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs4919471	chr10:102299239	SEC31B	chr10:102246403-102289636:-	-0.25	-6.06	3.19E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs4919472	chr10:102315864	SEC31B	chr10:102246403-102289636:-	-0.22	-5.27	2.24E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs4919690	chr10:104616500	AS3MT	chr10:104613967-104661653:+	0.26	4.92	1.29E-6	Arsenic metabolism	
STAD	cis	1	rs4919690	chr10:104616500	C10orf32	chr10:104613967-104624718:+	0.61	10.31	3.39E-22	Arsenic metabolism	
STAD	cis	1	rs4925166	chr17:18210810	FAM106A	chr17:18427880-18430160:-	-0.25	-4.32	2.01E-5	Multiple sclerosis	
STAD	cis	1	rs4925166	chr17:18210810	LOC220594	chr17:18414577-18445234:-	-0.35	-5.74	1.86E-8	Multiple sclerosis	
STAD	cis	1	rs4925540	chr1:247214878	ZNF670	chr1:247200087-247242069:-	-0.28	-4.3	2.2E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs4929949	chr11:8604593	TRIM66	chr11:8633586-8693413:-	0.19	4.09	5.16E-5	Body mass index	
STAD	cis	1	rs4932143	chr15:90372067	AP3S2	chr15:90373832-90456222:-	-0.62	-9.02	8.5E-18	Type 2 diabetes	
STAD	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.6	-9.03	7.79E-18	Type 2 diabetes	
STAD	cis	1	rs4936444	chr11:118743338	TREH	chr11:118528942-118550381:-	0.35	5.43	9.98E-8	Primary biliary cirrhosis	
STAD	cis	1	rs494003	chr11:65542298	CTSW	chr11:65647284-65651212:+	-0.34	-6.23	1.2E-9	Systemic lupus erythematosus	
STAD	cis	1	rs4948418	chr10:62185494	CCDC6	chr10:61548522-61666818:-	0.39	5.04	7.22E-7	Bipolar disorder	
STAD	cis	1	rs4951261	chr1:205717823	RAB7L1	chr1:205737115-205744610:-	-0.23	-4.1	5.05E-5	Menarche (age at onset)	
STAD	cis	1	rs4955485	chr3:134295843	ANAPC13	chr3:134196547-134204865:-	0.39	6.9	2.08E-11	Height	
STAD	cis	1	rs4955555	chr3:134286427	ANAPC13	chr3:134196547-134204865:-	0.39	6.89	2.32E-11	Height	
STAD	cis	1	rs4958424	chr5:150225036	LOC134466	chr5:150310000-150326146:-	0.3	4.89	1.45E-6	Crohn's disease	
STAD	cis	1	rs4958426	chr5:150278346	LOC134466	chr5:150310000-150326146:-	0.42	6.27	9.62E-10	Crohn's disease	
STAD	cis	1	rs4958842	chr5:150224877	LOC134466	chr5:150310000-150326146:-	0.42	6.4	4.46E-10	Crohn's disease	
STAD	cis	1	rs4958843	chr5:150224924	LOC134466	chr5:150310000-150326146:-	0.3	4.89	1.45E-6	Crohn's disease	
STAD	cis	1	rs4958848	chr5:150271122	LOC134466	chr5:150310000-150326146:-	0.3	4.67	4.15E-6	Crohn's disease	
STAD	cis	1	rs496584	chr15:43831923	ADAL	chr15:43622872-43646094:+	-0.48	-6.38	4.92E-10	Tumor biomarkers	
STAD	cis	1	rs496584	chr15:43831923	CATSPER2	chr15:43922774-43959900:-	-0.26	-4.66	4.32E-6	Tumor biomarkers	
STAD	cis	1	rs496584	chr15:43831923	LCMT2	chr15:43619976-43622891:-	-0.33	-4.31	2.08E-5	Tumor biomarkers	
STAD	cis	1	rs4971316	chr1:247210903	ZNF670	chr1:247200087-247242069:-	-0.29	-4.3	2.16E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs4971319	chr1:247211565	ZNF670	chr1:247200087-247242069:-	-0.29	-4.3	2.16E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs4973991	chr3:41927273	ULK4	chr3:41288091-42003660:-	-0.77	-12.1	7.8E-29	Diastolic blood pressure	
STAD	cis	1	rs4974483	chr3:134219001	ANAPC13	chr3:134196547-134204865:-	0.38	7.02	9.91E-12	Height	
STAD	cis	1	rs4974484	chr3:134219019	ANAPC13	chr3:134196547-134204865:-	0.37	6.62	1.18E-10	Height	
STAD	cis	1	rs4974493	chr3:134219993	ANAPC13	chr3:134196547-134204865:-	0.37	6.82	3.49E-11	Height	
STAD	cis	1	rs4975193	chr4:129980630	C4orf33	chr4:130014829-130033842:+	-0.39	-6.35	5.99E-10	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs4975194	chr4:129982377	C4orf33	chr4:130014829-130033842:+	-0.39	-6.35	5.99E-10	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs498872	chr11:118477367	TREH	chr11:118528942-118550381:-	0.3	5.16	4.03E-7	Glioma	
STAD	cis	1	rs503660	chr10:131418999	MGMT	chr10:131265454-131565783:+	0.27	4.89	1.44E-6	Response to temozolomide	
STAD	cis	1	rs506274	chr10:131409392	MGMT	chr10:131265454-131565783:+	0.24	4.27	2.47E-5	Response to temozolomide	
STAD	cis	1	rs508303	chr10:131424996	MGMT	chr10:131265454-131565783:+	-0.23	-4.02	6.94E-5	Response to temozolomide	
STAD	cis	1	rs513736	chr10:131406489	MGMT	chr10:131265454-131565783:+	0.24	4.2	3.37E-5	Response to temozolomide	
STAD	cis	1	rs516704	chr10:131419879	MGMT	chr10:131265454-131565783:+	0.24	4.24	2.82E-5	Response to temozolomide	
STAD	cis	1	rs522891	chr10:131430916	MGMT	chr10:131265454-131565783:+	-0.25	-4.32	1.95E-5	Response to temozolomide	
STAD	cis	1	rs530466	chr10:131427717	MGMT	chr10:131265454-131565783:+	0.25	4.27	2.41E-5	Response to temozolomide	
STAD	cis	1	rs531572	chr10:131427569	MGMT	chr10:131265454-131565783:+	-0.24	-4.16	3.93E-5	Response to temozolomide	
STAD	cis	1	rs531676	chr10:99637578	CRTAC1	chr10:99624758-99790585:-	0.28	6.37	5.43E-10	Metabolic syndrome	
STAD	cis	1	rs538969	chr10:131410608	MGMT	chr10:131265454-131565783:+	0.24	4.24	2.83E-5	Response to temozolomide	
STAD	cis	1	rs543725	chr11:57483039	MED19	chr11:57471182-57479673:-	-0.19	-3.8	0.000168	Schizophrenia	
STAD	cis	1	rs548390	chr10:131417427	MGMT	chr10:131265454-131565783:+	0.24	4.29	2.24E-5	Response to temozolomide	
STAD	cis	1	rs553371	chr10:131413676	MGMT	chr10:131265454-131565783:+	0.24	4.31	2.08E-5	Response to temozolomide	
STAD	cis	1	rs554792	chr10:131423181	MGMT	chr10:131265454-131565783:+	0.24	4.29	2.3E-5	Response to temozolomide	
STAD	cis	1	rs55670848	chr1:171697497	VAMP4	chr1:171669298-171711214:-	0.33	6.16	1.85E-9	Hippocampal atrophy	
STAD	cis	1	rs55696836	chr20:33549887	PROCR	chr20:33758727-33765164:+	-0.49	-5.22	2.92E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs55734215	chr20:33585437	PROCR	chr20:33758727-33765164:+	-0.46	-4.89	1.47E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs55753056	chr2:243929	SH3YL1	chr2:218138-264810:-	-0.6	-13.07	1.22E-32	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs55786720	chr6:56783647	BEND6	chr6:56819773-56892138:+	-0.25	-5.4	1.14E-7	Menarche (age at onset)	
STAD	cis	1	rs55835850	chr2:28949296	TRMT61B	chr2:29072690-29093175:-	0.32	5.34	1.61E-7	Body mass index	
STAD	cis	1	rs55836193	chr2:219907093	SLC23A3	chr2:220026183-220034817:-	0.39	4.48	9.72E-6	Height	
STAD	cis	1	rs55857306	chr1:11895795	CLCN6	chr1:11866207-11907674:+	0.29	4.25	2.68E-5	QRS complex (12-leadsum)	
STAD	cis	1	rs558764	chr10:131426957	MGMT	chr10:131265454-131565783:+	-0.23	-4.05	6.13E-5	Response to temozolomide	
STAD	cis	1	rs55879323	chr1:152168740	FLG2	chr1:152321214-152332482:-	-0.21	-4.06	5.97E-5	Inflammatory skin disease	
STAD	cis	1	rs55879323	chr1:152168740	FLG	chr1:152274651-152297679:-	-0.49	-10.2	8.03E-22	Inflammatory skin disease	
STAD	cis	1	rs55879323	chr1:152168740	HRNR	chr1:152184558-152196669:-	0.25	4.87	1.61E-6	Inflammatory skin disease	
STAD	cis	1	rs55895244	chr7:65387678	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs55909363	chr20:33549407	PROCR	chr20:33758727-33765164:+	-0.49	-5.22	2.92E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs55913793	chr3:134285968	ANAPC13	chr3:134196547-134204865:-	0.39	6.89	2.32E-11	Height	
STAD	cis	1	rs55914901	chr19:50528346	SIGLEC16	chr19:50472912-50479075:+	0.67	5.21	3.12E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
STAD	cis	1	rs55936726	chr2:258210	SH3YL1	chr2:218138-264810:-	-0.6	-12.74	2.44E-31	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs55946144	chr20:33629610	PROCR	chr20:33758727-33765164:+	-0.49	-5.32	1.8E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs55946380	chr2:268293	SH3YL1	chr2:218138-264810:-	-0.61	-12.98	2.83E-32	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs55973978	chr2:219913814	SLC23A3	chr2:220026183-220034817:-	0.35	3.99	7.97E-5	Height	
STAD	cis	1	rs56006038	chr2:219913837	SLC23A3	chr2:220026183-220034817:-	0.36	4.13	4.52E-5	Height	
STAD	cis	1	rs56013339	chr3:12543198	TSEN2	chr3:12525931-12581122:+	0.42	4.55	7.26E-6	Prostate cancer (gene x gene interaction)	
STAD	cis	1	rs56016656	chr7:65383481	CCT6P1	chr7:65216092-65228661:+	0.29	4.29	2.28E-5	Diabetic kidney disease	
STAD	cis	1	rs56028644	chr19:17388790	OCEL1	chr19:17337055-17340027:+	0.33	4.68	4.0E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
STAD	cis	1	rs56030203	chr6:56783857	BEND6	chr6:56819773-56892138:+	-0.25	-5.4	1.14E-7	Menarche (age at onset)	
STAD	cis	1	rs56033548	chr2:219936494	SLC23A3	chr2:220026183-220034817:-	0.36	4.22	2.98E-5	Height	
STAD	cis	1	rs56040780	chr16:28861881	EIF3CL	chr16:28699879-28747052:+;chr16	0.29	4.86	1.73E-6	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
STAD	cis	1	rs56091821	chr1:171651434	VAMP4	chr1:171669298-171711214:-	0.34	6.34	6.29E-10	Hippocampal atrophy	
STAD	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.77	11.87	5.79E-28	Diastolic blood pressure	
STAD	cis	1	rs56153133	chr1:11885647	CLCN6	chr1:11866207-11907674:+	0.27	3.92	0.000105	QRS complex (12-leadsum)	
STAD	cis	1	rs56154726	chr2:73721767	ALMS1P	chr2:73872046-73912692:+	0.49	7.76	7.41E-14	Metabolite levels	
STAD	cis	1	rs56154726	chr2:73721767	TPRKB	chr2:73956957-73964517:-	-0.23	-4.8	2.31E-6	Metabolite levels	
STAD	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.77	11.87	5.79E-28	Diastolic blood pressure	
STAD	cis	1	rs56167434	chr2:282137	SH3YL1	chr2:218138-264810:-	-0.6	-12.52	1.84E-30	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs56190030	chr1:11887382	CLCN6	chr1:11866207-11907674:+	0.26	3.96	9.09E-5	QRS complex (12-leadsum)	
STAD	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	0.79	9.58	1.17E-19	Diastolic blood pressure	
STAD	cis	1	rs56231040	chr14:104507049	TDRD9	chr14:104394817-104519002:+	0.24	3.97	8.59E-5	Bipolar disorder	
STAD	cis	1	rs56256440	chr10:79698207	DLG5	chr10:79550551-79686348:-	0.29	5.09	5.7E-7	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs56256440	chr10:79698207	POLR3A	chr10:79735906-79789259:-	0.24	4.61	5.35E-6	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs56291018	chr7:65390339	CCT6P1	chr7:65216092-65228661:+	0.29	4.28	2.37E-5	Diabetic kidney disease	
STAD	cis	1	rs56306402	chr20:33937704	GDF5	chr20:33897002-34042568:-	-0.18	-4.02	7.1E-5	Height	
STAD	cis	1	rs56306402	chr20:33937704	UQCC	chr20:33890383-33999833:-	0.24	4.28	2.38E-5	Height	
STAD	cis	1	rs56314138	chr3:121356656	IQCB1	chr3:121488610-121553926:-	0.28	4.69	3.73E-6	Cognitive performance	
STAD	cis	1	rs56317427	chr10:81861934	PLAC9	chr10:81892258-81904784:+	-0.28	-4.65	4.53E-6	Chronic obstructive pulmonary disease-related biomarkers	
STAD	cis	1	rs56321614	chr2:268191	SH3YL1	chr2:218138-264810:-	-0.59	-12.51	2.05E-30	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs56345529	chr1:171651372	VAMP4	chr1:171669298-171711214:-	0.34	6.3	8.11E-10	Hippocampal atrophy	
STAD	cis	1	rs56345933	chr2:219913735	SLC23A3	chr2:220026183-220034817:-	0.36	4.13	4.52E-5	Height	
STAD	cis	1	rs56363533	chr20:33626005	PROCR	chr20:33758727-33765164:+	-0.49	-5.31	1.83E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs56388436	chr2:219958903	SLC23A3	chr2:220026183-220034817:-	0.4	4.65	4.47E-6	Height	
STAD	cis	1	rs565974	chr10:131423274	MGMT	chr10:131265454-131565783:+	0.24	4.24	2.79E-5	Response to temozolomide	
STAD	cis	1	rs567700	chr10:131423126	MGMT	chr10:131265454-131565783:+	0.24	4.29	2.3E-5	Response to temozolomide	
STAD	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	0.76	12.24	2.24E-29	Diastolic blood pressure	
STAD	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.64	-16.51	8.52E-47	Crohn's disease	
STAD	cis	1	rs568617	chr11:65653242	SNX32	chr11:65601410-65621170:+	0.36	5.8	1.41E-8	Crohn's disease	
STAD	cis	1	rs56864281	chr15:85357649	LOC388152	chr15:84867600-84898920:-	-0.29	-4.34	1.81E-5	Schizophrenia	
STAD	cis	1	rs56884994	chr1:247211057	ZNF670	chr1:247200087-247242069:-	-0.27	-4.07	5.65E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs56901035	chr8:96043188	C8orf38	chr8:95908040-96088396:+	-0.34	-4.13	4.4E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs56922390	chr17:38157021	GSDMA	chr17:38119226-38134019:+	-0.32	-5.77	1.6E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs569235	chr10:131411620	MGMT	chr10:131265454-131565783:+	0.24	4.18	3.64E-5	Response to temozolomide	
STAD	cis	1	rs56985706	chr7:65394562	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs57001853	chr5:150272452	LOC134466	chr5:150310000-150326146:-	0.32	5.06	6.35E-7	Crohn's disease	
STAD	cis	1	rs57025426	chr10:102205868	SEC31B	chr10:102246403-102289636:-	-0.25	-5.98	5.08E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs57057549	chr7:65405738	CCT6P1	chr7:65216092-65228661:+	0.29	4.37	1.57E-5	Diabetic kidney disease	
STAD	cis	1	rs57075379	chr14:35577801	PPP2R3C	chr14:35554679-35591679:-	0.31	4.46	1.1E-5	Atopic dermatitis	
STAD	cis	1	rs574074	chr3:39561581	ENTPD3	chr3:40428673-40470109:+	-0.25	-3.9	0.000112	Attention deficit hyperactivity disorder	
STAD	cis	1	rs5745327	chr1:76270040	ACADM	chr1:76190043-76229353:+	0.27	4.01	7.26E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs5745343	chr1:76273805	ACADM	chr1:76190043-76229353:+	0.28	4.12	4.56E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs5745354	chr1:76275178	ACADM	chr1:76190043-76229353:+	0.27	4.01	7.26E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs5745392	chr1:76306809	ACADM	chr1:76190043-76229353:+	-0.32	-4.7	3.55E-6	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs5745542	chr1:76365073	ACADM	chr1:76190043-76229353:+	-0.31	-4.4	1.42E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs5749986	chr22:22157661	THAP7	chr22:21354061-21356404:-	-0.18	-4.18	3.61E-5	Multiple sclerosis	
STAD	cis	1	rs5750621	chr22:38956166	CBY1	chr22:39052658-39069853:+	0.2	3.81	0.000159	Resting heart rate	
STAD	cis	1	rs5750621	chr22:38956166	LOC646851	chr22:38974125-39052634:-	0.27	5.49	7.21E-8	Resting heart rate	
STAD	cis	1	rs5750622	chr22:38956464	LOC646851	chr22:38974125-39052634:-	0.25	5.21	3.1E-7	Resting heart rate	
STAD	cis	1	rs5750626	chr22:38977890	LOC646851	chr22:38974125-39052634:-	0.24	5.09	5.59E-7	Resting heart rate	
STAD	cis	1	rs5750627	chr22:38982321	LOC646851	chr22:38974125-39052634:-	0.24	5.32	1.75E-7	Resting heart rate	
STAD	cis	1	rs5750630	chr22:38985818	LOC646851	chr22:38974125-39052634:-	0.21	4.51	8.49E-6	Resting heart rate	
STAD	cis	1	rs5750633	chr22:38993467	LOC646851	chr22:38974125-39052634:-	0.24	5.3	1.97E-7	Resting heart rate	
STAD	cis	1	rs5750649	chr22:39036769	LOC646851	chr22:38974125-39052634:-	0.23	4.89	1.49E-6	Resting heart rate	
STAD	cis	1	rs5750652	chr22:39048316	LOC646851	chr22:38974125-39052634:-	0.23	4.89	1.49E-6	Resting heart rate	
STAD	cis	1	rs5750659	chr22:39068789	CBY1	chr22:39052658-39069853:+	0.21	4.17	3.83E-5	Resting heart rate	
STAD	cis	1	rs5750659	chr22:39068789	LOC646851	chr22:38974125-39052634:-	0.26	5.51	6.7E-8	Resting heart rate	
STAD	cis	1	rs5750662	chr22:39072472	CBY1	chr22:39052658-39069853:+	0.21	4.17	3.83E-5	Resting heart rate	
STAD	cis	1	rs5750662	chr22:39072472	LOC646851	chr22:38974125-39052634:-	0.26	5.51	6.7E-8	Resting heart rate	
STAD	cis	1	rs5750664	chr22:39072769	CBY1	chr22:39052658-39069853:+	0.21	4.12	4.57E-5	Resting heart rate	
STAD	cis	1	rs5750664	chr22:39072769	LOC646851	chr22:38974125-39052634:-	0.26	5.48	7.62E-8	Resting heart rate	
STAD	cis	1	rs5750668	chr22:39079964	CBY1	chr22:39052658-39069853:+	0.22	4.18	3.57E-5	Resting heart rate	
STAD	cis	1	rs5750668	chr22:39079964	LOC646851	chr22:38974125-39052634:-	0.26	5.51	6.38E-8	Resting heart rate	
STAD	cis	1	rs5750669	chr22:39080638	CBY1	chr22:39052658-39069853:+	0.2	3.89	0.00012	Resting heart rate	
STAD	cis	1	rs5750669	chr22:39080638	LOC646851	chr22:38974125-39052634:-	0.26	5.48	7.48E-8	Resting heart rate	
STAD	cis	1	rs5750671	chr22:39094619	LOC646851	chr22:38974125-39052634:-	0.27	5.71	2.27E-8	Resting heart rate	
STAD	cis	1	rs5750672	chr22:39104168	LOC646851	chr22:38974125-39052634:-	-0.26	-5.5	6.9E-8	Resting heart rate	
STAD	cis	1	rs5750673	chr22:39110124	CBY1	chr22:39052658-39069853:+	0.22	4.26	2.59E-5	Resting heart rate	
STAD	cis	1	rs5750673	chr22:39110124	LOC646851	chr22:38974125-39052634:-	0.26	5.41	1.11E-7	Resting heart rate	
STAD	cis	1	rs5750677	chr22:39147715	LOC646851	chr22:38974125-39052634:-	0.25	5.32	1.78E-7	Resting heart rate	
STAD	cis	1	rs5751255	chr22:42648408	C22orf32	chr22:42475699-42480287:+	0.22	4.43	1.2E-5	Cognitive function	
STAD	cis	1	rs5751255	chr22:42648408	CYP2D6	chr22:42522502-42526883:-	-0.35	-6.26	1.01E-9	Cognitive function	
STAD	cis	1	rs5751255	chr22:42648408	PHF5A	chr22:41855722-41864708:-	0.19	3.97	8.66E-5	Cognitive function	
STAD	cis	1	rs5752326	chr22:26843990	HPS4	chr22:26847447-26879820:-	0.39	3.94	9.61E-5	Ischemic stroke	
STAD	cis	1	rs5752327	chr22:26844070	HPS4	chr22:26847447-26879820:-	0.39	3.94	9.61E-5	Ischemic stroke	
STAD	cis	1	rs5752976	chr22:30281962	DUSP18	chr22:31048039-31063872:-	-0.5	-3.95	9.1E-5	LDL cholesterol	
STAD	cis	1	rs5753002	chr22:30435402	DUSP18	chr22:31048039-31063872:-	-0.52	-4.36	1.7E-5	LDL cholesterol	
STAD	cis	1	rs57542652	chr2:228088	SH3YL1	chr2:218138-264810:-	-0.59	-12.45	3.38E-30	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs5756813	chr22:38175477	GALR3	chr22:38219389-38221502:+	0.28	5.19	3.31E-7	Optic cup area;Vertical cup-disc ratio	
STAD	cis	1	rs5757141	chr22:38957483	CBY1	chr22:39052658-39069853:+	0.2	3.83	0.00015	Resting heart rate	
STAD	cis	1	rs5757141	chr22:38957483	LOC646851	chr22:38974125-39052634:-	0.26	5.41	1.11E-7	Resting heart rate	
STAD	cis	1	rs5757162	chr22:38993370	LOC646851	chr22:38974125-39052634:-	0.24	5.1	5.36E-7	Resting heart rate	
STAD	cis	1	rs5757166	chr22:38995385	LOC646851	chr22:38974125-39052634:-	0.24	5.24	2.64E-7	Resting heart rate	
STAD	cis	1	rs5757181	chr22:39013522	LOC646851	chr22:38974125-39052634:-	0.23	4.87	1.65E-6	Resting heart rate	
STAD	cis	1	rs5757187	chr22:39021522	LOC646851	chr22:38974125-39052634:-	-0.24	-5.1	5.2E-7	Resting heart rate	
STAD	cis	1	rs5757193	chr22:39034867	LOC646851	chr22:38974125-39052634:-	-0.22	-4.69	3.82E-6	Resting heart rate	
STAD	cis	1	rs5757196	chr22:39039855	LOC646851	chr22:38974125-39052634:-	0.23	4.86	1.73E-6	Resting heart rate	
STAD	cis	1	rs5757200	chr22:39043491	LOC646851	chr22:38974125-39052634:-	0.23	4.86	1.73E-6	Resting heart rate	
STAD	cis	1	rs5757203	chr22:39044152	LOC646851	chr22:38974125-39052634:-	0.23	4.86	1.73E-6	Resting heart rate	
STAD	cis	1	rs5757204	chr22:39046700	LOC646851	chr22:38974125-39052634:-	0.23	4.9	1.42E-6	Resting heart rate	
STAD	cis	1	rs5757208	chr22:39049230	LOC646851	chr22:38974125-39052634:-	0.23	4.86	1.73E-6	Resting heart rate	
STAD	cis	1	rs5757211	chr22:39051705	LOC646851	chr22:38974125-39052634:-	0.22	4.76	2.78E-6	Resting heart rate	
STAD	cis	1	rs5757213	chr22:39053888	LOC646851	chr22:38974125-39052634:-	0.23	4.86	1.73E-6	Resting heart rate	
STAD	cis	1	rs5757226	chr22:39070550	CBY1	chr22:39052658-39069853:+	0.21	4.17	3.83E-5	Resting heart rate	
STAD	cis	1	rs5757226	chr22:39070550	LOC646851	chr22:38974125-39052634:-	0.26	5.51	6.7E-8	Resting heart rate	
STAD	cis	1	rs5757231	chr22:39071658	CBY1	chr22:39052658-39069853:+	-0.21	-4.08	5.44E-5	Resting heart rate	
STAD	cis	1	rs5757231	chr22:39071658	LOC646851	chr22:38974125-39052634:-	-0.26	-5.48	7.5E-8	Resting heart rate	
STAD	cis	1	rs5757232	chr22:39071677	CBY1	chr22:39052658-39069853:+	0.21	4.17	3.83E-5	Resting heart rate	
STAD	cis	1	rs5757232	chr22:39071677	LOC646851	chr22:38974125-39052634:-	0.26	5.51	6.7E-8	Resting heart rate	
STAD	cis	1	rs5757234	chr22:39072686	LOC646851	chr22:38974125-39052634:-	0.25	5.43	9.96E-8	Resting heart rate	
STAD	cis	1	rs5757253	chr22:39104320	LOC646851	chr22:38974125-39052634:-	0.26	5.69	2.5E-8	Resting heart rate	
STAD	cis	1	rs57576577	chr16:31036367	MYST1	chr16:31128985-31142713:+	0.23	4	7.68E-5	Response to metformin (IC50)	
STAD	cis	1	rs5758659	chr22:42622003	C22orf32	chr22:42475699-42480287:+	0.21	4.21	3.2E-5	Cognitive function	
STAD	cis	1	rs5758659	chr22:42622003	CYP2D6	chr22:42522502-42526883:-	-0.36	-6.3	7.87E-10	Cognitive function	
STAD	cis	1	rs5758660	chr22:42623718	C22orf32	chr22:42475699-42480287:+	0.21	4.15	4.09E-5	Cognitive function	
STAD	cis	1	rs5758660	chr22:42623718	CYP2D6	chr22:42522502-42526883:-	-0.36	-6.37	5.41E-10	Cognitive function	
STAD	cis	1	rs5758677	chr22:42643039	C22orf32	chr22:42475699-42480287:+	0.2	4	7.51E-5	Cognitive function	
STAD	cis	1	rs5758677	chr22:42643039	CYP2D6	chr22:42522502-42526883:-	-0.36	-6.31	7.45E-10	Cognitive function	
STAD	cis	1	rs5760216	chr22:24539734	SUSD2	chr22:24577444-24585074:+	0.99	9.21	1.99E-18	Amyotrophic lateral sclerosis	
STAD	cis	1	rs5760220	chr22:24542480	SUSD2	chr22:24577444-24585074:+	0.98	9.38	5.63E-19	Amyotrophic lateral sclerosis	
STAD	cis	1	rs5760229	chr22:24560254	SUSD2	chr22:24577444-24585074:+	0.9	8.83	3.62E-17	Amyotrophic lateral sclerosis	
STAD	cis	1	rs5761529	chr22:26843708	HPS4	chr22:26847447-26879820:-	0.39	3.94	9.61E-5	Ischemic stroke	
STAD	cis	1	rs5761530	chr22:26843916	HPS4	chr22:26847447-26879820:-	0.4	4.45	1.12E-5	Ischemic stroke	
STAD	cis	1	rs5763566	chr22:30272481	DUSP18	chr22:31048039-31063872:-	-0.5	-3.95	9.1E-5	LDL cholesterol	
STAD	cis	1	rs5763585	chr22:30293559	DUSP18	chr22:31048039-31063872:-	-0.5	-3.95	9.1E-5	LDL cholesterol	
STAD	cis	1	rs5763609	chr22:30323090	DUSP18	chr22:31048039-31063872:-	-0.48	-3.86	0.000133	LDL cholesterol	
STAD	cis	1	rs57690120	chr20:33731437	PROCR	chr20:33758727-33765164:+	-0.49	-5.48	7.47E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs5770917	chr22:51017353	CPT1B	chr22:51007291-51017096:-	-0.31	-3.93	9.91E-5	Narcolepsy	
STAD	cis	1	rs577227	chr10:131404528	MGMT	chr10:131265454-131565783:+	0.24	4.29	2.3E-5	Response to temozolomide	
STAD	cis	1	rs578056	chr11:65514874	CTSW	chr11:65647284-65651212:+	-0.36	-6.39	4.66E-10	Systemic lupus erythematosus	
STAD	cis	1	rs57925408	chr8:96062930	C8orf38	chr8:95908040-96088396:+	-0.34	-4.05	6.3E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs57928699	chr18:44645593	HDHD2	chr18:44633782-44676871:-	0.51	4.94	1.15E-6	Sitting height ratio	
STAD	cis	1	rs58062456	chr7:65394852	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs580745	chr10:131414401	MGMT	chr10:131265454-131565783:+	0.24	4.32	1.95E-5	Response to temozolomide	
STAD	cis	1	rs58088385	chr20:33748229	PROCR	chr20:33758727-33765164:+	-0.5	-5.56	4.9E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs58147284	chr2:97508082	CNNM3	chr2:97481991-97501120:+	-0.33	-3.98	8.24E-5	Erectile dysfunction and prostate cancer treatment	
STAD	cis	1	rs58204112	chr14:74359417	PTGR2	chr14:74318534-74352166:+	0.52	6.23	1.23E-9	Morning vs. evening chronotype	
STAD	cis	1	rs583583	chr1:147083114	ACP6	chr1:147119168-147142634:-	0.31	4.48	1.0E-5	Schizophrenia (negative symptoms)	
STAD	cis	1	rs58416181	chr15:85264461	LOC388152	chr15:84867600-84898920:-	-0.27	-4.09	5.24E-5	Schizophrenia	
STAD	cis	1	rs58455759	chr1:171674987	VAMP4	chr1:171669298-171711214:-	0.34	6.31	7.45E-10	Hippocampal atrophy	
STAD	cis	1	rs58461606	chr2:267367	SH3YL1	chr2:218138-264810:-	-0.61	-13.02	2.06E-32	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs58660500	chr3:53086573	TMEM110	chr3:52867139-52931547:-	0.4	4.38	1.54E-5	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs58717741	chr5:150284936	LOC134466	chr5:150310000-150326146:-	0.37	6.02	3.96E-9	Crohn's disease	
STAD	cis	1	rs59150578	chr11:18340862	GTF2H1	chr11:18343816-18388590:+	0.38	6.21	1.39E-9	Pancreatic cancer	
STAD	cis	1	rs59204447	chr14:66106727	LOC645431	chr14:65877313-65879335:-	-0.36	-4.14	4.24E-5	Ischemic stroke	
STAD	cis	1	rs59244547	chr3:156582997	LEKR1	chr3:156544076-156763918:+	-0.37	-3.96	8.92E-5	Bone mineral density	
STAD	cis	1	rs59244622	chr2:97501632	CNNM3	chr2:97481991-97501120:+	-0.34	-4.04	6.44E-5	Erectile dysfunction and prostate cancer treatment	
STAD	cis	1	rs59363432	chr14:74397545	PTGR2	chr14:74318534-74352166:+	0.51	6.09	2.76E-9	Morning vs. evening chronotype	
STAD	cis	1	rs59531858	chr5:150247063	LOC134466	chr5:150310000-150326146:-	0.42	6.34	6.3E-10	Crohn's disease	
STAD	cis	1	rs59794892	chr7:65415873	CCT6P1	chr7:65216092-65228661:+	0.27	4.11	4.79E-5	Diabetic kidney disease	
STAD	cis	1	rs59925331	chr17:38169273	GSDMA	chr17:38119226-38134019:+	-0.32	-5.76	1.7E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs59937473	chr2:271797	SH3YL1	chr2:218138-264810:-	-0.59	-12.62	7.25E-31	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs5995610	chr22:39064681	LOC646851	chr22:38974125-39052634:-	0.24	5.07	6.11E-7	Resting heart rate	
STAD	cis	1	rs59980321	chr5:150241813	LOC134466	chr5:150310000-150326146:-	0.32	5.04	7.1E-7	Crohn's disease	
STAD	cis	1	rs5999515	chr22:22145101	THAP7	chr22:21354061-21356404:-	-0.19	-4.45	1.1E-5	Multiple sclerosis	
STAD	cis	1	rs5999521	chr22:22146399	THAP7	chr22:21354061-21356404:-	0.18	4.23	2.96E-5	Multiple sclerosis	
STAD	cis	1	rs5999750	chr22:22188009	THAP7	chr22:21354061-21356404:-	0.18	4.28	2.4E-5	Multiple sclerosis	
STAD	cis	1	rs6001173	chr22:39015302	LOC646851	chr22:38974125-39052634:-	0.25	5.35	1.53E-7	Resting heart rate	
STAD	cis	1	rs6001175	chr22:39018334	LOC646851	chr22:38974125-39052634:-	0.24	5.15	4.09E-7	Resting heart rate	
STAD	cis	1	rs6001182	chr22:39047443	LOC646851	chr22:38974125-39052634:-	0.23	4.86	1.73E-6	Resting heart rate	
STAD	cis	1	rs6001184	chr22:39052116	LOC646851	chr22:38974125-39052634:-	0.23	4.86	1.73E-6	Resting heart rate	
STAD	cis	1	rs6001185	chr22:39052155	LOC646851	chr22:38974125-39052634:-	0.23	4.86	1.73E-6	Resting heart rate	
STAD	cis	1	rs6001188	chr22:39062194	LOC646851	chr22:38974125-39052634:-	0.24	5.05	6.76E-7	Resting heart rate	
STAD	cis	1	rs6001191	chr22:39074452	CBY1	chr22:39052658-39069853:+	0.21	4.12	4.57E-5	Resting heart rate	
STAD	cis	1	rs6001191	chr22:39074452	LOC646851	chr22:38974125-39052634:-	0.26	5.48	7.62E-8	Resting heart rate	
STAD	cis	1	rs6001204	chr22:39100239	LOC646851	chr22:38974125-39052634:-	0.27	5.71	2.27E-8	Resting heart rate	
STAD	cis	1	rs6001214	chr22:39149155	LOC646851	chr22:38974125-39052634:-	0.24	5.13	4.67E-7	Resting heart rate	
STAD	cis	1	rs60134818	chr5:150261043	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs60144605	chr1:76359699	ACADM	chr1:76190043-76229353:+	-0.3	-4.25	2.63E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs60149603	chr2:285421	SH3YL1	chr2:218138-264810:-	-0.59	-12.38	6.29E-30	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs60178264	chr4:17685308	LAP3	chr4:17578927-17609590:+	-0.18	-3.91	0.000111	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs60228288	chr18:44640412	HDHD2	chr18:44633782-44676871:-	0.56	5.41	1.1E-7	Sitting height ratio	
STAD	cis	1	rs60422392	chr18:44621473	HDHD2	chr18:44633782-44676871:-	0.56	5.41	1.09E-7	Sitting height ratio	
STAD	cis	1	rs60484953	chr2:221560	SH3YL1	chr2:218138-264810:-	-0.59	-12.43	4.29E-30	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs6050573	chr20:25366065	NANP	chr20:25593575-25604648:-	-0.2	-3.91	0.00011	Liver enzyme levels (alkaline phosphatase)	
STAD	cis	1	rs6050598	chr20:25397257	NANP	chr20:25593575-25604648:-	-0.2	-3.9	0.000111	Liver enzyme levels (alkaline phosphatase)	
STAD	cis	1	rs6051080	chr20:25975674	FAM182A	chr20:26035250-26067552:+	0.28	4.84	1.85E-6	Colorectal or endometrial cancer	
STAD	cis	1	rs6051080	chr20:25975674	FAM182B	chr20:25744102-25848786:-	0.53	9.06	6.29E-18	Colorectal or endometrial cancer	
STAD	cis	1	rs6051080	chr20:25975674	LOC100134868	chr20:25990435-26002424:+	-0.37	-6.46	3.12E-10	Colorectal or endometrial cancer	
STAD	cis	1	rs60512868	chr3:48483445	TREX1	chr3:48501186-48509043:+	-0.25	-5.69	2.49E-8	Longevity	
STAD	cis	1	rs6060222	chr20:33682570	PROCR	chr20:33758727-33765164:+	-0.49	-5.51	6.64E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs6060230	chr20:33689308	PROCR	chr20:33758727-33765164:+	0.47	5.53	5.81E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs6060235	chr20:33691652	PROCR	chr20:33758727-33765164:+	-0.48	-5.3	1.92E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs6060236	chr20:33692618	PROCR	chr20:33758727-33765164:+	-0.5	-5.45	8.83E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs6060244	chr20:33699435	PROCR	chr20:33758727-33765164:+	0.39	4.79	2.32E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs6060245	chr20:33699625	PROCR	chr20:33758727-33765164:+	-0.48	-5.27	2.31E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs6060246	chr20:33701107	PROCR	chr20:33758727-33765164:+	-0.4	-4.48	9.76E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs6060401	chr20:34005214	GDF5	chr20:33897002-34042568:-	-0.19	-4.34	1.79E-5	Height	
STAD	cis	1	rs6060401	chr20:34005214	UQCC	chr20:33890383-33999833:-	0.24	4.19	3.44E-5	Height	
STAD	cis	1	rs6060402	chr20:34005240	GDF5	chr20:33897002-34042568:-	-0.2	-4.37	1.61E-5	Height	
STAD	cis	1	rs6060402	chr20:34005240	UQCC	chr20:33890383-33999833:-	0.23	4.1	5.1E-5	Height	
STAD	cis	1	rs60683927	chr7:65394768	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs60693825	chr14:35514456	PPP2R3C	chr14:35554679-35591679:-	0.27	3.87	0.000129	Atopic dermatitis	
STAD	cis	1	rs607987	chr11:30223574	C11orf46	chr11:30344649-30359978:+	-0.2	-3.86	0.000131	Body mass index	
STAD	cis	1	rs60843830	chr2:286756	SH3YL1	chr2:218138-264810:-	-0.58	-11.64	4.43E-27	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs60854219	chr18:44646664	HDHD2	chr18:44633782-44676871:-	0.51	4.94	1.15E-6	Sitting height ratio	
STAD	cis	1	rs60866116	chr20:33726150	PROCR	chr20:33758727-33765164:+	-0.45	-5.11	4.98E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs6087698	chr20:33948919	GDF5	chr20:33897002-34042568:-	-0.18	-4.03	6.62E-5	Height	
STAD	cis	1	rs6087698	chr20:33948919	UQCC	chr20:33890383-33999833:-	0.23	4.2	3.32E-5	Height	
STAD	cis	1	rs6087702	chr20:33995945	GDF5	chr20:33897002-34042568:-	-0.19	-4.26	2.62E-5	Height	
STAD	cis	1	rs6087702	chr20:33995945	UQCC	chr20:33890383-33999833:-	0.23	4.13	4.43E-5	Height	
STAD	cis	1	rs6087703	chr20:33996433	GDF5	chr20:33897002-34042568:-	-0.19	-4.3	2.16E-5	Height	
STAD	cis	1	rs6087703	chr20:33996433	UQCC	chr20:33890383-33999833:-	0.23	4.18	3.56E-5	Height	
STAD	cis	1	rs6087704	chr20:34001058	GDF5	chr20:33897002-34042568:-	-0.19	-4.29	2.23E-5	Height	
STAD	cis	1	rs6087704	chr20:34001058	UQCC	chr20:33890383-33999833:-	0.23	4.16	3.89E-5	Height	
STAD	cis	1	rs6087705	chr20:34001250	GDF5	chr20:33897002-34042568:-	-0.19	-4.17	3.8E-5	Height	
STAD	cis	1	rs6087705	chr20:34001250	UQCC	chr20:33890383-33999833:-	0.24	4.23	2.9E-5	Height	
STAD	cis	1	rs6088799	chr20:33934301	GDF5	chr20:33897002-34042568:-	-0.18	-4.06	5.89E-5	Height	
STAD	cis	1	rs6088799	chr20:33934301	UQCC	chr20:33890383-33999833:-	0.24	4.22	3.07E-5	Height	
STAD	cis	1	rs6088812	chr20:33974163	GDF5	chr20:33897002-34042568:-	-0.18	-4.16	3.93E-5	Height	
STAD	cis	1	rs6088812	chr20:33974163	UQCC	chr20:33890383-33999833:-	0.23	4.22	3.11E-5	Height	
STAD	cis	1	rs6088813	chr20:33975181	GDF5	chr20:33897002-34042568:-	-0.18	-4.16	3.93E-5	Height	
STAD	cis	1	rs6088813	chr20:33975181	UQCC	chr20:33890383-33999833:-	0.23	4.22	3.11E-5	Height	
STAD	cis	1	rs6088815	chr20:33976474	GDF5	chr20:33897002-34042568:-	-0.18	-4.08	5.4E-5	Height	
STAD	cis	1	rs6088815	chr20:33976474	UQCC	chr20:33890383-33999833:-	0.24	4.33	1.89E-5	Height	
STAD	cis	1	rs6088816	chr20:33982435	GDF5	chr20:33897002-34042568:-	-0.19	-4.23	2.98E-5	Height	
STAD	cis	1	rs6088816	chr20:33982435	UQCC	chr20:33890383-33999833:-	0.23	4.18	3.54E-5	Height	
STAD	cis	1	rs6088820	chr20:33987298	GDF5	chr20:33897002-34042568:-	-0.19	-4.18	3.6E-5	Height	
STAD	cis	1	rs6088820	chr20:33987298	UQCC	chr20:33890383-33999833:-	0.23	4.13	4.42E-5	Height	
STAD	cis	1	rs6088821	chr20:33987576	GDF5	chr20:33897002-34042568:-	-0.19	-4.23	2.98E-5	Height	
STAD	cis	1	rs6088821	chr20:33987576	UQCC	chr20:33890383-33999833:-	0.23	4.18	3.54E-5	Height	
STAD	cis	1	rs6088823	chr20:33994265	GDF5	chr20:33897002-34042568:-	-0.19	-4.3	2.16E-5	Height	
STAD	cis	1	rs6088823	chr20:33994265	UQCC	chr20:33890383-33999833:-	0.23	4.18	3.56E-5	Height	
STAD	cis	1	rs6088825	chr20:33995972	GDF5	chr20:33897002-34042568:-	-0.19	-4.3	2.16E-5	Height	
STAD	cis	1	rs6088825	chr20:33995972	UQCC	chr20:33890383-33999833:-	0.23	4.18	3.56E-5	Height	
STAD	cis	1	rs60942590	chr3:53016421	TMEM110	chr3:52867139-52931547:-	0.49	4.95	1.13E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs60957376	chr15:85280792	LOC388152	chr15:84867600-84898920:-	-0.28	-4.25	2.71E-5	Schizophrenia	
STAD	cis	1	rs60982898	chr6:49385806	MUT	chr6:49398994-49431031:-	0.39	7.34	1.25E-12	Folate pathway vitamin levels	
STAD	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.38	-6.89	2.19E-11	Forced vital capacity	
STAD	cis	1	rs61172708	chr3:52996052	TMEM110	chr3:52867139-52931547:-	0.49	4.97	9.81E-7	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.45	-6.27	9.84E-10	Triglycerides	
STAD	cis	1	rs6120974	chr20:34126827	ERGIC3	chr20:34129778-34145404:+	-0.29	-4.55	7.03E-6	Triglycerides	
STAD	cis	1	rs61270113	chr5:150226263	LOC134466	chr5:150310000-150326146:-	0.29	4.57	6.66E-6	Crohn's disease	
STAD	cis	1	rs61316646	chr18:44610670	HDHD2	chr18:44633782-44676871:-	0.52	5	8.57E-7	Sitting height ratio	
STAD	cis	1	rs6132333	chr20:20634106	XRN2	chr20:21283942-21370463:+	-0.38	-4.1	5.05E-5	IgG glycosylation	
STAD	cis	1	rs6132677	chr20:23840242	CST2	chr20:23804404-23807312:-	-0.25	-4.03	6.81E-5	Response to TNF antagonist treatment	
STAD	cis	1	rs6132678	chr20:23842323	CST2	chr20:23804404-23807312:-	-0.25	-4.03	6.81E-5	Response to TNF antagonist treatment	
STAD	cis	1	rs6132679	chr20:23842400	CST2	chr20:23804404-23807312:-	-0.25	-4.03	6.81E-5	Response to TNF antagonist treatment	
STAD	cis	1	rs6138139	chr20:23827431	CST2	chr20:23804404-23807312:-	-0.28	-4.44	1.19E-5	Response to TNF antagonist treatment	
STAD	cis	1	rs6138150	chr20:23847009	CST2	chr20:23804404-23807312:-	-0.25	-3.97	8.59E-5	Response to TNF antagonist treatment	
STAD	cis	1	rs6138151	chr20:23847180	CST2	chr20:23804404-23807312:-	-0.24	-3.85	0.000136	Response to TNF antagonist treatment	
STAD	cis	1	rs6141546	chr20:33949282	GDF5	chr20:33897002-34042568:-	-0.18	-4.03	6.62E-5	Height	
STAD	cis	1	rs6141546	chr20:33949282	UQCC	chr20:33890383-33999833:-	0.23	4.2	3.32E-5	Height	
STAD	cis	1	rs6141548	chr20:33971085	GDF5	chr20:33897002-34042568:-	-0.18	-4.11	4.85E-5	Height	
STAD	cis	1	rs6141548	chr20:33971085	UQCC	chr20:33890383-33999833:-	0.24	4.27	2.42E-5	Height	
STAD	cis	1	rs6141549	chr20:33974051	GDF5	chr20:33897002-34042568:-	-0.18	-4.16	3.93E-5	Height	
STAD	cis	1	rs6141549	chr20:33974051	UQCC	chr20:33890383-33999833:-	0.23	4.22	3.11E-5	Height	
STAD	cis	1	rs6142358	chr20:33960308	GDF5	chr20:33897002-34042568:-	0.18	4.18	3.54E-5	Height	
STAD	cis	1	rs6142358	chr20:33960308	UQCC	chr20:33890383-33999833:-	-0.22	-4.02	7.02E-5	Height	
STAD	cis	1	rs6142359	chr20:33960450	GDF5	chr20:33897002-34042568:-	-0.18	-4.09	5.15E-5	Height	
STAD	cis	1	rs6142359	chr20:33960450	UQCC	chr20:33890383-33999833:-	0.24	4.29	2.3E-5	Height	
STAD	cis	1	rs6142360	chr20:33960486	GDF5	chr20:33897002-34042568:-	-0.17	-3.87	0.000129	Height	
STAD	cis	1	rs6142360	chr20:33960486	UQCC	chr20:33890383-33999833:-	0.25	4.48	9.94E-6	Height	
STAD	cis	1	rs6142369	chr20:33973315	GDF5	chr20:33897002-34042568:-	-0.18	-4.14	4.23E-5	Height	
STAD	cis	1	rs6142369	chr20:33973315	UQCC	chr20:33890383-33999833:-	0.24	4.29	2.22E-5	Height	
STAD	cis	1	rs6142370	chr20:33973378	GDF5	chr20:33897002-34042568:-	-0.18	-4.16	3.93E-5	Height	
STAD	cis	1	rs6142370	chr20:33973378	UQCC	chr20:33890383-33999833:-	0.23	4.22	3.11E-5	Height	
STAD	cis	1	rs6142373	chr20:33983314	GDF5	chr20:33897002-34042568:-	-0.19	-4.18	3.6E-5	Height	
STAD	cis	1	rs6142373	chr20:33983314	UQCC	chr20:33890383-33999833:-	0.23	4.13	4.42E-5	Height	
STAD	cis	1	rs6142374	chr20:33985568	GDF5	chr20:33897002-34042568:-	-0.19	-4.23	2.98E-5	Height	
STAD	cis	1	rs6142374	chr20:33985568	UQCC	chr20:33890383-33999833:-	0.23	4.18	3.54E-5	Height	
STAD	cis	1	rs6142376	chr20:33992761	GDF5	chr20:33897002-34042568:-	-0.19	-4.23	2.98E-5	Height	
STAD	cis	1	rs6142376	chr20:33992761	UQCC	chr20:33890383-33999833:-	0.23	4.18	3.54E-5	Height	
STAD	cis	1	rs6142379	chr20:33999267	GDF5	chr20:33897002-34042568:-	-0.19	-4.3	2.13E-5	Height	
STAD	cis	1	rs6142379	chr20:33999267	UQCC	chr20:33890383-33999833:-	0.23	4.16	3.93E-5	Height	
STAD	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-1.03	-9.76	2.71E-20	Blood metabolite levels	
STAD	cis	1	rs615199	chr6:117113653	FAM162B	chr6:117073360-117086886:-	0.22	4.36	1.64E-5	C-reactive protein levels	
STAD	cis	1	rs61524473	chr15:45646283	GATM	chr15:45653324-45670980:-	-0.29	-4.63	4.97E-6	Metabolite levels (small molecules and protein measures)	
STAD	cis	1	rs61524473	chr15:45646283	SPATA5L1	chr15:45694519-45713614:+	0.32	5.97	5.45E-9	Metabolite levels (small molecules and protein measures)	
STAD	cis	1	rs61530785	chr5:150261364	LOC134466	chr5:150310000-150326146:-	0.41	6.17	1.66E-9	Crohn's disease	
STAD	cis	1	rs61634114	chr19:17387254	OCEL1	chr19:17337055-17340027:+	0.35	4.98	9.61E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
STAD	cis	1	rs61742833	chr11:490035	RNH1	chr11:494512-507273:-	-0.41	-4.63	5.0E-6	Body mass index	
STAD	cis	1	rs61783200	chr1:46297403	IPP	chr1:46160000-46216485:-	0.2	3.84	0.000146	Body mass index	
STAD	cis	1	rs61818802	chr1:113181739	ST7L	chr1:113066142-113162405:-	0.37	6.75	5.38E-11	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs61826828	chr1:174015261	SERPINC1	chr1:173872943-173886516:-	0.33	4.93	1.25E-6	Schizophrenia	
STAD	cis	1	rs61852630	chr1:247210193	ZNF670	chr1:247200087-247242069:-	-0.29	-4.3	2.16E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs61852637	chr1:247219636	ZNF670	chr1:247200087-247242069:-	-0.28	-4.3	2.2E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs61854764	chr10:69965475	ATOH7	chr10:69990386-69991855:-	-0.34	-3.97	8.53E-5	Optic nerve measurement (disc area)	
STAD	cis	1	rs61858625	chr10:38002042	HSD17B7P2	chr10:38645308-38667432:+	0.34	4.07	5.67E-5	Obesity (extreme)	
STAD	cis	1	rs61858629	chr10:38014770	HSD17B7P2	chr10:38645308-38667432:+	0.29	3.8	0.000168	Obesity (extreme)	
STAD	cis	1	rs61858886	chr10:38360701	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.81	0.000158	Obesity (extreme)	
STAD	cis	1	rs61859667	chr10:38016379	HSD17B7P2	chr10:38645308-38667432:+	0.33	3.95	9.45E-5	Obesity (extreme)	
STAD	cis	1	rs61876323	chr11:462855	RNH1	chr11:494512-507273:-	-0.42	-5.59	4.21E-8	Body mass index	
STAD	cis	1	rs61876326	chr11:467368	RNH1	chr11:494512-507273:-	-0.43	-5.77	1.6E-8	Body mass index	
STAD	cis	1	rs61876332	chr11:487101	RNH1	chr11:494512-507273:-	-0.43	-5.8	1.41E-8	Body mass index	
STAD	cis	1	rs61876333	chr11:487136	RNH1	chr11:494512-507273:-	-0.43	-5.66	2.94E-8	Body mass index	
STAD	cis	1	rs61876334	chr11:487201	RNH1	chr11:494512-507273:-	-0.43	-5.8	1.41E-8	Body mass index	
STAD	cis	1	rs61876335	chr11:488878	RNH1	chr11:494512-507273:-	-0.43	-5.76	1.69E-8	Body mass index	
STAD	cis	1	rs61876336	chr11:489537	RNH1	chr11:494512-507273:-	-0.43	-5.8	1.36E-8	Body mass index	
STAD	cis	1	rs61876340	chr11:495699	RNH1	chr11:494512-507273:-	-0.43	-5.71	2.25E-8	Body mass index	
STAD	cis	1	rs61876341	chr11:495892	RNH1	chr11:494512-507273:-	-0.43	-5.71	2.25E-8	Body mass index	
STAD	cis	1	rs61877760	chr11:506596	RNH1	chr11:494512-507273:-	-0.43	-5.65	3.15E-8	Body mass index	
STAD	cis	1	rs62019464	chr15:85294469	LOC388152	chr15:84867600-84898920:-	-0.28	-4.25	2.71E-5	Schizophrenia	
STAD	cis	1	rs62019469	chr15:85321220	LOC388152	chr15:84867600-84898920:-	-0.28	-4.24	2.78E-5	Schizophrenia	
STAD	cis	1	rs62021219	chr15:85256159	LOC388152	chr15:84867600-84898920:-	-0.28	-4.22	3.03E-5	Schizophrenia	
STAD	cis	1	rs62026530	chr15:84775840	LOC388152	chr15:84867600-84898920:-	-0.28	-4.04	6.33E-5	Schizophrenia	
STAD	cis	1	rs62096463	chr18:44628928	HDHD2	chr18:44633782-44676871:-	0.56	5.41	1.09E-7	Sitting height ratio	
STAD	cis	1	rs62096464	chr18:44629207	HDHD2	chr18:44633782-44676871:-	0.56	5.41	1.09E-7	Sitting height ratio	
STAD	cis	1	rs62096466	chr18:44636171	HDHD2	chr18:44633782-44676871:-	0.56	5.41	1.09E-7	Sitting height ratio	
STAD	cis	1	rs62096468	chr18:44637566	HDHD2	chr18:44633782-44676871:-	0.56	5.38	1.28E-7	Sitting height ratio	
STAD	cis	1	rs62096469	chr18:44638298	HDHD2	chr18:44633782-44676871:-	0.56	5.41	1.09E-7	Sitting height ratio	
STAD	cis	1	rs62096470	chr18:44641466	HDHD2	chr18:44633782-44676871:-	0.56	5.41	1.09E-7	Sitting height ratio	
STAD	cis	1	rs62096471	chr18:44643814	HDHD2	chr18:44633782-44676871:-	0.53	5.2	3.2E-7	Sitting height ratio	
STAD	cis	1	rs62096474	chr18:44647504	HDHD2	chr18:44633782-44676871:-	0.51	4.94	1.15E-6	Sitting height ratio	
STAD	cis	1	rs62096476	chr18:44658621	HDHD2	chr18:44633782-44676871:-	0.5	4.93	1.19E-6	Sitting height ratio	
STAD	cis	1	rs62096478	chr18:44662409	HDHD2	chr18:44633782-44676871:-	0.5	4.93	1.19E-6	Sitting height ratio	
STAD	cis	1	rs62103177	chr18:77624479	HSBP1L1	chr18:77724582-77730820:+	0.39	4.49	9.59E-6	Opioid sensitivity	
STAD	cis	1	rs62114497	chr2:214837	SH3YL1	chr2:218138-264810:-	-0.58	-12.07	9.93E-29	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs62114501	chr2:231741	SH3YL1	chr2:218138-264810:-	-0.6	-12.7	3.72E-31	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs62114505	chr2:242426	SH3YL1	chr2:218138-264810:-	-0.6	-12.77	1.87E-31	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs62114544	chr2:269679	SH3YL1	chr2:218138-264810:-	-0.6	-12.85	9.34E-32	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs62114548	chr2:274672	SH3YL1	chr2:218138-264810:-	-0.6	-12.65	5.73E-31	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs62151652	chr2:73700131	ALMS1P	chr2:73872046-73912692:+	0.49	7.85	4.04E-14	Metabolite levels	
STAD	cis	1	rs62151652	chr2:73700131	TPRKB	chr2:73956957-73964517:-	-0.23	-4.76	2.68E-6	Metabolite levels	
STAD	cis	1	rs62152793	chr2:97484948	CNNM3	chr2:97481991-97501120:+	-0.34	-4.19	3.51E-5	Erectile dysfunction and prostate cancer treatment	
STAD	cis	1	rs62152794	chr2:97485110	CNNM3	chr2:97481991-97501120:+	-0.33	-4.25	2.73E-5	Erectile dysfunction and prostate cancer treatment	
STAD	cis	1	rs62152834	chr2:97504863	CNNM3	chr2:97481991-97501120:+	-0.35	-4.21	3.17E-5	Erectile dysfunction and prostate cancer treatment	
STAD	cis	1	rs62211529	chr20:33959315	GDF5	chr20:33897002-34042568:-	-0.18	-3.99	7.76E-5	Height	
STAD	cis	1	rs62211529	chr20:33959315	UQCC	chr20:33890383-33999833:-	0.24	4.36	1.7E-5	Height	
STAD	cis	1	rs62268732	chr3:121370455	IQCB1	chr3:121488610-121553926:-	0.3	5.03	7.49E-7	Cognitive performance	
STAD	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.38	7.02	9.99E-12	Height	
STAD	cis	1	rs62271513	chr3:134298412	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.89	2.2E-11	Height	
STAD	cis	1	rs62271514	chr3:134298554	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.89	2.2E-11	Height	
STAD	cis	1	rs62271515	chr3:134300507	ANAPC13	chr3:134196547-134204865:-	0.38	6.73	6.07E-11	Height	
STAD	cis	1	rs62295634	chr4:17685346	LAP3	chr4:17578927-17609590:+	-0.18	-3.91	0.000107	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs62321365	chr4:107013723	TBCK	chr4:106967233-107237861:-	0.26	3.91	0.000108	Airflow obstruction	
STAD	cis	1	rs62402013	chr6:26915000	LOC100270746	chr6:26987146-26988085:-	-0.37	-6.65	1.02E-10	Schizophrenia	
STAD	cis	1	rs625658	chr1:155891045	RAB25	chr1:156030966-156040293:+	-0.18	-4.1	5.04E-5	Crohn's disease;Inflammatory bowel disease	
STAD	cis	1	rs629301	chr1:109818306	PSRC1	chr1:109822179-109825808:-	-0.25	-4.73	3.21E-6	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
STAD	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.64	-16.46	1.35E-46	Crohn's disease	
STAD	cis	1	rs641018	chr11:65655393	SNX32	chr11:65601410-65621170:+	0.36	5.86	9.94E-9	Crohn's disease	
STAD	cis	1	rs6427553	chr1:160855813	ITLN1	chr1:160846332-160854960:-	-0.23	-4.1	4.99E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
STAD	cis	1	rs6428476	chr1:89126005	CCBL2	chr1:89401456-89458643:-	0.3	6.7	7.46E-11	Height	
STAD	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.51	-8.32	1.49E-15	Homocysteine levels	
STAD	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.45	-7.21	2.98E-12	Homocysteine levels	
STAD	cis	1	rs6429582	chr1:46321843	IPP	chr1:46160000-46216485:-	-0.19	-3.95	9.31E-5	Body mass index	
STAD	cis	1	rs6429582	chr1:46321843	TMEM69	chr1:46153847-46160108:+	-0.17	-3.96	8.85E-5	Body mass index	
STAD	cis	1	rs6436106	chr2:219926913	SLC23A3	chr2:220026183-220034817:-	0.39	4.62	5.33E-6	Height	
STAD	cis	1	rs6439484	chr3:134249899	ANAPC13	chr3:134196547-134204865:-	0.38	6.88	2.38E-11	Height	
STAD	cis	1	rs6439487	chr3:134260860	ANAPC13	chr3:134196547-134204865:-	0.38	6.88	2.38E-11	Height	
STAD	cis	1	rs6439649	chr3:136371691	PCCB	chr3:135969167-136056737:+	-0.27	-4.43	1.25E-5	Schizophrenia	
STAD	cis	1	rs6441104	chr3:156681441	LEKR1	chr3:156544076-156763918:+	-0.35	-3.94	9.84E-5	Bone mineral density	
STAD	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.26	5.88	9.03E-9	Longevity	
STAD	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.27	-6.19	1.53E-9	Longevity	
STAD	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.28	-6.48	2.81E-10	Longevity	
STAD	cis	1	rs6442120	chr3:48464503	TREX1	chr3:48501186-48509043:+	-0.25	-5.74	1.9E-8	Longevity	
STAD	cis	1	rs6442123	chr3:48500286	TREX1	chr3:48501186-48509043:+	-0.26	-5.77	1.61E-8	Longevity	
STAD	cis	1	rs6444249	chr3:187425870	SST	chr3:187386696-187388201:-	-0.55	-4.4	1.37E-5	Response to citalopram treatment	
STAD	cis	1	rs6449319	chr4:17640283	LAP3	chr4:17578927-17609590:+	-0.18	-3.8	0.000165	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs6449323	chr4:17683916	LAP3	chr4:17578927-17609590:+	-0.19	-3.86	0.000131	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.87	17	6.55E-49	Type 2 diabetes	
STAD	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.84	16.33	4.77E-46	Type 2 diabetes	
STAD	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.7	14.76	1.68E-39	Response to antipsychotic treatment	
STAD	cis	1	rs6458685	chr6:49379536	CENPQ	chr6:49431096-49460820:+	-0.25	-5.31	1.89E-7	Homocysteine levels	
STAD	cis	1	rs6458685	chr6:49379536	MUT	chr6:49398994-49431031:-	0.23	4.22	2.99E-5	Homocysteine levels	
STAD	cis	1	rs6458688	chr6:49406056	CENPQ	chr6:49431096-49460820:+	-0.26	-5.41	1.08E-7	Homocysteine levels	
STAD	cis	1	rs6458688	chr6:49406056	MUT	chr6:49398994-49431031:-	0.23	4.12	4.69E-5	Homocysteine levels	
STAD	cis	1	rs6458690	chr6:49411619	MUT	chr6:49398994-49431031:-	0.38	7.06	7.51E-12	Folate pathway vitamin levels	
STAD	cis	1	rs6458694	chr6:49445306	MUT	chr6:49398994-49431031:-	0.38	7.06	7.78E-12	Folate pathway vitamin levels	
STAD	cis	1	rs6460260	chr7:65215455	CCT6P1	chr7:65216092-65228661:+	-0.28	-4.17	3.77E-5	Diabetic kidney disease	
STAD	cis	1	rs6460261	chr7:65215580	CCT6P1	chr7:65216092-65228661:+	-0.28	-4.17	3.77E-5	Diabetic kidney disease	
STAD	cis	1	rs6464573	chr7:143748098	ARHGEF35	chr7:143883677-143892736:-	0.32	5.04	7.02E-7	Obesity-related traits	
STAD	cis	1	rs6464574	chr7:143748257	ARHGEF35	chr7:143883677-143892736:-	-0.39	-5.93	6.59E-9	Obesity-related traits	
STAD	cis	1	rs646776	chr1:109818530	PSRC1	chr1:109822179-109825808:-	-0.25	-4.73	3.14E-6	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
STAD	cis	1	rs646867	chr1:25709258	RHCE	chr1:25688741-25756683:-	0.34	5.2	3.23E-7	Erythrocyte sedimentation rate	
STAD	cis	1	rs646867	chr1:25709258	RHD	chr1:25598981-25656935:+	-0.44	-9.05	7.03E-18	Erythrocyte sedimentation rate	
STAD	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.36	-6.27	9.86E-10	Rheumatoid arthritis	
STAD	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.37	-6.48	2.77E-10	Rheumatoid arthritis	
STAD	cis	1	rs6478867	chr9:131903923	CRAT	chr9:131857075-131873070:-	-0.23	-4.18	3.56E-5	Blood metabolite ratios	
STAD	cis	1	rs6480314	chr10:69967447	ATOH7	chr10:69990386-69991855:-	0.33	3.94	9.5E-5	Optic nerve measurement (disc area)	
STAD	cis	1	rs6483501	chr11:96108061	CCDC82	chr11:96085930-96123083:-	-0.38	-4.25	2.69E-5	Parkinson's disease	
STAD	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.37	-6.62	1.16E-10	Forced vital capacity	
STAD	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.42	7.68	1.32E-13	Forced vital capacity	
STAD	cis	1	rs6485872	chr11:48579710	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.89	0.000116	HDL cholesterol	
STAD	cis	1	rs6485888	chr11:48605339	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.86	0.000131	HDL cholesterol	
STAD	cis	1	rs6495206	chr15:76870963	SCAPER	chr15:76640529-77197744:-	-0.23	-4.75	2.8E-6	Blood metabolite levels	
STAD	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.62	-9.17	2.76E-18	Type 2 diabetes	
STAD	cis	1	rs6496932	chr15:85825567	ZNF592	chr15:85291818-85349661:+	0.21	3.92	0.000105	Corneal structure;Central corneal thickness	
STAD	cis	1	rs6503530	chr17:38161823	GSDMA	chr17:38119226-38134019:+	-0.32	-5.79	1.43E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs6503877	chr17:56841948	RAD51C	chr17:56769963-56811690:+	0.22	4.01	7.41E-5	Cognitive test performance	
STAD	cis	1	rs6503882	chr17:56915761	RAD51C	chr17:56769963-56811690:+	0.22	4.04	6.53E-5	Cognitive test performance	
STAD	cis	1	rs6518986	chr22:22185347	THAP7	chr22:21354061-21356404:-	0.18	4.28	2.4E-5	Multiple sclerosis	
STAD	cis	1	rs6519119	chr22:38989007	LOC646851	chr22:38974125-39052634:-	0.24	5.14	4.41E-7	Resting heart rate	
STAD	cis	1	rs6519120	chr22:38991393	CBY1	chr22:39052658-39069853:+	-0.22	-4.2	3.35E-5	Resting heart rate	
STAD	cis	1	rs6519120	chr22:38991393	LOC646851	chr22:38974125-39052634:-	-0.25	-5.44	9.46E-8	Resting heart rate	
STAD	cis	1	rs6519124	chr22:39045099	LOC646851	chr22:38974125-39052634:-	0.23	4.89	1.49E-6	Resting heart rate	
STAD	cis	1	rs6532078	chr4:76920809	NAAA	chr4:76831809-76862166:-	-0.37	-5.23	2.73E-7	Longevity	
STAD	cis	1	rs6533014	chr4:103349740	CISD2	chr4:103790135-103809913:+	0.19	4.48	9.95E-6	Homeostasis model assessment of beta-cell function (interaction)	
STAD	cis	1	rs6536882	chr4:165900680	C4orf39	chr4:165878100-165880273:+	0.2	4.5	8.8E-6	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs6536883	chr4:165900704	C4orf39	chr4:165878100-165880273:+	0.2	4.5	8.8E-6	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs6547872	chr2:28978074	TRMT61B	chr2:29072690-29093175:-	-0.33	-5.56	5.13E-8	Body mass index	
STAD	cis	1	rs6554100	chr4:54240108	SCFD2	chr4:53739152-54232242:-	0.29	4.4	1.39E-5	DNA methylation (variation)	
STAD	cis	1	rs6554106	chr4:54292791	SCFD2	chr4:53739152-54232242:-	0.28	4.19	3.52E-5	DNA methylation (variation)	
STAD	cis	1	rs6558296	chr8:145143802	KIAA1875	chr8:145162629-145173218:+	-0.52	-4.21	3.2E-5	Blood metabolite levels	
STAD	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.64	-16.46	1.35E-46	Crohn's disease	
STAD	cis	1	rs656980	chr11:65656282	SNX32	chr11:65601410-65621170:+	0.36	5.86	9.94E-9	Crohn's disease	
STAD	cis	1	rs6576943	chr1:84247430	TTLL7	chr1:84335059-84464833:-	0.17	4.18	3.54E-5	Select biomarker traits	
STAD	cis	1	rs6576986	chr2:97508320	CNNM3	chr2:97481991-97501120:+	-0.35	-4.11	4.75E-5	Erectile dysfunction and prostate cancer treatment	
STAD	cis	1	rs6578999	chr11:2231774	CD81	chr11:2398547-2418649:+	-0.3	-4.96	1.04E-6	Prostate cancer (early onset);Prostate cancer (gene x gene interaction);Prostate cancer	
STAD	cis	1	rs6579000	chr11:2232042	CD81	chr11:2398547-2418649:+	-0.28	-4.66	4.28E-6	Prostate cancer (early onset);Prostate cancer (gene x gene interaction);Prostate cancer	
STAD	cis	1	rs6579001	chr11:2232056	CD81	chr11:2398547-2418649:+	-0.28	-4.66	4.28E-6	Prostate cancer (early onset);Prostate cancer (gene x gene interaction);Prostate cancer	
STAD	cis	1	rs6579208	chr20:33598612	PROCR	chr20:33758727-33765164:+	-0.46	-4.98	9.52E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs6579210	chr20:33605802	PROCR	chr20:33758727-33765164:+	-0.48	-5.24	2.66E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs6579211	chr20:33605857	PROCR	chr20:33758727-33765164:+	-0.48	-5.19	3.46E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs6579234	chr20:33983485	GDF5	chr20:33897002-34042568:-	-0.19	-4.18	3.6E-5	Height	
STAD	cis	1	rs6579234	chr20:33983485	UQCC	chr20:33890383-33999833:-	0.23	4.13	4.42E-5	Height	
STAD	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.44	-6.03	3.78E-9	Cholesterol, total	
STAD	cis	1	rs6579245	chr20:34125271	ERGIC3	chr20:34129778-34145404:+	-0.29	-4.52	8.15E-6	Cholesterol, total	
STAD	cis	1	rs6579803	chr5:150255559	LOC134466	chr5:150310000-150326146:-	0.32	5.05	6.68E-7	Crohn's disease	
STAD	cis	1	rs6579804	chr5:150255931	LOC134466	chr5:150310000-150326146:-	0.32	5.05	6.68E-7	Crohn's disease	
STAD	cis	1	rs6579806	chr5:150271084	LOC134466	chr5:150310000-150326146:-	0.29	4.63	5.02E-6	Crohn's disease	
STAD	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.41	7.21	3.02E-12	Multiple sclerosis	
STAD	cis	1	rs6581155	chr12:58178162	TSFM	chr12:58176536-58191367:+	-0.31	-6.75	5.5E-11	Multiple sclerosis	
STAD	cis	1	rs6584379	chr10:102224490	SEC31B	chr10:102246403-102289636:-	-0.26	-6.36	5.79E-10	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs6584383	chr10:102303065	SEC31B	chr10:102246403-102289636:-	-0.23	-5.31	1.86E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs6588467	chr1:53630304	C1orf123	chr1:53679774-53686289:-	-0.19	-4.79	2.33E-6	Systemic lupus erythematosus	
STAD	cis	1	rs6599175	chr3:41786009	ULK4	chr3:41288091-42003660:-	-0.8	-12.53	1.66E-30	Diastolic blood pressure	
STAD	cis	1	rs6599176	chr3:41788492	ULK4	chr3:41288091-42003660:-	-0.72	-11.43	2.69E-26	Diastolic blood pressure	
STAD	cis	1	rs6599178	chr3:41842129	ULK4	chr3:41288091-42003660:-	0.78	12.23	2.43E-29	Diastolic blood pressure	
STAD	cis	1	rs6599179	chr3:41855284	ULK4	chr3:41288091-42003660:-	0.78	12.47	2.92E-30	Diastolic blood pressure	
STAD	cis	1	rs661422	chr3:39561389	ENTPD3	chr3:40428673-40470109:+	-0.38	-4.12	4.64E-5	Alzheimer's disease (cognitive decline)	
STAD	cis	1	rs6651271	chr8:96047621	C8orf38	chr8:95908040-96088396:+	-0.34	-4	7.69E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs6651272	chr8:96047933	C8orf38	chr8:95908040-96088396:+	0.34	4	7.56E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs6656992	chr1:46333068	IPP	chr1:46160000-46216485:-	0.2	3.84	0.000146	Body mass index	
STAD	cis	1	rs6659874	chr1:171654180	VAMP4	chr1:171669298-171711214:-	0.34	6.17	1.7E-9	Hippocampal atrophy	
STAD	cis	1	rs6662641	chr1:46571509	CCDC163P	chr1:45960581-45965646:-	-0.22	-3.84	0.000146	Body mass index	
STAD	cis	1	rs6662720	chr1:171654616	VAMP4	chr1:171669298-171711214:-	0.34	6.17	1.7E-9	Hippocampal atrophy	
STAD	cis	1	rs6662833	chr1:171654720	VAMP4	chr1:171669298-171711214:-	0.34	6.17	1.7E-9	Hippocampal atrophy	
STAD	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.52	-8.54	3.06E-16	Homocysteine levels	
STAD	cis	1	rs6667559	chr1:171653957	VAMP4	chr1:171669298-171711214:-	0.35	6.32	7.0E-10	Hippocampal atrophy	
STAD	cis	1	rs6669236	chr1:227813909	SNAP47	chr1:227916240-227968932:+	-0.23	-3.86	0.00013	Height	
STAD	cis	1	rs6669263	chr1:171692311	VAMP4	chr1:171669298-171711214:-	0.34	6.26	1.04E-9	Hippocampal atrophy	
STAD	cis	1	rs6669371	chr1:11882142	CLCN6	chr1:11866207-11907674:+	0.26	3.85	0.000137	QRS complex (12-leadsum)	
STAD	cis	1	rs6670427	chr1:171654522	VAMP4	chr1:171669298-171711214:-	0.34	6.15	1.89E-9	Hippocampal atrophy	
STAD	cis	1	rs6672178	chr1:53629849	C1orf123	chr1:53679774-53686289:-	-0.19	-4.83	2.01E-6	Systemic lupus erythematosus	
STAD	cis	1	rs6672276	chr1:53629901	C1orf123	chr1:53679774-53686289:-	-0.19	-4.83	2.01E-6	Systemic lupus erythematosus	
STAD	cis	1	rs6672898	chr1:46290588	IPP	chr1:46160000-46216485:-	0.2	3.84	0.000146	Body mass index	
STAD	cis	1	rs66753001	chr19:17394839	OCEL1	chr19:17337055-17340027:+	0.32	4.36	1.7E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
STAD	cis	1	rs66754062	chr20:23839051	CST2	chr20:23804404-23807312:-	-0.25	-4.02	6.97E-5	Response to TNF antagonist treatment	
STAD	cis	1	rs6678890	chr1:171694566	VAMP4	chr1:171669298-171711214:-	0.33	6.16	1.83E-9	Hippocampal atrophy	
STAD	cis	1	rs6679354	chr1:171668002	VAMP4	chr1:171669298-171711214:-	0.33	6.14	1.99E-9	Hippocampal atrophy	
STAD	cis	1	rs6679	chr1:113243048	ST7L	chr1:113066142-113162405:-	0.39	7.05	8.26E-12	Diastolic blood pressure;Blood pressure	
STAD	cis	1	rs6680380	chr1:46300189	IPP	chr1:46160000-46216485:-	0.2	3.84	0.000146	Body mass index	
STAD	cis	1	rs66824050	chr8:21815425	NPM2	chr8:21881636-21894407:+	-0.23	-4	7.47E-5	Mean corpuscular volume	
STAD	cis	1	rs6695567	chr1:53629585	C1orf123	chr1:53679774-53686289:-	-0.19	-4.83	2.0E-6	Systemic lupus erythematosus	
STAD	cis	1	rs6696239	chr1:227750068	SNAP47	chr1:227916240-227968932:+	-0.23	-3.91	0.000108	Height	
STAD	cis	1	rs6698409	chr1:227768358	SNAP47	chr1:227916240-227968932:+	-0.23	-3.91	0.000107	Height	
STAD	cis	1	rs6699417	chr1:89123443	CCBL2	chr1:89401456-89458643:-	-0.28	-6.17	1.73E-9	Height	
STAD	cis	1	rs6700597	chr1:46284246	IPP	chr1:46160000-46216485:-	0.2	3.93	0.000101	Body mass index	
STAD	cis	1	rs6700866	chr1:10306038	PGD	chr1:10459085-10480200:+	0.22	3.82	0.000154	Hepatocellular carcinoma	
STAD	cis	1	rs6701553	chr1:171654456	VAMP4	chr1:171669298-171711214:-	0.34	6.17	1.7E-9	Hippocampal atrophy	
STAD	cis	1	rs6701614	chr1:46309420	IPP	chr1:46160000-46216485:-	0.2	3.84	0.000146	Body mass index	
STAD	cis	1	rs6704770	chr2:232109816	ARMC9	chr2:232063342-232238606:+	0.21	4.59	6.07E-6	Food antigen IgG levels	
STAD	cis	1	rs670523	chr1:155878732	RAB25	chr1:156030966-156040293:+	-0.18	-3.98	8.18E-5	Crohn's disease;Inflammatory bowel disease	
STAD	cis	1	rs6705489	chr2:73648811	ALMS1P	chr2:73872046-73912692:+	0.48	7.72	1.02E-13	Metabolite levels	
STAD	cis	1	rs6705489	chr2:73648811	TPRKB	chr2:73956957-73964517:-	-0.22	-4.75	2.93E-6	Metabolite levels	
STAD	cis	1	rs67059283	chr10:79683235	DLG5	chr10:79550551-79686348:-	0.28	4.85	1.81E-6	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs67059283	chr10:79683235	POLR3A	chr10:79735906-79789259:-	0.23	4.33	1.88E-5	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs6707848	chr2:28988083	TRMT61B	chr2:29072690-29093175:-	-0.33	-5.63	3.54E-8	Body mass index	
STAD	cis	1	rs6708328	chr2:24412413	C2orf84	chr2:24397531-24414566:+	0.37	5.93	6.77E-9	Venous thromboembolism (SNP x SNP interaction)	
STAD	cis	1	rs6709534	chr2:217334	SH3YL1	chr2:218138-264810:-	-0.58	-12.14	5.7E-29	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs6710438	chr2:73820108	ALMS1P	chr2:73872046-73912692:+	-0.47	-7.49	4.78E-13	Metabolite levels	
STAD	cis	1	rs6710438	chr2:73820108	TPRKB	chr2:73956957-73964517:-	0.23	4.88	1.57E-6	Metabolite levels	
STAD	cis	1	rs6710959	chr2:28958603	TRMT61B	chr2:29072690-29093175:-	-0.31	-5.28	2.12E-7	Body mass index	
STAD	cis	1	rs6711033	chr2:73746643	ALMS1P	chr2:73872046-73912692:+	0.46	7.57	2.78E-13	Metabolite levels	
STAD	cis	1	rs6711033	chr2:73746643	TPRKB	chr2:73956957-73964517:-	-0.19	-4.2	3.35E-5	Metabolite levels	
STAD	cis	1	rs6711127	chr2:202213515	PPIL3	chr2:201735680-201753999:-	-0.55	-5.75	1.83E-8	Rheumatoid arthritis	
STAD	cis	1	rs6711312	chr2:232122348	ARMC9	chr2:232063342-232238606:+	0.2	4.3	2.12E-5	Food antigen IgG levels	
STAD	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.6	-7.58	2.47E-13	Rheumatoid arthritis	
STAD	cis	1	rs67121560	chr20:23833294	CST2	chr20:23804404-23807312:-	-0.25	-4.05	6.2E-5	Response to TNF antagonist treatment	
STAD	cis	1	rs6715284	chr2:202154397	PPIL3	chr2:201735680-201753999:-	-0.51	-6.78	4.45E-11	Rheumatoid arthritis	
STAD	cis	1	rs6715380	chr2:202214505	PPIL3	chr2:201735680-201753999:-	-0.53	-5.63	3.52E-8	Rheumatoid arthritis	
STAD	cis	1	rs6717980	chr2:27452784	C2orf28	chr2:27434899-27440044:+	0.24	4.08	5.54E-5	Blood metabolite levels	
STAD	cis	1	rs6719931	chr2:219914939	SLC23A3	chr2:220026183-220034817:-	0.38	4.38	1.52E-5	Height	
STAD	cis	1	rs6720809	chr2:88528943	THNSL2	chr2:88469835-88486145:+	-0.63	-6.73	6.18E-11	Plasma clusterin levels	
STAD	cis	1	rs6722069	chr2:88533151	THNSL2	chr2:88469835-88486145:+	-0.63	-6.68	8.05E-11	Plasma clusterin levels	
STAD	cis	1	rs67239267	chr7:143745116	ARHGEF35	chr7:143883677-143892736:-	-0.39	-6.08	2.93E-9	Obesity-related traits	
STAD	cis	1	rs6724253	chr2:232121998	ARMC9	chr2:232063342-232238606:+	0.19	4.21	3.12E-5	Food antigen IgG levels	
STAD	cis	1	rs6724465	chr2:219943846	SLC23A3	chr2:220026183-220034817:-	0.38	4.45	1.13E-5	Height	
STAD	cis	1	rs6724662	chr2:241831560	C2orf54	chr2:241825466-241835573:-	0.26	3.9	0.000114	Urinary metabolites	
STAD	cis	1	rs6731095	chr2:192589442	STAT4	chr2:191894306-192038902:-	-0.2	-3.83	0.000149	Colorectal cancer	
STAD	cis	1	rs6736866	chr2:73661986	ALMS1P	chr2:73872046-73912692:+	0.5	7.84	4.38E-14	Metabolite levels	
STAD	cis	1	rs6736866	chr2:73661986	TPRKB	chr2:73956957-73964517:-	-0.23	-4.71	3.51E-6	Metabolite levels	
STAD	cis	1	rs67412075	chr19:17385502	OCEL1	chr19:17337055-17340027:+	0.34	4.82	2.06E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
STAD	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.31	5.77	1.62E-8	Tuberculosis	
STAD	cis	1	rs6745368	chr2:73809974	ALMS1P	chr2:73872046-73912692:+	0.5	7.87	3.54E-14	Metabolite levels	
STAD	cis	1	rs6745368	chr2:73809974	TPRKB	chr2:73956957-73964517:-	-0.2	-4.16	3.96E-5	Metabolite levels	
STAD	cis	1	rs6748734	chr2:241837452	C2orf54	chr2:241825466-241835573:-	0.26	4.01	7.39E-5	Urinary metabolites	
STAD	cis	1	rs6751693	chr2:241837332	C2orf54	chr2:241825466-241835573:-	0.25	3.84	0.000142	Urinary metabolites	
STAD	cis	1	rs6752757	chr2:219943801	SLC23A3	chr2:220026183-220034817:-	0.38	4.49	9.47E-6	Height	
STAD	cis	1	rs6753344	chr2:73653138	ALMS1P	chr2:73872046-73912692:+	-0.49	-7.67	1.42E-13	Metabolite levels	
STAD	cis	1	rs6753344	chr2:73653138	TPRKB	chr2:73956957-73964517:-	0.21	4.38	1.54E-5	Metabolite levels	
STAD	cis	1	rs6755217	chr2:73641285	ALMS1P	chr2:73872046-73912692:+	0.48	7.62	1.96E-13	Metabolite levels	
STAD	cis	1	rs6755217	chr2:73641285	TPRKB	chr2:73956957-73964517:-	-0.24	-5.1	5.23E-7	Metabolite levels	
STAD	cis	1	rs6755241	chr2:73641364	ALMS1P	chr2:73872046-73912692:+	0.49	7.8	5.67E-14	Metabolite levels	
STAD	cis	1	rs6755241	chr2:73641364	TPRKB	chr2:73956957-73964517:-	-0.22	-4.74	3.06E-6	Metabolite levels	
STAD	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.66	-9.2	2.25E-18	Triptolide cytotoxicity	
STAD	cis	1	rs6763088	chr3:134254989	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.75	5.47E-11	Height	
STAD	cis	1	rs6763093	chr3:134254995	ANAPC13	chr3:134196547-134204865:-	-0.37	-6.66	9.53E-11	Height	
STAD	cis	1	rs6763829	chr3:41897046	ULK4	chr3:41288091-42003660:-	0.78	12.43	4.11E-30	Diastolic blood pressure	
STAD	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.38	6.79	4.2E-11	Height	
STAD	cis	1	rs6766510	chr3:12551807	TSEN2	chr3:12525931-12581122:+	0.44	4.6	5.81E-6	Prostate cancer (gene x gene interaction)	
STAD	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.39	7.19	3.31E-12	Height	
STAD	cis	1	rs6766897	chr3:134191303	ANAPC13	chr3:134196547-134204865:-	0.35	6.35	5.94E-10	Height	
STAD	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	0.76	12.23	2.49E-29	Diastolic blood pressure	
STAD	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	0.76	12.18	3.89E-29	Diastolic blood pressure	
STAD	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	0.75	12.02	1.51E-28	Diastolic blood pressure	
STAD	cis	1	rs6769885	chr3:134286913	ANAPC13	chr3:134196547-134204865:-	0.39	6.79	4.25E-11	Height	
STAD	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.26	-6.06	3.28E-9	Longevity	
STAD	cis	1	rs6772046	chr3:38479660	XYLB	chr3:38388251-38456467:+	0.21	4.16	3.95E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs67728539	chr7:65378124	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.37	6.72	6.29E-11	Height	
STAD	cis	1	rs6776700	chr3:48496758	TREX1	chr3:48501186-48509043:+	-0.26	-5.81	1.29E-8	Longevity	
STAD	cis	1	rs677977	chr1:147083744	ACP6	chr1:147119168-147142634:-	-0.31	-4.47	1.03E-5	Schizophrenia (negative symptoms)	
STAD	cis	1	rs6782563	chr3:134295959	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.88	2.41E-11	Height	
STAD	cis	1	rs6783001	chr3:41862232	ULK4	chr3:41288091-42003660:-	0.78	12.46	3.08E-30	Diastolic blood pressure	
STAD	cis	1	rs678347	chr8:102463602	SNX31	chr8:101585114-101661893:-	0.23	3.93	9.93E-5	Rheumatoid arthritis	
STAD	cis	1	rs6784322	chr3:48422235	TREX1	chr3:48501186-48509043:+	-0.24	-5.49	7.3E-8	Longevity	
STAD	cis	1	rs6785027	chr3:134211649	ANAPC13	chr3:134196547-134204865:-	-0.4	-7.38	9.47E-13	Height	
STAD	cis	1	rs6787371	chr3:134254991	ANAPC13	chr3:134196547-134204865:-	0.38	6.83	3.17E-11	Height	
STAD	cis	1	rs6787952	chr3:156609375	LEKR1	chr3:156544076-156763918:+	-0.4	-4.59	5.97E-6	Bone mineral density	
STAD	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	0.76	11.32	7.07E-26	Diastolic blood pressure	
STAD	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.37	6.69	7.72E-11	Height	
STAD	cis	1	rs6790732	chr3:41864872	ULK4	chr3:41288091-42003660:-	0.8	12.72	3.02E-31	Diastolic blood pressure	
STAD	cis	1	rs67912009	chr11:495057	RNH1	chr11:494512-507273:-	-0.42	-5.61	3.82E-8	Body mass index	
STAD	cis	1	rs6791806	chr3:41889995	ULK4	chr3:41288091-42003660:-	0.78	12.43	4.11E-30	Diastolic blood pressure	
STAD	cis	1	rs6793487	chr3:134299426	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.85	2.93E-11	Height	
STAD	cis	1	rs6794875	chr3:48455626	TREX1	chr3:48501186-48509043:+	-0.26	-6.02	4.0E-9	Longevity	
STAD	cis	1	rs6796210	chr3:41851718	ULK4	chr3:41288091-42003660:-	0.79	12.46	3.22E-30	Diastolic blood pressure	
STAD	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.27	-6.19	1.57E-9	Longevity	
STAD	cis	1	rs6797165	chr3:41887777	ULK4	chr3:41288091-42003660:-	0.78	12.38	6.16E-30	Diastolic blood pressure	
STAD	cis	1	rs6800862	chr3:134228628	ANAPC13	chr3:134196547-134204865:-	0.4	7.39	9.19E-13	Height	
STAD	cis	1	rs6801596	chr3:134252114	ANAPC13	chr3:134196547-134204865:-	0.39	6.93	1.77E-11	Height	
STAD	cis	1	rs6802340	chr3:41894034	ULK4	chr3:41288091-42003660:-	0.78	12.43	4.11E-30	Diastolic blood pressure	
STAD	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.38	7.02	9.99E-12	Height	
STAD	cis	1	rs6803560	chr3:41824480	ULK4	chr3:41288091-42003660:-	0.78	12.22	2.68E-29	Diastolic blood pressure	
STAD	cis	1	rs6803652	chr3:41824556	ULK4	chr3:41288091-42003660:-	0.78	12.22	2.68E-29	Diastolic blood pressure	
STAD	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.4	7.39	8.98E-13	Height	
STAD	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.27	-6.11	2.46E-9	Longevity	
STAD	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	0.76	12.18	3.89E-29	Diastolic blood pressure	
STAD	cis	1	rs6806417	chr3:134211446	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.96	1.4E-11	Height	
STAD	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.26	-6.06	3.28E-9	Longevity	
STAD	cis	1	rs68141011	chr6:28217797	ZNF323	chr6:28292517-28324048:-	0.29	3.9	0.000115	Depression	
STAD	cis	1	rs68141011	chr6:28217797	ZSCAN23	chr6:28393287-28411279:-	0.24	3.85	0.000135	Depression	
STAD	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.66	-13.14	6.87E-33	Response to antipsychotic treatment	
STAD	cis	1	rs68189316	chr7:65409169	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs6821283	chr4:165901645	C4orf39	chr4:165878100-165880273:+	0.2	4.43	1.24E-5	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs6827269	chr4:54320617	SCFD2	chr4:53739152-54232242:-	0.29	4.23	2.97E-5	DNA methylation (variation)	
STAD	cis	1	rs6827617	chr4:76916146	NAAA	chr4:76831809-76862166:-	-0.36	-5.14	4.3E-7	Longevity	
STAD	cis	1	rs6832503	chr4:48028442	CNGA1	chr4:47937996-48018610:-	-0.23	-4.52	8.07E-6	Renal underexcretion gout;Gout	
STAD	cis	1	rs6834934	chr4:54242085	SCFD2	chr4:53739152-54232242:-	0.29	4.4	1.41E-5	DNA methylation (variation)	
STAD	cis	1	rs6846238	chr4:17629939	LAP3	chr4:17578927-17609590:+	-0.19	-3.94	9.48E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs6846579	chr4:107011756	TBCK	chr4:106967233-107237861:-	0.26	3.92	0.000105	Airflow obstruction	
STAD	cis	1	rs6848360	chr4:17634442	LAP3	chr4:17578927-17609590:+	-0.18	-3.8	0.000165	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs6855591	chr4:165906723	C4orf39	chr4:165878100-165880273:+	0.2	4.46	1.07E-5	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs6857024	chr4:54242283	SCFD2	chr4:53739152-54232242:-	0.29	4.39	1.44E-5	DNA methylation (variation)	
STAD	cis	1	rs6862814	chr5:150245259	LOC134466	chr5:150310000-150326146:-	0.32	5.05	6.68E-7	Crohn's disease	
STAD	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.63	15.87	4.05E-44	Crohn's disease	
STAD	cis	1	rs687672	chr11:65649984	SNX32	chr11:65601410-65621170:+	-0.37	-5.98	5.08E-9	Crohn's disease	
STAD	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.87	16.87	2.34E-48	Type 2 diabetes	
STAD	cis	1	rs6901250	chr6:117114025	FAM162B	chr6:117073360-117086886:-	-0.22	-4.38	1.51E-5	C-reactive protein levels	
STAD	cis	1	rs6901575	chr6:28250984	ZSCAN23	chr6:28393287-28411279:-	0.25	4.09	5.24E-5	Depression	
STAD	cis	1	rs6902429	chr6:49393500	CENPQ	chr6:49431096-49460820:+	-0.25	-5.31	1.89E-7	Homocysteine levels	
STAD	cis	1	rs6902429	chr6:49393500	MUT	chr6:49398994-49431031:-	0.23	4.22	2.99E-5	Homocysteine levels	
STAD	cis	1	rs6905391	chr6:28262686	ZNF323	chr6:28292517-28324048:-	0.33	4.57	6.41E-6	Depression	
STAD	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.72	-15.31	9.16E-42	Response to antipsychotic treatment	
STAD	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.26	-5.38	1.31E-7	Homocysteine levels	
STAD	cis	1	rs6915187	chr6:49423547	MUT	chr6:49398994-49431031:-	0.23	4.05	6.06E-5	Homocysteine levels	
STAD	cis	1	rs6916888	chr6:49383804	CENPQ	chr6:49431096-49460820:+	-0.25	-5.31	1.89E-7	Homocysteine levels	
STAD	cis	1	rs6916888	chr6:49383804	MUT	chr6:49398994-49431031:-	0.23	4.22	2.99E-5	Homocysteine levels	
STAD	cis	1	rs6917758	chr6:90681466	LYRM2	chr6:90277863-90348474:-	0.26	3.84	0.000142	Obesity-related traits	
STAD	cis	1	rs6918347	chr6:49406348	CENPQ	chr6:49431096-49460820:+	-0.25	-5.35	1.5E-7	Homocysteine levels	
STAD	cis	1	rs6918347	chr6:49406348	MUT	chr6:49398994-49431031:-	0.23	4.11	4.74E-5	Homocysteine levels	
STAD	cis	1	rs6919346	chr6:160960359	MAP3K4	chr6:161412822-161538416:+	0.33	4.1	5.03E-5	Lp (a) levels	
STAD	cis	1	rs6923124	chr6:49419864	MUT	chr6:49398994-49431031:-	0.4	7.55	3.1E-13	Folate pathway vitamin levels	
STAD	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.7	14.98	2.25E-40	Response to antipsychotic treatment	
STAD	cis	1	rs6924002	chr6:117114223	FAM162B	chr6:117073360-117086886:-	0.22	4.45	1.11E-5	C-reactive protein levels	
STAD	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.58	-8.49	4.39E-16	Diabetic kidney disease	
STAD	cis	1	rs6932590	chr6:27248931	LOC100270746	chr6:26987146-26988085:-	0.33	4.94	1.15E-6	Schizophrenia	
STAD	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.66	-13.01	2.23E-32	Response to antipsychotic treatment	
STAD	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.64	-16.51	8.52E-47	Crohn's disease	
STAD	cis	1	rs693824	chr11:65654783	SNX32	chr11:65601410-65621170:+	0.36	5.8	1.41E-8	Crohn's disease	
STAD	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.66	-13.06	1.43E-32	Response to antipsychotic treatment	
STAD	cis	1	rs6949812	chr7:65387101	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.64	-16.52	7.16E-47	Crohn's disease	
STAD	cis	1	rs694994	chr11:65653309	SNX32	chr11:65601410-65621170:+	0.36	5.73	1.97E-8	Crohn's disease	
STAD	cis	1	rs6959670	chr7:110909169	IMMP2L	chr7:110303110-111202538:-	0.24	3.96	9.01E-5	Schizophrenia	
STAD	cis	1	rs6970243	chr7:65388490	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs6985880	chr8:96027599	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs6989862	chr8:96027568	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs7002940	chr8:96027392	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	0.58	11.55	9.7E-27	Bone mineral density	
STAD	cis	1	rs7008542	chr8:96027863	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs7014578	chr8:92077568	LRRC69	chr8:92114847-92231464:+	-0.25	-4.48	9.74E-6	Migraine - clinic-based	
STAD	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	0.58	11.41	3.33E-26	Bone mineral density	
STAD	cis	1	rs7020708	chr9:131885131	CRAT	chr9:131857075-131873070:-	0.25	4.6	5.62E-6	Blood metabolite ratios	
STAD	cis	1	rs7020708	chr9:131885131	PPP2R4	chr9:131873244-131911223:+	0.22	4.49	9.53E-6	Blood metabolite ratios	
STAD	cis	1	rs7021449	chr9:131899312	CRAT	chr9:131857075-131873070:-	0.28	5.01	8.2E-7	Blood metabolite ratios	
STAD	cis	1	rs7021449	chr9:131899312	PPP2R4	chr9:131873244-131911223:+	0.23	4.72	3.24E-6	Blood metabolite ratios	
STAD	cis	1	rs7022397	chr9:116007677	CDC26	chr9:116029290-116037869:-	-0.35	-6.33	6.58E-10	Hematology traits	
STAD	cis	1	rs7023900	chr9:131891152	CRAT	chr9:131857075-131873070:-	0.27	4.8	2.26E-6	Blood metabolite ratios	
STAD	cis	1	rs7023900	chr9:131891152	PPP2R4	chr9:131873244-131911223:+	0.22	4.5	8.99E-6	Blood metabolite ratios	
STAD	cis	1	rs7029536	chr9:130110411	SLC2A8	chr9:130159465-130170161:+	-0.28	-4.73	3.21E-6	Metabolite levels (HVA)	
STAD	cis	1	rs7036114	chr9:131893406	CRAT	chr9:131857075-131873070:-	0.27	4.8	2.26E-6	Blood metabolite ratios	
STAD	cis	1	rs7036114	chr9:131893406	PPP2R4	chr9:131873244-131911223:+	0.22	4.5	8.99E-6	Blood metabolite ratios	
STAD	cis	1	rs7036236	chr9:131899299	CRAT	chr9:131857075-131873070:-	0.26	4.79	2.33E-6	Blood metabolite ratios	
STAD	cis	1	rs7036236	chr9:131899299	PPP2R4	chr9:131873244-131911223:+	0.22	4.55	7.12E-6	Blood metabolite ratios	
STAD	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.37	-6.49	2.55E-10	Rheumatoid arthritis	
STAD	cis	1	rs7037163	chr9:131894340	CRAT	chr9:131857075-131873070:-	0.28	4.8	2.22E-6	Blood metabolite ratios	
STAD	cis	1	rs7037163	chr9:131894340	PPP2R4	chr9:131873244-131911223:+	0.21	4.22	3.02E-5	Blood metabolite ratios	
STAD	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.41	-7.05	8.37E-12	Multiple sclerosis	
STAD	cis	1	rs703842	chr12:58162739	TSFM	chr12:58176536-58191367:+	0.32	7	1.16E-11	Multiple sclerosis	
STAD	cis	1	rs703842	chr12:58162739	XRCC6BP1	chr12:58335445-58351051:+	0.22	4.08	5.46E-5	Multiple sclerosis	
STAD	cis	1	rs7038769	chr9:116007583	CDC26	chr9:116029290-116037869:-	-0.35	-6.33	6.58E-10	Hematology traits	
STAD	cis	1	rs705696	chr12:56480648	MYO1A	chr12:57422302-57443901:-	0.18	3.93	0.000102	Cognitive function	
STAD	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.48	9.01	9.64E-18	Cognitive function	
STAD	cis	1	rs7070776	chr10:102264672	SEC31B	chr10:102246403-102289636:-	-0.24	-5.8	1.39E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7071271	chr10:102264824	SEC31B	chr10:102246403-102289636:-	-0.24	-5.88	8.63E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.59	10.38	1.92E-22	Metabolite levels	
STAD	cis	1	rs7073586	chr10:102307671	SEC31B	chr10:102246403-102289636:-	-0.21	-4.93	1.21E-6	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7078799	chr10:102301447	SEC31B	chr10:102246403-102289636:-	-0.23	-5.37	1.36E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7079136	chr10:102292709	SEC31B	chr10:102246403-102289636:-	-0.24	-5.86	9.87E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7079756	chr10:102302105	SEC31B	chr10:102246403-102289636:-	-0.22	-5.26	2.41E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7080356	chr10:102266735	SEC31B	chr10:102246403-102289636:-	-0.24	-5.86	9.96E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7084810	chr10:102297546	SEC31B	chr10:102246403-102289636:-	-0.25	-6.03	3.75E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7085439	chr10:102210100	SEC31B	chr10:102246403-102289636:-	-0.25	-6.05	3.32E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7088512	chr10:102303498	SEC31B	chr10:102246403-102289636:-	-0.22	-5.26	2.41E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7088827	chr10:102303865	SEC31B	chr10:102246403-102289636:-	-0.22	-5.28	2.12E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7090431	chr10:102261753	SEC31B	chr10:102246403-102289636:-	-0.24	-5.81	1.32E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7090512	chr10:6110829	IL2RA	chr10:6053506-6104272:-	-0.14	-4.02	7.08E-5	Multiple sclerosis	
STAD	cis	1	rs709592	chr17:38175553	GSDMA	chr17:38119226-38134019:+	-0.31	-5.47	8.01E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs7099913	chr10:102314777	SEC31B	chr10:102246403-102289636:-	-0.21	-4.91	1.36E-6	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7099965	chr10:102301165	SEC31B	chr10:102246403-102289636:-	-0.23	-5.37	1.36E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7099	chr20:43997646	SYS1-DBNDD2	chr20:43991701-44039245:+	-0.3	-4.57	6.45E-6	Psoriasis	
STAD	cis	1	rs7100386	chr10:102301417	SEC31B	chr10:102246403-102289636:-	-0.23	-5.37	1.36E-7	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7105282	chr11:47805614	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.8	5.82E-14	Subjective well-being	
STAD	cis	1	rs7107184	chr11:48577069	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.91	0.000108	HDL cholesterol	
STAD	cis	1	rs7107356	chr11:47676170	C1QTNF4	chr11:47611216-47615961:-	0.22	5.52	6.1E-8	Neuroticism	
STAD	cis	1	rs710865	chr1:19568972	KIAA0090	chr1:19544585-19578046:-	-0.2	-3.84	0.000146	Brain structure	
STAD	cis	1	rs710866	chr1:19568722	KIAA0090	chr1:19544585-19578046:-	-0.2	-3.84	0.000146	Brain structure	
STAD	cis	1	rs7109474	chr11:2233219	CD81	chr11:2398547-2418649:+	-0.28	-4.66	4.28E-6	Prostate cancer (early onset);Prostate cancer (gene x gene interaction);Prostate cancer	
STAD	cis	1	rs7111	chr15:90373873	AP3S2	chr15:90373832-90456222:-	-0.64	-9.36	6.36E-19	Type 2 diabetes	
STAD	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.38	-6.89	2.19E-11	Forced vital capacity	
STAD	cis	1	rs7120333	chr11:47817441	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.64	1.73E-13	Subjective well-being	
STAD	cis	1	rs7121460	chr11:48545232	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.86	0.00013	HDL cholesterol	
STAD	cis	1	rs7123312	chr11:2232359	CD81	chr11:2398547-2418649:+	-0.3	-4.96	1.04E-6	Prostate cancer (early onset);Prostate cancer (gene x gene interaction);Prostate cancer	
STAD	cis	1	rs7127900	chr11:2233574	CD81	chr11:2398547-2418649:+	-0.28	-4.73	3.13E-6	Prostate cancer (early onset);Prostate cancer (gene x gene interaction);Prostate cancer	
STAD	cis	1	rs71299622	chr3:52917038	TMEM110	chr3:52867139-52931547:-	0.51	4.97	1.0E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs71301804	chr3:53073314	TMEM110	chr3:52867139-52931547:-	0.4	4.37	1.59E-5	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs71301808	chr3:53085577	TMEM110	chr3:52867139-52931547:-	0.41	4.51	8.49E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs71301809	chr3:53090312	TMEM110	chr3:52867139-52931547:-	0.4	4.38	1.54E-5	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs71301814	chr3:53117663	TMEM110	chr3:52867139-52931547:-	0.41	4.51	8.6E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs7130881	chr11:68995958	MYEOV	chr11:69061622-69156449:+	-0.34	-4.08	5.46E-5	Prostate cancer	
STAD	cis	1	rs713219	chr9:131900920	CRAT	chr9:131857075-131873070:-	0.28	4.97	1.0E-6	Blood metabolite ratios	
STAD	cis	1	rs713219	chr9:131900920	PPP2R4	chr9:131873244-131911223:+	0.23	4.79	2.33E-6	Blood metabolite ratios	
STAD	cis	1	rs71327038	chr3:46225995	CCR2	chr3:46395235-46402412:+	0.22	3.82	0.000158	Celiac disease	
STAD	cis	1	rs71327718	chr3:125592857	LOC100125556	chr3:125635444-125648865:+	0.62	6.51	2.31E-10	Metabolite levels (HVA/5-HIAA ratio)	
STAD	cis	1	rs7134594	chr12:110000193	MYO1H	chr12:109826524-109886176:+	0.21	3.99	7.88E-5	HDL cholesterol	
STAD	cis	1	rs7135854	chr12:129279988	MGC16384	chr12:129297749-129299295:-	-0.2	-4.23	2.91E-5	Systemic lupus erythematosus	
STAD	cis	1	rs7135987	chr12:129280117	MGC16384	chr12:129297749-129299295:-	-0.2	-4.22	3.09E-5	Systemic lupus erythematosus	
STAD	cis	1	rs7136092	chr12:129280164	MGC16384	chr12:129297749-129299295:-	-0.2	-4.11	4.79E-5	Systemic lupus erythematosus	
STAD	cis	1	rs71391092	chr16:74567075	RFWD3	chr16:74655298-74700779:-	0.26	4.33	1.92E-5	Schizophrenia	
STAD	cis	1	rs7144423	chr14:35572547	PPP2R3C	chr14:35554679-35591679:-	0.32	4.55	7.18E-6	Atopic dermatitis	
STAD	cis	1	rs7148538	chr14:74392342	PTGR2	chr14:74318534-74352166:+	0.51	6.12	2.25E-9	Morning vs. evening chronotype	
STAD	cis	1	rs71487292	chr11:486076	RNH1	chr11:494512-507273:-	-0.43	-5.66	2.94E-8	Body mass index	
STAD	cis	1	rs71487296	chr11:500282	RNH1	chr11:494512-507273:-	-0.43	-5.67	2.84E-8	Body mass index	
STAD	cis	1	rs7153160	chr14:74509377	LIN52	chr14:74551656-74667117:+	0.33	6.04	3.53E-9	Common traits (Other)	
STAD	cis	1	rs7153587	chr14:74509660	LIN52	chr14:74551656-74667117:+	0.33	6.1	2.54E-9	Common traits (Other)	
STAD	cis	1	rs7154306	chr14:35540499	PPP2R3C	chr14:35554679-35591679:-	0.31	4.4	1.39E-5	Atopic dermatitis	
STAD	cis	1	rs71550519	chr6:56780272	BEND6	chr6:56819773-56892138:+	-0.24	-5.06	6.56E-7	Menarche (age at onset)	
STAD	cis	1	rs7156322	chr14:35544330	PPP2R3C	chr14:35554679-35591679:-	0.31	4.4	1.42E-5	Atopic dermatitis	
STAD	cis	1	rs71564866	chr6:56771207	BEND6	chr6:56819773-56892138:+	-0.24	-5.06	6.44E-7	Menarche (age at onset)	
STAD	cis	1	rs71564868	chr6:56798441	BEND6	chr6:56819773-56892138:+	-0.24	-5.07	6.28E-7	Menarche (age at onset)	
STAD	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.36	-6.77	4.77E-11	Common traits (Other)	
STAD	cis	1	rs71617204	chr3:53042951	TMEM110	chr3:52867139-52931547:-	0.48	4.83	1.94E-6	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs717593	chr20:33652964	PROCR	chr20:33758727-33765164:+	-0.52	-5.56	4.96E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7191665	chr16:74688948	RFWD3	chr16:74655298-74700779:-	-0.22	-5.05	6.69E-7	Testicular germ cell tumor	
STAD	cis	1	rs7201320	chr16:74694058	RFWD3	chr16:74655298-74700779:-	-0.22	-5.06	6.55E-7	Testicular germ cell tumor	
STAD	cis	1	rs720475	chr7:144074929	OR2A7	chr7:143955790-143974852:-	-0.3	-4.24	2.83E-5	Breast cancer	
STAD	cis	1	rs7205409	chr16:642610	WFIKKN1	chr16:679239-684116:+	0.41	7.24	2.49E-12	Height	
STAD	cis	1	rs7209131	chr17:7376411	CHRNB1	chr17:7348406-7360931:+	-0.23	-3.94	9.65E-5	Height	
STAD	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.48	9.16	3.03E-18	Eye color traits	
STAD	cis	1	rs7210738	chr17:45757598	C17orf57	chr17:45401142-45518675:+	-0.29	-6.07	3.08E-9	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
STAD	cis	1	rs7211213	chr17:61769456	DDX42	chr17:61851567-61896676:+	-0.24	-3.85	0.000139	Body mass index	
STAD	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.48	9.16	3.03E-18	Eye color traits	
STAD	cis	1	rs7214085	chr17:38169095	GSDMA	chr17:38119226-38134019:+	-0.32	-5.76	1.7E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs7214921	chr17:40294025	DHX58	chr17:40253422-40264751:-	-0.34	-6.18	1.6E-9	Fibrinogen levels	
STAD	cis	1	rs7218362	chr17:56888299	RAD51C	chr17:56769963-56811690:+	0.22	4.09	5.15E-5	Cognitive test performance	
STAD	cis	1	rs7219014	chr17:37624790	PGAP3	chr17:37827376-37844310:-	-0.23	-4.34	1.84E-5	Urinary metabolites	
STAD	cis	1	rs7219220	chr17:40294280	DHX58	chr17:40253422-40264751:-	-0.34	-6.21	1.36E-9	Fibrinogen levels	
STAD	cis	1	rs7221109	chr17:38770286	SMARCE1	chr17:38783976-38804103:-	-0.25	-4.41	1.33E-5	Type 1 diabetes	
STAD	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.47	8.91	2.0E-17	Eye color traits	
STAD	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.47	-8.96	1.38E-17	Eye color traits	
STAD	cis	1	rs7224737	chr17:40289364	DHX58	chr17:40253422-40264751:-	0.34	6.27	9.49E-10	Fibrinogen levels	
STAD	cis	1	rs7225608	chr17:40298326	DHX58	chr17:40253422-40264751:-	-0.36	-6.75	5.38E-11	Fibrinogen levels	
STAD	cis	1	rs7226599	chr18:74491132	ZNF236	chr18:74536116-74682680:+	-0.21	-4.24	2.82E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
STAD	cis	1	rs722997	chr22:26849666	HPS4	chr22:26847447-26879820:-	0.38	3.81	0.000163	Ischemic stroke	
STAD	cis	1	rs7251653	chr19:18608283	ISYNA1	chr19:18545625-18548943:-	0.24	4.13	4.41E-5	Breast cancer	
STAD	cis	1	rs7252707	chr19:18612257	ISYNA1	chr19:18545625-18548943:-	0.27	4.71	3.44E-6	Breast cancer	
STAD	cis	1	rs7252848	chr19:18612351	ISYNA1	chr19:18545625-18548943:-	0.26	4.52	8.11E-6	Breast cancer	
STAD	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.26	5.81	1.27E-8	Longevity	
STAD	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.25	5.78	1.49E-8	Longevity	
STAD	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.36	6.99	1.19E-11	Schizophrenia	
STAD	cis	1	rs7258465	chr19:18533642	ISYNA1	chr19:18545625-18548943:-	0.23	4.04	6.49E-5	Breast cancer	
STAD	cis	1	rs725908	chr20:33968067	GDF5	chr20:33897002-34042568:-	-0.17	-3.88	0.000122	Height	
STAD	cis	1	rs725908	chr20:33968067	UQCC	chr20:33890383-33999833:-	0.25	4.47	1.05E-5	Height	
STAD	cis	1	rs7261312	chr20:33684909	PROCR	chr20:33758727-33765164:+	-0.48	-5.53	5.98E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs72627117	chr14:74355233	PTGR2	chr14:74318534-74352166:+	0.52	6.23	1.23E-9	Morning vs. evening chronotype	
STAD	cis	1	rs72627119	chr14:74356274	PTGR2	chr14:74318534-74352166:+	0.52	6.23	1.23E-9	Morning vs. evening chronotype	
STAD	cis	1	rs72627120	chr14:74363480	PTGR2	chr14:74318534-74352166:+	0.52	6.23	1.23E-9	Morning vs. evening chronotype	
STAD	cis	1	rs72627122	chr14:74368236	PTGR2	chr14:74318534-74352166:+	0.51	6.13	2.11E-9	Morning vs. evening chronotype	
STAD	cis	1	rs72627123	chr14:74368331	PTGR2	chr14:74318534-74352166:+	0.51	6.13	2.11E-9	Morning vs. evening chronotype	
STAD	cis	1	rs72627124	chr14:74369128	PTGR2	chr14:74318534-74352166:+	0.51	6.15	1.87E-9	Morning vs. evening chronotype	
STAD	cis	1	rs72627125	chr14:74369623	PTGR2	chr14:74318534-74352166:+	0.51	6.15	1.87E-9	Morning vs. evening chronotype	
STAD	cis	1	rs72627126	chr14:74370024	PTGR2	chr14:74318534-74352166:+	0.51	6.07	2.97E-9	Morning vs. evening chronotype	
STAD	cis	1	rs72627127	chr14:74370098	PTGR2	chr14:74318534-74352166:+	0.51	6.15	1.87E-9	Morning vs. evening chronotype	
STAD	cis	1	rs72627129	chr14:74374805	PTGR2	chr14:74318534-74352166:+	0.51	6.15	1.92E-9	Morning vs. evening chronotype	
STAD	cis	1	rs72627130	chr14:74374897	PTGR2	chr14:74318534-74352166:+	0.51	6.15	1.92E-9	Morning vs. evening chronotype	
STAD	cis	1	rs72627138	chr14:74401900	PTGR2	chr14:74318534-74352166:+	0.5	5.99	4.67E-9	Morning vs. evening chronotype	
STAD	cis	1	rs7263203	chr20:33773375	PROCR	chr20:33758727-33765164:+	-0.5	-5.47	7.96E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7263253	chr20:33649376	PROCR	chr20:33758727-33765164:+	-0.49	-5.22	2.9E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs72639533	chr10:37997810	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.91	0.000109	Obesity (extreme)	
STAD	cis	1	rs72639538	chr10:38360516	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.81	0.000158	Obesity (extreme)	
STAD	cis	1	rs72649163	chr1:20900592	FAM43B	chr1:20878932-20881512:+	0.18	4.2	3.36E-5	Age-related hearing impairment (interaction)	
STAD	cis	1	rs7265317	chr20:33768523	PROCR	chr20:33758727-33765164:+	-0.52	-5.91	7.57E-9	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs72677306	chr4:106997678	TBCK	chr4:106967233-107237861:-	0.25	3.86	0.000134	Airflow obstruction	
STAD	cis	1	rs7268447	chr20:33649593	PROCR	chr20:33758727-33765164:+	-0.48	-5.17	3.76E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7269138	chr20:33570007	PROCR	chr20:33758727-33765164:+	-0.48	-5.2	3.22E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7270326	chr20:33693582	PROCR	chr20:33758727-33765164:+	-0.48	-5.5	6.77E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7271729	chr20:33610992	PROCR	chr20:33758727-33765164:+	-0.48	-5.19	3.46E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7273734	chr20:33599403	PROCR	chr20:33758727-33765164:+	-0.39	-4.7	3.55E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7274866	chr20:33608616	PROCR	chr20:33758727-33765164:+	-0.48	-5.28	2.14E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs72768397	chr1:247219411	ZNF670	chr1:247200087-247242069:-	-0.27	-4.07	5.7E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs72782294	chr2:28953390	TRMT61B	chr2:29072690-29093175:-	0.31	5.23	2.76E-7	Body mass index	
STAD	cis	1	rs72811623	chr2:97496473	CNNM3	chr2:97481991-97501120:+	-0.34	-4.03	6.61E-5	Erectile dysfunction and prostate cancer treatment	
STAD	cis	1	rs72823619	chr2:102924615	IL1RL1	chr2:102927962-102968497:+	0.29	4.37	1.59E-5	Asthma	
STAD	cis	1	rs72823621	chr2:102925435	IL1RL1	chr2:102927962-102968497:+	0.3	4.46	1.05E-5	Asthma	
STAD	cis	1	rs72823632	chr2:102931534	IL1RL1	chr2:102927962-102968497:+	0.3	4.47	1.02E-5	Asthma	
STAD	cis	1	rs72823635	chr2:102931612	IL1RL1	chr2:102927962-102968497:+	0.3	4.37	1.57E-5	Asthma	
STAD	cis	1	rs72823646	chr2:102954213	IL1RL1	chr2:102927962-102968497:+	0.3	4.58	6.39E-6	Asthma	
STAD	cis	1	rs72845397	chr11:6950903	ZNF215	chr11:6947654-7005861:+	-0.45	-5.23	2.71E-7	Response to cytadine analogues (cytosine arabinoside)	
STAD	cis	1	rs728615	chr10:81848089	PLAC9	chr10:81892258-81904784:+	-0.28	-4.64	4.79E-6	Chronic obstructive pulmonary disease-related biomarkers	
STAD	cis	1	rs728616	chr10:81847914	PLAC9	chr10:81892258-81904784:+	-0.28	-4.61	5.52E-6	Chronic obstructive pulmonary disease-related biomarkers	
STAD	cis	1	rs7289577	chr22:39042214	LOC646851	chr22:38974125-39052634:-	0.23	5.01	8.38E-7	Resting heart rate	
STAD	cis	1	rs7289855	chr22:39042221	LOC646851	chr22:38974125-39052634:-	0.23	4.79	2.33E-6	Resting heart rate	
STAD	cis	1	rs72922733	chr11:65520746	CTSW	chr11:65647284-65651212:+	-0.36	-6.38	4.92E-10	Systemic lupus erythematosus	
STAD	cis	1	rs72931690	chr11:78073192	GAB2	chr11:77926343-78128766:-	-0.26	-3.82	0.000155	Testicular germ cell tumor	
STAD	cis	1	rs72934944	chr2:202190610	PPIL3	chr2:201735680-201753999:-	-0.55	-6.89	2.22E-11	Rheumatoid arthritis	
STAD	cis	1	rs72934960	chr2:202204749	PPIL3	chr2:201735680-201753999:-	-0.56	-5.68	2.68E-8	Rheumatoid arthritis	
STAD	cis	1	rs72934973	chr2:202213934	PPIL3	chr2:201735680-201753999:-	-0.55	-5.75	1.83E-8	Rheumatoid arthritis	
STAD	cis	1	rs72934999	chr2:202223524	PPIL3	chr2:201735680-201753999:-	-0.54	-5.9	8.02E-9	Rheumatoid arthritis	
STAD	cis	1	rs72937106	chr2:202225520	PPIL3	chr2:201735680-201753999:-	-0.54	-5.9	8.02E-9	Rheumatoid arthritis	
STAD	cis	1	rs72937118	chr2:202229527	PPIL3	chr2:201735680-201753999:-	-0.54	-5.9	8.02E-9	Rheumatoid arthritis	
STAD	cis	1	rs72937120	chr2:202232611	PPIL3	chr2:201735680-201753999:-	-0.54	-5.9	8.01E-9	Rheumatoid arthritis	
STAD	cis	1	rs72951729	chr2:219960543	SLC23A3	chr2:220026183-220034817:-	0.37	4.27	2.43E-5	Height	
STAD	cis	1	rs72951738	chr2:219966801	SLC23A3	chr2:220026183-220034817:-	0.4	4.64	4.67E-6	Height	
STAD	cis	1	rs72951747	chr2:219972043	SLC23A3	chr2:220026183-220034817:-	0.37	4.06	6.02E-5	Height	
STAD	cis	1	rs72967917	chr2:219911022	SLC23A3	chr2:220026183-220034817:-	0.35	4.02	7.08E-5	Height	
STAD	cis	1	rs72967918	chr2:219911844	SLC23A3	chr2:220026183-220034817:-	0.38	4.38	1.52E-5	Height	
STAD	cis	1	rs72967942	chr2:219917522	SLC23A3	chr2:220026183-220034817:-	0.38	4.38	1.5E-5	Height	
STAD	cis	1	rs72967946	chr2:219917979	SLC23A3	chr2:220026183-220034817:-	0.37	4.22	3.01E-5	Height	
STAD	cis	1	rs72967954	chr2:219922569	SLC23A3	chr2:220026183-220034817:-	0.37	4.32	1.96E-5	Height	
STAD	cis	1	rs7302634	chr12:129279931	MGC16384	chr12:129297749-129299295:-	-0.19	-3.96	8.92E-5	Systemic lupus erythematosus	
STAD	cis	1	rs73041998	chr1:171655119	VAMP4	chr1:171669298-171711214:-	0.34	6.15	1.87E-9	Hippocampal atrophy	
STAD	cis	1	rs73042000	chr1:171655212	VAMP4	chr1:171669298-171711214:-	0.34	6.15	1.87E-9	Hippocampal atrophy	
STAD	cis	1	rs73042001	chr1:171655251	VAMP4	chr1:171669298-171711214:-	0.34	6.15	1.87E-9	Hippocampal atrophy	
STAD	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	0.74	11.21	1.8E-25	Diastolic blood pressure	
STAD	cis	1	rs73069394	chr3:41787233	ULK4	chr3:41288091-42003660:-	0.75	11.59	6.99E-27	Diastolic blood pressure	
STAD	cis	1	rs73069396	chr3:41787236	ULK4	chr3:41288091-42003660:-	0.75	11.59	6.99E-27	Diastolic blood pressure	
STAD	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	0.75	11.87	5.89E-28	Diastolic blood pressure	
STAD	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.27	-6.19	1.57E-9	Longevity	
STAD	cis	1	rs73074650	chr12:22547929	KIAA0528	chr12:22601526-22697452:-	0.41	4.09	5.25E-5	Coronary artery calcification	
STAD	cis	1	rs73074659	chr12:22548841	KIAA0528	chr12:22601526-22697452:-	0.41	4.12	4.65E-5	Coronary artery calcification	
STAD	cis	1	rs73077367	chr3:41851959	ULK4	chr3:41288091-42003660:-	0.78	12.29	1.5E-29	Diastolic blood pressure	
STAD	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.78	12.01	1.76E-28	Diastolic blood pressure	
STAD	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	0.76	12.24	2.24E-29	Diastolic blood pressure	
STAD	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.76	11.66	3.87E-27	Diastolic blood pressure	
STAD	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.76	11.66	3.87E-27	Diastolic blood pressure	
STAD	cis	1	rs7309685	chr12:56935413	SPRYD4	chr12:56862301-56864765:+	-0.21	-3.97	8.55E-5	Adiponectin levels	
STAD	cis	1	rs7310284	chr12:56935652	SPRYD4	chr12:56862301-56864765:+	0.21	4.16	3.99E-5	Adiponectin levels	
STAD	cis	1	rs731152	chr17:40279680	DHX58	chr17:40253422-40264751:-	-0.34	-6.2	1.48E-9	Fibrinogen levels	
STAD	cis	1	rs73142121	chr7:65311206	CCT6P1	chr7:65216092-65228661:+	0.26	3.99	7.81E-5	Diabetic kidney disease	
STAD	cis	1	rs73142122	chr7:65311298	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.24E-5	Diabetic kidney disease	
STAD	cis	1	rs73142162	chr7:65374296	CCT6P1	chr7:65216092-65228661:+	0.28	4.22	2.98E-5	Diabetic kidney disease	
STAD	cis	1	rs73142166	chr7:65375832	CCT6P1	chr7:65216092-65228661:+	0.29	4.37	1.57E-5	Diabetic kidney disease	
STAD	cis	1	rs73150014	chr7:65450919	CCT6P1	chr7:65216092-65228661:+	0.26	3.81	0.000159	Diabetic kidney disease	
STAD	cis	1	rs73197056	chr12:91473658	KERA	chr12:91444273-91452131:-	0.28	4.65	4.65E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs73197065	chr12:91477437	KERA	chr12:91444273-91452131:-	0.28	4.61	5.58E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs73197078	chr12:91481558	KERA	chr12:91444273-91452131:-	0.28	4.76	2.7E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs73276406	chr8:96021760	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs73276417	chr8:96026312	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs73276437	chr8:96035511	C8orf38	chr8:95908040-96088396:+	-0.34	-4.13	4.47E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs73276444	chr8:96039247	C8orf38	chr8:95908040-96088396:+	-0.34	-4.13	4.4E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs73282234	chr5:150195924	LOC134466	chr5:150310000-150326146:-	0.37	5.55	5.28E-8	Crohn's disease	
STAD	cis	1	rs73282255	chr5:150223647	LOC134466	chr5:150310000-150326146:-	0.3	4.8	2.28E-6	Crohn's disease	
STAD	cis	1	rs73284126	chr5:150261307	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs73284133	chr14:65946612	LOC645431	chr14:65877313-65879335:-	-0.35	-4.01	7.41E-5	Ischemic stroke	
STAD	cis	1	rs73284141	chr5:150266086	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs73301712	chr14:59898245	C14orf149	chr14:59939406-59951126:-	-0.53	-5.37	1.33E-7	Schizophrenia	
STAD	cis	1	rs73301725	chr14:59902159	C14orf149	chr14:59939406-59951126:-	-0.53	-5.37	1.33E-7	Schizophrenia	
STAD	cis	1	rs73301741	chr14:59908444	C14orf149	chr14:59939406-59951126:-	-0.56	-5.52	6.22E-8	Schizophrenia	
STAD	cis	1	rs73301746	chr14:59908485	C14orf149	chr14:59939406-59951126:-	-0.56	-5.52	6.22E-8	Schizophrenia	
STAD	cis	1	rs73348070	chr5:127893533	FBN2	chr5:127593602-127873916:-	0.55	4.92	1.29E-6	Multiple system atrophy	
STAD	cis	1	rs73509996	chr19:17393449	OCEL1	chr19:17337055-17340027:+	0.32	4.36	1.7E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
STAD	cis	1	rs735531	chr20:33947730	GDF5	chr20:33897002-34042568:-	-0.18	-4.02	7.1E-5	Height	
STAD	cis	1	rs735531	chr20:33947730	UQCC	chr20:33890383-33999833:-	0.24	4.28	2.38E-5	Height	
STAD	cis	1	rs7356093	chr3:134238753	ANAPC13	chr3:134196547-134204865:-	0.39	6.94	1.63E-11	Height	
STAD	cis	1	rs736344	chr12:110001195	MYO1H	chr12:109826524-109886176:+	0.21	3.96	8.9E-5	HDL cholesterol	
STAD	cis	1	rs7371896	chr3:134249769	ANAPC13	chr3:134196547-134204865:-	0.38	6.9	2.13E-11	Height	
STAD	cis	1	rs7372217	chr3:41990122	ULK4	chr3:41288091-42003660:-	-0.76	-12.19	3.53E-29	Diastolic blood pressure	
STAD	cis	1	rs7373805	chr3:38455439	XYLB	chr3:38388251-38456467:+	0.21	4.21	3.16E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs7373816	chr3:38490443	XYLB	chr3:38388251-38456467:+	0.21	4.32	1.97E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs7374158	chr3:134270156	ANAPC13	chr3:134196547-134204865:-	0.38	6.78	4.34E-11	Height	
STAD	cis	1	rs7374325	chr3:134275601	ANAPC13	chr3:134196547-134204865:-	0.38	6.86	2.7E-11	Height	
STAD	cis	1	rs73903009	chr20:33678732	PROCR	chr20:33758727-33765164:+	-0.49	-5.39	1.22E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs73903017	chr20:33724758	PROCR	chr20:33758727-33765164:+	-0.45	-5.11	4.98E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs73903019	chr20:33727779	PROCR	chr20:33758727-33765164:+	-0.47	-5.21	3.06E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs73905019	chr20:33560314	PROCR	chr20:33758727-33765164:+	-0.41	-4.69	3.84E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs73905041	chr20:33592148	PROCR	chr20:33758727-33765164:+	-0.46	-4.99	9.23E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7395662	chr11:48518893	C1QTNF4	chr11:47611216-47615961:-	0.17	3.85	0.00014	HDL cholesterol	
STAD	cis	1	rs739636	chr17:40281063	DHX58	chr17:40253422-40264751:-	-0.37	-6.88	2.37E-11	Fibrinogen levels	
STAD	cis	1	rs739637	chr17:40280944	DHX58	chr17:40253422-40264751:-	-0.34	-6.2	1.48E-9	Fibrinogen levels	
STAD	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.48	9.05	7.13E-18	Eye color traits	
STAD	cis	1	rs7411035	chr1:160856076	ITLN1	chr1:160846332-160854960:-	-0.23	-4.1	4.99E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
STAD	cis	1	rs7412746	chr1:150860471	HORMAD1	chr1:150670542-150693352:-	-0.27	-4.68	3.94E-6	Melanoma	
STAD	cis	1	rs74210981	chr10:102287520	SEC31B	chr10:102246403-102289636:-	-0.24	-5.77	1.59E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.65	-6.99	1.19E-11	Plasma clusterin levels	
STAD	cis	1	rs7426847	chr3:134267519	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.75	5.47E-11	Height	
STAD	cis	1	rs7427165	chr3:121364624	IQCB1	chr3:121488610-121553926:-	0.28	4.79	2.39E-6	Cognitive performance	
STAD	cis	1	rs7427492	chr3:134261654	ANAPC13	chr3:134196547-134204865:-	0.38	6.86	2.7E-11	Height	
STAD	cis	1	rs7428326	chr3:134251184	ANAPC13	chr3:134196547-134204865:-	0.38	6.88	2.38E-11	Height	
STAD	cis	1	rs7428	chr2:85545490	TGOLN2	chr2:85545147-85555374:-	0.19	3.98	8.27E-5	Ear protrusion	
STAD	cis	1	rs7429866	chr3:134236306	ANAPC13	chr3:134196547-134204865:-	-0.38	-6.86	2.66E-11	Height	
STAD	cis	1	rs7432268	chr3:134242051	ANAPC13	chr3:134196547-134204865:-	0.38	6.86	2.7E-11	Height	
STAD	cis	1	rs7433663	chr3:134235790	ANAPC13	chr3:134196547-134204865:-	0.39	7	1.12E-11	Height	
STAD	cis	1	rs7433707	chr3:38443180	XYLB	chr3:38388251-38456467:+	0.22	4.44	1.2E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs7433991	chr3:134312292	ANAPC13	chr3:134196547-134204865:-	0.38	6.72	6.3E-11	Height	
STAD	cis	1	rs7436021	chr4:76905472	NAAA	chr4:76831809-76862166:-	-0.41	-5.95	5.91E-9	Longevity	
STAD	cis	1	rs74363821	chr6:26189524	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.33	1.88E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs744653	chr2:190378750	SLC40A1	chr2:190425318-190448484:-	0.32	4.05	6.16E-5	Iron status biomarkers (ferritin levels);Iron status biomarkers (transferrin levels)	
STAD	cis	1	rs74543591	chr20:33658658	PROCR	chr20:33758727-33765164:+	-0.52	-5.61	3.82E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs74544416	chr8:82657745	CHMP4C	chr8:82644688-82671746:+	-0.97	-9.93	7.3E-21	Epithelial ovarian cancer;Ovarian cancer	
STAD	cis	1	rs7456042	chr7:65299778	CCT6P1	chr7:65216092-65228661:+	0.26	3.99	7.81E-5	Diabetic kidney disease	
STAD	cis	1	rs74599371	chr20:33561495	PROCR	chr20:33758727-33765164:+	-0.46	-5.09	5.69E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs74626382	chr20:33746668	PROCR	chr20:33758727-33765164:+	-0.51	-5.61	3.78E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs746489	chr9:131910093	CRAT	chr9:131857075-131873070:-	0.27	4.89	1.47E-6	Blood metabolite ratios	
STAD	cis	1	rs746489	chr9:131910093	PPP2R4	chr9:131873244-131911223:+	0.22	4.61	5.48E-6	Blood metabolite ratios	
STAD	cis	1	rs74650218	chr10:102293830	SEC31B	chr10:102246403-102289636:-	-0.24	-5.78	1.55E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs74733602	chr2:86303442	GNLY	chr2:85921414-85925874:+	0.34	3.81	0.000164	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
STAD	cis	1	rs74737585	chr11:96114921	CCDC82	chr11:96085930-96123083:-	-0.38	-4.07	5.64E-5	Parkinson's disease	
STAD	cis	1	rs7474896	chr10:37982097	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.91	0.000109	Obesity (extreme)	
STAD	cis	1	rs7475154	chr10:131440584	MGMT	chr10:131265454-131565783:+	-0.26	-4.54	7.58E-6	Response to temozolomide	
STAD	cis	1	rs7477246	chr10:102261538	SEC31B	chr10:102246403-102289636:-	-0.24	-5.9	8.11E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7483920	chr11:48599969	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.95	9.25E-5	HDL cholesterol	
STAD	cis	1	rs7488394	chr12:91480002	KERA	chr12:91444273-91452131:-	0.28	4.76	2.7E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs7499271	chr16:20555259	ACSM1	chr16:20634559-20709066:-	0.49	4.02	7.03E-5	Serum metabolite levels	
STAD	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.48	9.14	3.37E-18	Eye color traits	
STAD	cis	1	rs75063298	chr10:102213600	SEC31B	chr10:102246403-102289636:-	-0.25	-6.01	4.38E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs75071288	chr5:150224379	LOC134466	chr5:150310000-150326146:-	0.3	4.89	1.45E-6	Crohn's disease	
STAD	cis	1	rs7511962	chr1:247212122	ZNF670	chr1:247200087-247242069:-	-0.28	-4.2	3.3E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs7512150	chr1:247212326	ZNF670	chr1:247200087-247242069:-	-0.27	-4.07	5.65E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs75165171	chr20:33651453	PROCR	chr20:33758727-33765164:+	-0.52	-5.56	4.96E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.65	-7.01	1.07E-11	Plasma clusterin levels	
STAD	cis	1	rs7519795	chr1:247212126	ZNF670	chr1:247200087-247242069:-	-0.28	-4.2	3.3E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs7521654	chr1:54364755	YIPF1	chr1:54317407-54355453:-	0.52	3.94	9.65E-5	Nonalcoholic fatty liver disease	
STAD	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.45	7.05	8.01E-12	Homocysteine levels	
STAD	cis	1	rs75244610	chr2:73415788	STAMBP	chr2:74056086-74100759:+	-0.44	-4.17	3.78E-5	Schizophrenia	
STAD	cis	1	rs7524495	chr1:46266932	IPP	chr1:46160000-46216485:-	0.2	3.93	0.000101	Body mass index	
STAD	cis	1	rs752672	chr4:109951681	CASP6	chr4:110609785-110624629:-	0.18	3.9	0.000112	Body mass index	
STAD	cis	1	rs7528684	chr1:157670816	FCRL3	chr1:157646278-157670775:-	0.21	6.29	8.75E-10	Type 1 diabetes autoantibodies	
STAD	cis	1	rs75287019	chr20:33721261	PROCR	chr20:33758727-33765164:+	-0.46	-5.08	5.79E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.65	-7.04	8.61E-12	Plasma clusterin levels	
STAD	cis	1	rs753129	chr4:56668431	EXOC1	chr4:56719816-56771244:+	0.24	4.3	2.13E-5	Psychosis in Alzheimer's disease	
STAD	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.5	-8.05	9.96E-15	Homocysteine levels	
STAD	cis	1	rs7536436	chr1:171665914	VAMP4	chr1:171669298-171711214:-	0.32	5.93	6.62E-9	Hippocampal atrophy	
STAD	cis	1	rs7536543	chr1:171666040	VAMP4	chr1:171669298-171711214:-	0.32	5.93	6.62E-9	Hippocampal atrophy	
STAD	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.46	-7.38	9.59E-13	Homocysteine levels	
STAD	cis	1	rs7537765	chr1:11887303	CLCN6	chr1:11866207-11907674:+	-0.27	-3.94	9.55E-5	QRS complex (12-leadsum)	
STAD	cis	1	rs7539932	chr1:46292354	IPP	chr1:46160000-46216485:-	0.2	3.84	0.000146	Body mass index	
STAD	cis	1	rs75399471	chr1:76339092	ACADM	chr1:76190043-76229353:+	-0.31	-4.09	5.34E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs754466	chr10:79680434	DLG5	chr10:79550551-79686348:-	0.3	5.4	1.18E-7	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs754466	chr10:79680434	POLR3A	chr10:79735906-79789259:-	0.23	4.59	5.87E-6	Liver enzyme levels (gamma-glutamyl transferase)	
STAD	cis	1	rs7546342	chr1:247213292	ZNF670	chr1:247200087-247242069:-	-0.27	-4.07	5.65E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs7549410	chr1:247214167	ZNF670	chr1:247200087-247242069:-	-0.28	-4.3	2.2E-5	Response to taxane treatment (docetaxel)	
STAD	cis	1	rs7550635	chr1:25299637	IL22RA1	chr1:24446261-24469611:-	-0.21	-3.92	0.000104	Psoriasis vulgaris	
STAD	cis	1	rs7551732	chr1:89139041	CCBL2	chr1:89401456-89458643:-	0.3	6.6	1.38E-10	Height	
STAD	cis	1	rs7552393	chr1:84254551	TTLL7	chr1:84335059-84464833:-	0.15	3.96	8.99E-5	Select biomarker traits	
STAD	cis	1	rs75535620	chr20:33601498	PROCR	chr20:33758727-33765164:+	-0.48	-5.12	4.86E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs75537616	chr20:33592588	PROCR	chr20:33758727-33765164:+	-0.47	-5.01	8.42E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7556615	chr1:46461369	IPP	chr1:46160000-46216485:-	0.2	3.97	8.57E-5	Body mass index	
STAD	cis	1	rs7556615	chr1:46461369	TMEM69	chr1:46153847-46160108:+	0.18	3.92	0.000104	Body mass index	
STAD	cis	1	rs7558944	chr2:73810909	ALMS1P	chr2:73872046-73912692:+	0.49	7.68	1.32E-13	Metabolite levels	
STAD	cis	1	rs7558944	chr2:73810909	TPRKB	chr2:73956957-73964517:-	-0.21	-4.43	1.25E-5	Metabolite levels	
STAD	cis	1	rs75615599	chr11:96112059	CCDC82	chr11:96085930-96123083:-	-0.38	-4.25	2.69E-5	Parkinson's disease	
STAD	cis	1	rs7562170	chr2:28943516	TRMT61B	chr2:29072690-29093175:-	0.31	5.15	4.14E-7	Body mass index	
STAD	cis	1	rs75635914	chr20:33555815	PROCR	chr20:33758727-33765164:+	-0.46	-5.12	4.74E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs75648520	chr20:33724221	PROCR	chr20:33758727-33765164:+	-0.51	-5.62	3.7E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7564890	chr2:73641853	ALMS1P	chr2:73872046-73912692:+	0.49	7.8	5.85E-14	Metabolite levels	
STAD	cis	1	rs7564890	chr2:73641853	TPRKB	chr2:73956957-73964517:-	-0.22	-4.62	5.21E-6	Metabolite levels	
STAD	cis	1	rs7566279	chr2:281178	SH3YL1	chr2:218138-264810:-	-0.6	-12.7	3.73E-31	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs7570971	chr2:135837906	LCT	chr2:136545415-136594750:-	-0.23	-3.81	0.000161	Body mass index;Blood metabolite levels;Cholesterol, total	
STAD	cis	1	rs7572722	chr2:73724675	ALMS1P	chr2:73872046-73912692:+	0.49	7.78	6.4E-14	Metabolite levels	
STAD	cis	1	rs7572722	chr2:73724675	TPRKB	chr2:73956957-73964517:-	-0.23	-4.76	2.78E-6	Metabolite levels	
STAD	cis	1	rs75774363	chr5:150223722	LOC134466	chr5:150310000-150326146:-	0.32	5.16	3.87E-7	Crohn's disease	
STAD	cis	1	rs7577696	chr2:32278782	NLRC4	chr2:32449518-32490801:-	-0.15	-4.01	7.37E-5	Inflammatory biomarkers	
STAD	cis	1	rs75777806	chr5:148403428	ARHGEF37	chr5:148961135-149014527:+	0.25	3.97	8.4E-5	Diastolic blood pressure	
STAD	cis	1	rs7579277	chr2:28996295	TRMT61B	chr2:29072690-29093175:-	-0.35	-5.93	6.67E-9	Body mass index	
STAD	cis	1	rs75800624	chr18:44633605	HDHD2	chr18:44633782-44676871:-	0.56	5.41	1.09E-7	Sitting height ratio	
STAD	cis	1	rs75800999	chr13:28055293	GTF3A	chr13:27998681-28009846:+	-0.38	-4.09	5.23E-5	Weight	
STAD	cis	1	rs7581224	chr2:84709215	DNAH6	chr2:84743579-85046711:+	0.29	5	8.58E-7	Coronary artery calcification	
STAD	cis	1	rs75824542	chr14:74523047	LIN52	chr14:74551656-74667117:+	0.33	6.12	2.22E-9	Common traits (Other)	
STAD	cis	1	rs7582606	chr2:73813945	ALMS1P	chr2:73872046-73912692:+	0.47	7.53	3.5E-13	Metabolite levels	
STAD	cis	1	rs7582606	chr2:73813945	TPRKB	chr2:73956957-73964517:-	-0.23	-4.91	1.33E-6	Metabolite levels	
STAD	cis	1	rs7583255	chr2:73797996	ALMS1P	chr2:73872046-73912692:+	0.51	8.07	8.54E-15	Metabolite levels	
STAD	cis	1	rs7583255	chr2:73797996	TPRKB	chr2:73956957-73964517:-	-0.2	-4.28	2.38E-5	Metabolite levels	
STAD	cis	1	rs7584535	chr2:232106857	ARMC9	chr2:232063342-232238606:+	0.22	4.75	2.81E-6	Food antigen IgG levels	
STAD	cis	1	rs7586463	chr2:73798476	ALMS1P	chr2:73872046-73912692:+	0.51	8.07	8.54E-15	Metabolite levels	
STAD	cis	1	rs7586463	chr2:73798476	TPRKB	chr2:73956957-73964517:-	-0.2	-4.28	2.38E-5	Metabolite levels	
STAD	cis	1	rs75866240	chr20:33558839	PROCR	chr20:33758727-33765164:+	-0.46	-5.09	5.69E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7586856	chr2:219968576	SLC23A3	chr2:220026183-220034817:-	0.39	4.52	8.37E-6	Height	
STAD	cis	1	rs75888794	chr20:33702998	PROCR	chr20:33758727-33765164:+	-0.48	-5.21	3.1E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs75889859	chr14:35539054	PPP2R3C	chr14:35554679-35591679:-	0.3	4.37	1.57E-5	Atopic dermatitis	
STAD	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.65	-6.99	1.21E-11	Plasma clusterin levels	
STAD	cis	1	rs75913297	chr10:81789845	LOC219347	chr10:81805991-81838949:-	0.57	7.42	7.54E-13	Chronic obstructive pulmonary disease-related biomarkers	
STAD	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.72	-10.78	6.89E-24	Triptolide cytotoxicity	
STAD	cis	1	rs75921373	chr6:26191843	HIST1H2AE	chr6:26217148-26217711:+	-0.33	-4.45	1.14E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs7593448	chr2:27449293	C2orf28	chr2:27434899-27440044:+	0.25	4.41	1.37E-5	Blood metabolite levels	
STAD	cis	1	rs7594511	chr2:73681639	ALMS1P	chr2:73872046-73912692:+	0.51	8.09	7.82E-15	Metabolite levels	
STAD	cis	1	rs7594511	chr2:73681639	TPRKB	chr2:73956957-73964517:-	-0.21	-4.31	2.11E-5	Metabolite levels	
STAD	cis	1	rs7595075	chr2:264019	SH3YL1	chr2:218138-264810:-	-0.6	-12.85	9.1E-32	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs7595949	chr2:219927218	SLC23A3	chr2:220026183-220034817:-	0.39	4.62	5.33E-6	Height	
STAD	cis	1	rs7598396	chr2:73652628	ALMS1P	chr2:73872046-73912692:+	0.49	7.97	1.81E-14	Metabolite levels	
STAD	cis	1	rs7598396	chr2:73652628	TPRKB	chr2:73956957-73964517:-	-0.21	-4.49	9.22E-6	Metabolite levels	
STAD	cis	1	rs7598419	chr2:73798223	ALMS1P	chr2:73872046-73912692:+	0.5	7.87	3.51E-14	Metabolite levels	
STAD	cis	1	rs7598419	chr2:73798223	TPRKB	chr2:73956957-73964517:-	-0.22	-4.65	4.62E-6	Metabolite levels	
STAD	cis	1	rs7598876	chr2:28974466	TRMT61B	chr2:29072690-29093175:-	-0.31	-5.26	2.42E-7	Body mass index	
STAD	cis	1	rs7598980	chr2:219968422	SLC23A3	chr2:220026183-220034817:-	0.4	4.67	4.07E-6	Height	
STAD	cis	1	rs7600987	chr2:219915871	SLC23A3	chr2:220026183-220034817:-	0.39	4.48	9.92E-6	Height	
STAD	cis	1	rs7604393	chr2:241825034	C2orf54	chr2:241825466-241835573:-	0.25	3.82	0.000153	Urinary metabolites	
STAD	cis	1	rs7605824	chr2:280819	SH3YL1	chr2:218138-264810:-	0.6	12.85	9.1E-32	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs7608697	chr2:61204641	C2orf74	chr2:61372243-61391964:+	0.23	3.98	8.15E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
STAD	cis	1	rs7608910	chr2:61204856	C2orf74	chr2:61372243-61391964:+	-0.24	-4.22	2.99E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
STAD	cis	1	rs7609851	chr3:156638503	LEKR1	chr3:156544076-156763918:+	-0.39	-4.62	5.26E-6	Bone mineral density	
STAD	cis	1	rs7611238	chr3:195072918	C3orf21	chr3:194789015-194991895:-	0.27	4.84	1.91E-6	Body mass index	
STAD	cis	1	rs7611611	chr3:134307877	ANAPC13	chr3:134196547-134204865:-	0.39	6.78	4.41E-11	Height	
STAD	cis	1	rs7611828	chr3:134250325	ANAPC13	chr3:134196547-134204865:-	0.38	6.88	2.38E-11	Height	
STAD	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.62	-8.57	2.41E-16	Blood pressure (smoking interaction)	
STAD	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.63	8.42	7.25E-16	Blood pressure (smoking interaction)	
STAD	cis	1	rs7616844	chr3:41874343	ULK4	chr3:41288091-42003660:-	0.78	12.44	3.76E-30	Diastolic blood pressure	
STAD	cis	1	rs7617397	chr3:41959037	ULK4	chr3:41288091-42003660:-	-0.78	-12.27	1.68E-29	Diastolic blood pressure	
STAD	cis	1	rs7617912	chr3:156576412	LEKR1	chr3:156544076-156763918:+	-0.36	-3.96	8.97E-5	Bone mineral density	
STAD	cis	1	rs76191812	chr20:33563911	PROCR	chr20:33758727-33765164:+	-0.46	-5.09	5.69E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs76192904	chr1:76359995	ACADM	chr1:76190043-76229353:+	-0.31	-4.52	8.1E-6	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs7619451	chr3:134233238	ANAPC13	chr3:134196547-134204865:-	0.33	5.42	1.05E-7	Height	
STAD	cis	1	rs7620458	chr3:156576850	LEKR1	chr3:156544076-156763918:+	-0.41	-4.65	4.55E-6	Bone mineral density	
STAD	cis	1	rs7622259	chr3:41881351	ULK4	chr3:41288091-42003660:-	0.78	12.44	3.76E-30	Diastolic blood pressure	
STAD	cis	1	rs762317	chr3:38497659	XYLB	chr3:38388251-38456467:+	0.21	4.26	2.61E-5	Electrocardiographic conduction measures	
STAD	cis	1	rs7624372	chr3:41881107	ULK4	chr3:41288091-42003660:-	0.78	12.44	3.76E-30	Diastolic blood pressure	
STAD	cis	1	rs76244536	chr2:73403620	STAMBP	chr2:74056086-74100759:+	-0.42	-3.83	0.000151	Schizophrenia	
STAD	cis	1	rs762676	chr22:51017794	CPT1B	chr22:51007291-51017096:-	-0.38	-5.23	2.71E-7	Narcolepsy	
STAD	cis	1	rs762677	chr22:51017713	CPT1B	chr22:51007291-51017096:-	-0.36	-4.89	1.48E-6	Narcolepsy	
STAD	cis	1	rs763014	chr16:675680	WFIKKN1	chr16:679239-684116:+	0.46	8.13	5.63E-15	Height	
STAD	cis	1	rs7630741	chr3:48419723	TREX1	chr3:48501186-48509043:+	-0.26	-5.81	1.28E-8	Longevity	
STAD	cis	1	rs7630874	chr3:134293291	ANAPC13	chr3:134196547-134204865:-	-0.39	-6.76	5.0E-11	Height	
STAD	cis	1	rs7631057	chr3:41817951	ULK4	chr3:41288091-42003660:-	0.75	11.93	3.59E-28	Diastolic blood pressure	
STAD	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	0.79	12.02	1.6E-28	Diastolic blood pressure	
STAD	cis	1	rs76329209	chr6:26196430	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.67E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs7633265	chr3:195048814	C3orf21	chr3:194789015-194991895:-	0.26	4.55	7.09E-6	Body mass index	
STAD	cis	1	rs7634377	chr3:48421258	TREX1	chr3:48501186-48509043:+	-0.26	-5.97	5.45E-9	Longevity	
STAD	cis	1	rs7635522	chr3:48423656	TREX1	chr3:48501186-48509043:+	-0.26	-6	4.45E-9	Longevity	
STAD	cis	1	rs7636044	chr3:48484560	TREX1	chr3:48501186-48509043:+	-0.25	-5.69	2.49E-8	Longevity	
STAD	cis	1	rs76363448	chr20:33655535	PROCR	chr20:33758727-33765164:+	-0.52	-5.61	3.82E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.26	-5.95	6.1E-9	Longevity	
STAD	cis	1	rs7637227	chr3:134244155	ANAPC13	chr3:134196547-134204865:-	0.39	6.91	2.02E-11	Height	
STAD	cis	1	rs763919	chr20:44016052	SYS1-DBNDD2	chr20:43991701-44039245:+	-0.26	-3.89	0.000119	Psoriasis	
STAD	cis	1	rs7639514	chr3:156576067	LEKR1	chr3:156544076-156763918:+	-0.39	-4.65	4.52E-6	Bone mineral density	
STAD	cis	1	rs76449854	chr22:30281664	DUSP18	chr22:31048039-31063872:-	-0.5	-3.95	9.1E-5	LDL cholesterol	
STAD	cis	1	rs7645295	chr3:134307734	ANAPC13	chr3:134196547-134204865:-	0.39	6.66	9.12E-11	Height	
STAD	cis	1	rs7645611	chr3:53125297	TMEM110	chr3:52867139-52931547:-	0.35	3.86	0.000134	Immune reponse to smallpox (secreted IL-2)	
STAD	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	0.78	11.87	5.89E-28	Diastolic blood pressure	
STAD	cis	1	rs76472382	chr14:59954385	C14orf149	chr14:59939406-59951126:-	-0.49	-4.63	4.88E-6	Schizophrenia	
STAD	cis	1	rs7648357	chr3:41849670	ULK4	chr3:41288091-42003660:-	0.79	12.29	1.38E-29	Diastolic blood pressure	
STAD	cis	1	rs7648578	chr3:41858731	ULK4	chr3:41288091-42003660:-	0.77	12.41	4.85E-30	Diastolic blood pressure	
STAD	cis	1	rs7648990	chr3:134244390	ANAPC13	chr3:134196547-134204865:-	0.38	6.88	2.38E-11	Height	
STAD	cis	1	rs7649340	chr3:87783074	HTR1F	chr3:88031726-88042919:+	-0.24	-3.95	9.3E-5	Electroencephalographic traits in alcoholism	
STAD	cis	1	rs7650227	chr3:41794937	ULK4	chr3:41288091-42003660:-	0.75	11.81	9.9E-28	Diastolic blood pressure	
STAD	cis	1	rs76507298	chr20:33623522	PROCR	chr20:33758727-33765164:+	-0.49	-5.22	2.9E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.26	-5.97	5.24E-9	Longevity	
STAD	cis	1	rs7651757	chr3:195077305	C3orf21	chr3:194789015-194991895:-	0.26	4.44	1.15E-5	Body mass index	
STAD	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.25	5.7	2.36E-8	Longevity	
STAD	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.44	-5.32	1.73E-7	Tumor biomarkers	
STAD	cis	1	rs76542740	chr15:43891512	CATSPER2	chr15:43922774-43959900:-	-0.39	-6.79	4.3E-11	Tumor biomarkers	
STAD	cis	1	rs76548544	chr5:150223515	LOC134466	chr5:150310000-150326146:-	0.3	4.8	2.28E-6	Crohn's disease	
STAD	cis	1	rs76553384	chr14:74383679	PTGR2	chr14:74318534-74352166:+	0.5	6.01	4.29E-9	Morning vs. evening chronotype	
STAD	cis	1	rs7655841	chr4:129890790	C4orf33	chr4:130014829-130033842:+	0.38	6.15	1.9E-9	Chronic obstructive pulmonary disease (moderate to severe)	
STAD	cis	1	rs7656037	chr4:39717965	RPL9	chr4:39455747-39460568:-	-0.31	-5.11	5.05E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
STAD	cis	1	rs76579763	chr14:59935971	C14orf149	chr14:59939406-59951126:-	-0.56	-5.16	3.92E-7	Schizophrenia	
STAD	cis	1	rs76594057	chr18:44637272	HDHD2	chr18:44633782-44676871:-	0.56	5.41	1.09E-7	Sitting height ratio	
STAD	cis	1	rs7659718	chr4:17638020	LAP3	chr4:17578927-17609590:+	-0.18	-3.8	0.000165	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs7661070	chr4:39724365	RPL9	chr4:39455747-39460568:-	-0.32	-5.39	1.2E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
STAD	cis	1	rs7661631	chr4:17679751	LAP3	chr4:17578927-17609590:+	0.19	3.88	0.000123	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs76648234	chr20:33689941	PROCR	chr20:33758727-33765164:+	-0.52	-5.55	5.41E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7665727	chr4:277057	ZNF718	chr4:53272-156488:+	0.32	3.8	0.000167	Immune response to smallpox vaccine (IL-6)	
STAD	cis	1	rs76683169	chr10:102358397	SEC31B	chr10:102246403-102289636:-	-0.22	-4.59	5.86E-6	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs7671752	chr4:17661398	LAP3	chr4:17578927-17609590:+	-0.18	-3.85	0.000135	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs76722536	chr6:26192946	HIST1H2AE	chr6:26217148-26217711:+	-0.31	-4.24	2.85E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs7673500	chr4:17621383	LAP3	chr4:17578927-17609590:+	-0.2	-4.13	4.4E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs767463	chr2:182457803	CERKL	chr2:182401402-182545381:-	-0.29	-4.97	1.0E-6	Response to iloperidone treatment (QT prolongation)	
STAD	cis	1	rs76812330	chr19:50531860	SIGLEC16	chr19:50472912-50479075:+	0.65	5.11	5.13E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
STAD	cis	1	rs7682402	chr4:1743343	FAM53A	chr4:1641609-1685854:-	-0.48	-7.17	3.76E-12	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs76841360	chr1:40060025	PPIEL	chr1:39987953-40025370:-	0.24	4.15	4.16E-5	C-reactive protein levels or triglyceride levels (pleiotropy)	
STAD	cis	1	rs76850134	chr20:33671725	PROCR	chr20:33758727-33765164:+	-0.52	-5.61	3.82E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7687557	chr4:39769260	RPL9	chr4:39455747-39460568:-	-0.29	-5.04	7.05E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
STAD	cis	1	rs7692919	chr4:165902781	C4orf39	chr4:165878100-165880273:+	0.19	4.22	3.01E-5	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs7693977	chr4:165903050	C4orf39	chr4:165878100-165880273:+	0.18	4.19	3.44E-5	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs7694020	chr4:17682597	LAP3	chr4:17578927-17609590:+	-0.2	-4.35	1.76E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs76971629	chr13:28051031	GTF3A	chr13:27998681-28009846:+	-0.38	-4.08	5.55E-5	Weight	
STAD	cis	1	rs7704297	chr5:148390295	ARHGEF37	chr5:148961135-149014527:+	0.25	3.9	0.000113	Diastolic blood pressure	
STAD	cis	1	rs7705093	chr5:96290647	ERAP1	chr5:96096515-96149837:-	-0.26	-5.15	4.16E-7	Birdshot chorioretinopathy	
STAD	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	1.05	31.57	1.83E-109	Birdshot chorioretinopathy	
STAD	cis	1	rs7705542	chr5:150228318	LOC134466	chr5:150310000-150326146:-	0.28	4.54	7.53E-6	Crohn's disease	
STAD	cis	1	rs7709388	chr5:150246539	LOC134466	chr5:150310000-150326146:-	0.32	5.05	6.68E-7	Crohn's disease	
STAD	cis	1	rs7709464	chr5:150269441	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs7709650	chr5:150246685	LOC134466	chr5:150310000-150326146:-	0.32	5.19	3.43E-7	Crohn's disease	
STAD	cis	1	rs77114905	chr5:148385614	ARHGEF37	chr5:148961135-149014527:+	0.25	3.88	0.000125	Diastolic blood pressure	
STAD	cis	1	rs7714415	chr5:150270292	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs7714584	chr5:150270420	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs7715981	chr5:150258107	LOC134466	chr5:150310000-150326146:-	0.3	4.7	3.59E-6	Crohn's disease	
STAD	cis	1	rs7716903	chr5:150258574	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs77187281	chr19:50507667	SIGLEC16	chr19:50472912-50479075:+	0.69	5.36	1.44E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
STAD	cis	1	rs7724036	chr5:150284808	LOC134466	chr5:150310000-150326146:-	-0.29	-4.85	1.81E-6	Crohn's disease	
STAD	cis	1	rs77257477	chr8:96045399	C8orf38	chr8:95908040-96088396:+	-0.34	-3.98	8.07E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs77279246	chr11:96109554	CCDC82	chr11:96085930-96123083:-	-0.38	-4.25	2.69E-5	Parkinson's disease	
STAD	cis	1	rs7732643	chr5:150261436	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs7732945	chr5:150261601	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs7734778	chr5:150256556	LOC134466	chr5:150310000-150326146:-	0.31	4.98	9.44E-7	Crohn's disease	
STAD	cis	1	rs7734928	chr5:150256613	LOC134466	chr5:150310000-150326146:-	0.31	4.98	9.4E-7	Crohn's disease	
STAD	cis	1	rs7736554	chr5:150258308	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs7736873	chr5:150258482	LOC134466	chr5:150310000-150326146:-	0.29	4.65	4.54E-6	Crohn's disease	
STAD	cis	1	rs7737208	chr5:130400016	LYRM7	chr5:130506641-130541119:+	0.28	3.94	9.71E-5	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
STAD	cis	1	rs7740487	chr6:28216486	ZNF323	chr6:28292517-28324048:-	0.29	3.9	0.000115	Depression	
STAD	cis	1	rs7740487	chr6:28216486	ZSCAN23	chr6:28393287-28411279:-	0.24	3.85	0.000135	Depression	
STAD	cis	1	rs77437249	chr20:33564738	PROCR	chr20:33758727-33765164:+	-0.46	-5.09	5.69E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs77477310	chr14:35615793	PPP2R3C	chr14:35554679-35591679:-	0.26	3.84	0.000141	Atopic dermatitis	
STAD	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.72	-15.29	1.07E-41	Response to antipsychotic treatment	
STAD	cis	1	rs7750918	chr6:49430082	MUT	chr6:49398994-49431031:-	0.37	6.86	2.64E-11	Folate pathway vitamin levels	
STAD	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs7759001	chr6:27341409	ZNF391	chr6:27356524-27369227:+	0.34	5.08	5.92E-7	Glomerular filtration rate (creatinine)	
STAD	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.25	-5.17	3.78E-7	Homocysteine levels	
STAD	cis	1	rs7759071	chr6:49433198	MUT	chr6:49398994-49431031:-	0.23	4.13	4.48E-5	Homocysteine levels	
STAD	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.66	-13.11	9.01E-33	Response to antipsychotic treatment	
STAD	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.72	-15.26	1.41E-41	Response to antipsychotic treatment	
STAD	cis	1	rs77698001	chr5:150250367	LOC134466	chr5:150310000-150326146:-	0.32	5.19	3.43E-7	Crohn's disease	
STAD	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs7774688	chr6:49387292	CENPQ	chr6:49431096-49460820:+	-0.25	-5.31	1.89E-7	Homocysteine levels	
STAD	cis	1	rs7774688	chr6:49387292	MUT	chr6:49398994-49431031:-	0.23	4.22	2.99E-5	Homocysteine levels	
STAD	cis	1	rs7777389	chr7:143744802	ARHGEF35	chr7:143883677-143892736:-	-0.39	-6.08	2.93E-9	Obesity-related traits	
STAD	cis	1	rs77789667	chr14:59940418	C14orf149	chr14:59939406-59951126:-	-0.53	-4.71	3.5E-6	Schizophrenia	
STAD	cis	1	rs77790737	chr8:96037156	C8orf38	chr8:95908040-96088396:+	-0.34	-4.13	4.4E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.33	6.06	3.17E-9	Tuberculosis	
STAD	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.33	6.13	2.1E-9	Tuberculosis	
STAD	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.32	6.03	3.79E-9	Tuberculosis	
STAD	cis	1	rs7794661	chr7:65389730	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs7795242	chr7:65390094	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs77957229	chr6:26185226	HIST1H2AE	chr6:26217148-26217711:+	-0.35	-4.71	3.46E-6	Renal underexcretion gout;Gout	
STAD	cis	1	rs77961951	chr6:26186075	HIST1H2AE	chr6:26217148-26217711:+	-0.35	-4.67	4.21E-6	Renal underexcretion gout;Gout	
STAD	cis	1	rs78012445	chr6:26195080	HIST1H2AE	chr6:26217148-26217711:+	-0.33	-4.45	1.14E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs78013255	chr5:148397622	ARHGEF37	chr5:148961135-149014527:+	0.25	3.95	9.35E-5	Diastolic blood pressure	
STAD	cis	1	rs7802797	chr7:110911133	IMMP2L	chr7:110303110-111202538:-	0.24	3.96	9.01E-5	Schizophrenia	
STAD	cis	1	rs78055011	chr20:33618606	PROCR	chr20:33758727-33765164:+	-0.48	-5.19	3.46E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs78075821	chr1:171724645	VAMP4	chr1:171669298-171711214:-	0.34	6.23	1.21E-9	Hippocampal atrophy	
STAD	cis	1	rs78124692	chr3:46202237	CCR2	chr3:46395235-46402412:+	0.22	3.94	9.68E-5	Celiac disease	
STAD	cis	1	rs7815944	chr8:129427518	MYC	chr8:128747765-128753678:+	-0.33	-3.89	0.000119	Atopic dermatitis	
STAD	cis	1	rs78177356	chr14:60008967	C14orf149	chr14:59939406-59951126:-	-0.59	-5.7	2.33E-8	Schizophrenia	
STAD	cis	1	rs7818688	chr8:96024082	C8orf38	chr8:95908040-96088396:+	-0.34	-4.12	4.64E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs78202808	chr20:33667424	PROCR	chr20:33758727-33765164:+	-0.49	-5.32	1.78E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs78207779	chr14:35506387	PPP2R3C	chr14:35554679-35591679:-	0.28	3.9	0.000112	Atopic dermatitis	
STAD	cis	1	rs78210154	chr11:96109480	CCDC82	chr11:96085930-96123083:-	-0.38	-4.25	2.69E-5	Parkinson's disease	
STAD	cis	1	rs78213404	chr1:171685491	VAMP4	chr1:171669298-171711214:-	0.34	6.29	8.76E-10	Hippocampal atrophy	
STAD	cis	1	rs7821592	chr8:21811530	NPM2	chr8:21881636-21894407:+	-0.23	-3.92	0.000105	Mean corpuscular volume	
STAD	cis	1	rs7822232	chr8:145145687	KIAA1875	chr8:145162629-145173218:+	-0.53	-4.52	8.1E-6	Blood metabolite levels	
STAD	cis	1	rs78223982	chr1:76465203	ACADM	chr1:76190043-76229353:+	-0.31	-4.32	1.94E-5	Attention function in attention deficit hyperactive disorder	
STAD	cis	1	rs782594	chr2:55844445	PNPT1	chr2:55861198-55921011:-	-0.18	-4.17	3.81E-5	Metabolic syndrome	
STAD	cis	1	rs78273785	chr13:28052884	GTF3A	chr13:27998681-28009846:+	-0.38	-4.08	5.55E-5	Weight	
STAD	cis	1	rs7832570	chr8:96023795	C8orf38	chr8:95908040-96088396:+	-0.34	-4.05	6.16E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs78431982	chr11:96105659	CCDC82	chr11:96085930-96123083:-	-0.36	-3.9	0.000112	Parkinson's disease	
STAD	cis	1	rs7849160	chr9:131874552	CRAT	chr9:131857075-131873070:-	0.27	4.87	1.65E-6	Blood metabolite ratios	
STAD	cis	1	rs7849160	chr9:131874552	PPP2R4	chr9:131873244-131911223:+	0.23	4.73	3.15E-6	Blood metabolite ratios	
STAD	cis	1	rs7849270	chr9:131874641	CRAT	chr9:131857075-131873070:-	0.26	4.62	5.3E-6	Blood metabolite ratios	
STAD	cis	1	rs7849270	chr9:131874641	PPP2R4	chr9:131873244-131911223:+	0.22	4.44	1.16E-5	Blood metabolite ratios	
STAD	cis	1	rs78520676	chr11:517173	RNH1	chr11:494512-507273:-	-0.42	-5.2	3.15E-7	Body mass index	
STAD	cis	1	rs785485	chr1:46574424	CCDC163P	chr1:45960581-45965646:-	-0.22	-3.84	0.000146	Body mass index	
STAD	cis	1	rs785488	chr1:46576095	CCDC163P	chr1:45960581-45965646:-	-0.22	-3.84	0.000146	Body mass index	
STAD	cis	1	rs785489	chr1:46576390	CCDC163P	chr1:45960581-45965646:-	-0.22	-3.84	0.000146	Body mass index	
STAD	cis	1	rs785491	chr1:46583418	CCDC163P	chr1:45960581-45965646:-	-0.22	-3.91	0.000108	Body mass index	
STAD	cis	1	rs785492	chr1:46583607	CCDC163P	chr1:45960581-45965646:-	-0.22	-3.91	0.000108	Body mass index	
STAD	cis	1	rs785494	chr1:46586626	CCDC163P	chr1:45960581-45965646:-	-0.22	-3.89	0.000119	Body mass index	
STAD	cis	1	rs785495	chr1:46587887	CCDC163P	chr1:45960581-45965646:-	-0.22	-3.9	0.000111	Body mass index	
STAD	cis	1	rs785503	chr1:46595868	CCDC163P	chr1:45960581-45965646:-	-0.22	-3.91	0.000108	Body mass index	
STAD	cis	1	rs785520	chr1:46568836	CCDC163P	chr1:45960581-45965646:-	-0.22	-3.84	0.000146	Body mass index	
STAD	cis	1	rs7855278	chr9:131921365	CRAT	chr9:131857075-131873070:-	-0.28	-5.07	6.22E-7	Blood metabolite ratios	
STAD	cis	1	rs7855278	chr9:131921365	PPP2R4	chr9:131873244-131911223:+	-0.24	-4.88	1.57E-6	Blood metabolite ratios	
STAD	cis	1	rs786425	chr12:124085502	DDX55	chr12:124086672-124105483:+	0.26	5.31	1.86E-7	Pubertal anthropometrics	
STAD	cis	1	rs7868408	chr9:131917864	CRAT	chr9:131857075-131873070:-	0.28	4.97	9.82E-7	Blood metabolite ratios	
STAD	cis	1	rs7868408	chr9:131917864	PPP2R4	chr9:131873244-131911223:+	0.22	4.58	6.32E-6	Blood metabolite ratios	
STAD	cis	1	rs7869804	chr9:131913144	CRAT	chr9:131857075-131873070:-	0.27	4.89	1.47E-6	Blood metabolite ratios	
STAD	cis	1	rs7869804	chr9:131913144	PPP2R4	chr9:131873244-131911223:+	0.22	4.61	5.48E-6	Blood metabolite ratios	
STAD	cis	1	rs78724141	chr8:82659661	CHMP4C	chr8:82644688-82671746:+	-0.97	-9.93	7.3E-21	Epithelial ovarian cancer;Ovarian cancer	
STAD	cis	1	rs78740005	chr8:82659306	CHMP4C	chr8:82644688-82671746:+	-0.98	-9.96	5.93E-21	Epithelial ovarian cancer;Ovarian cancer	
STAD	cis	1	rs78803505	chr7:65382572	CCT6P1	chr7:65216092-65228661:+	0.28	4.14	4.33E-5	Diabetic kidney disease	
STAD	cis	1	rs7893456	chr10:5007862	AKR1C1	chr10:4934796-5020157:+	0.36	4.03	6.71E-5	Height	
STAD	cis	1	rs78967641	chr20:33783053	PROCR	chr20:33758727-33765164:+	-0.5	-5.68	2.7E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs79021324	chr14:59941424	C14orf149	chr14:59939406-59951126:-	-0.53	-4.71	3.5E-6	Schizophrenia	
STAD	cis	1	rs79048371	chr20:33731484	PROCR	chr20:33758727-33765164:+	-0.51	-5.67	2.85E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs7905961	chr10:102297391	SEC31B	chr10:102246403-102289636:-	-0.24	-5.71	2.21E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.71	15.25	1.68E-41	Response to antipsychotic treatment	
STAD	cis	1	rs79197732	chr20:33562476	PROCR	chr20:33758727-33765164:+	-0.46	-5.09	5.69E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs79199019	chr14:35581125	PPP2R3C	chr14:35554679-35591679:-	0.3	4.37	1.57E-5	Atopic dermatitis	
STAD	cis	1	rs79264785	chr6:26194121	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.67E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs7927771	chr11:47781306	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.71	1.09E-13	Subjective well-being	
STAD	cis	1	rs7928083	chr11:48613148	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.86	0.000131	HDL cholesterol	
STAD	cis	1	rs79318564	chr15:84786150	LOC388152	chr15:84867600-84898920:-	-0.27	-3.9	0.000111	Schizophrenia	
STAD	cis	1	rs79341738	chr20:33702104	PROCR	chr20:33758727-33765164:+	-0.48	-5.27	2.31E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs79366248	chr4:266659	ZNF718	chr4:53272-156488:+	0.33	3.85	0.000137	Immune response to smallpox vaccine (IL-6)	
STAD	cis	1	rs79396265	chr8:96071272	C8orf38	chr8:95908040-96088396:+	-0.35	-4.08	5.46E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs794149	chr4:109960242	CASP6	chr4:110609785-110624629:-	0.18	3.91	0.000107	Body mass index	
STAD	cis	1	rs79436302	chr14:35578797	PPP2R3C	chr14:35554679-35591679:-	0.3	4.37	1.57E-5	Atopic dermatitis	
STAD	cis	1	rs79438986	chr20:33702280	PROCR	chr20:33758727-33765164:+	-0.52	-5.52	6.34E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs79439610	chr20:33654689	PROCR	chr20:33758727-33765164:+	-0.52	-5.56	4.96E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs79440439	chr11:478147	RNH1	chr11:494512-507273:-	-0.43	-5.64	3.34E-8	Body mass index	
STAD	cis	1	rs7944356	chr11:48610154	C1QTNF4	chr11:47611216-47615961:-	-0.17	-3.86	0.000131	HDL cholesterol	
STAD	cis	1	rs7947378	chr11:18381327	GTF2H1	chr11:18343816-18388590:+	0.37	6.04	3.55E-9	Pancreatic cancer	
STAD	cis	1	rs7947730	chr11:47786184	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.71	1.09E-13	Subjective well-being	
STAD	cis	1	rs7949348	chr11:48493801	C1QTNF4	chr11:47611216-47615961:-	-0.18	-4.17	3.79E-5	HDL cholesterol	
STAD	cis	1	rs7953014	chr12:109998097	MYO1H	chr12:109826524-109886176:+	0.21	3.98	8.29E-5	HDL cholesterol	
STAD	cis	1	rs7954144	chr12:110015893	MYO1H	chr12:109826524-109886176:+	0.21	3.97	8.41E-5	HDL cholesterol	
STAD	cis	1	rs7957145	chr12:57302120	ARHGAP9	chr12:57866039-57882597:-	-0.15	-4.67	4.07E-6	Airway wall thickness	
STAD	cis	1	rs79602855	chr19:50525725	SIGLEC16	chr19:50472912-50479075:+	0.77	5.73	1.96E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
STAD	cis	1	rs79633979	chr19:50488612	SIGLEC16	chr19:50472912-50479075:+	0.69	5.5	6.8E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
STAD	cis	1	rs7964021	chr12:109997645	MYO1H	chr12:109826524-109886176:+	0.21	3.98	8.29E-5	HDL cholesterol	
STAD	cis	1	rs79702597	chr14:35558856	PPP2R3C	chr14:35554679-35591679:-	0.31	4.49	9.38E-6	Atopic dermatitis	
STAD	cis	1	rs7970815	chr12:129288366	MGC16384	chr12:129297749-129299295:-	-0.22	-4.46	1.07E-5	Systemic lupus erythematosus	
STAD	cis	1	rs79716074	chr2:277003	SH3YL1	chr2:218138-264810:-	-0.6	-12.82	1.23E-31	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs7980687	chr12:123822711	CDK2AP1	chr12:123745542-123756687:-	-0.42	-6.61	1.24E-10	Educational attainment;Height;Head circumference (infant)	
STAD	cis	1	rs79808876	chr11:465763	RNH1	chr11:494512-507273:-	-0.43	-5.77	1.6E-8	Body mass index	
STAD	cis	1	rs79831012	chr10:102237059	SEC31B	chr10:102246403-102289636:-	-0.25	-6.13	2.11E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs79868973	chr6:26189312	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.42	1.28E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs798719	chr4:1698183	FAM53A	chr4:1641609-1685854:-	-0.46	-6.96	1.48E-11	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs798724	chr4:1704643	FAM53A	chr4:1641609-1685854:-	-0.43	-6.74	5.67E-11	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs798741	chr4:1712413	FAM53A	chr4:1641609-1685854:-	-0.44	-7.04	8.6E-12	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs798744	chr4:1714684	FAM53A	chr4:1641609-1685854:-	-0.46	-7.02	9.98E-12	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs798754	chr4:1720757	FAM53A	chr4:1641609-1685854:-	-0.43	-6.69	7.61E-11	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs798755	chr4:1720824	FAM53A	chr4:1641609-1685854:-	-0.41	-6.31	7.7E-10	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs798756	chr4:1707447	FAM53A	chr4:1641609-1685854:-	-0.45	-6.76	5.13E-11	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs798762	chr4:1731150	FAM53A	chr4:1641609-1685854:-	-0.45	-6.85	2.94E-11	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs798766	chr4:1734239	FAM53A	chr4:1641609-1685854:-	0.46	6.86	2.74E-11	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs798767	chr4:1734281	FAM53A	chr4:1641609-1685854:-	-0.47	-6.89	2.29E-11	Urinary bladder cancer;Bladder cancer	
STAD	cis	1	rs79888893	chr14:35510676	PPP2R3C	chr14:35554679-35591679:-	0.29	4.09	5.23E-5	Atopic dermatitis	
STAD	cis	1	rs7992643	chr13:100555038	CLYBL	chr13:100258936-100544823:+	-0.25	-4.36	1.7E-5	Attention deficit hyperactivity disorder	
STAD	cis	1	rs79986235	chr2:219944135	SLC23A3	chr2:220026183-220034817:-	0.38	4.49	9.47E-6	Height	
STAD	cis	1	rs7999059	chr13:44807194	SERP2	chr13:44947978-44971849:+	0.22	3.8	0.000165	Amyotrophic lateral sclerosis	
STAD	cis	1	rs80007414	chr3:46202238	CCR2	chr3:46395235-46402412:+	0.22	3.94	9.68E-5	Celiac disease	
STAD	cis	1	rs8002861	chr13:44474517	CCDC122	chr13:44410491-44453826:-	-0.28	-5.18	3.48E-7	Leprosy	
STAD	cis	1	rs8003506	chr14:75586288	MLH3	chr14:75480467-75518235:-	-0.21	-4.07	5.73E-5	Height	
STAD	cis	1	rs8006419	chr14:65500735	CHURC1	chr14:65381140-65411309:+	-0.2	-3.94	9.61E-5	Red blood cell traits	
STAD	cis	1	rs80075680	chr5:150223737	LOC134466	chr5:150310000-150326146:-	0.3	4.85	1.76E-6	Crohn's disease	
STAD	cis	1	rs80076579	chr4:106991115	TBCK	chr4:106967233-107237861:-	0.25	3.88	0.000125	Airflow obstruction	
STAD	cis	1	rs80095925	chr6:26184942	HIST1H2AE	chr6:26217148-26217711:+	-0.35	-4.67	4.21E-6	Renal underexcretion gout;Gout	
STAD	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.44	-8.96	1.31E-17	IgG glycosylation	
STAD	cis	1	rs80109502	chr20:33587596	PROCR	chr20:33758727-33765164:+	-0.46	-4.89	1.47E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs8013540	chr14:35513760	PPP2R3C	chr14:35554679-35591679:-	0.27	3.87	0.000129	Atopic dermatitis	
STAD	cis	1	rs80170004	chr20:33551462	PROCR	chr20:33758727-33765164:+	-0.49	-5.21	3.0E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs8018967	chr14:73976934	HEATR4	chr14:73945193-74025651:-	-0.2	-3.82	0.000156	Blood metabolite ratios	
STAD	cis	1	rs8019491	chr14:66168110	LOC645431	chr14:65877313-65879335:-	-0.34	-3.95	9.3E-5	Ischemic stroke	
STAD	cis	1	rs80202648	chr19:50494386	SIGLEC16	chr19:50472912-50479075:+	0.69	5.42	1.03E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
STAD	cis	1	rs8023482	chr15:40307095	SRP14	chr15:40327891-40331389:-	-0.25	-3.85	0.000138	Response to haloperidol in psychosis	
STAD	cis	1	rs8023776	chr15:90897952	IQGAP1	chr15:90931473-91045475:+	-0.23	-3.95	9.13E-5	Rheumatoid arthritis	
STAD	cis	1	rs80252525	chr1:54358596	YIPF1	chr1:54317407-54355453:-	0.5	3.84	0.000145	Nonalcoholic fatty liver disease	
STAD	cis	1	rs80259160	chr6:26190199	HIST1H2AE	chr6:26217148-26217711:+	-0.33	-4.45	1.14E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs80277764	chr20:33739456	PROCR	chr20:33758727-33765164:+	-0.53	-5.82	1.26E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs80285556	chr19:50540170	SIGLEC16	chr19:50472912-50479075:+	0.65	5.04	7.07E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
STAD	cis	1	rs80313145	chr6:26194965	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.28	2.39E-5	Renal underexcretion gout;Gout	
STAD	cis	1	rs80314222	chr19:50525514	SIGLEC16	chr19:50472912-50479075:+	0.77	5.73	1.96E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
STAD	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.59	-8.78	5.08E-17	Type 2 diabetes	
STAD	cis	1	rs8049173	chr16:11436882	C16orf75	chr16:11343506-11445617:+	0.28	3.87	0.000129	Vein graft stenosis in coronary artery bypass grafting	
STAD	cis	1	rs8055187	chr16:158324	NPRL3	chr16:134273-188672:-	0.24	3.86	0.000131	Red blood cell traits	
STAD	cis	1	rs8055427	chr16:11436883	C16orf75	chr16:11343506-11445617:+	0.28	3.87	0.000129	Vein graft stenosis in coronary artery bypass grafting	
STAD	cis	1	rs8062783	chr16:74691264	RFWD3	chr16:74655298-74700779:-	0.22	5.08	5.85E-7	Testicular germ cell tumor	
STAD	cis	1	rs8065437	chr17:45721653	C17orf57	chr17:45401142-45518675:+	0.3	6.38	5.03E-10	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
STAD	cis	1	rs8065669	chr17:45724996	C17orf57	chr17:45401142-45518675:+	0.31	6.6	1.36E-10	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
STAD	cis	1	rs8069687	chr17:61883023	DDX42	chr17:61851567-61896676:+	0.29	4.75	2.91E-6	Body mass index	
STAD	cis	1	rs8070446	chr17:40285879	DHX58	chr17:40253422-40264751:-	-0.34	-6.2	1.48E-9	Fibrinogen levels	
STAD	cis	1	rs8070454	chr17:38160754	GSDMA	chr17:38119226-38134019:+	-0.32	-5.77	1.6E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs8072100	chr17:45674687	C17orf57	chr17:45401142-45518675:+	-0.29	-6.23	1.23E-9	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
STAD	cis	1	rs8072215	chr17:40271970	DHX58	chr17:40253422-40264751:-	-0.36	-6.74	5.74E-11	Fibrinogen levels	
STAD	cis	1	rs8074708	chr17:40286354	DHX58	chr17:40253422-40264751:-	0.34	6.32	7.03E-10	Fibrinogen levels	
STAD	cis	1	rs8076336	chr17:18212614	LOC220594	chr17:18414577-18445234:-	0.24	3.95	9.4E-5	Parental longevity (combined parental age at death)	
STAD	cis	1	rs8076336	chr17:18212614	TOP3A	chr17:18177235-18218321:-	0.19	3.92	0.000103	Parental longevity (combined parental age at death)	
STAD	cis	1	rs807670	chr22:19154608	SLC25A1	chr22:19163095-19166301:-	-0.21	-4.34	1.85E-5	Metabolite levels	
STAD	cis	1	rs8077577	chr17:18064730	ALKBH5	chr17:18086867-18113265:+	-0.27	-3.91	0.000109	Obesity-related traits	
STAD	cis	1	rs8078723	chr17:38166879	GSDMA	chr17:38119226-38134019:+	-0.32	-5.66	3.02E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
STAD	cis	1	rs8090276	chr18:8331233	NDUFV2	chr18:9102675-9134336:+	0.27	4.24	2.84E-5	Sitting height ratio	
STAD	cis	1	rs8099917	chr19:39743165	NCCRP1	chr19:39687604-39692522:+	0.26	3.84	0.000145	Response to hepatitis C treatment;Chronic hepatitis C infection	
STAD	cis	1	rs8103622	chr19:18572834	ISYNA1	chr19:18545625-18548943:-	0.25	4.3	2.14E-5	Breast cancer	
STAD	cis	1	rs8105994	chr19:18593553	ISYNA1	chr19:18545625-18548943:-	0.24	4.01	7.23E-5	Breast cancer	
STAD	cis	1	rs8106096	chr19:18536416	ISYNA1	chr19:18545625-18548943:-	0.23	3.91	0.00011	Breast cancer	
STAD	cis	1	rs8107367	chr19:18564705	ISYNA1	chr19:18545625-18548943:-	0.24	4.25	2.7E-5	Breast cancer	
STAD	cis	1	rs8109573	chr19:18617151	ISYNA1	chr19:18545625-18548943:-	0.25	4.41	1.35E-5	Breast cancer	
STAD	cis	1	rs8111708	chr19:18558876	ISYNA1	chr19:18545625-18548943:-	0.23	4.08	5.54E-5	Breast cancer	
STAD	cis	1	rs8117100	chr20:33692261	PROCR	chr20:33758727-33765164:+	-0.5	-5.43	1.0E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs8117847	chr20:33642480	PROCR	chr20:33758727-33765164:+	-0.41	-4.6	5.6E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs8118005	chr20:33636219	PROCR	chr20:33758727-33765164:+	-0.49	-5.35	1.5E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs8118978	chr20:33574458	PROCR	chr20:33758727-33765164:+	-0.46	-5.07	6.03E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs8119827	chr20:33726873	PROCR	chr20:33758727-33765164:+	-0.48	-5.32	1.75E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs8121957	chr20:33676109	PROCR	chr20:33758727-33765164:+	-0.49	-5.39	1.22E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs8123978	chr20:33598789	PROCR	chr20:33758727-33765164:+	-0.46	-4.89	1.47E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs8124662	chr20:33639256	PROCR	chr20:33758727-33765164:+	-0.48	-5.26	2.38E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs8137478	chr22:51017296	CPT1B	chr22:51007291-51017096:-	-0.38	-5.23	2.71E-7	Narcolepsy	
STAD	cis	1	rs8138799	chr22:24556902	SUSD2	chr22:24577444-24585074:+	0.88	8.67	1.15E-16	Amyotrophic lateral sclerosis	
STAD	cis	1	rs8138996	chr22:39047435	LOC646851	chr22:38974125-39052634:-	0.23	4.86	1.73E-6	Resting heart rate	
STAD	cis	1	rs8140617	chr22:38970439	LOC646851	chr22:38974125-39052634:-	-0.25	-5.29	2.06E-7	Resting heart rate	
STAD	cis	1	rs8141797	chr22:24582041	SUSD2	chr22:24577444-24585074:+	-0.8	-8.13	5.61E-15	Amyotrophic lateral sclerosis	
STAD	cis	1	rs8142098	chr22:39058757	LOC646851	chr22:38974125-39052634:-	0.24	5.05	6.87E-7	Resting heart rate	
STAD	cis	1	rs8170	chr19:17389704	OCEL1	chr19:17337055-17340027:+	0.33	4.67	4.25E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
STAD	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.41	6.99	1.18E-11	Multiple sclerosis	
STAD	cis	1	rs8181644	chr12:58173466	TSFM	chr12:58176536-58191367:+	-0.32	-6.75	5.53E-11	Multiple sclerosis	
STAD	cis	1	rs823144	chr1:205744546	RAB7L1	chr1:205737115-205744610:-	0.3	4.84	1.9E-6	Parkinson's disease	
STAD	cis	1	rs823301	chr3:195123495	C3orf21	chr3:194789015-194991895:-	-0.26	-4.49	9.31E-6	Body mass index	
STAD	cis	1	rs823306	chr3:195108320	C3orf21	chr3:194789015-194991895:-	-0.26	-4.49	9.24E-6	Body mass index	
STAD	cis	1	rs823310	chr3:195127093	C3orf21	chr3:194789015-194991895:-	-0.26	-4.49	9.24E-6	Body mass index	
STAD	cis	1	rs823314	chr3:195132402	C3orf21	chr3:194789015-194991895:-	-0.26	-4.49	9.24E-6	Body mass index	
STAD	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	0.88	17.74	4.91E-52	Type 2 diabetes	
STAD	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.88	17.55	2.94E-51	Type 2 diabetes	
STAD	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.87	17.09	2.81E-49	Type 2 diabetes	
STAD	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	0.87	18.12	1.08E-53	Type 2 diabetes	
STAD	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	0.87	18.05	2.15E-53	Type 2 diabetes	
STAD	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	0.87	18.03	2.76E-53	Type 2 diabetes	
STAD	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.88	17.79	3.04E-52	Type 2 diabetes	
STAD	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	0.88	17.64	1.23E-51	Type 2 diabetes	
STAD	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	0.88	17.74	4.91E-52	Type 2 diabetes	
STAD	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.88	-17.5	4.89E-51	Type 2 diabetes	
STAD	cis	1	rs853676	chr6:28299687	ZNF323	chr6:28292517-28324048:-	0.33	4.56	6.87E-6	Depression	
STAD	cis	1	rs853678	chr6:28297313	ZNF323	chr6:28292517-28324048:-	0.33	4.58	6.15E-6	Depression	
STAD	cis	1	rs853679	chr6:28296863	ZNF323	chr6:28292517-28324048:-	0.33	4.58	6.15E-6	Depression	
STAD	cis	1	rs853685	chr6:28288785	ZNF323	chr6:28292517-28324048:-	0.33	4.58	6.15E-6	Depression	
STAD	cis	1	rs853694	chr6:28279100	ZNF323	chr6:28292517-28324048:-	0.33	4.58	6.15E-6	Depression	
STAD	cis	1	rs8589	chr6:49403282	CENPQ	chr6:49431096-49460820:+	-0.26	-5.42	1.03E-7	Homocysteine levels	
STAD	cis	1	rs8589	chr6:49403282	MUT	chr6:49398994-49431031:-	0.23	4.12	4.59E-5	Homocysteine levels	
STAD	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.87	-18.24	3.39E-54	Type 2 diabetes	
STAD	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	0.88	17.74	4.91E-52	Type 2 diabetes	
STAD	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.84	16.4	2.4E-46	Type 2 diabetes	
STAD	cis	1	rs864643	chr3:39555580	ENTPD3	chr3:40428673-40470109:+	-0.23	-3.81	0.000162	Attention deficit hyperactivity disorder	
STAD	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	0.88	17.74	4.91E-52	Type 2 diabetes	
STAD	cis	1	rs867186	chr20:33764554	PROCR	chr20:33758727-33765164:+	0.48	5.79	1.44E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs868945	chr2:219924439	SLC23A3	chr2:220026183-220034817:-	0.37	4.32	1.95E-5	Height	
STAD	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.48	9.51	2.0E-19	Kawasaki disease	
STAD	cis	1	rs877636	chr12:56480583	MYO1A	chr12:57422302-57443901:-	-0.19	-4.3	2.14E-5	Cognitive function	
STAD	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.49	-9.72	3.85E-20	Cognitive function	
STAD	cis	1	rs877710	chr12:109993976	MMAB	chr12:109991523-110011358:-	-0.2	-3.8	0.000168	HDL cholesterol	
STAD	cis	1	rs877710	chr12:109993976	MYO1H	chr12:109826524-109886176:+	0.21	4.09	5.19E-5	HDL cholesterol	
STAD	cis	1	rs879568	chr18:34311659	C18orf10	chr18:34366472-34409158:-	-0.34	-5.03	7.38E-7	QRS duration	
STAD	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.36	-6.37	5.47E-10	Rheumatoid arthritis	
STAD	cis	1	rs881827	chr21:48019868	C21orf56	chr21:47581063-47604373:-	-0.28	-4.51	8.43E-6	Lymphocyte counts	
STAD	cis	1	rs881827	chr21:48019868	C21orf57	chr21:47706267-47717664:+	-0.28	-4.54	7.39E-6	Lymphocyte counts	
STAD	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.46	-7.41	7.97E-13	Homocysteine levels	
STAD	cis	1	rs883565	chr3:39055317	TTC21A	chr3:39149152-39180394:+	0.24	4.58	6.34E-6	Handedness	
STAD	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.66	-13	2.4E-32	Response to antipsychotic treatment	
STAD	cis	1	rs888192	chr12:109995097	MYO1H	chr12:109826524-109886176:+	-0.21	-4.14	4.35E-5	HDL cholesterol	
STAD	cis	1	rs889312	chr5:56031884	C5orf35	chr5:56205103-56213010:+	0.27	4.43	1.24E-5	Breast cancer (early onset);Breast cancer	
STAD	cis	1	rs8897	chr3:49460407	CCDC36	chr3:49235861-49295537:+	0.21	3.92	0.000106	Menarche (age at onset)	
STAD	cis	1	rs891368	chr3:53123273	RFT1	chr3:53122503-53164470:-	-0.24	-3.87	0.000126	Height	
STAD	cis	1	rs892055	chr19:38912764	C19orf33	chr19:38794804-38795646:+	0.18	3.83	0.000149	Asperger disorder	
STAD	cis	1	rs892864	chr5:127835859	FBN2	chr5:127593602-127873916:-	0.47	4.07	5.7E-5	Multiple system atrophy	
STAD	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.27	6.06	3.21E-9	Longevity	
STAD	cis	1	rs906134	chr7:65444288	CCT6P1	chr7:65216092-65228661:+	0.27	4.02	6.99E-5	Diabetic kidney disease	
STAD	cis	1	rs916134	chr12:54069803	ATP5G2	chr12:54058945-54070512:-	0.24	4.87	1.61E-6	Height	
STAD	cis	1	rs917911	chr12:9905851	CLECL1	chr12:9868457-9885860:-	0.18	5.38	1.26E-7	Type 1 diabetes	
STAD	cis	1	rs9213	chr2:218386	SH3YL1	chr2:218138-264810:-	-0.58	-11.99	2.13E-28	Spherical equivalent (joint main effects and education interaction)	
STAD	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.25	5.66	2.93E-8	Longevity	
STAD	cis	1	rs926299	chr22:39095698	LOC646851	chr22:38974125-39052634:-	0.27	5.71	2.27E-8	Resting heart rate	
STAD	cis	1	rs927579	chr13:28075079	GTF3A	chr13:27998681-28009846:+	-0.36	-3.87	0.000128	Weight	
STAD	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.86	16.95	1.09E-48	Type 2 diabetes	
STAD	cis	1	rs9289275	chr3:125648659	LOC100125556	chr3:125635444-125648865:+	0.64	8.22	3.14E-15	Blood pressure (smoking interaction)	
STAD	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.4	7.41	8.04E-13	Height	
STAD	cis	1	rs9289475	chr3:134236459	ANAPC13	chr3:134196547-134204865:-	0.39	7	1.12E-11	Height	
STAD	cis	1	rs9289476	chr3:134237103	ANAPC13	chr3:134196547-134204865:-	0.39	7.01	1.03E-11	Height	
STAD	cis	1	rs9289478	chr3:134268619	ANAPC13	chr3:134196547-134204865:-	0.39	6.93	1.77E-11	Height	
STAD	cis	1	rs9291659	chr4:17662360	LAP3	chr4:17578927-17609590:+	-0.19	-4.16	4.0E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs9296095	chr6:33542523	TAPBP	chr6:33267472-33281989:-	-0.23	-3.86	0.000135	Platelet count	
STAD	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.81	17.5	5.0E-51	Plasma homocysteine levels (post-methionine load test)	
STAD	cis	1	rs9296504	chr6:46629505	TDRD6	chr6:46655866-46670149:+	-0.19	-4.1	5.12E-5	QRS complex (Sokolow-Lyon)	
STAD	cis	1	rs9296505	chr6:46629841	TDRD6	chr6:46655866-46670149:+	-0.18	-3.98	8.24E-5	QRS complex (Sokolow-Lyon)	
STAD	cis	1	rs9296616	chr6:49414235	MUT	chr6:49398994-49431031:-	0.39	7.2	3.12E-12	Folate pathway vitamin levels	
STAD	cis	1	rs9296617	chr6:49428360	MUT	chr6:49398994-49431031:-	0.38	6.98	1.26E-11	Folate pathway vitamin levels	
STAD	cis	1	rs9296832	chr6:56100909	COL21A1	chr6:55921389-56258892:-	0.28	6.03	3.84E-9	Pulse pressure	
STAD	cis	1	rs9297950	chr8:96025659	C8orf38	chr8:95908040-96088396:+	-0.33	-3.91	0.000109	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs9297951	chr8:96041437	C8orf38	chr8:95908040-96088396:+	-0.34	-4.13	4.4E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
STAD	cis	1	rs929843	chr16:70045748	CLEC18A	chr16:69984626-69997887:+	-0.42	-4.79	2.36E-6	Menarche (age at onset)	
STAD	cis	1	rs9303029	chr17:80408815	C17orf62	chr17:80400520-80408694:-	-0.25	-3.92	0.000104	Protein quantitative trait loci	
STAD	cis	1	rs9303401	chr17:56847945	RAD51C	chr17:56769963-56811690:+	0.22	3.97	8.61E-5	Cognitive test performance	
STAD	cis	1	rs9304742	chr19:53451291	ZNF702P	chr19:53471505-53496784:-	0.26	4.13	4.35E-5	Psoriasis	
STAD	cis	1	rs9306329	chr22:39072454	CBY1	chr22:39052658-39069853:+	0.21	4.17	3.83E-5	Resting heart rate	
STAD	cis	1	rs9306329	chr22:39072454	LOC646851	chr22:38974125-39052634:-	0.26	5.51	6.7E-8	Resting heart rate	
STAD	cis	1	rs9307050	chr4:76905649	NAAA	chr4:76831809-76862166:-	-0.41	-5.95	5.91E-9	Longevity	
STAD	cis	1	rs930847	chr15:101558562	TM2D3	chr15:102173180-102192594:-	-0.26	-3.9	0.000115	Corneal structure	
STAD	cis	1	rs9309473	chr2:73743982	ALMS1P	chr2:73872046-73912692:+	0.5	7.96	1.92E-14	Metabolite levels	
STAD	cis	1	rs9309473	chr2:73743982	TPRKB	chr2:73956957-73964517:-	-0.21	-4.35	1.76E-5	Metabolite levels	
STAD	cis	1	rs9311423	chr3:48420308	TREX1	chr3:48501186-48509043:+	-0.26	-6.01	4.38E-9	Longevity	
STAD	cis	1	rs931182	chr4:54243230	SCFD2	chr4:53739152-54232242:-	0.29	4.4	1.41E-5	DNA methylation (variation)	
STAD	cis	1	rs9319374	chr13:28047587	GTF3A	chr13:27998681-28009846:+	-0.35	-3.82	0.000153	Weight	
STAD	cis	1	rs9320287	chr6:109744690	SMPD2	chr6:109761931-109765121:+	0.24	4.88	1.54E-6	Height	
STAD	cis	1	rs9324660	chr5:150257054	LOC134466	chr5:150310000-150326146:-	0.31	4.98	9.4E-7	Crohn's disease	
STAD	cis	1	rs932833	chr9:131884041	CRAT	chr9:131857075-131873070:-	0.25	4.6	5.62E-6	Blood metabolite ratios	
STAD	cis	1	rs932833	chr9:131884041	PPP2R4	chr9:131873244-131911223:+	0.22	4.49	9.53E-6	Blood metabolite ratios	
STAD	cis	1	rs932835	chr9:131887071	CRAT	chr9:131857075-131873070:-	0.27	4.82	2.06E-6	Blood metabolite ratios	
STAD	cis	1	rs932835	chr9:131887071	PPP2R4	chr9:131873244-131911223:+	0.22	4.53	7.73E-6	Blood metabolite ratios	
STAD	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.37	6.52	2.13E-10	Height	
STAD	cis	1	rs9349804	chr6:56098876	COL21A1	chr6:55921389-56258892:-	0.27	5.88	8.67E-9	Pulse pressure	
STAD	cis	1	rs9357037	chr6:27327349	ZNF391	chr6:27356524-27369227:+	0.37	5.72	2.11E-8	Glomerular filtration rate (creatinine)	
STAD	cis	1	rs9362395	chr6:87854341	C6orf162	chr6:88032306-88052043:+	0.43	4.51	8.67E-6	Schizophrenia	
STAD	cis	1	rs9369898	chr6:49382193	CENPQ	chr6:49431096-49460820:+	-0.25	-5.31	1.89E-7	Homocysteine levels	
STAD	cis	1	rs9369898	chr6:49382193	MUT	chr6:49398994-49431031:-	0.23	4.22	2.99E-5	Homocysteine levels	
STAD	cis	1	rs937108	chr7:65428452	CCT6P1	chr7:65216092-65228661:+	0.27	4.13	4.46E-5	Diabetic kidney disease	
STAD	cis	1	rs9381040	chr6:41154650	UNC5CL	chr6:40994772-41039015:-	-0.17	-3.92	0.000107	Alzheimer's disease (late onset)	
STAD	cis	1	rs9381469	chr6:46630068	TDRD6	chr6:46655866-46670149:+	0.19	4.08	5.55E-5	QRS complex (Sokolow-Lyon)	
STAD	cis	1	rs9381784	chr6:49398115	CENPQ	chr6:49431096-49460820:+	0.24	5.05	6.93E-7	Homocysteine levels	
STAD	cis	1	rs9381784	chr6:49398115	MUT	chr6:49398994-49431031:-	-0.23	-4.16	3.97E-5	Homocysteine levels	
STAD	cis	1	rs9394931	chr6:42873245	PEX6	chr6:42931613-42946981:-	-0.41	-7.46	5.75E-13	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
STAD	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.26	-5.38	1.31E-7	Homocysteine levels	
STAD	cis	1	rs9395493	chr6:49427409	MUT	chr6:49398994-49431031:-	0.23	4.05	6.06E-5	Homocysteine levels	
STAD	cis	1	rs939558	chr3:41976040	ULK4	chr3:41288091-42003660:-	-0.78	-12.31	1.15E-29	Diastolic blood pressure	
STAD	cis	1	rs940174	chr3:136309710	PCCB	chr3:135969167-136056737:+	0.25	4.17	3.7E-5	Schizophrenia	
STAD	cis	1	rs941653	chr14:35592538	PPP2R3C	chr14:35554679-35591679:-	0.28	4.04	6.36E-5	Atopic dermatitis	
STAD	cis	1	rs9417261	chr10:38111769	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.82	0.000157	Obesity (extreme)	
STAD	cis	1	rs9417263	chr10:38114690	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.82	0.000157	Obesity (extreme)	
STAD	cis	1	rs9417264	chr10:38117570	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.82	0.000157	Obesity (extreme)	
STAD	cis	1	rs9417268	chr10:38133194	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.82	0.000157	Obesity (extreme)	
STAD	cis	1	rs9418288	chr10:38107136	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.88	0.000122	Obesity (extreme)	
STAD	cis	1	rs9418289	chr10:38109805	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.88	0.000122	Obesity (extreme)	
STAD	cis	1	rs9418294	chr10:38115586	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.82	0.000157	Obesity (extreme)	
STAD	cis	1	rs9418298	chr10:38137236	HSD17B7P2	chr10:38645308-38667432:+	0.32	3.82	0.000157	Obesity (extreme)	
STAD	cis	1	rs941946	chr14:104503662	TDRD9	chr14:104394817-104519002:+	0.23	3.87	0.000127	Bipolar disorder	
STAD	cis	1	rs9419897	chr10:102246125	SEC31B	chr10:102246403-102289636:-	-0.24	-5.9	7.68E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs9420782	chr10:102235015	SEC31B	chr10:102246403-102289636:-	-0.24	-6.04	3.58E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs9420785	chr10:102240451	SEC31B	chr10:102246403-102289636:-	-0.24	-5.94	6.32E-9	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs9420797	chr10:102331147	SEC31B	chr10:102246403-102289636:-	-0.23	-5.69	2.49E-8	Palmitoleic acid (16:1n-7) plasma levels	
STAD	cis	1	rs9425766	chr1:173853127	SERPINC1	chr1:173872943-173886516:-	0.23	3.87	0.00013	Life satisfaction	
STAD	cis	1	rs943466	chr6:33731787	NUDT3	chr6:34256002-34360441:-	0.28	3.9	0.000111	Body mass index	
STAD	cis	1	rs945635	chr1:157670290	FCRL3	chr1:157646278-157670775:-	0.24	7.11	5.73E-12	Type 1 diabetes autoantibodies	
STAD	cis	1	rs945961	chr20:33769926	PROCR	chr20:33758727-33765164:+	-0.5	-5.47	7.96E-8	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs9463473	chr6:49380121	MUT	chr6:49398994-49431031:-	0.39	7.28	1.83E-12	Folate pathway vitamin levels	
STAD	cis	1	rs9463474	chr6:49380199	MUT	chr6:49398994-49431031:-	0.39	7.28	1.83E-12	Folate pathway vitamin levels	
STAD	cis	1	rs9463475	chr6:49380899	MUT	chr6:49398994-49431031:-	-0.4	-7.41	8.02E-13	Folate pathway vitamin levels	
STAD	cis	1	rs9463477	chr6:49386446	MUT	chr6:49398994-49431031:-	0.39	7.34	1.25E-12	Folate pathway vitamin levels	
STAD	cis	1	rs9463478	chr6:49386564	CENPQ	chr6:49431096-49460820:+	-0.25	-5.31	1.89E-7	Homocysteine levels	
STAD	cis	1	rs9463478	chr6:49386564	MUT	chr6:49398994-49431031:-	0.23	4.22	2.99E-5	Homocysteine levels	
STAD	cis	1	rs9463479	chr6:49393275	MUT	chr6:49398994-49431031:-	0.39	7.34	1.25E-12	Folate pathway vitamin levels	
STAD	cis	1	rs9463480	chr6:49400795	MUT	chr6:49398994-49431031:-	0.38	7.13	4.93E-12	Folate pathway vitamin levels	
STAD	cis	1	rs946529	chr1:46485548	TMEM69	chr1:46153847-46160108:+	0.18	3.87	0.000126	Body mass index	
STAD	cis	1	rs947211	chr1:205752665	RAB7L1	chr1:205737115-205744610:-	0.29	4.7	3.57E-6	Parkinson's disease	
STAD	cis	1	rs9473549	chr6:49380020	MUT	chr6:49398994-49431031:-	0.37	6.83	3.31E-11	Folate pathway vitamin levels	
STAD	cis	1	rs9473550	chr6:49385182	CENPQ	chr6:49431096-49460820:+	-0.25	-5.45	9.12E-8	Homocysteine levels	
STAD	cis	1	rs9473550	chr6:49385182	MUT	chr6:49398994-49431031:-	0.23	4.27	2.5E-5	Homocysteine levels	
STAD	cis	1	rs9473552	chr6:49387154	MUT	chr6:49398994-49431031:-	0.39	7.34	1.25E-12	Folate pathway vitamin levels	
STAD	cis	1	rs9473553	chr6:49395977	MUT	chr6:49398994-49431031:-	0.39	7.34	1.25E-12	Folate pathway vitamin levels	
STAD	cis	1	rs9473555	chr6:49409487	MUT	chr6:49398994-49431031:-	0.38	7.12	5.13E-12	Folate pathway vitamin levels	
STAD	cis	1	rs9473560	chr6:49427918	MUT	chr6:49398994-49431031:-	0.38	7.06	7.88E-12	Folate pathway vitamin levels	
STAD	cis	1	rs9473561	chr6:49428755	MUT	chr6:49398994-49431031:-	0.39	7.27	1.99E-12	Folate pathway vitamin levels	
STAD	cis	1	rs9473563	chr6:49453651	MUT	chr6:49398994-49431031:-	0.38	6.91	2.03E-11	Folate pathway vitamin levels	
STAD	cis	1	rs9475752	chr6:56780741	BEND6	chr6:56819773-56892138:+	-0.24	-5.38	1.28E-7	Menarche (age at onset)	
STAD	cis	1	rs9480933	chr6:109671391	SMPD2	chr6:109761931-109765121:+	0.21	4.21	3.11E-5	Height	
STAD	cis	1	rs9480953	chr6:109739144	SMPD2	chr6:109761931-109765121:+	0.25	4.93	1.21E-6	Height	
STAD	cis	1	rs9480955	chr6:109744533	SMPD2	chr6:109761931-109765121:+	0.24	4.88	1.54E-6	Height	
STAD	cis	1	rs9487094	chr6:109742015	SMPD2	chr6:109761931-109765121:+	0.25	4.93	1.21E-6	Height	
STAD	cis	1	rs9487605	chr6:111582885	KIAA1919	chr6:111580482-111590259:+	-0.41	-7.56	2.93E-13	Inflammatory skin disease	
STAD	cis	1	rs9491140	chr6:124691237	NKAIN2	chr6:124125069-125146784:+	0.37	6.58	1.53E-10	Neuroticism	
STAD	cis	1	rs9491142	chr6:124693017	HDDC2	chr6:125596496-125623282:-	0.21	3.81	0.000159	Neuroticism	
STAD	cis	1	rs9491142	chr6:124693017	NKAIN2	chr6:124125069-125146784:+	0.36	6.34	6.26E-10	Neuroticism	
STAD	cis	1	rs950169	chr15:84706461	LOC388152	chr15:84867600-84898920:-	-0.3	-4.38	1.54E-5	Schizophrenia	
STAD	cis	1	rs9527	chr10:104623578	AS3MT	chr10:104613967-104661653:+	-0.22	-3.93	9.9E-5	Arsenic metabolism	
STAD	cis	1	rs9527	chr10:104623578	C10orf32	chr10:104613967-104624718:+	-0.61	-9.96	5.66E-21	Arsenic metabolism	
STAD	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.67	13.25	2.42E-33	Response to antipsychotic treatment	
STAD	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.66	-13.26	2.24E-33	Response to antipsychotic treatment	
STAD	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.66	-13.12	8.1E-33	Response to antipsychotic treatment	
STAD	cis	1	rs9579086	chr13:28058537	GTF3A	chr13:27998681-28009846:+	-0.36	-3.84	0.000143	Weight	
STAD	cis	1	rs9579087	chr13:28059780	GTF3A	chr13:27998681-28009846:+	-0.36	-3.94	9.84E-5	Weight	
STAD	cis	1	rs9581868	chr13:28070682	GTF3A	chr13:27998681-28009846:+	-0.36	-3.87	0.000128	Weight	
STAD	cis	1	rs958962	chr4:109974200	CASP6	chr4:110609785-110624629:-	0.18	3.94	9.54E-5	Body mass index	
STAD	cis	1	rs9593	chr12:109994870	MYO1H	chr12:109826524-109886176:+	0.22	4.14	4.23E-5	HDL cholesterol	
STAD	cis	1	rs9607287	chr22:22163425	THAP7	chr22:21354061-21356404:-	0.18	4.29	2.21E-5	Multiple sclerosis	
STAD	cis	1	rs9607566	chr22:39075434	CBY1	chr22:39052658-39069853:+	0.21	4.17	3.83E-5	Resting heart rate	
STAD	cis	1	rs9607566	chr22:39075434	LOC646851	chr22:38974125-39052634:-	0.26	5.51	6.7E-8	Resting heart rate	
STAD	cis	1	rs9610986	chr22:39025277	LOC646851	chr22:38974125-39052634:-	0.23	5.01	8.46E-7	Resting heart rate	
STAD	cis	1	rs9610993	chr22:39042818	LOC646851	chr22:38974125-39052634:-	0.22	4.76	2.69E-6	Resting heart rate	
STAD	cis	1	rs9622833	chr22:39000397	LOC646851	chr22:38974125-39052634:-	0.24	5.08	6.0E-7	Resting heart rate	
STAD	cis	1	rs9624447	chr22:24681555	POM121L9P	chr22:24647589-24661490:+	-0.25	-5.98	5.12E-9	Gut microbiome composition (summer)	
STAD	cis	1	rs964503	chr4:103349213	CISD2	chr4:103790135-103809913:+	0.19	4.46	1.08E-5	Homeostasis model assessment of beta-cell function (interaction)	
STAD	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.72	-15.26	1.41E-41	Response to antipsychotic treatment	
STAD	cis	1	rs9653557	chr2:73795962	ALMS1P	chr2:73872046-73912692:+	0.51	8.07	8.68E-15	Metabolite levels	
STAD	cis	1	rs9653557	chr2:73795962	TPRKB	chr2:73956957-73964517:-	-0.21	-4.29	2.26E-5	Metabolite levels	
STAD	cis	1	rs9660992	chr1:205249450	DSTYK	chr1:205111632-205180727:-	0.21	3.89	0.000119	Mean platelet volume	
STAD	cis	1	rs9661596	chr1:171652664	VAMP4	chr1:171669298-171711214:-	0.34	6.34	6.29E-10	Hippocampal atrophy	
STAD	cis	1	rs9662174	chr1:171652144	VAMP4	chr1:171669298-171711214:-	0.34	6.34	6.29E-10	Hippocampal atrophy	
STAD	cis	1	rs9662506	chr1:171655984	VAMP4	chr1:171669298-171711214:-	0.34	6.15	1.87E-9	Hippocampal atrophy	
STAD	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.48	9.17	2.86E-18	Eye color traits	
STAD	cis	1	rs9677476	chr2:232126290	ARMC9	chr2:232063342-232238606:+	-0.2	-4.5	8.97E-6	Food antigen IgG levels	
STAD	cis	1	rs968567	chr11:61595564	FADS2	chr11:61583728-61634825:+	0.64	8.12	6.31E-15	Blood metabolite levels;Rheumatoid arthritis;Glycerophospholipid levels	
STAD	cis	1	rs9687065	chr5:148391140	ARHGEF37	chr5:148961135-149014527:+	0.25	3.9	0.000115	Diastolic blood pressure	
STAD	cis	1	rs9687471	chr5:148390791	ARHGEF37	chr5:148961135-149014527:+	0.25	3.91	0.000108	Diastolic blood pressure	
STAD	cis	1	rs9689	chr1:25688276	RHCE	chr1:25688741-25756683:-	0.31	4.91	1.34E-6	Erythrocyte sedimentation rate	
STAD	cis	1	rs9689	chr1:25688276	RHD	chr1:25598981-25656935:+	-0.43	-9.27	1.3E-18	Erythrocyte sedimentation rate	
STAD	cis	1	rs9697030	chr9:131920181	CRAT	chr9:131857075-131873070:-	0.29	5.19	3.32E-7	Blood metabolite ratios	
STAD	cis	1	rs9697030	chr9:131920181	PPP2R4	chr9:131873244-131911223:+	0.24	4.83	1.94E-6	Blood metabolite ratios	
STAD	cis	1	rs9738216	chr12:129281788	MGC16384	chr12:129297749-129299295:-	-0.19	-3.95	9.13E-5	Systemic lupus erythematosus	
STAD	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.48	9.14	3.44E-18	Eye color traits	
STAD	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.47	8.82	3.93E-17	Eye color traits	
STAD	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.38	6.75	5.31E-11	Forced vital capacity	
STAD	cis	1	rs9783347	chr11:18384938	GTF2H1	chr11:18343816-18388590:+	0.36	6.09	2.68E-9	Pancreatic cancer	
STAD	cis	1	rs9783386	chr11:18386625	GTF2H1	chr11:18343816-18388590:+	0.37	5.96	5.52E-9	Pancreatic cancer	
STAD	cis	1	rs9789738	chr2:182476981	CERKL	chr2:182401402-182545381:-	-0.28	-4.8	2.23E-6	Response to iloperidone treatment (QT prolongation)	
STAD	cis	1	rs9809619	chr3:134280948	ANAPC13	chr3:134196547-134204865:-	0.39	6.89	2.32E-11	Height	
STAD	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.27	-6.19	1.53E-9	Longevity	
STAD	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.25	5.9	7.87E-9	Longevity	
STAD	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.4	7.39	8.98E-13	Height	
STAD	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.37	-6.67	9.02E-11	Height	
STAD	cis	1	rs9815103	chr3:48414215	TREX1	chr3:48501186-48509043:+	-0.27	-6.1	2.6E-9	Longevity	
STAD	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.75	11.11	4.33E-25	Diastolic blood pressure	
STAD	cis	1	rs9817615	chr3:48470756	TREX1	chr3:48501186-48509043:+	-0.25	-5.78	1.57E-8	Longevity	
STAD	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	0.74	12	1.93E-28	Diastolic blood pressure	
STAD	cis	1	rs9819532	chr3:134288644	ANAPC13	chr3:134196547-134204865:-	0.39	6.89	2.32E-11	Height	
STAD	cis	1	rs9820192	chr3:41889281	ULK4	chr3:41288091-42003660:-	0.78	12.43	4.11E-30	Diastolic blood pressure	
STAD	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.77	11.72	2.26E-27	Diastolic blood pressure	
STAD	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.77	11.86	6.42E-28	Diastolic blood pressure	
STAD	cis	1	rs9825741	chr3:41761828	ULK4	chr3:41288091-42003660:-	-0.73	-11.47	1.97E-26	Diastolic blood pressure	
STAD	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.27	-6.19	1.53E-9	Longevity	
STAD	cis	1	rs9826496	chr3:134224437	ANAPC13	chr3:134196547-134204865:-	0.39	7.01	1.07E-11	Height	
STAD	cis	1	rs9827987	chr3:134272621	ANAPC13	chr3:134196547-134204865:-	0.38	6.86	2.7E-11	Height	
STAD	cis	1	rs9828398	chr3:41895893	ULK4	chr3:41288091-42003660:-	0.78	12.43	4.11E-30	Diastolic blood pressure	
STAD	cis	1	rs9828815	chr3:134265749	ANAPC13	chr3:134196547-134204865:-	0.38	6.88	2.38E-11	Height	
STAD	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.38	6.99	1.19E-11	Height	
STAD	cis	1	rs9830064	chr3:41881801	ULK4	chr3:41288091-42003660:-	0.78	12.41	4.78E-30	Diastolic blood pressure	
STAD	cis	1	rs9832785	chr3:134213070	ANAPC13	chr3:134196547-134204865:-	0.37	6.82	3.49E-11	Height	
STAD	cis	1	rs9834098	chr3:41833493	ULK4	chr3:41288091-42003660:-	0.77	12.05	1.23E-28	Diastolic blood pressure	
STAD	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.37	6.69	7.57E-11	Height	
STAD	cis	1	rs9835204	chr3:134261342	ANAPC13	chr3:134196547-134204865:-	0.38	6.88	2.38E-11	Height	
STAD	cis	1	rs9836053	chr3:150885877	P2RY12	chr3:151055238-151102544:-	0.24	3.94	9.78E-5	Heschl's gyrus morphology	
STAD	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.26	-5.93	6.84E-9	Longevity	
STAD	cis	1	rs9838965	chr3:41927938	ULK4	chr3:41288091-42003660:-	-0.77	-12.26	1.84E-29	Diastolic blood pressure	
STAD	cis	1	rs9839399	chr3:41928044	ULK4	chr3:41288091-42003660:-	-0.77	-12.26	1.84E-29	Diastolic blood pressure	
STAD	cis	1	rs9840037	chr3:41827522	ULK4	chr3:41288091-42003660:-	0.78	12.16	4.39E-29	Diastolic blood pressure	
STAD	cis	1	rs9840532	chr3:41885697	ULK4	chr3:41288091-42003660:-	0.78	12.2	3.33E-29	Diastolic blood pressure	
STAD	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.37	6.81	3.63E-11	Height	
STAD	cis	1	rs984222	chr1:119503843	WARS2	chr1:119573841-119683295:-	-0.41	-7.2	3.16E-12	Waist-to-hip ratio adjusted for body mass index;Waist-hip ratio	
STAD	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-0.67	-10.08	2.23E-21	Diastolic blood pressure	
STAD	cis	1	rs9842305	chr3:41998412	ULK4	chr3:41288091-42003660:-	-0.75	-12.05	1.22E-28	Diastolic blood pressure	
STAD	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.77	11.93	3.62E-28	Diastolic blood pressure	
STAD	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	0.74	11.18	2.28E-25	Diastolic blood pressure	
STAD	cis	1	rs9849509	chr3:48483432	TREX1	chr3:48501186-48509043:+	-0.25	-5.69	2.49E-8	Longevity	
STAD	cis	1	rs9850015	chr3:134269541	ANAPC13	chr3:134196547-134204865:-	0.38	6.86	2.7E-11	Height	
STAD	cis	1	rs9851441	chr3:134315091	ANAPC13	chr3:134196547-134204865:-	0.38	6.8	3.87E-11	Height	
STAD	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.37	6.72	6.62E-11	Height	
STAD	cis	1	rs9854776	chr3:46294851	MYL3	chr3:46899357-46904973:-	-0.21	-3.8	0.000167	Obesity-related traits;Monocyte chemoattractant protein-1	
STAD	cis	1	rs9854833	chr3:41775577	ULK4	chr3:41288091-42003660:-	0.76	11.32	7.07E-26	Diastolic blood pressure	
STAD	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	0.74	12	1.93E-28	Diastolic blood pressure	
STAD	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	0.74	12	1.93E-28	Diastolic blood pressure	
STAD	cis	1	rs9856633	chr3:42013850	ULK4	chr3:41288091-42003660:-	0.77	12.38	6.3E-30	Diastolic blood pressure	
STAD	cis	1	rs9856693	chr3:134306913	ANAPC13	chr3:134196547-134204865:-	0.39	6.78	4.41E-11	Height	
STAD	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	0.77	11.97	2.48E-28	Diastolic blood pressure	
STAD	cis	1	rs9860340	chr3:87783976	HTR1F	chr3:88031726-88042919:+	0.23	3.82	0.000154	Electroencephalographic traits in alcoholism	
STAD	cis	1	rs9862534	chr3:49598064	CCDC36	chr3:49235861-49295537:+	0.2	4	7.67E-5	Menarche (age at onset)	
STAD	cis	1	rs9863786	chr3:134247203	ANAPC13	chr3:134196547-134204865:-	0.38	6.88	2.38E-11	Height	
STAD	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	0.73	10.88	2.85E-24	Diastolic blood pressure	
STAD	cis	1	rs9864346	chr3:134312352	ANAPC13	chr3:134196547-134204865:-	0.39	6.84	3.17E-11	Height	
STAD	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.27	-6.09	2.72E-9	Longevity	
STAD	cis	1	rs9864439	chr3:134298671	ANAPC13	chr3:134196547-134204865:-	0.39	6.87	2.52E-11	Height	
STAD	cis	1	rs9865127	chr3:41807448	ULK4	chr3:41288091-42003660:-	0.74	11.83	8.64E-28	Diastolic blood pressure	
STAD	cis	1	rs9865780	chr3:41895802	ULK4	chr3:41288091-42003660:-	0.78	12.43	4.11E-30	Diastolic blood pressure	
STAD	cis	1	rs9866092	chr3:41895967	ULK4	chr3:41288091-42003660:-	0.78	12.43	4.11E-30	Diastolic blood pressure	
STAD	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.74	-11.5	1.47E-26	Diastolic blood pressure	
STAD	cis	1	rs9868809	chr3:48681053	WDR6	chr3:49044637-49053386:+	0.38	4.28	2.32E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
STAD	cis	1	rs9869207	chr3:41878661	ULK4	chr3:41288091-42003660:-	0.78	12.44	3.76E-30	Diastolic blood pressure	
STAD	cis	1	rs9869981	chr3:134248801	ANAPC13	chr3:134196547-134204865:-	0.38	6.88	2.38E-11	Height	
STAD	cis	1	rs9871305	chr3:134213538	ANAPC13	chr3:134196547-134204865:-	0.37	6.62	1.18E-10	Height	
STAD	cis	1	rs9872999	chr3:133457514	TF	chr3:133419211-133497635:+	-0.29	-6.2	1.48E-9	Iron status biomarkers	
STAD	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.77	11.87	5.79E-28	Diastolic blood pressure	
STAD	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.76	11.66	3.87E-27	Diastolic blood pressure	
STAD	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	0.76	11.32	7.07E-26	Diastolic blood pressure	
STAD	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	0.76	11.91	4.25E-28	Diastolic blood pressure	
STAD	cis	1	rs9876658	chr3:134179453	ANAPC13	chr3:134196547-134204865:-	-0.34	-6.41	4.17E-10	Height	
STAD	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.25	-5.73	2.06E-8	Longevity	
STAD	cis	1	rs9876960	chr3:41985812	ULK4	chr3:41288091-42003660:-	-0.75	-12.14	5.3E-29	Diastolic blood pressure	
STAD	cis	1	rs9881491	chr3:48487911	TREX1	chr3:48501186-48509043:+	-0.25	-5.74	1.92E-8	Longevity	
STAD	cis	1	rs9883753	chr3:134247231	ANAPC13	chr3:134196547-134204865:-	0.39	6.93	1.77E-11	Height	
STAD	cis	1	rs9883759	chr3:48463618	TREX1	chr3:48501186-48509043:+	-0.25	-5.74	1.9E-8	Longevity	
STAD	cis	1	rs9883927	chr3:48463711	TREX1	chr3:48501186-48509043:+	-0.25	-5.69	2.44E-8	Longevity	
STAD	cis	1	rs9884031	chr3:134256500	ANAPC13	chr3:134196547-134204865:-	0.39	6.89	2.24E-11	Height	
STAD	cis	1	rs9889618	chr17:40293467	DHX58	chr17:40253422-40264751:-	-0.34	-6.18	1.6E-9	Fibrinogen levels	
STAD	cis	1	rs9889640	chr17:40293497	DHX58	chr17:40253422-40264751:-	-0.34	-6.18	1.6E-9	Fibrinogen levels	
STAD	cis	1	rs9891018	chr17:61827856	DDX42	chr17:61851567-61896676:+	-0.25	-3.95	9.4E-5	Body mass index	
STAD	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.48	9.05	7.13E-18	Eye color traits	
STAD	cis	1	rs9903204	chr17:40288062	DHX58	chr17:40253422-40264751:-	-0.34	-6.31	7.75E-10	Fibrinogen levels	
STAD	cis	1	rs9904677	chr17:56873025	RAD51C	chr17:56769963-56811690:+	0.22	3.97	8.61E-5	Cognitive test performance	
STAD	cis	1	rs9909940	chr17:80689036	FN3KRP	chr17:80674582-80685889:+	-0.3	-4.72	3.32E-6	Glycated hemoglobin levels	
STAD	cis	1	rs9909	chr11:47799775	C1QTNF4	chr11:47611216-47615961:-	-0.32	-7.71	1.09E-13	Subjective well-being	
STAD	cis	1	rs9911854	chr17:80408348	C17orf62	chr17:80400520-80408694:-	-0.24	-3.84	0.000145	Protein quantitative trait loci	
STAD	cis	1	rs9912088	chr17:40288278	DHX58	chr17:40253422-40264751:-	-0.34	-6.31	7.75E-10	Fibrinogen levels	
STAD	cis	1	rs9914266	chr17:2133250	SRR	chr17:2207248-2228553:+	0.2	3.98	8.16E-5	Myocardial infarction	
STAD	cis	1	rs991427	chr12:91474422	KERA	chr12:91444273-91452131:-	0.29	4.94	1.14E-6	Systolic blood pressure (alcohol consumption interaction)	
STAD	cis	1	rs9915255	chr17:40284191	DHX58	chr17:40253422-40264751:-	-0.34	-6.09	2.67E-9	Fibrinogen levels	
STAD	cis	1	rs9917978	chr4:165885143	C4orf39	chr4:165878100-165880273:+	0.2	4.52	8.04E-6	Ovarian cancer in BRCA1 mutation carriers	
STAD	cis	1	rs9920762	chr15:90368171	AP3S2	chr15:90373832-90456222:-	-0.64	-9.15	3.13E-18	Type 2 diabetes	
STAD	cis	1	rs9920775	chr15:90368273	AP3S2	chr15:90373832-90456222:-	-0.63	-9.24	1.67E-18	Type 2 diabetes	
STAD	cis	1	rs9921222	chr16:375782	DECR2	chr16:451858-462486:+	-0.22	-3.86	0.000133	Bone mineral density (spine);Bone mineral density	
STAD	cis	1	rs9921338	chr16:11416839	C16orf75	chr16:11343506-11445617:+	-0.3	-4.21	3.22E-5	Vein graft stenosis in coronary artery bypass grafting	
STAD	cis	1	rs9923145	chr16:74686166	RFWD3	chr16:74655298-74700779:-	-0.22	-5.07	6.14E-7	Testicular germ cell tumor	
STAD	cis	1	rs9929496	chr16:74668473	RFWD3	chr16:74655298-74700779:-	-0.23	-5.15	4.15E-7	Testicular germ cell tumor	
STAD	cis	1	rs9931225	chr16:74699293	RFWD3	chr16:74655298-74700779:-	-0.24	-5.37	1.36E-7	Testicular germ cell tumor	
STAD	cis	1	rs993394	chr6:117117143	FAM162B	chr6:117073360-117086886:-	0.22	4.46	1.08E-5	C-reactive protein levels	
STAD	cis	1	rs993648	chr2:182455994	CERKL	chr2:182401402-182545381:-	0.29	5.02	7.87E-7	Response to iloperidone treatment (QT prolongation)	
STAD	cis	1	rs993650	chr2:182455848	CERKL	chr2:182401402-182545381:-	0.28	4.84	1.87E-6	Response to iloperidone treatment (QT prolongation)	
STAD	cis	1	rs9941751	chr20:33645709	PROCR	chr20:33758727-33765164:+	-0.49	-5.32	1.8E-7	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
STAD	cis	1	rs9947295	chr18:11759432	GNAL	chr18:11689136-11883144:+	-0.26	-4.16	3.9E-5	QT interval (interaction)	
STAD	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.39	-7.23	2.6E-12	Height	
STAD	cis	1	rs9973492	chr2:97498481	CNNM3	chr2:97481991-97501120:+	-0.35	-4.22	3.0E-5	Erectile dysfunction and prostate cancer treatment	
STAD	cis	1	rs9985356	chr3:134232920	ANAPC13	chr3:134196547-134204865:-	-0.37	-6.91	1.95E-11	Height	
STAD	cis	1	rs9988866	chr11:18392983	GTF2H1	chr11:18343816-18388590:+	0.38	6.4	4.49E-10	Pancreatic cancer	
STAD	cis	1	rs9989967	chr3:134238964	ANAPC13	chr3:134196547-134204865:-	0.39	6.93	1.77E-11	Height	
STAD	cis	1	rs9990351	chr3:134239191	ANAPC13	chr3:134196547-134204865:-	-0.37	-6.87	2.56E-11	Height	
STAD	cis	1	rs9991307	chr4:17662408	LAP3	chr4:17578927-17609590:+	-0.19	-4.16	4.0E-5	Parasitemia in Tripanosoma cruzi seropositivity	
STAD	cis	1	rs9992101	chr4:77360431	STBD1	chr4:77172853-77232282:+	-0.32	-4.88	1.57E-6	Creatinine levels	
STAD	cis	1	rs9995007	chr4:76897791	NAAA	chr4:76831809-76862166:-	-0.42	-6.03	3.79E-9	Longevity	
STAD	trans	1	rs10037055	chr5:176691279	LOC388955	chr2:63849182-63850159:-	-0.45	-10.71	1.22E-23	Migraine without aura	
STAD	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.94E-49	Educational attainment	
STAD	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.84E-49	Educational attainment	
STAD	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.69	14.56	1.2E-38	Educational attainment	
STAD	trans	1	rs10778875	chr12:82576040	UBE3B	chr12:109915439-109974506:+	-0.4	-6.2	1.43E-9	QRS complex (Cornell)	
STAD	trans	1	rs10778876	chr12:82576220	UBE3B	chr12:109915439-109974506:+	-0.4	-6.2	1.43E-9	QRS complex (Cornell)	
STAD	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.94E-49	Educational attainment	
STAD	trans	1	rs10794671	chr1:121168242	NBPF14	chr1:148003643-148346791:-	0.33	7.46	5.58E-13	Hip geometry	
STAD	trans	1	rs10903159	chr1:121181997	NBPF14	chr1:148003643-148346791:-	0.33	7.48	4.92E-13	Hip geometry	
STAD	trans	1	rs10903161	chr1:121178741	NBPF14	chr1:148003643-148346791:-	0.32	7.21	2.99E-12	Hip geometry	
STAD	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.7	14.88	5.48E-40	Educational attainment	
STAD	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.7	14.89	5.26E-40	Educational attainment	
STAD	trans	1	rs11249350	chr1:121178446	NBPF14	chr1:148003643-148346791:-	0.33	7.5	4.27E-13	Hip geometry	
STAD	trans	1	rs11249351	chr1:121171942	NBPF14	chr1:148003643-148346791:-	0.32	7.25	2.31E-12	Hip geometry	
STAD	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.7	14.89	5.26E-40	Educational attainment	
STAD	trans	1	rs11816094	chr10:59785405	RIPPLY2	chr6:84562985-84567232:+	0.57	6.21	1.35E-9	Blood pressure	
STAD	trans	1	rs12047116	chr1:121185770	NBPF14	chr1:148003643-148346791:-	0.33	7.53	3.55E-13	Hip geometry	
STAD	trans	1	rs12145080	chr1:121185531	NBPF14	chr1:148003643-148346791:-	-0.32	-7.48	5.12E-13	Hip geometry	
STAD	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.73	15.96	1.81E-44	Educational attainment	
STAD	trans	1	rs13176668	chr5:3729143	TSPY1	chrY:9304564-9347389:+	0.3	6.3	8.09E-10	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	
STAD	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.65	-13.25	2.39E-33	Educational attainment	
STAD	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.71	14.91	4.33E-40	Educational attainment	
STAD	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.72	15.34	7.01E-42	Educational attainment	
STAD	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.94E-49	Educational attainment	
STAD	trans	1	rs1591882	chr1:121183313	NBPF14	chr1:148003643-148346791:-	0.32	7.17	3.72E-12	Hip geometry	
STAD	trans	1	rs16911636	chr10:59782369	RIPPLY2	chr6:84562985-84567232:+	0.57	6.21	1.35E-9	Blood pressure	
STAD	trans	1	rs16911644	chr10:59782682	RIPPLY2	chr6:84562985-84567232:+	0.57	6.21	1.35E-9	Blood pressure	
STAD	trans	1	rs16911648	chr10:59782764	RIPPLY2	chr6:84562985-84567232:+	0.57	6.21	1.35E-9	Blood pressure	
STAD	trans	1	rs1832558	chr1:121177380	NBPF14	chr1:148003643-148346791:-	0.31	7.08	6.65E-12	Hip geometry	
STAD	trans	1	rs1856572	chr1:121169579	NBPF14	chr1:148003643-148346791:-	0.33	7.46	5.58E-13	Hip geometry	
STAD	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.72	15.42	3.11E-42	Educational attainment	
STAD	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.94E-49	Educational attainment	
STAD	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.94E-49	Educational attainment	
STAD	trans	1	rs1986111	chr1:121204788	NBPF14	chr1:148003643-148346791:-	0.33	7.75	8.0E-14	Hip geometry	
STAD	trans	1	rs2084385	chr3:196553867	LOC646214	chr15:21932514-21940739:-	-0.56	-8.1	6.96E-15	Total ventricular volume (Alzheimer's disease interaction)	
STAD	trans	1	rs2084386	chr3:196554020	LOC646214	chr15:21932514-21940739:-	-0.59	-8.01	1.37E-14	Total ventricular volume (Alzheimer's disease interaction)	
STAD	trans	1	rs2185281	chr1:121179991	NBPF14	chr1:148003643-148346791:-	0.33	7.37	1.01E-12	Hip geometry	
STAD	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.69	14.56	1.2E-38	Educational attainment	
STAD	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.76	17.26	5.57E-50	Educational attainment	
STAD	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.69	14.53	1.54E-38	Educational attainment	
STAD	trans	1	rs2292239	chr12:56482180	RPS26P11	chrX:71264259-71264809:+	0.44	8.12	6.33E-15	Cognitive function	
STAD	trans	1	rs2319969	chr1:121207335	NBPF14	chr1:148003643-148346791:-	0.34	7.69	1.22E-13	Hip geometry	
STAD	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.7	14.89	5.26E-40	Educational attainment	
STAD	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.7	14.89	5.26E-40	Educational attainment	
STAD	trans	1	rs34140539	chr5:3735800	TSPY1	chrY:9304564-9347389:+	0.31	6.41	4.27E-10	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	
STAD	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.7	14.57	1.03E-38	Educational attainment	
STAD	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.69	14.56	1.2E-38	Educational attainment	
STAD	trans	1	rs4529850	chr10:59780725	RIPPLY2	chr6:84562985-84567232:+	0.62	6.96	1.44E-11	Blood pressure	
STAD	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.7	14.91	4.28E-40	Educational attainment	
STAD	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.72	15.34	7.01E-42	Educational attainment	
STAD	trans	1	rs4759229	chr12:56474480	RPS26P11	chrX:71264259-71264809:+	-0.46	-8.38	9.81E-16	Cognitive function	
STAD	trans	1	rs4844380	chr1:121193620	NBPF14	chr1:148003643-148346791:-	0.34	7.75	8.27E-14	Hip geometry	
STAD	trans	1	rs4844381	chr1:121184898	NBPF14	chr1:148003643-148346791:-	0.33	7.65	1.62E-13	Hip geometry	
STAD	trans	1	rs4844607	chr1:121184059	NBPF14	chr1:148003643-148346791:-	-0.33	-7.41	7.77E-13	Hip geometry	
STAD	trans	1	rs4844616	chr1:121171208	NBPF14	chr1:148003643-148346791:-	0.33	7.54	3.27E-13	Hip geometry	
STAD	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.72	15.36	5.64E-42	Educational attainment	
STAD	trans	1	rs62334638	chr5:3737822	TSPY1	chrY:9304564-9347389:+	0.31	6.49	2.63E-10	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	
STAD	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.94E-49	Educational attainment	
STAD	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.94E-49	Educational attainment	
STAD	trans	1	rs6600669	chr1:121213639	NBPF14	chr1:148003643-148346791:-	0.33	7.6	2.25E-13	Hip geometry	
STAD	trans	1	rs6600671	chr1:121200490	NBPF14	chr1:148003643-148346791:-	-0.34	-7.74	8.61E-14	Hip geometry	
STAD	trans	1	rs6886255	chr5:176718361	LOC388955	chr2:63849182-63850159:-	0.45	10.47	8.92E-23	Migraine without aura	
STAD	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.69	14.38	6.51E-38	Educational attainment	
STAD	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.7	14.9	4.6E-40	Educational attainment	
STAD	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.77	-17.68	8.72E-52	Educational attainment	
STAD	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.93E-49	Educational attainment	
STAD	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.7	14.91	4.28E-40	Educational attainment	
STAD	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.93E-49	Educational attainment	
STAD	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.68	14.26	1.95E-37	Educational attainment	
STAD	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.76	17.1	2.47E-49	Educational attainment	
STAD	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.93E-49	Educational attainment	
STAD	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.72	15.34	7.01E-42	Educational attainment	
STAD	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.86E-49	Educational attainment	
STAD	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.86E-49	Educational attainment	
STAD	trans	1	rs705696	chr12:56480648	RPS26P11	chrX:71264259-71264809:+	0.45	7.81	5.42E-14	Cognitive function	
STAD	trans	1	rs7129556	chr11:77300048	INTS4L1	chr7:64601603-64694599:+	-0.52	-7.52	3.71E-13	Weight loss (gastric bypass surgery)	
STAD	trans	1	rs73290945	chr10:59785875	RIPPLY2	chr6:84562985-84567232:+	0.57	6.21	1.35E-9	Blood pressure	
STAD	trans	1	rs73290947	chr10:59786109	RIPPLY2	chr6:84562985-84567232:+	0.57	6.21	1.35E-9	Blood pressure	
STAD	trans	1	rs73292716	chr10:59787727	RIPPLY2	chr6:84562985-84567232:+	0.59	6.46	3.16E-10	Blood pressure	
STAD	trans	1	rs7532615	chr1:121172840	NBPF14	chr1:148003643-148346791:-	-0.34	-7.67	1.35E-13	Hip geometry	
STAD	trans	1	rs76080267	chr10:59786029	RIPPLY2	chr6:84562985-84567232:+	0.57	6.21	1.35E-9	Blood pressure	
STAD	trans	1	rs76726082	chr10:59786025	RIPPLY2	chr6:84562985-84567232:+	0.57	6.21	1.35E-9	Blood pressure	
STAD	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.76	17.26	5.57E-50	Educational attainment	
STAD	trans	1	rs77243899	chr10:59786157	RIPPLY2	chr6:84562985-84567232:+	0.57	6.21	1.35E-9	Blood pressure	
STAD	trans	1	rs78050826	chr10:59785910	RIPPLY2	chr6:84562985-84567232:+	0.57	6.21	1.35E-9	Blood pressure	
STAD	trans	1	rs877636	chr12:56480583	RPS26P11	chrX:71264259-71264809:+	-0.44	-8.08	8.12E-15	Cognitive function	
STAD	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.74	-15.81	7.05E-44	Educational attainment	
STAD	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.68	14.27	1.82E-37	Educational attainment	
STAD	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.69	14.56	1.2E-38	Educational attainment	
STAD	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.71	14.97	2.45E-40	Educational attainment	
STAD	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.7	14.89	5.26E-40	Educational attainment	
STAD	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.7	14.89	5.26E-40	Educational attainment	
STAD	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.69	14.56	1.2E-38	Educational attainment	
STAD	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.76	17.26	5.57E-50	Educational attainment	
STAD	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.68	14.26	1.95E-37	Educational attainment	
STAD	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.69	14.56	1.2E-38	Educational attainment	
STAD	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.7	14.89	5.26E-40	Educational attainment	
STAD	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.74	-16.07	6.16E-45	Educational attainment	
STAD	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.72	15.37	5.29E-42	Educational attainment	
STAD	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.71	15.36	5.48E-42	Educational attainment	
STAD	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.76	17.26	5.57E-50	Educational attainment	
STAD	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.76	-16.52	7.28E-47	Educational attainment	
STAD	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.94E-49	Educational attainment	
STAD	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.76	17.13	1.94E-49	Educational attainment	
STAD	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.75	16.73	9.74E-48	Educational attainment	
